id	sid	tid	token	lemma	pos
brj-24403	1	1	peer	peer	NOUN
brj-24403	1	2	-	-	PUNCT
brj-24403	1	3	review	review	NOUN
brj-24403	1	4	article	article	NOUN
brj-24403	1	5	peer	peer	NOUN
brj-24403	1	6	-	-	PUNCT
brj-24403	1	7	reviewed	review	VERB
brj-24403	1	8	article	article	NOUN
brj-24403	1	9	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	1	10	li	li	PROPN
brj-24403	1	11	et	et	PROPN
brj-24403	1	12	al	al	PROPN
brj-24403	1	13	.	.	PROPN
brj-24403	2	1	(	(	PUNCT
brj-24403	2	2	2025	2025	NUM
brj-24403	2	3	)	)	PUNCT
brj-24403	2	4	.	.	PUNCT
brj-24403	3	1	“	"	PUNCT
brj-24403	3	2	herbal	herbal	ADJ
brj-24403	3	3	anti	anti	ADJ
brj-24403	3	4	-	-	ADJ
brj-24403	3	5	epileptic	epileptic	ADJ
brj-24403	3	6	extract	extract	NOUN
brj-24403	3	7	,	,	PUNCT
brj-24403	3	8	”	"	PUNCT
brj-24403	3	9	bioresources	bioresource	NOUN
brj-24403	3	10	20(2	20(2	NUM
brj-24403	3	11	)	)	PUNCT
brj-24403	3	12	,	,	PUNCT
brj-24403	3	13	4701	4701	NUM
brj-24403	3	14	-	-	SYM
brj-24403	3	15	4719	4719	NUM
brj-24403	3	16	.	.	PUNCT
brj-24403	3	17	4701	4701	NUM
brj-24403	4	1	antiepileptic	antiepileptic	ADJ
brj-24403	4	2	activity	activity	NOUN
brj-24403	4	3	of	of	ADP
brj-24403	4	4	callicarpa	callicarpa	ADJ
brj-24403	4	5	kwangtungensis	kwangtungensis	NOUN
brj-24403	4	6	chun	chun	PROPN
brj-24403	4	7	extract	extract	VERB
brj-24403	4	8	in	in	ADP
brj-24403	4	9	pilocarpine	pilocarpine	NOUN
brj-24403	4	10	induced	induce	VERB
brj-24403	4	11	epilepsy	epilepsy	NOUN
brj-24403	4	12	in	in	ADP
brj-24403	4	13	mice	mouse	NOUN
brj-24403	4	14	via	via	ADP
brj-24403	4	15	modulating	modulate	VERB
brj-24403	4	16	gabaergic	gabaergic	ADJ
brj-24403	4	17	and	and	CCONJ
brj-24403	4	18	daergic	daergic	ADJ
brj-24403	4	19	transmission	transmission	NOUN
brj-24403	4	20	shiqing	shiqe	VERB
brj-24403	4	21	li	li	PROPN
brj-24403	4	22	,	,	PUNCT
brj-24403	4	23	a	a	PRON
brj-24403	4	24	,	,	PUNCT
brj-24403	4	25	#	#	PROPN
brj-24403	4	26	meizhi	meizhi	PROPN
brj-24403	4	27	li	li	PROPN
brj-24403	4	28	,	,	PUNCT
brj-24403	4	29	b	b	PROPN
brj-24403	4	30	,	,	PUNCT
brj-24403	4	31	#	#	PROPN
brj-24403	4	32	rutong	rutong	PROPN
brj-24403	4	33	wei	wei	PROPN
brj-24403	4	34	,	,	PUNCT
brj-24403	4	35	a	a	DET
brj-24403	4	36	huawen	huawen	NOUN
brj-24403	4	37	liu	liu	PROPN
brj-24403	4	38	,	,	PUNCT
brj-24403	4	39	a	a	DET
brj-24403	4	40	erwei	erwei	NOUN
brj-24403	4	41	hu	hu	PROPN
brj-24403	4	42	,	,	PUNCT
brj-24403	4	43	c	c	X
brj-24403	4	44	*	*	PUNCT
brj-24403	4	45	and	and	CCONJ
brj-24403	4	46	zhibing	zhibe	VERB
brj-24403	4	47	zhou	zhou	PROPN
brj-24403	4	48	c	c	NOUN
brj-24403	4	49	,	,	PUNCT
brj-24403	4	50	*	*	PUNCT
brj-24403	4	51	the	the	DET
brj-24403	4	52	effect	effect	NOUN
brj-24403	4	53	of	of	ADP
brj-24403	4	54	callicarpa	callicarpa	ADJ
brj-24403	4	55	kwangtungensis	kwangtungensis	PROPN
brj-24403	4	56	chun	chun	PROPN
brj-24403	4	57	(	(	PUNCT
brj-24403	4	58	ckc	ckc	PROPN
brj-24403	4	59	)	)	PUNCT
brj-24403	4	60	was	be	AUX
brj-24403	4	61	evaluated	evaluate	VERB
brj-24403	4	62	in	in	ADP
brj-24403	4	63	pilocarpine	pilocarpine	NOUN
brj-24403	4	64	(	(	PUNCT
brj-24403	4	65	p350	p350	PROPN
brj-24403	4	66	,	,	PUNCT
brj-24403	4	67	350	350	NUM
brj-24403	4	68	mg	mg	NUM
brj-24403	4	69	/	/	SYM
brj-24403	4	70	kg)-induced	kg)-induce	VERB
brj-24403	4	71	epilepsy	epilepsy	NOUN
brj-24403	4	72	in	in	ADP
brj-24403	4	73	mice	mouse	NOUN
brj-24403	4	74	.	.	PUNCT
brj-24403	5	1	the	the	DET
brj-24403	5	2	behavioral	behavioral	ADJ
brj-24403	5	3	patterns	pattern	NOUN
brj-24403	5	4	of	of	ADP
brj-24403	5	5	experimental	experimental	ADJ
brj-24403	5	6	mice	mouse	NOUN
brj-24403	5	7	were	be	AUX
brj-24403	5	8	investigated	investigate	VERB
brj-24403	5	9	by	by	ADP
brj-24403	5	10	the	the	DET
brj-24403	5	11	number	number	NOUN
brj-24403	5	12	of	of	ADP
brj-24403	5	13	convulsed	convulsed	ADJ
brj-24403	5	14	animals	animal	NOUN
brj-24403	5	15	,	,	PUNCT
brj-24403	5	16	survivors	survivor	NOUN
brj-24403	5	17	,	,	PUNCT
brj-24403	5	18	after	after	ADP
brj-24403	5	19	p350	p350	PROPN
brj-24403	5	20	-	-	PUNCT
brj-24403	5	21	induced	induce	VERB
brj-24403	5	22	convulsions	convulsion	NOUN
brj-24403	5	23	,	,	PUNCT
brj-24403	5	24	latency	latency	NOUN
brj-24403	5	25	to	to	ADP
brj-24403	5	26	1st	1st	ADJ
brj-24403	5	27	convulsion	convulsion	NOUN
brj-24403	5	28	,	,	PUNCT
brj-24403	5	29	and	and	CCONJ
brj-24403	5	30	latency	latency	NOUN
brj-24403	5	31	to	to	ADP
brj-24403	5	32	death	death	NOUN
brj-24403	5	33	.	.	PUNCT
brj-24403	6	1	the	the	DET
brj-24403	6	2	administration	administration	NOUN
brj-24403	6	3	of	of	ADP
brj-24403	6	4	cnc	cnc	PROPN
brj-24403	6	5	extended	extend	VERB
brj-24403	6	6	both	both	CCONJ
brj-24403	6	7	the	the	DET
brj-24403	6	8	latency	latency	NOUN
brj-24403	6	9	to	to	ADP
brj-24403	6	10	the	the	DET
brj-24403	6	11	first	first	ADJ
brj-24403	6	12	convulsion	convulsion	NOUN
brj-24403	6	13	and	and	CCONJ
brj-24403	6	14	the	the	DET
brj-24403	6	15	time	time	NOUN
brj-24403	6	16	to	to	ADP
brj-24403	6	17	death	death	NOUN
brj-24403	6	18	in	in	ADP
brj-24403	6	19	a	a	DET
brj-24403	6	20	dosedependent	dosedependent	NOUN
brj-24403	6	21	manner	manner	NOUN
brj-24403	6	22	.	.	PUNCT
brj-24403	7	1	the	the	DET
brj-24403	7	2	role	role	NOUN
brj-24403	7	3	of	of	ADP
brj-24403	7	4	receptors	receptor	NOUN
brj-24403	7	5	in	in	ADP
brj-24403	7	6	the	the	DET
brj-24403	7	7	anti	anti	ADJ
brj-24403	7	8	-	-	ADJ
brj-24403	7	9	convulsive	convulsive	ADJ
brj-24403	7	10	action	action	NOUN
brj-24403	7	11	of	of	ADP
brj-24403	7	12	cnc	cnc	PROPN
brj-24403	7	13	was	be	AUX
brj-24403	7	14	investigated	investigate	VERB
brj-24403	7	15	using	use	VERB
brj-24403	7	16	a	a	DET
brj-24403	7	17	combination	combination	NOUN
brj-24403	7	18	of	of	ADP
brj-24403	7	19	atropine	atropine	NOUN
brj-24403	7	20	(	(	PUNCT
brj-24403	7	21	cholinergic	cholinergic	ADJ
brj-24403	7	22	receptor	receptor	NOUN
brj-24403	7	23	antagonist	antagonist	NOUN
brj-24403	7	24	)	)	PUNCT
brj-24403	7	25	,	,	PUNCT
brj-24403	7	26	memantine	memantine	NOUN
brj-24403	7	27	(	(	PUNCT
brj-24403	7	28	nmda	nmda	ADJ
brj-24403	7	29	-	-	PUNCT
brj-24403	7	30	type	type	NOUN
brj-24403	7	31	glutamate	glutamate	NOUN
brj-24403	7	32	receptors	receptor	NOUN
brj-24403	7	33	blocker	blocker	NOUN
brj-24403	7	34	)	)	PUNCT
brj-24403	7	35	,	,	PUNCT
brj-24403	7	36	and	and	CCONJ
brj-24403	7	37	diazepam	diazepam	NOUN
brj-24403	7	38	(	(	PUNCT
brj-24403	7	39	gaba	gaba	PROPN
brj-24403	7	40	agonist	agonist	NOUN
brj-24403	7	41	)	)	PUNCT
brj-24403	7	42	.	.	PUNCT
brj-24403	8	1	the	the	DET
brj-24403	8	2	cnc	cnc	PROPN
brj-24403	8	3	increased	increase	VERB
brj-24403	8	4	latency	latency	NOUN
brj-24403	8	5	to	to	ADP
brj-24403	8	6	the	the	DET
brj-24403	8	7	1st	1st	ADJ
brj-24403	8	8	convulsion	convulsion	NOUN
brj-24403	8	9	and	and	CCONJ
brj-24403	8	10	to	to	ADP
brj-24403	8	11	death	death	NOUN
brj-24403	8	12	in	in	ADP
brj-24403	8	13	diazepam	diazepam	NOUN
brj-24403	8	14	combination	combination	NOUN
brj-24403	8	15	while	while	SCONJ
brj-24403	8	16	there	there	PRON
brj-24403	8	17	was	be	VERB
brj-24403	8	18	no	no	DET
brj-24403	8	19	significant	significant	ADJ
brj-24403	8	20	alteration	alteration	NOUN
brj-24403	8	21	in	in	ADP
brj-24403	8	22	other	other	ADJ
brj-24403	8	23	two	two	NUM
brj-24403	8	24	combination	combination	NOUN
brj-24403	8	25	,	,	PUNCT
brj-24403	8	26	suggesting	suggest	VERB
brj-24403	8	27	that	that	SCONJ
brj-24403	8	28	cnc	cnc	PROPN
brj-24403	8	29	anticonvulsive	anticonvulsive	ADJ
brj-24403	8	30	action	action	NOUN
brj-24403	8	31	is	be	AUX
brj-24403	8	32	mediated	mediate	VERB
brj-24403	8	33	through	through	ADP
brj-24403	8	34	the	the	DET
brj-24403	8	35	gaba	gaba	NOUN
brj-24403	8	36	receptor	receptor	NOUN
brj-24403	8	37	.	.	PUNCT
brj-24403	9	1	the	the	DET
brj-24403	9	2	cnc	cnc	PROPN
brj-24403	9	3	increased	increase	VERB
brj-24403	9	4	the	the	DET
brj-24403	9	5	striatal	striatal	ADJ
brj-24403	9	6	concentration	concentration	NOUN
brj-24403	9	7	of	of	ADP
brj-24403	9	8	dopamine	dopamine	NOUN
brj-24403	9	9	(	(	PUNCT
brj-24403	9	10	da	da	NOUN
brj-24403	9	11	)	)	PUNCT
brj-24403	9	12	and	and	CCONJ
brj-24403	9	13	dopac	dopac	ADJ
brj-24403	9	14	in	in	ADP
brj-24403	9	15	the	the	DET
brj-24403	9	16	brain	brain	NOUN
brj-24403	9	17	,	,	PUNCT
brj-24403	9	18	suggesting	suggest	VERB
brj-24403	9	19	that	that	SCONJ
brj-24403	9	20	it	it	PRON
brj-24403	9	21	prevents	prevent	VERB
brj-24403	9	22	convulsion	convulsion	NOUN
brj-24403	9	23	in	in	ADP
brj-24403	9	24	animals	animal	NOUN
brj-24403	9	25	by	by	ADP
brj-24403	9	26	inhibiting	inhibit	VERB
brj-24403	9	27	da	da	NOUN
brj-24403	9	28	metabolism	metabolism	NOUN
brj-24403	9	29	.	.	PUNCT
brj-24403	10	1	the	the	DET
brj-24403	10	2	cnc	cnc	PROPN
brj-24403	10	3	improved	improve	VERB
brj-24403	10	4	the	the	DET
brj-24403	10	5	antioxidant	antioxidant	ADJ
brj-24403	10	6	status	status	NOUN
brj-24403	10	7	of	of	ADP
brj-24403	10	8	brain	brain	NOUN
brj-24403	10	9	as	as	SCONJ
brj-24403	10	10	evidenced	evidence	VERB
brj-24403	10	11	by	by	ADP
brj-24403	10	12	decrease	decrease	NOUN
brj-24403	10	13	in	in	ADP
brj-24403	10	14	level	level	NOUN
brj-24403	10	15	of	of	ADP
brj-24403	10	16	tabars	tabar	NOUN
brj-24403	10	17	,	,	PUNCT
brj-24403	10	18	carbonyl	carbonyl	NOUN
brj-24403	10	19	protein	protein	NOUN
brj-24403	10	20	,	,	PUNCT
brj-24403	10	21	and	and	CCONJ
brj-24403	10	22	nitric	nitric	ADJ
brj-24403	10	23	oxide	oxide	NOUN
brj-24403	10	24	,	,	PUNCT
brj-24403	10	25	whereas	whereas	SCONJ
brj-24403	10	26	the	the	DET
brj-24403	10	27	levels	level	NOUN
brj-24403	10	28	of	of	ADP
brj-24403	10	29	sulfhydryl	sulfhydryl	ADJ
brj-24403	10	30	protein	protein	NOUN
brj-24403	10	31	,	,	PUNCT
brj-24403	10	32	sod	sod	NOUN
brj-24403	10	33	,	,	PUNCT
brj-24403	10	34	and	and	CCONJ
brj-24403	10	35	cat	cat	NOUN
brj-24403	10	36	were	be	AUX
brj-24403	10	37	increased	increase	VERB
brj-24403	10	38	.	.	PUNCT
brj-24403	11	1	thus	thus	ADV
brj-24403	11	2	,	,	PUNCT
brj-24403	11	3	the	the	DET
brj-24403	11	4	anti	anti	ADJ
brj-24403	11	5	-	-	ADJ
brj-24403	11	6	epileptic	epileptic	ADJ
brj-24403	11	7	potential	potential	NOUN
brj-24403	11	8	of	of	ADP
brj-24403	11	9	callicarpa	callicarpa	ADJ
brj-24403	11	10	kwangtungensis	kwangtungensis	NOUN
brj-24403	11	11	chun	chun	PROPN
brj-24403	11	12	is	be	AUX
brj-24403	11	13	accomplished	accomplish	VERB
brj-24403	11	14	by	by	ADP
brj-24403	11	15	modulating	modulate	VERB
brj-24403	11	16	gabaergic	gabaergic	ADJ
brj-24403	11	17	and	and	CCONJ
brj-24403	11	18	daergic	daergic	ADJ
brj-24403	11	19	transmission	transmission	NOUN
brj-24403	11	20	.	.	PUNCT
brj-24403	12	1	doi	doi	NOUN
brj-24403	12	2	:	:	PUNCT
brj-24403	12	3	10.15376	10.15376	NUM
brj-24403	12	4	/	/	SYM
brj-24403	12	5	biores.20.2.4701	biores.20.2.4701	NOUN
brj-24403	12	6	-	-	PUNCT
brj-24403	12	7	4719	4719	NUM
brj-24403	12	8	keywords	keyword	NOUN
brj-24403	12	9	:	:	PUNCT
brj-24403	12	10	epilepsy	epilepsy	NOUN
brj-24403	12	11	;	;	PUNCT
brj-24403	12	12	latency	latency	NOUN
brj-24403	12	13	;	;	PUNCT
brj-24403	12	14	gaba	gaba	NOUN
brj-24403	12	15	;	;	PUNCT
brj-24403	12	16	oxidative	oxidative	ADJ
brj-24403	12	17	stress	stress	NOUN
brj-24403	12	18	;	;	PUNCT
brj-24403	12	19	dopamine	dopamine	NOUN
brj-24403	12	20	contact	contact	NOUN
brj-24403	12	21	information	information	NOUN
brj-24403	12	22	:	:	PUNCT
brj-24403	12	23	a	a	DET
brj-24403	12	24	:	:	PUNCT
brj-24403	12	25	department	department	NOUN
brj-24403	12	26	of	of	ADP
brj-24403	12	27	neurosurgery	neurosurgery	NOUN
brj-24403	12	28	,	,	PUNCT
brj-24403	12	29	the	the	DET
brj-24403	12	30	people	people	NOUN
brj-24403	12	31	’s	’s	PART
brj-24403	12	32	hospital	hospital	NOUN
brj-24403	12	33	of	of	ADP
brj-24403	12	34	nanchang	nanchang	PROPN
brj-24403	12	35	,	,	PUNCT
brj-24403	12	36	330000	330000	NUM
brj-24403	12	37	,	,	PUNCT
brj-24403	12	38	china	china	PROPN
brj-24403	12	39	;	;	PUNCT
brj-24403	12	40	b	b	X
brj-24403	12	41	:	:	PUNCT
brj-24403	12	42	department	department	NOUN
brj-24403	12	43	of	of	ADP
brj-24403	12	44	endocrinology	endocrinology	NOUN
brj-24403	12	45	,	,	PUNCT
brj-24403	12	46	the	the	DET
brj-24403	12	47	people	people	NOUN
brj-24403	12	48	’s	’s	PART
brj-24403	12	49	hospital	hospital	NOUN
brj-24403	12	50	of	of	ADP
brj-24403	12	51	nanchang	nanchang	PROPN
brj-24403	12	52	,	,	PUNCT
brj-24403	12	53	330000	330000	NUM
brj-24403	12	54	,	,	PUNCT
brj-24403	12	55	china	china	PROPN
brj-24403	12	56	;	;	PUNCT
brj-24403	12	57	c	c	X
brj-24403	12	58	:	:	PUNCT
brj-24403	12	59	department	department	NOUN
brj-24403	12	60	of	of	ADP
brj-24403	12	61	breast	breast	NOUN
brj-24403	12	62	surgery	surgery	NOUN
brj-24403	12	63	,	,	PUNCT
brj-24403	12	64	the	the	DET
brj-24403	12	65	people	people	NOUN
brj-24403	12	66	’s	’s	PART
brj-24403	12	67	hospital	hospital	NOUN
brj-24403	12	68	of	of	ADP
brj-24403	12	69	nanchang	nanchang	PROPN
brj-24403	12	70	,	,	PUNCT
brj-24403	12	71	330000	330000	NUM
brj-24403	12	72	,	,	PUNCT
brj-24403	12	73	china	china	PROPN
brj-24403	12	74	;	;	PUNCT
brj-24403	12	75	#	#	ADV
brj-24403	12	76	:	:	PUNCT
brj-24403	12	77	contributed	contribute	VERB
brj-24403	12	78	equally	equally	ADV
brj-24403	12	79	,	,	PUNCT
brj-24403	12	80	*	*	PUNCT
brj-24403	12	81	corresponding	correspond	VERB
brj-24403	12	82	authors	author	NOUN
brj-24403	12	83	:	:	PUNCT
brj-24403	12	84	hew987654321@outlook.com	hew987654321@outlook.com	X
brj-24403	12	85	;	;	PUNCT
brj-24403	12	86	zhouzhibing1986@outlook.com	zhouzhibing1986@outlook.com	NUM
brj-24403	12	87	introduction	introduction	NOUN
brj-24403	12	88	globally	globally	ADV
brj-24403	12	89	,	,	PUNCT
brj-24403	12	90	epilepsy	epilepsy	PROPN
brj-24403	12	91	is	be	AUX
brj-24403	12	92	the	the	DET
brj-24403	12	93	third	third	ADJ
brj-24403	12	94	most	most	ADV
brj-24403	12	95	common	common	ADJ
brj-24403	12	96	neurological	neurological	ADJ
brj-24403	12	97	condition	condition	NOUN
brj-24403	12	98	,	,	PUNCT
brj-24403	12	99	after	after	ADP
brj-24403	12	100	stroke	stroke	NOUN
brj-24403	12	101	and	and	CCONJ
brj-24403	12	102	alzheimer	alzheimer	PROPN
brj-24403	12	103	’s	’s	PART
brj-24403	12	104	(	(	PUNCT
brj-24403	12	105	beghi	beghi	PROPN
brj-24403	12	106	2007	2007	NUM
brj-24403	12	107	)	)	PUNCT
brj-24403	12	108	.	.	PUNCT
brj-24403	13	1	the	the	DET
brj-24403	13	2	prevalence	prevalence	NOUN
brj-24403	13	3	of	of	ADP
brj-24403	13	4	epilepsy	epilepsy	NOUN
brj-24403	13	5	has	have	AUX
brj-24403	13	6	steadily	steadily	ADV
brj-24403	13	7	increased	increase	VERB
brj-24403	13	8	in	in	ADP
brj-24403	13	9	recent	recent	ADJ
brj-24403	13	10	decades	decade	NOUN
brj-24403	13	11	,	,	PUNCT
brj-24403	13	12	a	a	DET
brj-24403	13	13	trend	trend	NOUN
brj-24403	13	14	that	that	PRON
brj-24403	13	15	has	have	AUX
brj-24403	13	16	been	be	AUX
brj-24403	13	17	ascribed	ascribe	VERB
brj-24403	13	18	to	to	ADP
brj-24403	13	19	a	a	DET
brj-24403	13	20	number	number	NOUN
brj-24403	13	21	of	of	ADP
brj-24403	13	22	variables	variable	NOUN
brj-24403	13	23	,	,	PUNCT
brj-24403	13	24	such	such	ADJ
brj-24403	13	25	as	as	ADP
brj-24403	13	26	enhanced	enhanced	ADJ
brj-24403	13	27	diagnostic	diagnostic	ADJ
brj-24403	13	28	skills	skill	NOUN
brj-24403	13	29	,	,	PUNCT
brj-24403	13	30	longer	long	ADJ
brj-24403	13	31	life	life	NOUN
brj-24403	13	32	expectancies	expectancy	NOUN
brj-24403	13	33	,	,	PUNCT
brj-24403	13	34	and	and	CCONJ
brj-24403	13	35	genetic	genetic	ADJ
brj-24403	13	36	and	and	CCONJ
brj-24403	13	37	environmental	environmental	ADJ
brj-24403	13	38	predispositions	predisposition	NOUN
brj-24403	13	39	.	.	PUNCT
brj-24403	14	1	the	the	DET
brj-24403	14	2	increasing	increase	VERB
brj-24403	14	3	incidence	incidence	NOUN
brj-24403	14	4	presents	present	VERB
brj-24403	14	5	considerable	considerable	ADJ
brj-24403	14	6	problems	problem	NOUN
brj-24403	14	7	to	to	ADP
brj-24403	14	8	global	global	ADJ
brj-24403	14	9	healthcare	healthcare	PROPN
brj-24403	14	10	systems	system	NOUN
brj-24403	14	11	,	,	PUNCT
brj-24403	14	12	exacerbating	exacerbate	VERB
brj-24403	14	13	the	the	DET
brj-24403	14	14	socioeconomic	socioeconomic	ADJ
brj-24403	14	15	burden	burden	NOUN
brj-24403	14	16	related	relate	VERB
brj-24403	14	17	to	to	ADP
brj-24403	14	18	its	its	PRON
brj-24403	14	19	management	management	NOUN
brj-24403	14	20	(	(	PUNCT
brj-24403	14	21	ioannou	ioannou	NOUN
brj-24403	14	22	et	et	PROPN
brj-24403	14	23	al	al	PROPN
brj-24403	14	24	.	.	PROPN
brj-24403	14	25	2022	2022	NUM
brj-24403	14	26	)	)	PUNCT
brj-24403	14	27	.	.	PUNCT
brj-24403	15	1	research	research	NOUN
brj-24403	15	2	suggests	suggest	VERB
brj-24403	15	3	that	that	SCONJ
brj-24403	15	4	a	a	DET
brj-24403	15	5	significant	significant	ADJ
brj-24403	15	6	percentage	percentage	NOUN
brj-24403	15	7	of	of	ADP
brj-24403	15	8	epilepsy	epilepsy	NOUN
brj-24403	15	9	patients	patient	NOUN
brj-24403	15	10	may	may	AUX
brj-24403	15	11	have	have	VERB
brj-24403	15	12	spontaneous	spontaneous	ADJ
brj-24403	15	13	remission	remission	NOUN
brj-24403	15	14	;	;	PUNCT
brj-24403	15	15	however	however	ADV
brj-24403	15	16	,	,	PUNCT
brj-24403	15	17	the	the	DET
brj-24403	15	18	mechanisms	mechanism	NOUN
brj-24403	15	19	involved	involve	VERB
brj-24403	15	20	are	be	AUX
brj-24403	15	21	not	not	PART
brj-24403	15	22	well	well	ADV
brj-24403	15	23	comprehended	comprehend	VERB
brj-24403	15	24	(	(	PUNCT
brj-24403	15	25	fisher	fisher	PROPN
brj-24403	15	26	et	et	PROPN
brj-24403	15	27	al	al	PROPN
brj-24403	15	28	.	.	PROPN
brj-24403	15	29	2005	2005	NUM
brj-24403	15	30	)	)	PUNCT
brj-24403	15	31	.	.	PUNCT
brj-24403	16	1	despite	despite	SCONJ
brj-24403	16	2	progress	progress	NOUN
brj-24403	16	3	in	in	ADP
brj-24403	16	4	treatment	treatment	NOUN
brj-24403	16	5	methods	method	NOUN
brj-24403	16	6	,	,	PUNCT
brj-24403	16	7	attaining	attain	VERB
brj-24403	16	8	perfect	perfect	ADJ
brj-24403	16	9	seizure	seizure	NOUN
brj-24403	16	10	control	control	NOUN
brj-24403	16	11	continues	continue	VERB
brj-24403	16	12	to	to	PART
brj-24403	16	13	be	be	AUX
brj-24403	16	14	hard	hard	ADJ
brj-24403	16	15	for	for	ADP
brj-24403	16	16	numerous	numerous	ADJ
brj-24403	16	17	individuals	individual	NOUN
brj-24403	16	18	.	.	PUNCT
brj-24403	17	1	antiepileptic	antiepileptic	ADJ
brj-24403	17	2	medicines	medicine	NOUN
brj-24403	17	3	(	(	PUNCT
brj-24403	17	4	aeds	aed	NOUN
brj-24403	17	5	)	)	PUNCT
brj-24403	17	6	frequently	frequently	ADV
brj-24403	17	7	serve	serve	VERB
brj-24403	17	8	as	as	ADP
brj-24403	17	9	the	the	DET
brj-24403	17	10	primary	primary	ADJ
brj-24403	17	11	treatment	treatment	NOUN
brj-24403	17	12	option	option	NOUN
brj-24403	17	13	;	;	PUNCT
brj-24403	17	14	however	however	ADV
brj-24403	17	15	,	,	PUNCT
brj-24403	17	16	they	they	PRON
brj-24403	17	17	include	include	VERB
brj-24403	17	18	intrinsic	intrinsic	ADJ
brj-24403	17	19	limitations	limitation	NOUN
brj-24403	17	20	.	.	PUNCT
brj-24403	18	1	although	although	SCONJ
brj-24403	18	2	peer	peer	NOUN
brj-24403	18	3	-	-	PUNCT
brj-24403	18	4	reviewed	review	VERB
brj-24403	18	5	article	article	NOUN
brj-24403	18	6	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	18	7	li	li	PROPN
brj-24403	18	8	et	et	PROPN
brj-24403	18	9	al	al	PROPN
brj-24403	18	10	.	.	PROPN
brj-24403	19	1	(	(	PUNCT
brj-24403	19	2	2025	2025	NUM
brj-24403	19	3	)	)	PUNCT
brj-24403	19	4	.	.	PUNCT
brj-24403	20	1	“	"	PUNCT
brj-24403	20	2	herbal	herbal	ADJ
brj-24403	20	3	anti	anti	ADJ
brj-24403	20	4	-	-	ADJ
brj-24403	20	5	epileptic	epileptic	ADJ
brj-24403	20	6	extract	extract	NOUN
brj-24403	20	7	,	,	PUNCT
brj-24403	20	8	”	"	PUNCT
brj-24403	20	9	bioresources	bioresource	NOUN
brj-24403	20	10	20(2	20(2	NUM
brj-24403	20	11	)	)	PUNCT
brj-24403	20	12	,	,	PUNCT
brj-24403	20	13	4701	4701	NUM
brj-24403	20	14	-	-	SYM
brj-24403	20	15	4719	4719	NUM
brj-24403	20	16	.	.	PUNCT
brj-24403	21	1	4702	4702	NUM
brj-24403	21	2	certain	certain	ADJ
brj-24403	21	3	patients	patient	NOUN
brj-24403	21	4	exhibit	exhibit	VERB
brj-24403	21	5	positive	positive	ADJ
brj-24403	21	6	responses	response	NOUN
brj-24403	21	7	to	to	ADP
brj-24403	21	8	antiepileptic	antiepileptic	ADJ
brj-24403	21	9	drugs	drug	NOUN
brj-24403	21	10	(	(	PUNCT
brj-24403	21	11	aeds	aed	NOUN
brj-24403	21	12	)	)	PUNCT
brj-24403	21	13	,	,	PUNCT
brj-24403	21	14	a	a	DET
brj-24403	21	15	significant	significant	ADJ
brj-24403	21	16	proportion	proportion	NOUN
brj-24403	21	17	develops	develop	VERB
brj-24403	21	18	drug	drug	NOUN
brj-24403	21	19	-	-	PUNCT
brj-24403	21	20	resistant	resistant	ADJ
brj-24403	21	21	epilepsy	epilepsy	NOUN
brj-24403	21	22	,	,	PUNCT
brj-24403	21	23	which	which	PRON
brj-24403	21	24	is	be	AUX
brj-24403	21	25	characterized	characterize	VERB
brj-24403	21	26	by	by	ADP
brj-24403	21	27	the	the	DET
brj-24403	21	28	inability	inability	NOUN
brj-24403	21	29	to	to	PART
brj-24403	21	30	attain	attain	VERB
brj-24403	21	31	prolonged	prolonged	ADJ
brj-24403	21	32	seizure	seizure	NOUN
brj-24403	21	33	independence	independence	NOUN
brj-24403	21	34	despite	despite	SCONJ
brj-24403	21	35	undergoing	undergo	VERB
brj-24403	21	36	trials	trial	NOUN
brj-24403	21	37	of	of	ADP
brj-24403	21	38	a	a	DET
brj-24403	21	39	minimum	minimum	NOUN
brj-24403	21	40	of	of	ADP
brj-24403	21	41	two	two	NUM
brj-24403	21	42	welltolerated	welltolerate	VERB
brj-24403	21	43	and	and	CCONJ
brj-24403	21	44	suitably	suitably	ADV
brj-24403	21	45	selected	select	VERB
brj-24403	21	46	pharmacological	pharmacological	ADJ
brj-24403	21	47	treatments	treatment	NOUN
brj-24403	21	48	(	(	PUNCT
brj-24403	21	49	turski	turski	PROPN
brj-24403	21	50	et	et	PROPN
brj-24403	21	51	al	al	PROPN
brj-24403	21	52	.	.	PROPN
brj-24403	21	53	1989	1989	NUM
brj-24403	21	54	;	;	PUNCT
brj-24403	21	55	howard	howard	PROPN
brj-24403	21	56	et	et	PROPN
brj-24403	21	57	al	al	PROPN
brj-24403	21	58	.	.	PROPN
brj-24403	21	59	2011	2011	NUM
brj-24403	21	60	;	;	PUNCT
brj-24403	21	61	catterall	catterall	NUM
brj-24403	21	62	2014	2014	NUM
brj-24403	21	63	)	)	PUNCT
brj-24403	21	64	.	.	PUNCT
brj-24403	22	1	this	this	DET
brj-24403	22	2	medication	medication	NOUN
brj-24403	22	3	resistance	resistance	NOUN
brj-24403	22	4	highlights	highlight	VERB
brj-24403	22	5	the	the	DET
brj-24403	22	6	pressing	press	VERB
brj-24403	22	7	necessity	necessity	NOUN
brj-24403	22	8	for	for	ADP
brj-24403	22	9	innovative	innovative	ADJ
brj-24403	22	10	therapeutic	therapeutic	ADJ
brj-24403	22	11	strategies	strategy	NOUN
brj-24403	22	12	.	.	PUNCT
brj-24403	23	1	the	the	DET
brj-24403	23	2	side	side	NOUN
brj-24403	23	3	effects	effect	NOUN
brj-24403	23	4	of	of	ADP
brj-24403	23	5	present	present	ADJ
brj-24403	23	6	antiepileptic	antiepileptic	ADJ
brj-24403	23	7	drugs	drug	NOUN
brj-24403	23	8	,	,	PUNCT
brj-24403	23	9	such	such	ADJ
brj-24403	23	10	as	as	ADP
brj-24403	23	11	cognitive	cognitive	ADJ
brj-24403	23	12	impairment	impairment	NOUN
brj-24403	23	13	,	,	PUNCT
brj-24403	23	14	hepatotoxicity	hepatotoxicity	NOUN
brj-24403	23	15	,	,	PUNCT
brj-24403	23	16	and	and	CCONJ
brj-24403	23	17	teratogenicity	teratogenicity	NOUN
brj-24403	23	18	,	,	PUNCT
brj-24403	23	19	often	often	ADV
brj-24403	23	20	undermine	undermine	VERB
brj-24403	23	21	patient	patient	ADJ
brj-24403	23	22	adherence	adherence	NOUN
brj-24403	23	23	and	and	CCONJ
brj-24403	23	24	quality	quality	NOUN
brj-24403	23	25	of	of	ADP
brj-24403	23	26	life	life	NOUN
brj-24403	23	27	,	,	PUNCT
brj-24403	23	28	highlighting	highlight	VERB
brj-24403	23	29	the	the	DET
brj-24403	23	30	urgent	urgent	ADJ
brj-24403	23	31	need	need	NOUN
brj-24403	23	32	for	for	ADP
brj-24403	23	33	safer	safe	ADJ
brj-24403	23	34	and	and	CCONJ
brj-24403	23	35	more	more	ADV
brj-24403	23	36	effective	effective	ADJ
brj-24403	23	37	treatments	treatment	NOUN
brj-24403	23	38	.	.	PUNCT
brj-24403	24	1	in	in	ADP
brj-24403	24	2	the	the	DET
brj-24403	24	3	pursuit	pursuit	NOUN
brj-24403	24	4	of	of	ADP
brj-24403	24	5	novel	novel	ADJ
brj-24403	24	6	medicines	medicine	NOUN
brj-24403	24	7	,	,	PUNCT
brj-24403	24	8	natural	natural	ADJ
brj-24403	24	9	compounds	compound	NOUN
brj-24403	24	10	have	have	AUX
brj-24403	24	11	surfaced	surface	VERB
brj-24403	24	12	as	as	ADP
brj-24403	24	13	a	a	DET
brj-24403	24	14	viable	viable	ADJ
brj-24403	24	15	pathway	pathway	NOUN
brj-24403	24	16	.	.	PUNCT
brj-24403	25	1	historically	historically	ADV
brj-24403	25	2	,	,	PUNCT
brj-24403	25	3	natural	natural	ADJ
brj-24403	25	4	compounds	compound	NOUN
brj-24403	25	5	have	have	AUX
brj-24403	25	6	proven	prove	VERB
brj-24403	25	7	fundamental	fundamental	ADJ
brj-24403	25	8	to	to	ADP
brj-24403	25	9	drug	drug	NOUN
brj-24403	25	10	discovery	discovery	NOUN
brj-24403	25	11	,	,	PUNCT
brj-24403	25	12	providing	provide	VERB
brj-24403	25	13	a	a	DET
brj-24403	25	14	wide	wide	ADJ
brj-24403	25	15	array	array	NOUN
brj-24403	25	16	of	of	ADP
brj-24403	25	17	bioactive	bioactive	ADJ
brj-24403	25	18	molecules	molecule	NOUN
brj-24403	25	19	with	with	ADP
brj-24403	25	20	various	various	ADJ
brj-24403	25	21	pharmacological	pharmacological	ADJ
brj-24403	25	22	effects	effect	NOUN
brj-24403	25	23	(	(	PUNCT
brj-24403	25	24	butler	butler	PROPN
brj-24403	25	25	et	et	PROPN
brj-24403	25	26	al	al	PROPN
brj-24403	25	27	.	.	PROPN
brj-24403	25	28	2014	2014	NUM
brj-24403	25	29	)	)	PUNCT
brj-24403	25	30	.	.	PUNCT
brj-24403	26	1	their	their	PRON
brj-24403	26	2	function	function	NOUN
brj-24403	26	3	in	in	ADP
brj-24403	26	4	alleviating	alleviate	VERB
brj-24403	26	5	neurological	neurological	ADJ
brj-24403	26	6	disorders	disorder	NOUN
brj-24403	26	7	is	be	AUX
brj-24403	26	8	especially	especially	ADV
brj-24403	26	9	significant	significant	ADJ
brj-24403	26	10	,	,	PUNCT
brj-24403	26	11	as	as	SCONJ
brj-24403	26	12	numerous	numerous	ADJ
brj-24403	26	13	natural	natural	ADJ
brj-24403	26	14	compounds	compound	NOUN
brj-24403	26	15	demonstrate	demonstrate	VERB
brj-24403	26	16	neuroprotective	neuroprotective	ADJ
brj-24403	26	17	,	,	PUNCT
brj-24403	26	18	anti	anti	ADJ
brj-24403	26	19	-	-	ADJ
brj-24403	26	20	inflammatory	inflammatory	ADJ
brj-24403	26	21	,	,	PUNCT
brj-24403	26	22	and	and	CCONJ
brj-24403	26	23	antioxidative	antioxidative	ADJ
brj-24403	26	24	characteristics	characteristic	NOUN
brj-24403	26	25	.	.	PUNCT
brj-24403	27	1	these	these	DET
brj-24403	27	2	chemicals	chemical	NOUN
brj-24403	27	3	possess	possess	VERB
brj-24403	27	4	the	the	DET
brj-24403	27	5	capacity	capacity	NOUN
brj-24403	27	6	to	to	PART
brj-24403	27	7	influence	influence	VERB
brj-24403	27	8	disease	disease	NOUN
brj-24403	27	9	progression	progression	NOUN
brj-24403	27	10	and	and	CCONJ
brj-24403	27	11	serve	serve	VERB
brj-24403	27	12	as	as	ADP
brj-24403	27	13	a	a	DET
brj-24403	27	14	foundation	foundation	NOUN
brj-24403	27	15	for	for	ADP
brj-24403	27	16	the	the	DET
brj-24403	27	17	development	development	NOUN
brj-24403	27	18	of	of	ADP
brj-24403	27	19	medicines	medicine	NOUN
brj-24403	27	20	with	with	ADP
brj-24403	27	21	innovative	innovative	ADJ
brj-24403	27	22	modes	mode	NOUN
brj-24403	27	23	of	of	ADP
brj-24403	27	24	action	action	NOUN
brj-24403	27	25	(	(	PUNCT
brj-24403	27	26	cragg	cragg	X
brj-24403	27	27	et	et	PROPN
brj-24403	27	28	al	al	PROPN
brj-24403	27	29	.	.	PROPN
brj-24403	27	30	1997	1997	NUM
brj-24403	27	31	;	;	PUNCT
brj-24403	27	32	luo	luo	PROPN
brj-24403	27	33	et	et	PROPN
brj-24403	27	34	al	al	PROPN
brj-24403	27	35	.	.	PROPN
brj-24403	27	36	2014	2014	NUM
brj-24403	27	37	)	)	PUNCT
brj-24403	27	38	.	.	PUNCT
brj-24403	28	1	the	the	DET
brj-24403	28	2	investigation	investigation	NOUN
brj-24403	28	3	of	of	ADP
brj-24403	28	4	natural	natural	ADJ
brj-24403	28	5	compounds	compound	NOUN
brj-24403	28	6	for	for	ADP
brj-24403	28	7	anticonvulsant	anticonvulsant	ADJ
brj-24403	28	8	properties	property	NOUN
brj-24403	28	9	has	have	AUX
brj-24403	28	10	accelerated	accelerate	VERB
brj-24403	28	11	,	,	PUNCT
brj-24403	28	12	with	with	ADP
brj-24403	28	13	numerous	numerous	ADJ
brj-24403	28	14	studies	study	NOUN
brj-24403	28	15	validating	validate	VERB
brj-24403	28	16	their	their	PRON
brj-24403	28	17	effectiveness	effectiveness	NOUN
brj-24403	28	18	in	in	ADP
brj-24403	28	19	preclinical	preclinical	ADJ
brj-24403	28	20	epileptic	epileptic	ADJ
brj-24403	28	21	models	model	NOUN
brj-24403	28	22	(	(	PUNCT
brj-24403	28	23	hassanzadeh	hassanzadeh	X
brj-24403	28	24	et	et	PROPN
brj-24403	28	25	al	al	PROPN
brj-24403	28	26	.	.	PROPN
brj-24403	28	27	2021	2021	NUM
brj-24403	28	28	;	;	PUNCT
brj-24403	28	29	sharifi	sharifi	NOUN
brj-24403	28	30	-	-	PUNCT
brj-24403	28	31	rad	rad	NOUN
brj-24403	28	32	et	et	PROPN
brj-24403	28	33	al	al	PROPN
brj-24403	28	34	.	.	PROPN
brj-24403	28	35	2021	2021	NUM
brj-24403	28	36	)	)	PUNCT
brj-24403	28	37	.	.	PUNCT
brj-24403	29	1	compounds	compound	NOUN
brj-24403	29	2	sourced	source	VERB
brj-24403	29	3	from	from	ADP
brj-24403	29	4	plants	plant	NOUN
brj-24403	29	5	,	,	PUNCT
brj-24403	29	6	fungi	fungus	NOUN
brj-24403	29	7	,	,	PUNCT
brj-24403	29	8	and	and	CCONJ
brj-24403	29	9	marine	marine	ADJ
brj-24403	29	10	organisms	organism	NOUN
brj-24403	29	11	have	have	AUX
brj-24403	29	12	demonstrated	demonstrate	VERB
brj-24403	29	13	potential	potential	NOUN
brj-24403	29	14	in	in	ADP
brj-24403	29	15	targeting	target	VERB
brj-24403	29	16	pathways	pathway	NOUN
brj-24403	29	17	associated	associate	VERB
brj-24403	29	18	with	with	ADP
brj-24403	29	19	seizure	seizure	NOUN
brj-24403	29	20	development	development	NOUN
brj-24403	29	21	and	and	CCONJ
brj-24403	29	22	propagation	propagation	NOUN
brj-24403	29	23	(	(	PUNCT
brj-24403	29	24	copmans	copman	NOUN
brj-24403	29	25	et	et	PROPN
brj-24403	29	26	al	al	PROPN
brj-24403	29	27	.	.	PROPN
brj-24403	29	28	2019	2019	NUM
brj-24403	29	29	;	;	PUNCT
brj-24403	30	1	he	he	PRON
brj-24403	30	2	et	et	PROPN
brj-24403	30	3	al	al	PROPN
brj-24403	30	4	.	.	PROPN
brj-24403	30	5	2024	2024	NUM
brj-24403	30	6	;	;	PUNCT
brj-24403	30	7	wang	wang	PROPN
brj-24403	30	8	et	et	PROPN
brj-24403	30	9	al	al	PROPN
brj-24403	30	10	.	.	PROPN
brj-24403	30	11	2024	2024	NUM
brj-24403	30	12	)	)	PUNCT
brj-24403	30	13	.	.	PUNCT
brj-24403	31	1	flavonoids	flavonoid	NOUN
brj-24403	31	2	,	,	PUNCT
brj-24403	31	3	terpenoids	terpenoid	NOUN
brj-24403	31	4	,	,	PUNCT
brj-24403	31	5	and	and	CCONJ
brj-24403	31	6	alkaloids	alkaloid	NOUN
brj-24403	31	7	have	have	AUX
brj-24403	31	8	demonstrated	demonstrate	VERB
brj-24403	31	9	modulatory	modulatory	ADJ
brj-24403	31	10	effects	effect	NOUN
brj-24403	31	11	on	on	ADP
brj-24403	31	12	neurotransmitter	neurotransmitter	NOUN
brj-24403	31	13	systems	system	NOUN
brj-24403	31	14	,	,	PUNCT
brj-24403	31	15	ion	ion	NOUN
brj-24403	31	16	channels	channel	NOUN
brj-24403	31	17	,	,	PUNCT
brj-24403	31	18	and	and	CCONJ
brj-24403	31	19	oxidative	oxidative	ADJ
brj-24403	31	20	stress	stress	NOUN
brj-24403	31	21	,	,	PUNCT
brj-24403	31	22	which	which	PRON
brj-24403	31	23	are	be	AUX
brj-24403	31	24	critical	critical	ADJ
brj-24403	31	25	factors	factor	NOUN
brj-24403	31	26	in	in	ADP
brj-24403	31	27	epileptogenesis	epileptogenesis	NOUN
brj-24403	31	28	(	(	PUNCT
brj-24403	31	29	sharifi	sharifi	NOUN
brj-24403	31	30	-	-	PUNCT
brj-24403	31	31	rad	rad	NOUN
brj-24403	31	32	et	et	PROPN
brj-24403	31	33	al	al	PROPN
brj-24403	31	34	.	.	PROPN
brj-24403	31	35	2021	2021	NUM
brj-24403	31	36	)	)	PUNCT
brj-24403	31	37	.	.	PUNCT
brj-24403	32	1	these	these	DET
brj-24403	32	2	findings	finding	NOUN
brj-24403	32	3	underscore	underscore	VERB
brj-24403	32	4	the	the	DET
brj-24403	32	5	potential	potential	NOUN
brj-24403	32	6	of	of	ADP
brj-24403	32	7	natural	natural	ADJ
brj-24403	32	8	products	product	NOUN
brj-24403	32	9	as	as	ADP
brj-24403	32	10	a	a	DET
brj-24403	32	11	source	source	NOUN
brj-24403	32	12	of	of	ADP
brj-24403	32	13	lead	lead	ADJ
brj-24403	32	14	compounds	compound	NOUN
brj-24403	32	15	for	for	ADP
brj-24403	32	16	the	the	DET
brj-24403	32	17	advancement	advancement	NOUN
brj-24403	32	18	of	of	ADP
brj-24403	32	19	next	next	ADJ
brj-24403	32	20	-	-	PUNCT
brj-24403	32	21	generation	generation	NOUN
brj-24403	32	22	anticonvulsants	anticonvulsant	NOUN
brj-24403	32	23	.	.	PUNCT
brj-24403	33	1	thus	thus	ADV
brj-24403	33	2	,	,	PUNCT
brj-24403	33	3	epilepsy	epilepsy	NOUN
brj-24403	33	4	presents	present	VERB
brj-24403	33	5	considerable	considerable	ADJ
brj-24403	33	6	medical	medical	ADJ
brj-24403	33	7	and	and	CCONJ
brj-24403	33	8	socioeconomic	socioeconomic	ADJ
brj-24403	33	9	challenges	challenge	NOUN
brj-24403	33	10	,	,	PUNCT
brj-24403	33	11	the	the	DET
brj-24403	33	12	incorporation	incorporation	NOUN
brj-24403	33	13	of	of	ADP
brj-24403	33	14	natural	natural	ADJ
brj-24403	33	15	product	product	NOUN
brj-24403	33	16	research	research	NOUN
brj-24403	33	17	into	into	ADP
brj-24403	33	18	medication	medication	NOUN
brj-24403	33	19	discovery	discovery	NOUN
brj-24403	33	20	offers	offer	VERB
brj-24403	33	21	enormous	enormous	ADJ
brj-24403	33	22	potential	potential	NOUN
brj-24403	33	23	.	.	PUNCT
brj-24403	34	1	by	by	ADP
brj-24403	34	2	utilizing	utilize	VERB
brj-24403	34	3	the	the	DET
brj-24403	34	4	therapeutic	therapeutic	ADJ
brj-24403	34	5	potential	potential	NOUN
brj-24403	34	6	of	of	ADP
brj-24403	34	7	these	these	DET
brj-24403	34	8	bioactive	bioactive	ADJ
brj-24403	34	9	molecules	molecule	NOUN
brj-24403	34	10	,	,	PUNCT
brj-24403	34	11	researchers	researcher	NOUN
brj-24403	34	12	may	may	AUX
brj-24403	34	13	discover	discover	VERB
brj-24403	34	14	novel	novel	ADJ
brj-24403	34	15	techniques	technique	NOUN
brj-24403	34	16	to	to	PART
brj-24403	34	17	meet	meet	VERB
brj-24403	34	18	the	the	DET
brj-24403	34	19	unmet	unmet	NOUN
brj-24403	34	20	requirements	requirement	NOUN
brj-24403	34	21	of	of	ADP
brj-24403	34	22	epilepsy	epilepsy	NOUN
brj-24403	34	23	patients	patient	NOUN
brj-24403	34	24	,	,	PUNCT
brj-24403	34	25	especially	especially	ADV
brj-24403	34	26	those	those	PRON
brj-24403	34	27	with	with	ADP
brj-24403	34	28	drug	drug	NOUN
brj-24403	34	29	-	-	PUNCT
brj-24403	34	30	resistant	resistant	ADJ
brj-24403	34	31	variants	variant	NOUN
brj-24403	34	32	of	of	ADP
brj-24403	34	33	the	the	DET
brj-24403	34	34	condition	condition	NOUN
brj-24403	34	35	(	(	PUNCT
brj-24403	34	36	de	de	X
brj-24403	34	37	boer	boer	PROPN
brj-24403	34	38	et	et	PROPN
brj-24403	34	39	al	al	PROPN
brj-24403	34	40	.	.	PROPN
brj-24403	34	41	2008	2008	NUM
brj-24403	34	42	)	)	PUNCT
brj-24403	34	43	.	.	PUNCT
brj-24403	35	1	the	the	DET
brj-24403	35	2	verbenaceae	verbenaceae	PROPN
brj-24403	35	3	family	family	NOUN
brj-24403	35	4	includes	include	VERB
brj-24403	35	5	the	the	DET
brj-24403	35	6	genus	genus	NOUN
brj-24403	35	7	callicarpa	callicarpa	NOUN
brj-24403	35	8	,	,	PUNCT
brj-24403	35	9	which	which	PRON
brj-24403	35	10	is	be	AUX
brj-24403	35	11	home	home	NOUN
brj-24403	35	12	to	to	ADP
brj-24403	35	13	about	about	ADV
brj-24403	35	14	190	190	NUM
brj-24403	35	15	species	specie	NOUN
brj-24403	35	16	mainly	mainly	ADV
brj-24403	35	17	found	find	VERB
brj-24403	35	18	in	in	ADP
brj-24403	35	19	the	the	DET
brj-24403	35	20	tropics	tropic	NOUN
brj-24403	35	21	and	and	CCONJ
brj-24403	35	22	subtropics	subtropic	NOUN
brj-24403	35	23	of	of	ADP
brj-24403	35	24	asia	asia	PROPN
brj-24403	35	25	and	and	CCONJ
brj-24403	35	26	oceania	oceania	PROPN
brj-24403	35	27	(	(	PUNCT
brj-24403	35	28	zhang	zhang	PROPN
brj-24403	35	29	et	et	PROPN
brj-24403	35	30	al	al	PROPN
brj-24403	35	31	.	.	PROPN
brj-24403	35	32	2023	2023	NUM
brj-24403	35	33	)	)	PUNCT
brj-24403	35	34	.	.	PUNCT
brj-24403	36	1	this	this	DET
brj-24403	36	2	genus	genus	NOUN
brj-24403	36	3	has	have	AUX
brj-24403	36	4	long	long	ADV
brj-24403	36	5	been	be	AUX
brj-24403	36	6	acknowledged	acknowledge	VERB
brj-24403	36	7	for	for	ADP
brj-24403	36	8	its	its	PRON
brj-24403	36	9	therapeutic	therapeutic	ADJ
brj-24403	36	10	properties	property	NOUN
brj-24403	36	11	,	,	PUNCT
brj-24403	36	12	with	with	ADP
brj-24403	36	13	numerous	numerous	ADJ
brj-24403	36	14	species	specie	NOUN
brj-24403	36	15	being	be	AUX
brj-24403	36	16	employed	employ	VERB
brj-24403	36	17	in	in	ADP
brj-24403	36	18	diverse	diverse	ADJ
brj-24403	36	19	cultural	cultural	ADJ
brj-24403	36	20	therapies	therapy	NOUN
brj-24403	36	21	.	.	PUNCT
brj-24403	37	1	callicarpa	callicarpa	ADJ
brj-24403	37	2	macrophylla	macrophylla	NOUN
brj-24403	37	3	,	,	PUNCT
brj-24403	37	4	callicarpa	callicarpa	NOUN
brj-24403	37	5	nudiflora	nudiflora	PROPN
brj-24403	37	6	,	,	PUNCT
brj-24403	37	7	and	and	CCONJ
brj-24403	37	8	callicarpa	callicarpa	ADJ
brj-24403	37	9	dichotoma	dichotoma	NOUN
brj-24403	37	10	are	be	AUX
brj-24403	37	11	notable	notable	ADJ
brj-24403	37	12	for	for	ADP
brj-24403	37	13	their	their	PRON
brj-24403	37	14	historical	historical	ADJ
brj-24403	37	15	uses	use	NOUN
brj-24403	37	16	in	in	ADP
brj-24403	37	17	traditional	traditional	ADJ
brj-24403	37	18	medicine	medicine	NOUN
brj-24403	37	19	,	,	PUNCT
brj-24403	37	20	treating	treat	VERB
brj-24403	37	21	a	a	DET
brj-24403	37	22	wide	wide	ADJ
brj-24403	37	23	range	range	NOUN
brj-24403	37	24	of	of	ADP
brj-24403	37	25	diseases	disease	NOUN
brj-24403	37	26	(	(	PUNCT
brj-24403	37	27	soni	soni	PROPN
brj-24403	37	28	et	et	PROPN
brj-24403	37	29	al	al	PROPN
brj-24403	37	30	.	.	PROPN
brj-24403	37	31	2014	2014	NUM
brj-24403	37	32	)	)	PUNCT
brj-24403	37	33	.	.	PUNCT
brj-24403	38	1	these	these	DET
brj-24403	38	2	herbs	herb	NOUN
brj-24403	38	3	have	have	AUX
brj-24403	38	4	been	be	AUX
brj-24403	38	5	essential	essential	ADJ
brj-24403	38	6	to	to	ADP
brj-24403	38	7	traditional	traditional	ADJ
brj-24403	38	8	medicinal	medicinal	ADJ
brj-24403	38	9	methods	method	NOUN
brj-24403	38	10	,	,	PUNCT
brj-24403	38	11	esteemed	esteem	VERB
brj-24403	38	12	for	for	ADP
brj-24403	38	13	their	their	PRON
brj-24403	38	14	enduring	endure	VERB
brj-24403	38	15	therapeutic	therapeutic	ADJ
brj-24403	38	16	powers	power	NOUN
brj-24403	38	17	over	over	ADP
brj-24403	38	18	generations	generation	NOUN
brj-24403	38	19	(	(	PUNCT
brj-24403	38	20	yang	yang	PROPN
brj-24403	38	21	et	et	PROPN
brj-24403	38	22	al	al	PROPN
brj-24403	38	23	.	.	PROPN
brj-24403	38	24	2021	2021	NUM
brj-24403	38	25	;	;	PUNCT
brj-24403	38	26	kim	kim	PROPN
brj-24403	38	27	et	et	PROPN
brj-24403	38	28	al	al	PROPN
brj-24403	38	29	.	.	PROPN
brj-24403	38	30	2022	2022	NUM
brj-24403	38	31	;	;	PUNCT
brj-24403	38	32	ma	ma	PROPN
brj-24403	38	33	et	et	PROPN
brj-24403	38	34	al	al	PROPN
brj-24403	38	35	.	.	PROPN
brj-24403	38	36	2022	2022	NUM
brj-24403	38	37	)	)	PUNCT
brj-24403	38	38	.	.	PUNCT
brj-24403	39	1	comprehensive	comprehensive	ADJ
brj-24403	39	2	phytochemical	phytochemical	ADJ
brj-24403	39	3	studies	study	NOUN
brj-24403	39	4	of	of	ADP
brj-24403	39	5	the	the	DET
brj-24403	39	6	callicarpa	callicarpa	ADJ
brj-24403	39	7	genus	genus	NOUN
brj-24403	39	8	have	have	AUX
brj-24403	39	9	uncovered	uncover	VERB
brj-24403	39	10	a	a	DET
brj-24403	39	11	substantial	substantial	ADJ
brj-24403	39	12	array	array	NOUN
brj-24403	39	13	of	of	ADP
brj-24403	39	14	bioactive	bioactive	ADJ
brj-24403	39	15	chemicals	chemical	NOUN
brj-24403	39	16	.	.	PUNCT
brj-24403	40	1	prominent	prominent	ADJ
brj-24403	40	2	among	among	ADP
brj-24403	40	3	them	they	PRON
brj-24403	40	4	are	be	AUX
brj-24403	40	5	terpenoids	terpenoid	NOUN
brj-24403	40	6	,	,	PUNCT
brj-24403	40	7	especially	especially	ADV
brj-24403	40	8	diterpenoids	diterpenoid	NOUN
brj-24403	40	9	,	,	PUNCT
brj-24403	40	10	in	in	ADP
brj-24403	40	11	addition	addition	NOUN
brj-24403	40	12	to	to	ADP
brj-24403	40	13	phenylethanoids	phenylethanoid	NOUN
brj-24403	40	14	,	,	PUNCT
brj-24403	40	15	phenylpropanoids	phenylpropanoid	NOUN
brj-24403	40	16	,	,	PUNCT
brj-24403	40	17	and	and	CCONJ
brj-24403	40	18	flavonoids	flavonoid	NOUN
brj-24403	40	19	.	.	PUNCT
brj-24403	41	1	these	these	DET
brj-24403	41	2	chemical	chemical	NOUN
brj-24403	41	3	compounds	compound	NOUN
brj-24403	41	4	are	be	AUX
brj-24403	41	5	linked	link	VERB
brj-24403	41	6	to	to	ADP
brj-24403	41	7	various	various	ADJ
brj-24403	41	8	pharmacological	pharmacological	ADJ
brj-24403	41	9	actions	action	NOUN
brj-24403	41	10	.	.	PUNCT
brj-24403	42	1	research	research	NOUN
brj-24403	42	2	underscores	underscore	VERB
brj-24403	42	3	their	their	PRON
brj-24403	42	4	potential	potential	NOUN
brj-24403	42	5	as	as	ADP
brj-24403	42	6	anti	anti	ADJ
brj-24403	42	7	-	-	ADJ
brj-24403	42	8	inflammatory	inflammatory	ADJ
brj-24403	42	9	agents	agent	NOUN
brj-24403	42	10	and	and	CCONJ
brj-24403	42	11	their	their	PRON
brj-24403	42	12	capacity	capacity	NOUN
brj-24403	42	13	to	to	PART
brj-24403	42	14	facilitate	facilitate	VERB
brj-24403	42	15	hemostasis	hemostasis	NOUN
brj-24403	42	16	.	.	PUNCT
brj-24403	43	1	peer	peer	NOUN
brj-24403	43	2	-	-	PUNCT
brj-24403	43	3	reviewed	review	VERB
brj-24403	43	4	article	article	NOUN
brj-24403	43	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	43	6	li	li	PROPN
brj-24403	43	7	et	et	PROPN
brj-24403	43	8	al	al	PROPN
brj-24403	43	9	.	.	PROPN
brj-24403	44	1	(	(	PUNCT
brj-24403	44	2	2025	2025	NUM
brj-24403	44	3	)	)	PUNCT
brj-24403	44	4	.	.	PUNCT
brj-24403	45	1	“	"	PUNCT
brj-24403	45	2	herbal	herbal	ADJ
brj-24403	45	3	anti	anti	ADJ
brj-24403	45	4	-	-	ADJ
brj-24403	45	5	epileptic	epileptic	ADJ
brj-24403	45	6	extract	extract	NOUN
brj-24403	45	7	,	,	PUNCT
brj-24403	45	8	”	"	PUNCT
brj-24403	45	9	bioresources	bioresource	NOUN
brj-24403	45	10	20(2	20(2	NUM
brj-24403	45	11	)	)	PUNCT
brj-24403	45	12	,	,	PUNCT
brj-24403	45	13	4701	4701	NUM
brj-24403	45	14	-	-	SYM
brj-24403	45	15	4719	4719	NUM
brj-24403	45	16	.	.	PUNCT
brj-24403	46	1	4703	4703	NUM
brj-24403	46	2	furthermore	furthermore	ADV
brj-24403	46	3	,	,	PUNCT
brj-24403	46	4	chemicals	chemical	NOUN
brj-24403	46	5	from	from	ADP
brj-24403	46	6	this	this	DET
brj-24403	46	7	genus	genus	NOUN
brj-24403	46	8	exhibit	exhibit	NOUN
brj-24403	46	9	antitubercular	antitubercular	ADJ
brj-24403	46	10	,	,	PUNCT
brj-24403	46	11	antiplatelet	antiplatelet	NOUN
brj-24403	46	12	aggregation	aggregation	NOUN
brj-24403	46	13	,	,	PUNCT
brj-24403	46	14	and	and	CCONJ
brj-24403	46	15	cytotoxic	cytotoxic	ADJ
brj-24403	46	16	properties	property	NOUN
brj-24403	46	17	,	,	PUNCT
brj-24403	46	18	as	as	ADV
brj-24403	46	19	well	well	ADV
brj-24403	46	20	as	as	ADP
brj-24403	46	21	the	the	DET
brj-24403	46	22	ability	ability	NOUN
brj-24403	46	23	to	to	PART
brj-24403	46	24	stimulate	stimulate	VERB
brj-24403	46	25	neurite	neurite	ADJ
brj-24403	46	26	outgrowth	outgrowth	NOUN
brj-24403	46	27	,	,	PUNCT
brj-24403	46	28	highlighting	highlight	VERB
brj-24403	46	29	their	their	PRON
brj-24403	46	30	significance	significance	NOUN
brj-24403	46	31	in	in	ADP
brj-24403	46	32	both	both	CCONJ
brj-24403	46	33	traditional	traditional	ADJ
brj-24403	46	34	and	and	CCONJ
brj-24403	46	35	contemporary	contemporary	ADJ
brj-24403	46	36	medicine	medicine	NOUN
brj-24403	46	37	(	(	PUNCT
brj-24403	46	38	zhao	zhao	PROPN
brj-24403	46	39	et	et	PROPN
brj-24403	46	40	al	al	PROPN
brj-24403	46	41	.	.	PROPN
brj-24403	46	42	2021	2021	NUM
brj-24403	46	43	;	;	PUNCT
brj-24403	46	44	huang	huang	PROPN
brj-24403	46	45	et	et	PROPN
brj-24403	46	46	al	al	PROPN
brj-24403	46	47	.	.	PROPN
brj-24403	46	48	2022	2022	NUM
brj-24403	46	49	;	;	PUNCT
brj-24403	46	50	li	li	PROPN
brj-24403	46	51	et	et	PROPN
brj-24403	46	52	al	al	PROPN
brj-24403	46	53	.	.	PROPN
brj-24403	46	54	2022	2022	NUM
brj-24403	46	55	)	)	PUNCT
brj-24403	46	56	.	.	PUNCT
brj-24403	47	1	callicarpa	callicarpa	PROPN
brj-24403	47	2	kwangtungensis	kwangtungensis	PROPN
brj-24403	47	3	chun	chun	PROPN
brj-24403	47	4	(	(	PUNCT
brj-24403	47	5	cnc	cnc	PROPN
brj-24403	47	6	)	)	PUNCT
brj-24403	47	7	,	,	PUNCT
brj-24403	47	8	a	a	DET
brj-24403	47	9	notably	notably	ADV
brj-24403	47	10	important	important	ADJ
brj-24403	47	11	species	specie	NOUN
brj-24403	47	12	,	,	PUNCT
brj-24403	47	13	is	be	AUX
brj-24403	47	14	a	a	DET
brj-24403	47	15	shrub	shrub	NOUN
brj-24403	47	16	indigenous	indigenous	ADJ
brj-24403	47	17	to	to	ADP
brj-24403	47	18	southern	southern	ADJ
brj-24403	47	19	mainland	mainland	NOUN
brj-24403	47	20	china	china	PROPN
brj-24403	47	21	.	.	PUNCT
brj-24403	48	1	this	this	DET
brj-24403	48	2	plant	plant	NOUN
brj-24403	48	3	has	have	VERB
brj-24403	48	4	a	a	DET
brj-24403	48	5	significant	significant	ADJ
brj-24403	48	6	role	role	NOUN
brj-24403	48	7	in	in	ADP
brj-24403	48	8	local	local	ADJ
brj-24403	48	9	folk	folk	NOUN
brj-24403	48	10	medicine	medicine	NOUN
brj-24403	48	11	,	,	PUNCT
brj-24403	48	12	with	with	ADP
brj-24403	48	13	its	its	PRON
brj-24403	48	14	leaves	leave	NOUN
brj-24403	48	15	and	and	CCONJ
brj-24403	48	16	twigs	twig	NOUN
brj-24403	48	17	employed	employ	VERB
brj-24403	48	18	to	to	PART
brj-24403	48	19	address	address	VERB
brj-24403	48	20	ailments	ailment	NOUN
brj-24403	48	21	such	such	ADJ
brj-24403	48	22	as	as	ADP
brj-24403	48	23	reproductive	reproductive	ADJ
brj-24403	48	24	performance	performance	NOUN
brj-24403	48	25	(	(	PUNCT
brj-24403	48	26	chen	chen	PROPN
brj-24403	48	27	et	et	PROPN
brj-24403	48	28	al	al	PROPN
brj-24403	48	29	.	.	PROPN
brj-24403	48	30	2020	2020	NUM
brj-24403	48	31	)	)	PUNCT
brj-24403	48	32	,	,	PUNCT
brj-24403	48	33	antioxidant	antioxidant	ADJ
brj-24403	48	34	activity	activity	NOUN
brj-24403	48	35	(	(	PUNCT
brj-24403	48	36	cai	cai	X
brj-24403	48	37	et	et	PROPN
brj-24403	48	38	al	al	PROPN
brj-24403	48	39	.	.	PROPN
brj-24403	48	40	2014	2014	NUM
brj-24403	48	41	)	)	PUNCT
brj-24403	48	42	,	,	PUNCT
brj-24403	48	43	and	and	CCONJ
brj-24403	48	44	antiinflammatory	antiinflammatory	NOUN
brj-24403	48	45	activities	activity	NOUN
brj-24403	48	46	(	(	PUNCT
brj-24403	48	47	zheng	zheng	X
brj-24403	48	48	et	et	PROPN
brj-24403	48	49	al	al	PROPN
brj-24403	48	50	.	.	PROPN
brj-24403	48	51	2021	2021	NUM
brj-24403	48	52	)	)	PUNCT
brj-24403	48	53	.	.	PUNCT
brj-24403	49	1	the	the	DET
brj-24403	49	2	traditional	traditional	ADJ
brj-24403	49	3	applications	application	NOUN
brj-24403	49	4	highlight	highlight	VERB
brj-24403	49	5	the	the	DET
brj-24403	49	6	cultural	cultural	ADJ
brj-24403	49	7	significance	significance	NOUN
brj-24403	49	8	of	of	ADP
brj-24403	49	9	the	the	DET
brj-24403	49	10	callicarpa	callicarpa	ADJ
brj-24403	49	11	genus	genus	NOUN
brj-24403	49	12	and	and	CCONJ
brj-24403	49	13	indicate	indicate	VERB
brj-24403	49	14	its	its	PRON
brj-24403	49	15	potential	potential	NOUN
brj-24403	49	16	for	for	ADP
brj-24403	49	17	future	future	ADJ
brj-24403	49	18	pharmaceutical	pharmaceutical	ADJ
brj-24403	49	19	research	research	NOUN
brj-24403	49	20	and	and	CCONJ
brj-24403	49	21	development	development	NOUN
brj-24403	49	22	.	.	PUNCT
brj-24403	50	1	however	however	ADV
brj-24403	50	2	,	,	PUNCT
brj-24403	50	3	no	no	DET
brj-24403	50	4	study	study	NOUN
brj-24403	50	5	has	have	AUX
brj-24403	50	6	reported	report	VERB
brj-24403	50	7	the	the	DET
brj-24403	50	8	antiepileptic	antiepileptic	ADJ
brj-24403	50	9	potential	potential	NOUN
brj-24403	50	10	of	of	ADP
brj-24403	50	11	callicarpa	callicarpa	ADJ
brj-24403	50	12	kwangtungensis	kwangtungensis	NOUN
brj-24403	50	13	chun	chun	PROPN
brj-24403	50	14	.	.	PUNCT
brj-24403	51	1	thus	thus	ADV
brj-24403	51	2	,	,	PUNCT
brj-24403	51	3	concerning	concern	VERB
brj-24403	51	4	the	the	DET
brj-24403	51	5	above	above	NOUN
brj-24403	51	6	,	,	PUNCT
brj-24403	51	7	in	in	ADP
brj-24403	51	8	the	the	DET
brj-24403	51	9	present	present	ADJ
brj-24403	51	10	study	study	NOUN
brj-24403	51	11	,	,	PUNCT
brj-24403	51	12	the	the	DET
brj-24403	51	13	aim	aim	NOUN
brj-24403	51	14	was	be	AUX
brj-24403	51	15	to	to	PART
brj-24403	51	16	explore	explore	VERB
brj-24403	51	17	the	the	DET
brj-24403	51	18	pharmacological	pharmacological	ADJ
brj-24403	51	19	activity	activity	NOUN
brj-24403	51	20	of	of	ADP
brj-24403	51	21	ckc	ckc	NOUN
brj-24403	51	22	against	against	ADP
brj-24403	51	23	pilocarpine	pilocarpine	PROPN
brj-24403	51	24	(	(	PUNCT
brj-24403	51	25	pilo	pilo	NOUN
brj-24403	51	26	)	)	PUNCT
brj-24403	51	27	induced	induce	VERB
brj-24403	51	28	epilepsy	epilepsy	NOUN
brj-24403	51	29	in	in	ADP
brj-24403	51	30	mice	mouse	NOUN
brj-24403	51	31	.	.	PUNCT
brj-24403	52	1	the	the	DET
brj-24403	52	2	pilocarpine	pilocarpine	NOUN
brj-24403	52	3	-	-	PUNCT
brj-24403	52	4	induced	induce	VERB
brj-24403	52	5	epilepsy	epilepsy	NOUN
brj-24403	52	6	model	model	NOUN
brj-24403	52	7	possesses	possess	VERB
brj-24403	52	8	considerable	considerable	ADJ
brj-24403	52	9	pharmacological	pharmacological	NOUN
brj-24403	52	10	significance	significance	NOUN
brj-24403	52	11	due	due	ADP
brj-24403	52	12	to	to	ADP
brj-24403	52	13	its	its	PRON
brj-24403	52	14	accurate	accurate	ADJ
brj-24403	52	15	representation	representation	NOUN
brj-24403	52	16	of	of	ADP
brj-24403	52	17	human	human	ADJ
brj-24403	52	18	temporal	temporal	ADJ
brj-24403	52	19	lobe	lobe	NOUN
brj-24403	52	20	epilepsy	epilepsy	NOUN
brj-24403	52	21	(	(	PUNCT
brj-24403	52	22	tle	tle	NOUN
brj-24403	52	23	)	)	PUNCT
brj-24403	52	24	.	.	PUNCT
brj-24403	53	1	pilocarpine	pilocarpine	PROPN
brj-24403	53	2	,	,	PUNCT
brj-24403	53	3	a	a	DET
brj-24403	53	4	muscarinic	muscarinic	ADJ
brj-24403	53	5	cholinergic	cholinergic	ADJ
brj-24403	53	6	receptor	receptor	NOUN
brj-24403	53	7	agonist	agonist	NOUN
brj-24403	53	8	,	,	PUNCT
brj-24403	53	9	precipitates	precipitate	NOUN
brj-24403	53	10	status	status	NOUN
brj-24403	53	11	epilepticus	epilepticus	VERB
brj-24403	53	12	by	by	ADP
brj-24403	53	13	facilitating	facilitate	VERB
brj-24403	53	14	excessive	excessive	ADJ
brj-24403	53	15	neuronal	neuronal	ADJ
brj-24403	53	16	excitation	excitation	NOUN
brj-24403	53	17	,	,	PUNCT
brj-24403	53	18	ultimately	ultimately	ADV
brj-24403	53	19	resulting	result	VERB
brj-24403	53	20	in	in	ADP
brj-24403	53	21	chronic	chronic	ADJ
brj-24403	53	22	epileptogenesis	epileptogenesis	NOUN
brj-24403	53	23	.	.	PUNCT
brj-24403	54	1	this	this	DET
brj-24403	54	2	procedure	procedure	NOUN
brj-24403	54	3	emulates	emulate	VERB
brj-24403	54	4	essential	essential	ADJ
brj-24403	54	5	pathophysiological	pathophysiological	ADJ
brj-24403	54	6	characteristics	characteristic	NOUN
brj-24403	54	7	of	of	ADP
brj-24403	54	8	natural	natural	ADJ
brj-24403	54	9	temporal	temporal	ADJ
brj-24403	54	10	lobe	lobe	NOUN
brj-24403	54	11	epilepsy	epilepsy	NOUN
brj-24403	54	12	,	,	PUNCT
brj-24403	54	13	such	such	ADJ
brj-24403	54	14	as	as	ADP
brj-24403	54	15	hippocampal	hippocampal	ADJ
brj-24403	54	16	sclerosis	sclerosis	NOUN
brj-24403	54	17	,	,	PUNCT
brj-24403	54	18	mossy	mossy	NOUN
brj-24403	54	19	fiber	fiber	NOUN
brj-24403	54	20	sprouting	sprouting	NOUN
brj-24403	54	21	,	,	PUNCT
brj-24403	54	22	and	and	CCONJ
brj-24403	54	23	gliosis	gliosis	NOUN
brj-24403	54	24	,	,	PUNCT
brj-24403	54	25	rendering	render	VERB
brj-24403	54	26	it	it	PRON
brj-24403	54	27	an	an	DET
brj-24403	54	28	indispensable	indispensable	ADJ
brj-24403	54	29	instrument	instrument	NOUN
brj-24403	54	30	in	in	ADP
brj-24403	54	31	seizure	seizure	NOUN
brj-24403	54	32	research	research	NOUN
brj-24403	54	33	and	and	CCONJ
brj-24403	54	34	antiepileptic	antiepileptic	ADJ
brj-24403	54	35	medication	medication	NOUN
brj-24403	54	36	development	development	NOUN
brj-24403	54	37	(	(	PUNCT
brj-24403	54	38	turski	turski	PROPN
brj-24403	54	39	et	et	PROPN
brj-24403	54	40	al	al	PROPN
brj-24403	54	41	.	.	PROPN
brj-24403	54	42	1983	1983	NUM
brj-24403	54	43	;	;	PUNCT
brj-24403	54	44	cavalheiro	cavalheiro	NOUN
brj-24403	54	45	et	et	PROPN
brj-24403	54	46	al	al	PROPN
brj-24403	54	47	.	.	PROPN
brj-24403	54	48	1987	1987	NUM
brj-24403	54	49	)	)	PUNCT
brj-24403	54	50	.	.	PUNCT
brj-24403	55	1	evidence	evidence	NOUN
brj-24403	55	2	indicates	indicate	VERB
brj-24403	55	3	that	that	SCONJ
brj-24403	55	4	,	,	PUNCT
brj-24403	55	5	when	when	SCONJ
brj-24403	55	6	meticulously	meticulously	ADV
brj-24403	55	7	controlled	control	VERB
brj-24403	55	8	,	,	PUNCT
brj-24403	55	9	pilocarpine	pilocarpine	NOUN
brj-24403	55	10	-	-	PUNCT
brj-24403	55	11	induced	induce	VERB
brj-24403	55	12	seizures	seizure	NOUN
brj-24403	55	13	effectively	effectively	ADV
brj-24403	55	14	replicate	replicate	VERB
brj-24403	55	15	spontaneous	spontaneous	ADJ
brj-24403	55	16	seizure	seizure	NOUN
brj-24403	55	17	occurrences	occurrence	NOUN
brj-24403	55	18	in	in	ADP
brj-24403	55	19	relation	relation	NOUN
brj-24403	55	20	to	to	ADP
brj-24403	55	21	experimental	experimental	ADJ
brj-24403	55	22	bias	bias	NOUN
brj-24403	55	23	.	.	PUNCT
brj-24403	56	1	electrophysiological	electrophysiological	ADJ
brj-24403	56	2	recordings	recording	NOUN
brj-24403	56	3	and	and	CCONJ
brj-24403	56	4	behavioral	behavioral	ADJ
brj-24403	56	5	analysis	analysis	NOUN
brj-24403	56	6	demonstrate	demonstrate	VERB
brj-24403	56	7	that	that	SCONJ
brj-24403	56	8	these	these	DET
brj-24403	56	9	seizures	seizure	NOUN
brj-24403	56	10	exhibit	exhibit	VERB
brj-24403	56	11	comparable	comparable	ADJ
brj-24403	56	12	features	feature	NOUN
brj-24403	56	13	and	and	CCONJ
brj-24403	56	14	temporal	temporal	ADJ
brj-24403	56	15	profiles	profile	NOUN
brj-24403	56	16	to	to	PART
brj-24403	56	17	normally	normally	ADV
brj-24403	56	18	occurring	occur	VERB
brj-24403	56	19	seizures	seizure	NOUN
brj-24403	56	20	(	(	PUNCT
brj-24403	56	21	mazarati	mazarati	PROPN
brj-24403	56	22	et	et	PROPN
brj-24403	56	23	al	al	PROPN
brj-24403	56	24	.	.	PROPN
brj-24403	56	25	1998	1998	NUM
brj-24403	56	26	)	)	PUNCT
brj-24403	56	27	.	.	PUNCT
brj-24403	57	1	despite	despite	SCONJ
brj-24403	57	2	pilocarpine	pilocarpine	NOUN
brj-24403	57	3	’s	’s	PART
brj-24403	57	4	action	action	NOUN
brj-24403	57	5	through	through	ADP
brj-24403	57	6	a	a	DET
brj-24403	57	7	particular	particular	ADJ
brj-24403	57	8	cholinergic	cholinergic	ADJ
brj-24403	57	9	route	route	NOUN
brj-24403	57	10	,	,	PUNCT
brj-24403	57	11	the	the	DET
brj-24403	57	12	ensuing	ensue	VERB
brj-24403	57	13	neuroplastic	neuroplastic	ADJ
brj-24403	57	14	alterations	alteration	NOUN
brj-24403	57	15	resemble	resemble	VERB
brj-24403	57	16	those	those	PRON
brj-24403	57	17	seen	see	VERB
brj-24403	57	18	in	in	ADP
brj-24403	57	19	idiopathic	idiopathic	ADJ
brj-24403	57	20	temporal	temporal	ADJ
brj-24403	57	21	lobe	lobe	NOUN
brj-24403	57	22	epilepsy	epilepsy	NOUN
brj-24403	57	23	,	,	PUNCT
brj-24403	57	24	indicating	indicate	VERB
brj-24403	57	25	minimal	minimal	ADJ
brj-24403	57	26	pharmacological	pharmacological	ADJ
brj-24403	57	27	bias	bias	NOUN
brj-24403	57	28	in	in	ADP
brj-24403	57	29	the	the	DET
brj-24403	57	30	induction	induction	NOUN
brj-24403	57	31	process	process	NOUN
brj-24403	57	32	.	.	PUNCT
brj-24403	58	1	this	this	DET
brj-24403	58	2	model	model	NOUN
brj-24403	58	3	continues	continue	VERB
brj-24403	58	4	to	to	PART
brj-24403	58	5	be	be	AUX
brj-24403	58	6	a	a	DET
brj-24403	58	7	highly	highly	ADV
brj-24403	58	8	dependable	dependable	ADJ
brj-24403	58	9	experimental	experimental	ADJ
brj-24403	58	10	framework	framework	NOUN
brj-24403	58	11	for	for	ADP
brj-24403	58	12	assessing	assess	VERB
brj-24403	58	13	possible	possible	ADJ
brj-24403	58	14	anticonvulsant	anticonvulsant	ADJ
brj-24403	58	15	treatments	treatment	NOUN
brj-24403	58	16	.	.	PUNCT
brj-24403	59	1	these	these	DET
brj-24403	59	2	data	datum	NOUN
brj-24403	59	3	substantiate	substantiate	VERB
brj-24403	59	4	the	the	DET
brj-24403	59	5	efficacy	efficacy	NOUN
brj-24403	59	6	of	of	ADP
brj-24403	59	7	pilocarpine	pilocarpine	NOUN
brj-24403	59	8	in	in	ADP
brj-24403	59	9	simulating	simulate	VERB
brj-24403	59	10	clinically	clinically	ADV
brj-24403	59	11	pertinent	pertinent	ADJ
brj-24403	59	12	epileptogenesis	epileptogenesis	NOUN
brj-24403	59	13	without	without	ADP
brj-24403	59	14	considerable	considerable	ADJ
brj-24403	59	15	methodological	methodological	ADJ
brj-24403	59	16	bias	bias	NOUN
brj-24403	59	17	,	,	PUNCT
brj-24403	59	18	hence	hence	ADV
brj-24403	59	19	enhancing	enhance	VERB
brj-24403	59	20	our	our	PRON
brj-24403	59	21	therapeutic	therapeutic	ADJ
brj-24403	59	22	understanding	understanding	NOUN
brj-24403	59	23	.	.	PUNCT
brj-24403	60	1	experimental	experimental	ADJ
brj-24403	60	2	chemicals	chemical	NOUN
brj-24403	60	3	all	all	DET
brj-24403	60	4	the	the	DET
brj-24403	60	5	chemicals	chemical	NOUN
brj-24403	60	6	were	be	AUX
brj-24403	60	7	procured	procure	VERB
brj-24403	60	8	from	from	ADP
brj-24403	60	9	sigma	sigma	PROPN
brj-24403	60	10	aldrich	aldrich	PROPN
brj-24403	60	11	usa	usa	PROPN
brj-24403	60	12	,	,	PUNCT
brj-24403	60	13	unless	unless	SCONJ
brj-24403	60	14	otherwise	otherwise	ADV
brj-24403	60	15	stated	state	VERB
brj-24403	60	16	.	.	PUNCT
brj-24403	61	1	collection	collection	NOUN
brj-24403	61	2	and	and	CCONJ
brj-24403	61	3	identification	identification	NOUN
brj-24403	61	4	of	of	ADP
brj-24403	61	5	plant	plant	NOUN
brj-24403	61	6	the	the	DET
brj-24403	61	7	callicarpa	callicarpa	PROPN
brj-24403	61	8	kwangtungensis	kwangtungensis	NOUN
brj-24403	61	9	chun	chun	PROPN
brj-24403	61	10	plant	plant	NOUN
brj-24403	61	11	was	be	AUX
brj-24403	61	12	collected	collect	VERB
brj-24403	61	13	at	at	ADP
brj-24403	61	14	peak	peak	NOUN
brj-24403	61	15	flowering	flower	VERB
brj-24403	61	16	to	to	ADP
brj-24403	61	17	early	early	ADJ
brj-24403	61	18	fruiting	fruiting	NOUN
brj-24403	61	19	stage	stage	NOUN
brj-24403	61	20	from	from	ADP
brj-24403	61	21	the	the	DET
brj-24403	61	22	botanical	botanical	ADJ
brj-24403	61	23	garden	garden	NOUN
brj-24403	61	24	of	of	ADP
brj-24403	61	25	the	the	DET
brj-24403	61	26	people	people	NOUN
brj-24403	61	27	’s	’s	PART
brj-24403	61	28	hospital	hospital	NOUN
brj-24403	61	29	of	of	ADP
brj-24403	61	30	nanchang	nanchang	PROPN
brj-24403	61	31	and	and	CCONJ
brj-24403	61	32	was	be	AUX
brj-24403	61	33	identified	identify	VERB
brj-24403	61	34	by	by	ADP
brj-24403	61	35	an	an	DET
brj-24403	61	36	experienced	experienced	ADJ
brj-24403	61	37	botanist	botanist	NOUN
brj-24403	61	38	.	.	PUNCT
brj-24403	62	1	this	this	DET
brj-24403	62	2	growth	growth	NOUN
brj-24403	62	3	stage	stage	NOUN
brj-24403	62	4	was	be	AUX
brj-24403	62	5	selected	select	VERB
brj-24403	62	6	based	base	VERB
brj-24403	62	7	on	on	ADP
brj-24403	62	8	standard	standard	ADJ
brj-24403	62	9	phytochemical	phytochemical	ADJ
brj-24403	62	10	collection	collection	NOUN
brj-24403	62	11	practices	practice	NOUN
brj-24403	62	12	,	,	PUNCT
brj-24403	62	13	as	as	SCONJ
brj-24403	62	14	the	the	DET
brj-24403	62	15	plant	plant	NOUN
brj-24403	62	16	is	be	AUX
brj-24403	62	17	metabolically	metabolically	ADV
brj-24403	62	18	most	most	ADV
brj-24403	62	19	active	active	ADJ
brj-24403	62	20	during	during	ADP
brj-24403	62	21	this	this	DET
brj-24403	62	22	period	period	NOUN
brj-24403	62	23	,	,	PUNCT
brj-24403	62	24	ensuring	ensure	VERB
brj-24403	62	25	a	a	DET
brj-24403	62	26	higher	high	ADJ
brj-24403	62	27	concentration	concentration	NOUN
brj-24403	62	28	of	of	ADP
brj-24403	62	29	bioactive	bioactive	ADJ
brj-24403	62	30	secondary	secondary	ADJ
brj-24403	62	31	metabolites	metabolite	NOUN
brj-24403	62	32	such	such	ADJ
brj-24403	62	33	as	as	ADP
brj-24403	62	34	flavonoids	flavonoid	NOUN
brj-24403	62	35	,	,	PUNCT
brj-24403	62	36	terpenoids	terpenoid	NOUN
brj-24403	62	37	,	,	PUNCT
brj-24403	62	38	and	and	CCONJ
brj-24403	62	39	phenolic	phenolic	ADJ
brj-24403	62	40	compounds	compound	NOUN
brj-24403	62	41	.	.	PUNCT
brj-24403	63	1	a	a	DET
brj-24403	63	2	sample	sample	NOUN
brj-24403	63	3	specimen	speciman	NOUN
brj-24403	63	4	voucher	voucher	ADV
brj-24403	63	5	was	be	AUX
brj-24403	63	6	stored	store	VERB
brj-24403	63	7	in	in	ADP
brj-24403	63	8	the	the	DET
brj-24403	63	9	herbarium	herbarium	NOUN
brj-24403	63	10	of	of	ADP
brj-24403	63	11	the	the	DET
brj-24403	63	12	institute	institute	NOUN
brj-24403	63	13	(	(	PUNCT
brj-24403	63	14	hb/2024/021	hb/2024/021	PROPN
brj-24403	63	15	)	)	PUNCT
brj-24403	63	16	.	.	PUNCT
brj-24403	64	1	peer	peer	NOUN
brj-24403	64	2	-	-	PUNCT
brj-24403	64	3	reviewed	review	VERB
brj-24403	64	4	article	article	NOUN
brj-24403	64	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	64	6	li	li	PROPN
brj-24403	64	7	et	et	PROPN
brj-24403	64	8	al	al	PROPN
brj-24403	64	9	.	.	PROPN
brj-24403	65	1	(	(	PUNCT
brj-24403	65	2	2025	2025	NUM
brj-24403	65	3	)	)	PUNCT
brj-24403	65	4	.	.	PUNCT
brj-24403	66	1	“	"	PUNCT
brj-24403	66	2	herbal	herbal	ADJ
brj-24403	66	3	anti	anti	ADJ
brj-24403	66	4	-	-	ADJ
brj-24403	66	5	epileptic	epileptic	ADJ
brj-24403	66	6	extract	extract	NOUN
brj-24403	66	7	,	,	PUNCT
brj-24403	66	8	”	"	PUNCT
brj-24403	66	9	bioresources	bioresource	NOUN
brj-24403	66	10	20(2	20(2	NUM
brj-24403	66	11	)	)	PUNCT
brj-24403	66	12	,	,	PUNCT
brj-24403	66	13	4701	4701	NUM
brj-24403	66	14	-	-	SYM
brj-24403	66	15	4719	4719	NUM
brj-24403	66	16	.	.	PUNCT
brj-24403	67	1	4704	4704	NUM
brj-24403	67	2	preparation	preparation	NOUN
brj-24403	67	3	of	of	ADP
brj-24403	67	4	cnc	cnc	PROPN
brj-24403	67	5	extract	extract	VERB
brj-24403	67	6	the	the	DET
brj-24403	67	7	whole	whole	ADJ
brj-24403	67	8	plant	plant	NOUN
brj-24403	67	9	material	material	NOUN
brj-24403	67	10	was	be	AUX
brj-24403	67	11	collected	collect	VERB
brj-24403	67	12	and	and	CCONJ
brj-24403	67	13	thoroughly	thoroughly	ADV
brj-24403	67	14	cleaned	clean	VERB
brj-24403	67	15	with	with	ADP
brj-24403	67	16	tap	tap	NOUN
brj-24403	67	17	water	water	NOUN
brj-24403	67	18	to	to	PART
brj-24403	67	19	remove	remove	VERB
brj-24403	67	20	soil	soil	NOUN
brj-24403	67	21	particles	particle	NOUN
brj-24403	67	22	,	,	PUNCT
brj-24403	67	23	dust	dust	NOUN
brj-24403	67	24	,	,	PUNCT
brj-24403	67	25	and	and	CCONJ
brj-24403	67	26	other	other	ADJ
brj-24403	67	27	extraneous	extraneous	ADJ
brj-24403	67	28	matter	matter	NOUN
brj-24403	67	29	.	.	PUNCT
brj-24403	68	1	the	the	DET
brj-24403	68	2	cleaned	clean	VERB
brj-24403	68	3	plant	plant	NOUN
brj-24403	68	4	material	material	NOUN
brj-24403	68	5	was	be	AUX
brj-24403	68	6	initially	initially	ADV
brj-24403	68	7	air	air	NOUN
brj-24403	68	8	-	-	PUNCT
brj-24403	68	9	dried	dry	VERB
brj-24403	68	10	at	at	ADP
brj-24403	68	11	room	room	NOUN
brj-24403	68	12	temperature	temperature	NOUN
brj-24403	68	13	for	for	SCONJ
brj-24403	68	14	24	24	NUM
brj-24403	68	15	h	h	NOUN
brj-24403	68	16	to	to	PART
brj-24403	68	17	eliminate	eliminate	VERB
brj-24403	68	18	surface	surface	NOUN
brj-24403	68	19	moisture	moisture	NOUN
brj-24403	68	20	.	.	PUNCT
brj-24403	69	1	subsequently	subsequently	ADV
brj-24403	69	2	,	,	PUNCT
brj-24403	69	3	the	the	DET
brj-24403	69	4	material	material	NOUN
brj-24403	69	5	was	be	AUX
brj-24403	69	6	shade	shade	NOUN
brj-24403	69	7	-	-	PUNCT
brj-24403	69	8	dried	dry	VERB
brj-24403	69	9	in	in	ADP
brj-24403	69	10	a	a	DET
brj-24403	69	11	well	well	ADV
brj-24403	69	12	-	-	PUNCT
brj-24403	69	13	ventilated	ventilate	VERB
brj-24403	69	14	area	area	NOUN
brj-24403	69	15	at	at	ADP
brj-24403	69	16	ambient	ambient	ADJ
brj-24403	69	17	temperature	temperature	NOUN
brj-24403	69	18	(	(	PUNCT
brj-24403	69	19	25	25	NUM
brj-24403	69	20	to	to	PART
brj-24403	69	21	35	35	NUM
brj-24403	69	22	°	°	NOUN
brj-24403	69	23	c	c	NOUN
brj-24403	69	24	)	)	PUNCT
brj-24403	69	25	for	for	ADP
brj-24403	69	26	approximately	approximately	ADV
brj-24403	69	27	two	two	NUM
brj-24403	69	28	weeks	week	NOUN
brj-24403	69	29	,	,	PUNCT
brj-24403	69	30	following	follow	VERB
brj-24403	69	31	standard	standard	ADJ
brj-24403	69	32	phytochemical	phytochemical	ADJ
brj-24403	69	33	preparation	preparation	NOUN
brj-24403	69	34	protocols	protocol	NOUN
brj-24403	69	35	.	.	PUNCT
brj-24403	70	1	since	since	SCONJ
brj-24403	70	2	the	the	DET
brj-24403	70	3	plant	plant	NOUN
brj-24403	70	4	material	material	NOUN
brj-24403	70	5	included	include	VERB
brj-24403	70	6	fruits	fruit	NOUN
brj-24403	70	7	,	,	PUNCT
brj-24403	70	8	which	which	PRON
brj-24403	70	9	inherently	inherently	ADV
brj-24403	70	10	retain	retain	VERB
brj-24403	70	11	higher	high	ADJ
brj-24403	70	12	moisture	moisture	NOUN
brj-24403	70	13	content	content	NOUN
brj-24403	70	14	compared	compare	VERB
brj-24403	70	15	to	to	ADP
brj-24403	70	16	leaves	leave	NOUN
brj-24403	70	17	and	and	CCONJ
brj-24403	70	18	stems	stem	NOUN
brj-24403	70	19	,	,	PUNCT
brj-24403	70	20	the	the	DET
brj-24403	70	21	adequacy	adequacy	NOUN
brj-24403	70	22	of	of	ADP
brj-24403	70	23	the	the	DET
brj-24403	70	24	drying	dry	VERB
brj-24403	70	25	period	period	NOUN
brj-24403	70	26	was	be	AUX
brj-24403	70	27	closely	closely	ADV
brj-24403	70	28	monitored	monitor	VERB
brj-24403	70	29	.	.	PUNCT
brj-24403	71	1	the	the	DET
brj-24403	71	2	drying	dry	VERB
brj-24403	71	3	progress	progress	NOUN
brj-24403	71	4	was	be	AUX
brj-24403	71	5	assessed	assess	VERB
brj-24403	71	6	through	through	ADP
brj-24403	71	7	regular	regular	ADJ
brj-24403	71	8	physical	physical	ADJ
brj-24403	71	9	inspection	inspection	NOUN
brj-24403	71	10	,	,	PUNCT
brj-24403	71	11	ensuring	ensure	VERB
brj-24403	71	12	that	that	SCONJ
brj-24403	71	13	the	the	DET
brj-24403	71	14	leaves	leave	NOUN
brj-24403	71	15	and	and	CCONJ
brj-24403	71	16	stems	stem	NOUN
brj-24403	71	17	became	become	VERB
brj-24403	71	18	brittle	brittle	ADJ
brj-24403	71	19	while	while	SCONJ
brj-24403	71	20	the	the	DET
brj-24403	71	21	fruits	fruit	NOUN
brj-24403	71	22	exhibited	exhibit	VERB
brj-24403	71	23	hardness	hardness	NOUN
brj-24403	71	24	and	and	CCONJ
brj-24403	71	25	shrivelling	shrivel	VERB
brj-24403	71	26	without	without	ADP
brj-24403	71	27	residual	residual	ADJ
brj-24403	71	28	softness	softness	NOUN
brj-24403	71	29	.	.	PUNCT
brj-24403	72	1	additionally	additionally	ADV
brj-24403	72	2	,	,	PUNCT
brj-24403	72	3	representative	representative	ADJ
brj-24403	72	4	samples	sample	NOUN
brj-24403	72	5	were	be	AUX
brj-24403	72	6	weighed	weigh	VERB
brj-24403	72	7	at	at	ADP
brj-24403	72	8	intervals	interval	NOUN
brj-24403	72	9	of	of	ADP
brj-24403	72	10	two	two	NUM
brj-24403	72	11	to	to	PART
brj-24403	72	12	three	three	NUM
brj-24403	72	13	days	day	NOUN
brj-24403	72	14	,	,	PUNCT
brj-24403	72	15	and	and	CCONJ
brj-24403	72	16	drying	dry	VERB
brj-24403	72	17	was	be	AUX
brj-24403	72	18	considered	consider	VERB
brj-24403	72	19	complete	complete	ADJ
brj-24403	72	20	when	when	SCONJ
brj-24403	72	21	no	no	DET
brj-24403	72	22	further	further	ADJ
brj-24403	72	23	reduction	reduction	NOUN
brj-24403	72	24	in	in	ADP
brj-24403	72	25	weight	weight	NOUN
brj-24403	72	26	was	be	AUX
brj-24403	72	27	observed	observe	VERB
brj-24403	72	28	over	over	ADP
brj-24403	72	29	two	two	NUM
brj-24403	72	30	consecutive	consecutive	ADJ
brj-24403	72	31	measurements	measurement	NOUN
brj-24403	72	32	.	.	PUNCT
brj-24403	73	1	to	to	PART
brj-24403	73	2	confirm	confirm	VERB
brj-24403	73	3	minimal	minimal	ADJ
brj-24403	73	4	residual	residual	ADJ
brj-24403	73	5	moisture	moisture	NOUN
brj-24403	73	6	,	,	PUNCT
brj-24403	73	7	a	a	DET
brj-24403	73	8	subsample	subsample	NOUN
brj-24403	73	9	was	be	AUX
brj-24403	73	10	subjected	subject	VERB
brj-24403	73	11	to	to	ADP
brj-24403	73	12	oven	oven	NOUN
brj-24403	73	13	-	-	PUNCT
brj-24403	73	14	drying	dry	VERB
brj-24403	73	15	at	at	ADP
brj-24403	73	16	105	105	NUM
brj-24403	73	17	°	°	ADP
brj-24403	73	18	c	c	NOUN
brj-24403	73	19	for	for	ADP
brj-24403	73	20	three	three	NUM
brj-24403	73	21	hours	hour	NOUN
brj-24403	73	22	,	,	PUNCT
brj-24403	73	23	and	and	CCONJ
brj-24403	73	24	the	the	DET
brj-24403	73	25	resulting	result	VERB
brj-24403	73	26	weight	weight	NOUN
brj-24403	73	27	loss	loss	NOUN
brj-24403	73	28	was	be	AUX
brj-24403	73	29	found	find	VERB
brj-24403	73	30	to	to	PART
brj-24403	73	31	be	be	AUX
brj-24403	73	32	negligible	negligible	ADJ
brj-24403	73	33	.	.	PUNCT
brj-24403	74	1	the	the	DET
brj-24403	74	2	completely	completely	ADV
brj-24403	74	3	dried	dry	VERB
brj-24403	74	4	plant	plant	NOUN
brj-24403	74	5	material	material	NOUN
brj-24403	74	6	was	be	AUX
brj-24403	74	7	then	then	ADV
brj-24403	74	8	milled	mill	VERB
brj-24403	74	9	to	to	ADP
brj-24403	74	10	a	a	DET
brj-24403	74	11	coarse	coarse	ADJ
brj-24403	74	12	powder	powder	NOUN
brj-24403	74	13	using	use	VERB
brj-24403	74	14	a	a	DET
brj-24403	74	15	ball	ball	NOUN
brj-24403	74	16	mill	mill	NOUN
brj-24403	74	17	and	and	CCONJ
brj-24403	74	18	sieved	sieve	VERB
brj-24403	74	19	through	through	ADP
brj-24403	74	20	a	a	DET
brj-24403	74	21	200	200	NUM
brj-24403	74	22	-	-	PUNCT
brj-24403	74	23	mesh	mesh	NOUN
brj-24403	74	24	sieve	sieve	NOUN
brj-24403	74	25	to	to	PART
brj-24403	74	26	obtain	obtain	VERB
brj-24403	74	27	uniform	uniform	ADJ
brj-24403	74	28	particle	particle	NOUN
brj-24403	74	29	size	size	NOUN
brj-24403	74	30	.	.	PUNCT
brj-24403	75	1	the	the	DET
brj-24403	75	2	powdered	powdered	ADJ
brj-24403	75	3	material	material	NOUN
brj-24403	75	4	was	be	AUX
brj-24403	75	5	stored	store	VERB
brj-24403	75	6	in	in	ADP
brj-24403	75	7	airtight	airtight	NOUN
brj-24403	75	8	containers	container	NOUN
brj-24403	75	9	at	at	ADP
brj-24403	75	10	room	room	NOUN
brj-24403	75	11	temperature	temperature	NOUN
brj-24403	75	12	until	until	ADP
brj-24403	75	13	further	further	ADJ
brj-24403	75	14	use	use	NOUN
brj-24403	75	15	.	.	PUNCT
brj-24403	76	1	preparation	preparation	NOUN
brj-24403	76	2	of	of	ADP
brj-24403	76	3	petroleum	petroleum	NOUN
brj-24403	76	4	ether	ether	NOUN
brj-24403	76	5	extract	extract	VERB
brj-24403	76	6	a	a	DET
brj-24403	76	7	total	total	NOUN
brj-24403	76	8	of	of	ADP
brj-24403	76	9	500	500	NUM
brj-24403	76	10	g	g	NOUN
brj-24403	76	11	of	of	ADP
brj-24403	76	12	the	the	DET
brj-24403	76	13	dried	dry	VERB
brj-24403	76	14	,	,	PUNCT
brj-24403	76	15	powdered	powdered	ADJ
brj-24403	76	16	plant	plant	NOUN
brj-24403	76	17	material	material	NOUN
brj-24403	76	18	was	be	AUX
brj-24403	76	19	subjected	subject	VERB
brj-24403	76	20	to	to	ADP
brj-24403	76	21	exhaustive	exhaustive	ADJ
brj-24403	76	22	extraction	extraction	NOUN
brj-24403	76	23	using	use	VERB
brj-24403	76	24	a	a	DET
brj-24403	76	25	soxhlet	soxhlet	ADJ
brj-24403	76	26	apparatus	apparatus	NOUN
brj-24403	76	27	with	with	ADP
brj-24403	76	28	petroleum	petroleum	NOUN
brj-24403	76	29	ether	ether	NOUN
brj-24403	76	30	(	(	PUNCT
brj-24403	76	31	boiling	boiling	NOUN
brj-24403	76	32	range	range	NOUN
brj-24403	76	33	40	40	NUM
brj-24403	76	34	to	to	PART
brj-24403	76	35	60	60	NUM
brj-24403	76	36	°	°	NOUN
brj-24403	76	37	c	c	NOUN
brj-24403	76	38	)	)	PUNCT
brj-24403	76	39	for	for	ADP
brj-24403	76	40	36	36	NUM
brj-24403	76	41	hours	hour	NOUN
brj-24403	76	42	.	.	PUNCT
brj-24403	77	1	petroleum	petroleum	NOUN
brj-24403	77	2	ether	ether	NOUN
brj-24403	77	3	was	be	AUX
brj-24403	77	4	selected	select	VERB
brj-24403	77	5	as	as	ADP
brj-24403	77	6	the	the	DET
brj-24403	77	7	extraction	extraction	NOUN
brj-24403	77	8	solvent	solvent	NOUN
brj-24403	77	9	due	due	ADP
brj-24403	77	10	to	to	ADP
brj-24403	77	11	its	its	PRON
brj-24403	77	12	non	non	ADJ
brj-24403	77	13	-	-	ADJ
brj-24403	77	14	polar	polar	ADJ
brj-24403	77	15	nature	nature	NOUN
brj-24403	77	16	,	,	PUNCT
brj-24403	77	17	which	which	PRON
brj-24403	77	18	facilitates	facilitate	VERB
brj-24403	77	19	the	the	DET
brj-24403	77	20	selective	selective	ADJ
brj-24403	77	21	extraction	extraction	NOUN
brj-24403	77	22	of	of	ADP
brj-24403	77	23	lipophilic	lipophilic	ADJ
brj-24403	77	24	phytoconstituents	phytoconstituent	NOUN
brj-24403	77	25	such	such	ADJ
brj-24403	77	26	as	as	ADP
brj-24403	77	27	fatty	fatty	NOUN
brj-24403	77	28	acids	acid	NOUN
brj-24403	77	29	,	,	PUNCT
brj-24403	77	30	terpenoids	terpenoid	NOUN
brj-24403	77	31	,	,	PUNCT
brj-24403	77	32	and	and	CCONJ
brj-24403	77	33	phytosterols	phytosterol	NOUN
brj-24403	77	34	.	.	PUNCT
brj-24403	78	1	its	its	PRON
brj-24403	78	2	low	low	ADJ
brj-24403	78	3	boiling	boiling	NOUN
brj-24403	78	4	point	point	NOUN
brj-24403	78	5	further	far	ADV
brj-24403	78	6	enabled	enable	VERB
brj-24403	78	7	efficient	efficient	ADJ
brj-24403	78	8	solvent	solvent	NOUN
brj-24403	78	9	recovery	recovery	NOUN
brj-24403	78	10	under	under	ADP
brj-24403	78	11	reduced	reduced	ADJ
brj-24403	78	12	pressure	pressure	NOUN
brj-24403	78	13	without	without	ADP
brj-24403	78	14	degrading	degrade	VERB
brj-24403	78	15	thermolabile	thermolabile	NOUN
brj-24403	78	16	compounds	compound	NOUN
brj-24403	78	17	.	.	PUNCT
brj-24403	79	1	the	the	DET
brj-24403	79	2	obtained	obtain	VERB
brj-24403	79	3	extract	extract	NOUN
brj-24403	79	4	was	be	AUX
brj-24403	79	5	concentrated	concentrate	VERB
brj-24403	79	6	using	use	VERB
brj-24403	79	7	a	a	DET
brj-24403	79	8	rotary	rotary	ADJ
brj-24403	79	9	evaporator	evaporator	NOUN
brj-24403	79	10	under	under	ADP
brj-24403	79	11	reduced	reduce	VERB
brj-24403	79	12	pressure	pressure	NOUN
brj-24403	79	13	and	and	CCONJ
brj-24403	79	14	further	far	ADV
brj-24403	79	15	dried	dry	VERB
brj-24403	79	16	using	use	VERB
brj-24403	79	17	a	a	DET
brj-24403	79	18	vacuum	vacuum	NOUN
brj-24403	79	19	pump	pump	NOUN
brj-24403	79	20	to	to	PART
brj-24403	79	21	yield	yield	VERB
brj-24403	79	22	25	25	NUM
brj-24403	79	23	g	g	NOUN
brj-24403	79	24	of	of	ADP
brj-24403	79	25	semi	semi	ADJ
brj-24403	79	26	-	-	ADJ
brj-24403	79	27	solid	solid	ADJ
brj-24403	79	28	crude	crude	ADJ
brj-24403	79	29	extract	extract	NOUN
brj-24403	79	30	.	.	PUNCT
brj-24403	80	1	the	the	DET
brj-24403	80	2	extract	extract	NOUN
brj-24403	80	3	was	be	AUX
brj-24403	80	4	stored	store	VERB
brj-24403	80	5	in	in	ADP
brj-24403	80	6	an	an	DET
brj-24403	80	7	airtight	airtight	NOUN
brj-24403	80	8	container	container	NOUN
brj-24403	80	9	at	at	ADP
brj-24403	80	10	4	4	NUM
brj-24403	80	11	°	°	NOUN
brj-24403	80	12	c	c	NOUN
brj-24403	80	13	until	until	ADP
brj-24403	80	14	further	further	ADJ
brj-24403	80	15	analysis	analysis	NOUN
brj-24403	80	16	and	and	CCONJ
brj-24403	80	17	bioassay	bioassay	NOUN
brj-24403	80	18	evaluation	evaluation	NOUN
brj-24403	80	19	.	.	PUNCT
brj-24403	81	1	preliminary	preliminary	ADJ
brj-24403	81	2	phytochemical	phytochemical	ADJ
brj-24403	81	3	screening	screen	VERB
brj-24403	81	4	the	the	DET
brj-24403	81	5	petroleum	petroleum	NOUN
brj-24403	81	6	ether	ether	NOUN
brj-24403	81	7	extract	extract	NOUN
brj-24403	81	8	was	be	AUX
brj-24403	81	9	subjected	subject	VERB
brj-24403	81	10	to	to	ADP
brj-24403	81	11	qualitative	qualitative	VERB
brj-24403	81	12	phytochemical	phytochemical	ADJ
brj-24403	81	13	screening	screening	NOUN
brj-24403	81	14	to	to	PART
brj-24403	81	15	identify	identify	VERB
brj-24403	81	16	the	the	DET
brj-24403	81	17	major	major	ADJ
brj-24403	81	18	classes	class	NOUN
brj-24403	81	19	of	of	ADP
brj-24403	81	20	non	non	ADJ
brj-24403	81	21	-	-	ADJ
brj-24403	81	22	polar	polar	ADJ
brj-24403	81	23	secondary	secondary	ADJ
brj-24403	81	24	metabolites	metabolite	NOUN
brj-24403	81	25	,	,	PUNCT
brj-24403	81	26	following	follow	VERB
brj-24403	81	27	standard	standard	ADJ
brj-24403	81	28	procedures	procedure	NOUN
brj-24403	81	29	:	:	PUNCT
brj-24403	81	30	test	test	NOUN
brj-24403	81	31	for	for	ADP
brj-24403	81	32	phytosterols	phytosterol	NOUN
brj-24403	81	33	(	(	PUNCT
brj-24403	81	34	liebermann	liebermann	PROPN
brj-24403	81	35	–	–	PUNCT
brj-24403	81	36	burchard	burchard	PROPN
brj-24403	81	37	test	test	NOUN
brj-24403	81	38	)	)	PUNCT
brj-24403	81	39	two	two	NUM
brj-24403	81	40	milliliters	milliliter	NOUN
brj-24403	81	41	of	of	ADP
brj-24403	81	42	the	the	DET
brj-24403	81	43	extract	extract	NOUN
brj-24403	81	44	solution	solution	NOUN
brj-24403	81	45	were	be	AUX
brj-24403	81	46	mixed	mix	VERB
brj-24403	81	47	with	with	ADP
brj-24403	81	48	2	2	NUM
brj-24403	81	49	ml	ml	NOUN
brj-24403	81	50	of	of	ADP
brj-24403	81	51	chloroform	chloroform	NOUN
brj-24403	81	52	.	.	PUNCT
brj-24403	82	1	to	to	ADP
brj-24403	82	2	this	this	PRON
brj-24403	82	3	,	,	PUNCT
brj-24403	82	4	2	2	NUM
brj-24403	82	5	to	to	PART
brj-24403	82	6	3	3	NUM
brj-24403	82	7	drops	drop	NOUN
brj-24403	82	8	of	of	ADP
brj-24403	82	9	acetic	acetic	ADJ
brj-24403	82	10	anhydride	anhydride	NOUN
brj-24403	82	11	were	be	AUX
brj-24403	82	12	added	add	VERB
brj-24403	82	13	,	,	PUNCT
brj-24403	82	14	followed	follow	VERB
brj-24403	82	15	by	by	ADP
brj-24403	82	16	the	the	DET
brj-24403	82	17	careful	careful	ADJ
brj-24403	82	18	addition	addition	NOUN
brj-24403	82	19	of	of	ADP
brj-24403	82	20	1	1	NUM
brj-24403	82	21	ml	ml	ADP
brj-24403	82	22	concentrated	concentrate	VERB
brj-24403	82	23	sulfuric	sulfuric	NOUN
brj-24403	82	24	acid	acid	NOUN
brj-24403	82	25	along	along	ADP
brj-24403	82	26	the	the	DET
brj-24403	82	27	side	side	NOUN
brj-24403	82	28	of	of	ADP
brj-24403	82	29	the	the	DET
brj-24403	82	30	test	test	NOUN
brj-24403	82	31	tube	tube	NOUN
brj-24403	82	32	.	.	PUNCT
brj-24403	83	1	the	the	DET
brj-24403	83	2	formation	formation	NOUN
brj-24403	83	3	of	of	ADP
brj-24403	83	4	a	a	DET
brj-24403	83	5	bluish	bluish	ADJ
brj-24403	83	6	-	-	PUNCT
brj-24403	83	7	green	green	ADJ
brj-24403	83	8	color	color	NOUN
brj-24403	83	9	indicated	indicate	VERB
brj-24403	83	10	the	the	DET
brj-24403	83	11	presence	presence	NOUN
brj-24403	83	12	of	of	ADP
brj-24403	83	13	phytosterols	phytosterol	NOUN
brj-24403	83	14	.	.	PUNCT
brj-24403	84	1	test	test	NOUN
brj-24403	84	2	for	for	ADP
brj-24403	84	3	terpenoids	terpenoid	NOUN
brj-24403	84	4	(	(	PUNCT
brj-24403	84	5	salkowski	salkowski	PROPN
brj-24403	84	6	’s	’s	PART
brj-24403	84	7	test	test	NOUN
brj-24403	84	8	)	)	PUNCT
brj-24403	84	9	a	a	DET
brj-24403	84	10	small	small	ADJ
brj-24403	84	11	quantity	quantity	NOUN
brj-24403	84	12	of	of	ADP
brj-24403	84	13	the	the	DET
brj-24403	84	14	extract	extract	NOUN
brj-24403	84	15	was	be	AUX
brj-24403	84	16	dissolved	dissolve	VERB
brj-24403	84	17	in	in	ADP
brj-24403	84	18	2	2	NUM
brj-24403	84	19	ml	ml	NOUN
brj-24403	84	20	of	of	ADP
brj-24403	84	21	chloroform	chloroform	NOUN
brj-24403	84	22	.	.	PUNCT
brj-24403	85	1	to	to	ADP
brj-24403	85	2	this	this	PRON
brj-24403	85	3	,	,	PUNCT
brj-24403	85	4	2	2	NUM
brj-24403	85	5	ml	ml	NOUN
brj-24403	85	6	of	of	ADP
brj-24403	85	7	concentrated	concentrated	ADJ
brj-24403	85	8	sulfuric	sulfuric	NOUN
brj-24403	85	9	acid	acid	NOUN
brj-24403	85	10	was	be	AUX
brj-24403	85	11	carefully	carefully	ADV
brj-24403	85	12	added	add	VERB
brj-24403	85	13	to	to	PART
brj-24403	85	14	form	form	VERB
brj-24403	85	15	a	a	DET
brj-24403	85	16	layer	layer	NOUN
brj-24403	85	17	.	.	PUNCT
brj-24403	86	1	a	a	DET
brj-24403	86	2	reddish	reddish	ADJ
brj-24403	86	3	-	-	PUNCT
brj-24403	86	4	brown	brown	ADJ
brj-24403	86	5	coloration	coloration	NOUN
brj-24403	86	6	at	at	ADP
brj-24403	86	7	the	the	DET
brj-24403	86	8	interface	interface	NOUN
brj-24403	86	9	indicated	indicate	VERB
brj-24403	86	10	the	the	DET
brj-24403	86	11	presence	presence	NOUN
brj-24403	86	12	of	of	ADP
brj-24403	86	13	terpenoids	terpenoid	NOUN
brj-24403	86	14	.	.	PUNCT
brj-24403	87	1	peer	peer	NOUN
brj-24403	87	2	-	-	PUNCT
brj-24403	87	3	reviewed	review	VERB
brj-24403	87	4	article	article	NOUN
brj-24403	87	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	87	6	li	li	PROPN
brj-24403	87	7	et	et	PROPN
brj-24403	87	8	al	al	PROPN
brj-24403	87	9	.	.	PROPN
brj-24403	88	1	(	(	PUNCT
brj-24403	88	2	2025	2025	NUM
brj-24403	88	3	)	)	PUNCT
brj-24403	88	4	.	.	PUNCT
brj-24403	89	1	“	"	PUNCT
brj-24403	89	2	herbal	herbal	ADJ
brj-24403	89	3	anti	anti	ADJ
brj-24403	89	4	-	-	ADJ
brj-24403	89	5	epileptic	epileptic	ADJ
brj-24403	89	6	extract	extract	NOUN
brj-24403	89	7	,	,	PUNCT
brj-24403	89	8	”	"	PUNCT
brj-24403	89	9	bioresources	bioresource	NOUN
brj-24403	89	10	20(2	20(2	NUM
brj-24403	89	11	)	)	PUNCT
brj-24403	89	12	,	,	PUNCT
brj-24403	89	13	4701	4701	NUM
brj-24403	89	14	-	-	SYM
brj-24403	89	15	4719	4719	NUM
brj-24403	89	16	.	.	PUNCT
brj-24403	89	17	4705	4705	NUM
brj-24403	89	18	test	test	NOUN
brj-24403	89	19	for	for	ADP
brj-24403	89	20	fixed	fix	VERB
brj-24403	89	21	oils	oil	NOUN
brj-24403	89	22	and	and	CCONJ
brj-24403	89	23	fats	fat	NOUN
brj-24403	89	24	(	(	PUNCT
brj-24403	89	25	spot	spot	NOUN
brj-24403	89	26	test	test	NOUN
brj-24403	89	27	)	)	PUNCT
brj-24403	89	28	a	a	DET
brj-24403	89	29	small	small	ADJ
brj-24403	89	30	amount	amount	NOUN
brj-24403	89	31	of	of	ADP
brj-24403	89	32	the	the	DET
brj-24403	89	33	extract	extract	NOUN
brj-24403	89	34	was	be	AUX
brj-24403	89	35	pressed	press	VERB
brj-24403	89	36	between	between	ADP
brj-24403	89	37	two	two	NUM
brj-24403	89	38	filter	filter	NOUN
brj-24403	89	39	papers	paper	NOUN
brj-24403	89	40	.	.	PUNCT
brj-24403	90	1	the	the	DET
brj-24403	90	2	appearance	appearance	NOUN
brj-24403	90	3	of	of	ADP
brj-24403	90	4	a	a	DET
brj-24403	90	5	persistent	persistent	ADJ
brj-24403	90	6	,	,	PUNCT
brj-24403	90	7	translucent	translucent	ADJ
brj-24403	90	8	oily	oily	ADJ
brj-24403	90	9	spot	spot	NOUN
brj-24403	90	10	indicated	indicate	VERB
brj-24403	90	11	the	the	DET
brj-24403	90	12	presence	presence	NOUN
brj-24403	90	13	of	of	ADP
brj-24403	90	14	fixed	fix	VERB
brj-24403	90	15	oils	oil	NOUN
brj-24403	90	16	and	and	CCONJ
brj-24403	90	17	fats	fat	NOUN
brj-24403	90	18	.	.	PUNCT
brj-24403	91	1	detection	detection	NOUN
brj-24403	91	2	of	of	ADP
brj-24403	91	3	fats	fat	NOUN
brj-24403	91	4	and	and	CCONJ
brj-24403	91	5	oils	oil	NOUN
brj-24403	91	6	(	(	PUNCT
brj-24403	91	7	sudan	sudan	PROPN
brj-24403	91	8	iii	iii	PROPN
brj-24403	91	9	staining	staining	NOUN
brj-24403	91	10	)	)	PUNCT
brj-24403	91	11	the	the	DET
brj-24403	91	12	extract	extract	NOUN
brj-24403	91	13	was	be	AUX
brj-24403	91	14	dissolved	dissolve	VERB
brj-24403	91	15	in	in	ADP
brj-24403	91	16	ethanol	ethanol	NOUN
brj-24403	91	17	,	,	PUNCT
brj-24403	91	18	and	and	CCONJ
brj-24403	91	19	a	a	DET
brj-24403	91	20	few	few	ADJ
brj-24403	91	21	drops	drop	NOUN
brj-24403	91	22	of	of	ADP
brj-24403	91	23	sudan	sudan	PROPN
brj-24403	91	24	iii	iii	PROPN
brj-24403	91	25	solution	solution	NOUN
brj-24403	91	26	were	be	AUX
brj-24403	91	27	added	add	VERB
brj-24403	91	28	.	.	PUNCT
brj-24403	92	1	the	the	DET
brj-24403	92	2	formation	formation	NOUN
brj-24403	92	3	of	of	ADP
brj-24403	92	4	red	red	ADJ
brj-24403	92	5	-	-	PUNCT
brj-24403	92	6	colored	color	VERB
brj-24403	92	7	droplets	droplet	NOUN
brj-24403	92	8	indicated	indicate	VERB
brj-24403	92	9	the	the	DET
brj-24403	92	10	presence	presence	NOUN
brj-24403	92	11	of	of	ADP
brj-24403	92	12	fats	fat	NOUN
brj-24403	92	13	and	and	CCONJ
brj-24403	92	14	oils	oil	NOUN
brj-24403	92	15	.	.	PUNCT
brj-24403	93	1	test	test	NOUN
brj-24403	93	2	for	for	ADP
brj-24403	93	3	alkaloids	alkaloid	NOUN
brj-24403	93	4	the	the	DET
brj-24403	93	5	extract	extract	NOUN
brj-24403	93	6	was	be	AUX
brj-24403	93	7	treated	treat	VERB
brj-24403	93	8	with	with	ADP
brj-24403	93	9	dragendorff	dragendorff	PROPN
brj-24403	93	10	’s	’s	PART
brj-24403	93	11	reagent	reagent	NOUN
brj-24403	93	12	.	.	PUNCT
brj-24403	94	1	the	the	DET
brj-24403	94	2	absence	absence	NOUN
brj-24403	94	3	of	of	ADP
brj-24403	94	4	an	an	DET
brj-24403	94	5	orange	orange	ADJ
brj-24403	94	6	or	or	CCONJ
brj-24403	94	7	reddish	reddish	ADJ
brj-24403	94	8	-	-	PUNCT
brj-24403	94	9	brown	brown	NOUN
brj-24403	94	10	precipitate	precipitate	NOUN
brj-24403	94	11	indicated	indicate	VERB
brj-24403	94	12	the	the	DET
brj-24403	94	13	absence	absence	NOUN
brj-24403	94	14	of	of	ADP
brj-24403	94	15	alkaloids	alkaloid	NOUN
brj-24403	94	16	.	.	PUNCT
brj-24403	94	17	test	test	NOUN
brj-24403	94	18	for	for	ADP
brj-24403	94	19	flavonoids	flavonoid	NOUN
brj-24403	94	20	a	a	DET
brj-24403	94	21	small	small	ADJ
brj-24403	94	22	quantity	quantity	NOUN
brj-24403	94	23	of	of	ADP
brj-24403	94	24	the	the	DET
brj-24403	94	25	extract	extract	NOUN
brj-24403	94	26	was	be	AUX
brj-24403	94	27	treated	treat	VERB
brj-24403	94	28	with	with	ADP
brj-24403	94	29	a	a	DET
brj-24403	94	30	few	few	ADJ
brj-24403	94	31	drops	drop	NOUN
brj-24403	94	32	of	of	ADP
brj-24403	94	33	10	10	NUM
brj-24403	94	34	%	%	NOUN
brj-24403	94	35	lead	lead	NOUN
brj-24403	94	36	acetate	acetate	NOUN
brj-24403	94	37	solution	solution	NOUN
brj-24403	94	38	.	.	PUNCT
brj-24403	95	1	the	the	DET
brj-24403	95	2	absence	absence	NOUN
brj-24403	95	3	of	of	ADP
brj-24403	95	4	a	a	DET
brj-24403	95	5	yellow	yellow	ADJ
brj-24403	95	6	precipitate	precipitate	NOUN
brj-24403	95	7	indicated	indicate	VERB
brj-24403	95	8	the	the	DET
brj-24403	95	9	absence	absence	NOUN
brj-24403	95	10	of	of	ADP
brj-24403	95	11	flavonoids	flavonoid	NOUN
brj-24403	95	12	.	.	PUNCT
brj-24403	96	1	test	test	NOUN
brj-24403	96	2	for	for	ADP
brj-24403	96	3	tannins	tannin	NOUN
brj-24403	96	4	to	to	ADP
brj-24403	96	5	a	a	DET
brj-24403	96	6	small	small	ADJ
brj-24403	96	7	portion	portion	NOUN
brj-24403	96	8	of	of	ADP
brj-24403	96	9	the	the	DET
brj-24403	96	10	extract	extract	NOUN
brj-24403	96	11	solution	solution	NOUN
brj-24403	96	12	,	,	PUNCT
brj-24403	96	13	a	a	DET
brj-24403	96	14	few	few	ADJ
brj-24403	96	15	drops	drop	NOUN
brj-24403	96	16	of	of	ADP
brj-24403	96	17	5	5	NUM
brj-24403	96	18	%	%	NOUN
brj-24403	96	19	ferric	ferric	ADJ
brj-24403	96	20	chloride	chloride	NOUN
brj-24403	96	21	solution	solution	NOUN
brj-24403	96	22	were	be	AUX
brj-24403	96	23	added	add	VERB
brj-24403	96	24	.	.	PUNCT
brj-24403	97	1	the	the	DET
brj-24403	97	2	absence	absence	NOUN
brj-24403	97	3	of	of	ADP
brj-24403	97	4	a	a	DET
brj-24403	97	5	dark	dark	ADJ
brj-24403	97	6	blue	blue	ADJ
brj-24403	97	7	or	or	CCONJ
brj-24403	97	8	greenish	greenish	ADJ
brj-24403	97	9	-	-	PUNCT
brj-24403	97	10	black	black	ADJ
brj-24403	97	11	color	color	NOUN
brj-24403	97	12	indicated	indicate	VERB
brj-24403	97	13	the	the	DET
brj-24403	97	14	absence	absence	NOUN
brj-24403	97	15	of	of	ADP
brj-24403	97	16	tannins	tannin	NOUN
brj-24403	97	17	.	.	PUNCT
brj-24403	98	1	test	test	NOUN
brj-24403	98	2	for	for	ADP
brj-24403	98	3	saponins	saponin	NOUN
brj-24403	98	4	(	(	PUNCT
brj-24403	98	5	foam	foam	NOUN
brj-24403	98	6	test	test	NOUN
brj-24403	98	7	)	)	PUNCT
brj-24403	98	8	a	a	DET
brj-24403	98	9	small	small	ADJ
brj-24403	98	10	quantity	quantity	NOUN
brj-24403	98	11	of	of	ADP
brj-24403	98	12	the	the	DET
brj-24403	98	13	extract	extract	NOUN
brj-24403	98	14	was	be	AUX
brj-24403	98	15	vigorously	vigorously	ADV
brj-24403	98	16	shaken	shake	VERB
brj-24403	98	17	with	with	ADP
brj-24403	98	18	distilled	distil	VERB
brj-24403	98	19	water	water	NOUN
brj-24403	98	20	in	in	ADP
brj-24403	98	21	a	a	DET
brj-24403	98	22	test	test	NOUN
brj-24403	98	23	tube	tube	NOUN
brj-24403	98	24	.	.	PUNCT
brj-24403	99	1	the	the	DET
brj-24403	99	2	absence	absence	NOUN
brj-24403	99	3	of	of	ADP
brj-24403	99	4	persistent	persistent	ADJ
brj-24403	99	5	froth	froth	NOUN
brj-24403	99	6	indicated	indicate	VERB
brj-24403	99	7	the	the	DET
brj-24403	99	8	absence	absence	NOUN
brj-24403	99	9	of	of	ADP
brj-24403	99	10	saponins	saponin	NOUN
brj-24403	99	11	.	.	PUNCT
brj-24403	100	1	test	test	NOUN
brj-24403	100	2	for	for	ADP
brj-24403	100	3	glycosides	glycoside	NOUN
brj-24403	100	4	(	(	PUNCT
brj-24403	100	5	keller	keller	PROPN
brj-24403	100	6	–	–	PUNCT
brj-24403	100	7	killiani	killiani	ADJ
brj-24403	100	8	test	test	NOUN
brj-24403	100	9	)	)	PUNCT
brj-24403	100	10	two	two	NUM
brj-24403	100	11	milliliters	milliliter	NOUN
brj-24403	100	12	of	of	ADP
brj-24403	100	13	the	the	DET
brj-24403	100	14	extract	extract	NOUN
brj-24403	100	15	solution	solution	NOUN
brj-24403	100	16	were	be	AUX
brj-24403	100	17	mixed	mix	VERB
brj-24403	100	18	with	with	ADP
brj-24403	100	19	1	1	NUM
brj-24403	100	20	ml	ml	NOUN
brj-24403	100	21	of	of	ADP
brj-24403	100	22	glacial	glacial	ADJ
brj-24403	100	23	acetic	acetic	ADJ
brj-24403	100	24	acid	acid	NOUN
brj-24403	100	25	containing	contain	VERB
brj-24403	100	26	a	a	DET
brj-24403	100	27	trace	trace	NOUN
brj-24403	100	28	amount	amount	NOUN
brj-24403	100	29	of	of	ADP
brj-24403	100	30	ferric	ferric	ADJ
brj-24403	100	31	chloride	chloride	NOUN
brj-24403	100	32	.	.	PUNCT
brj-24403	101	1	this	this	PRON
brj-24403	101	2	was	be	AUX
brj-24403	101	3	carefully	carefully	ADV
brj-24403	101	4	under	under	ADV
brj-24403	101	5	-	-	PUNCT
brj-24403	101	6	layered	layered	ADJ
brj-24403	101	7	with	with	ADP
brj-24403	101	8	1	1	NUM
brj-24403	101	9	ml	ml	NOUN
brj-24403	101	10	of	of	ADP
brj-24403	101	11	concentrated	concentrated	ADJ
brj-24403	101	12	sulfuric	sulfuric	ADJ
brj-24403	101	13	acid	acid	NOUN
brj-24403	101	14	.	.	PUNCT
brj-24403	102	1	the	the	DET
brj-24403	102	2	absence	absence	NOUN
brj-24403	102	3	of	of	ADP
brj-24403	102	4	a	a	DET
brj-24403	102	5	reddish	reddish	ADJ
brj-24403	102	6	-	-	PUNCT
brj-24403	102	7	brown	brown	ADJ
brj-24403	102	8	layer	layer	NOUN
brj-24403	102	9	at	at	ADP
brj-24403	102	10	the	the	DET
brj-24403	102	11	junction	junction	NOUN
brj-24403	102	12	indicated	indicate	VERB
brj-24403	102	13	the	the	DET
brj-24403	102	14	absence	absence	NOUN
brj-24403	102	15	of	of	ADP
brj-24403	102	16	cardiac	cardiac	ADJ
brj-24403	102	17	glycosides	glycoside	NOUN
brj-24403	102	18	.	.	PUNCT
brj-24403	103	1	animals	animal	NOUN
brj-24403	103	2	male	male	ADJ
brj-24403	103	3	swiss	swiss	ADJ
brj-24403	103	4	mice	mouse	NOUN
brj-24403	103	5	,	,	PUNCT
brj-24403	103	6	weighing	weigh	VERB
brj-24403	103	7	25	25	NUM
brj-24403	103	8	to	to	PART
brj-24403	103	9	30	30	NUM
brj-24403	103	10	g	g	NOUN
brj-24403	103	11	,	,	PUNCT
brj-24403	103	12	were	be	AUX
brj-24403	103	13	obtained	obtain	VERB
brj-24403	103	14	from	from	ADP
brj-24403	103	15	the	the	DET
brj-24403	103	16	institutional	institutional	ADJ
brj-24403	103	17	animal	animal	NOUN
brj-24403	103	18	house	house	NOUN
brj-24403	103	19	and	and	CCONJ
brj-24403	103	20	housed	house	VERB
brj-24403	103	21	in	in	ADP
brj-24403	103	22	a	a	DET
brj-24403	103	23	strictly	strictly	ADV
brj-24403	103	24	aseptic	aseptic	ADJ
brj-24403	103	25	environment	environment	NOUN
brj-24403	103	26	.	.	PUNCT
brj-24403	104	1	the	the	DET
brj-24403	104	2	mice	mouse	NOUN
brj-24403	104	3	were	be	AUX
brj-24403	104	4	maintained	maintain	VERB
brj-24403	104	5	under	under	ADP
brj-24403	104	6	controlled	control	VERB
brj-24403	104	7	conditions	condition	NOUN
brj-24403	104	8	,	,	PUNCT
brj-24403	104	9	including	include	VERB
brj-24403	104	10	a	a	DET
brj-24403	104	11	12	12	NUM
brj-24403	104	12	-	-	PUNCT
brj-24403	104	13	h	h	NOUN
brj-24403	104	14	light	light	ADJ
brj-24403	104	15	/	/	SYM
brj-24403	104	16	dark	dark	ADJ
brj-24403	104	17	cycle	cycle	NOUN
brj-24403	104	18	at	at	ADP
brj-24403	104	19	a	a	DET
brj-24403	104	20	constant	constant	ADJ
brj-24403	104	21	temperature	temperature	NOUN
brj-24403	104	22	of	of	ADP
brj-24403	104	23	21	21	NUM
brj-24403	104	24	to	to	PART
brj-24403	104	25	24	24	NUM
brj-24403	104	26	°	°	NOUN
brj-24403	104	27	c	c	NOUN
brj-24403	104	28	,	,	PUNCT
brj-24403	104	29	with	with	ADP
brj-24403	104	30	uninterrupted	uninterrupted	ADJ
brj-24403	104	31	access	access	NOUN
brj-24403	104	32	to	to	ADP
brj-24403	104	33	food	food	NOUN
brj-24403	104	34	and	and	CCONJ
brj-24403	104	35	water	water	NOUN
brj-24403	104	36	.	.	PUNCT
brj-24403	105	1	to	to	PART
brj-24403	105	2	ensure	ensure	VERB
brj-24403	105	3	acclimatization	acclimatization	NOUN
brj-24403	105	4	to	to	ADP
brj-24403	105	5	the	the	DET
brj-24403	105	6	laboratory	laboratory	NOUN
brj-24403	105	7	environment	environment	NOUN
brj-24403	105	8	and	and	CCONJ
brj-24403	105	9	minimize	minimize	VERB
brj-24403	105	10	stress	stress	NOUN
brj-24403	105	11	,	,	PUNCT
brj-24403	105	12	the	the	DET
brj-24403	105	13	animals	animal	NOUN
brj-24403	105	14	were	be	AUX
brj-24403	105	15	kept	keep	VERB
brj-24403	105	16	under	under	ADP
brj-24403	105	17	these	these	DET
brj-24403	105	18	conditions	condition	NOUN
brj-24403	105	19	for	for	ADP
brj-24403	105	20	seven	seven	NUM
brj-24403	105	21	days	day	NOUN
brj-24403	105	22	before	before	ADP
brj-24403	105	23	the	the	DET
brj-24403	105	24	commencement	commencement	NOUN
brj-24403	105	25	of	of	ADP
brj-24403	105	26	the	the	DET
brj-24403	105	27	experiment	experiment	NOUN
brj-24403	105	28	.	.	PUNCT
brj-24403	106	1	ethical	ethical	ADJ
brj-24403	106	2	statement	statement	NOUN
brj-24403	106	3	all	all	DET
brj-24403	106	4	animal	animal	NOUN
brj-24403	106	5	experiments	experiment	NOUN
brj-24403	106	6	were	be	AUX
brj-24403	106	7	conducted	conduct	VERB
brj-24403	106	8	in	in	ADP
brj-24403	106	9	accordance	accordance	NOUN
brj-24403	106	10	with	with	ADP
brj-24403	106	11	international	international	ADJ
brj-24403	106	12	,	,	PUNCT
brj-24403	106	13	national	national	ADJ
brj-24403	106	14	,	,	PUNCT
brj-24403	106	15	and	and	CCONJ
brj-24403	106	16	institutional	institutional	ADJ
brj-24403	106	17	guidelines	guideline	NOUN
brj-24403	106	18	for	for	ADP
brj-24403	106	19	the	the	DET
brj-24403	106	20	care	care	NOUN
brj-24403	106	21	and	and	CCONJ
brj-24403	106	22	use	use	NOUN
brj-24403	106	23	of	of	ADP
brj-24403	106	24	laboratory	laboratory	NOUN
brj-24403	106	25	animals	animal	NOUN
brj-24403	106	26	.	.	PUNCT
brj-24403	107	1	the	the	DET
brj-24403	107	2	study	study	NOUN
brj-24403	107	3	protocol	protocol	NOUN
brj-24403	107	4	was	be	AUX
brj-24403	107	5	reviewed	review	VERB
brj-24403	107	6	and	and	CCONJ
brj-24403	107	7	approved	approve	VERB
brj-24403	107	8	by	by	ADP
brj-24403	107	9	the	the	DET
brj-24403	107	10	animal	animal	NOUN
brj-24403	107	11	ethical	ethical	PROPN
brj-24403	107	12	committee	committee	NOUN
brj-24403	107	13	of	of	ADP
brj-24403	107	14	the	the	DET
brj-24403	107	15	people	people	NOUN
brj-24403	107	16	’s	’s	PART
brj-24403	107	17	hospital	hospital	NOUN
brj-24403	107	18	of	of	ADP
brj-24403	107	19	nanchang	nanchang	PROPN
brj-24403	107	20	,	,	PUNCT
brj-24403	107	21	china	china	PROPN
brj-24403	107	22	(	(	PUNCT
brj-24403	107	23	approval	approval	NOUN
brj-24403	107	24	number	number	NOUN
brj-24403	107	25	:	:	PUNCT
brj-24403	107	26	k	k	PROPN
brj-24403	107	27	-	-	PUNCT
brj-24403	107	28	ky2022023	ky2022023	NOUN
brj-24403	107	29	)	)	PUNCT
brj-24403	107	30	.	.	PUNCT
brj-24403	108	1	all	all	DET
brj-24403	108	2	procedures	procedure	NOUN
brj-24403	108	3	adhered	adhere	VERB
brj-24403	108	4	to	to	ADP
brj-24403	108	5	the	the	DET
brj-24403	108	6	national	national	PROPN
brj-24403	108	7	institutes	institutes	PROPN
brj-24403	108	8	of	of	ADP
brj-24403	108	9	health	health	PROPN
brj-24403	108	10	(	(	PUNCT
brj-24403	108	11	nih	nih	NOUN
brj-24403	108	12	)	)	PUNCT
brj-24403	108	13	guide	guide	NOUN
brj-24403	108	14	for	for	ADP
brj-24403	108	15	the	the	DET
brj-24403	108	16	care	care	NOUN
brj-24403	108	17	and	and	CCONJ
brj-24403	108	18	use	use	NOUN
brj-24403	108	19	of	of	ADP
brj-24403	108	20	laboratory	laboratory	NOUN
brj-24403	108	21	animals	animal	NOUN
brj-24403	108	22	.	.	PUNCT
brj-24403	109	1	every	every	DET
brj-24403	109	2	effort	effort	NOUN
brj-24403	109	3	was	be	AUX
brj-24403	109	4	made	make	VERB
brj-24403	109	5	to	to	PART
brj-24403	109	6	minimize	minimize	VERB
brj-24403	109	7	animal	animal	NOUN
brj-24403	109	8	suffering	suffering	NOUN
brj-24403	109	9	and	and	CCONJ
brj-24403	109	10	to	to	PART
brj-24403	109	11	use	use	VERB
brj-24403	109	12	the	the	DET
brj-24403	109	13	minimum	minimum	ADJ
brj-24403	109	14	number	number	NOUN
brj-24403	109	15	of	of	ADP
brj-24403	109	16	animals	animal	NOUN
brj-24403	109	17	required	require	VERB
brj-24403	109	18	to	to	PART
brj-24403	109	19	achieve	achieve	VERB
brj-24403	109	20	reliable	reliable	ADJ
brj-24403	109	21	scientific	scientific	ADJ
brj-24403	109	22	results	result	NOUN
brj-24403	109	23	.	.	PUNCT
brj-24403	110	1	peer	peer	NOUN
brj-24403	110	2	-	-	PUNCT
brj-24403	110	3	reviewed	review	VERB
brj-24403	110	4	article	article	NOUN
brj-24403	110	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	110	6	li	li	PROPN
brj-24403	110	7	et	et	PROPN
brj-24403	110	8	al	al	PROPN
brj-24403	110	9	.	.	PROPN
brj-24403	111	1	(	(	PUNCT
brj-24403	111	2	2025	2025	NUM
brj-24403	111	3	)	)	PUNCT
brj-24403	111	4	.	.	PUNCT
brj-24403	112	1	“	"	PUNCT
brj-24403	112	2	herbal	herbal	ADJ
brj-24403	112	3	anti	anti	ADJ
brj-24403	112	4	-	-	ADJ
brj-24403	112	5	epileptic	epileptic	ADJ
brj-24403	112	6	extract	extract	NOUN
brj-24403	112	7	,	,	PUNCT
brj-24403	112	8	”	"	PUNCT
brj-24403	112	9	bioresources	bioresource	NOUN
brj-24403	112	10	20(2	20(2	NUM
brj-24403	112	11	)	)	PUNCT
brj-24403	112	12	,	,	PUNCT
brj-24403	112	13	4701	4701	NUM
brj-24403	112	14	-	-	SYM
brj-24403	112	15	4719	4719	NUM
brj-24403	112	16	.	.	PUNCT
brj-24403	113	1	4706	4706	NUM
brj-24403	113	2	experimental	experimental	ADJ
brj-24403	113	3	protocol	protocol	NOUN
brj-24403	113	4	the	the	DET
brj-24403	113	5	mice	mouse	NOUN
brj-24403	113	6	were	be	AUX
brj-24403	113	7	acutely	acutely	ADV
brj-24403	113	8	administered	administer	VERB
brj-24403	113	9	cnc	cnc	ADJ
brj-24403	113	10	extract	extract	NOUN
brj-24403	113	11	at	at	ADP
brj-24403	113	12	doses	dose	NOUN
brj-24403	113	13	of	of	ADP
brj-24403	113	14	25	25	NUM
brj-24403	113	15	,	,	PUNCT
brj-24403	113	16	50	50	NUM
brj-24403	113	17	,	,	PUNCT
brj-24403	113	18	or	or	CCONJ
brj-24403	113	19	100	100	NUM
brj-24403	113	20	mg	mg	NUM
brj-24403	113	21	/	/	SYM
brj-24403	113	22	kg	kg	PROPN
brj-24403	113	23	via	via	ADP
brj-24403	113	24	intraperitoneal	intraperitoneal	ADJ
brj-24403	113	25	injection	injection	NOUN
brj-24403	113	26	(	(	PUNCT
brj-24403	113	27	i.p	i.p	PROPN
brj-24403	113	28	.	.	PROPN
brj-24403	113	29	)	)	PUNCT
brj-24403	113	30	.	.	PUNCT
brj-24403	114	1	thirty	thirty	NUM
brj-24403	114	2	minutes	minute	NOUN
brj-24403	114	3	following	follow	VERB
brj-24403	114	4	the	the	DET
brj-24403	114	5	cnc	cnc	PROPN
brj-24403	114	6	extract	extract	PROPN
brj-24403	114	7	administration	administration	NOUN
brj-24403	114	8	,	,	PUNCT
brj-24403	114	9	the	the	DET
brj-24403	114	10	animals	animal	NOUN
brj-24403	114	11	received	receive	VERB
brj-24403	114	12	an	an	DET
brj-24403	114	13	injection	injection	NOUN
brj-24403	114	14	of	of	ADP
brj-24403	114	15	pilocarpine	pilocarpine	NOUN
brj-24403	114	16	(	(	PUNCT
brj-24403	114	17	pilo	pilo	PROPN
brj-24403	114	18	)	)	PUNCT
brj-24403	114	19	at	at	ADP
brj-24403	114	20	a	a	DET
brj-24403	114	21	dose	dose	NOUN
brj-24403	114	22	of	of	ADP
brj-24403	114	23	350	350	NUM
brj-24403	114	24	mg	mg	PROPN
brj-24403	114	25	/	/	SYM
brj-24403	114	26	kg	kg	PROPN
brj-24403	114	27	(	(	PUNCT
brj-24403	114	28	i.p	i.p	PROPN
brj-24403	114	29	.	.	PROPN
brj-24403	114	30	)	)	PUNCT
brj-24403	114	31	to	to	PART
brj-24403	114	32	induce	induce	VERB
brj-24403	114	33	seizures	seizure	NOUN
brj-24403	114	34	.	.	PUNCT
brj-24403	115	1	for	for	ADP
brj-24403	115	2	the	the	DET
brj-24403	115	3	combination	combination	NOUN
brj-24403	115	4	treatment	treatment	NOUN
brj-24403	115	5	experiments	experiment	NOUN
brj-24403	115	6	,	,	PUNCT
brj-24403	115	7	additional	additional	ADJ
brj-24403	115	8	pharmacological	pharmacological	ADJ
brj-24403	115	9	agents	agent	NOUN
brj-24403	115	10	were	be	AUX
brj-24403	115	11	incorporated	incorporate	VERB
brj-24403	115	12	into	into	ADP
brj-24403	115	13	the	the	DET
brj-24403	115	14	protocol	protocol	NOUN
brj-24403	115	15	to	to	PART
brj-24403	115	16	evaluate	evaluate	VERB
brj-24403	115	17	potential	potential	ADJ
brj-24403	115	18	interactions	interaction	NOUN
brj-24403	115	19	.	.	PUNCT
brj-24403	116	1	specifically	specifically	ADV
brj-24403	116	2	,	,	PUNCT
brj-24403	116	3	atropine	atropine	NOUN
brj-24403	116	4	(	(	PUNCT
brj-24403	116	5	atr	atr	PROPN
brj-24403	116	6	,	,	PUNCT
brj-24403	116	7	i.p	i.p	PROPN
brj-24403	116	8	.	.	PROPN
brj-24403	116	9	)	)	PUNCT
brj-24403	116	10	,	,	PUNCT
brj-24403	116	11	diazepam	diazepam	NOUN
brj-24403	116	12	(	(	PUNCT
brj-24403	116	13	dzp	dzp	PROPN
brj-24403	116	14	,	,	PUNCT
brj-24403	116	15	i.p	i.p	PROPN
brj-24403	116	16	.	.	PROPN
brj-24403	116	17	)	)	PUNCT
brj-24403	116	18	,	,	PUNCT
brj-24403	116	19	memantine	memantine	NOUN
brj-24403	116	20	(	(	PUNCT
brj-24403	116	21	mem	mem	ADJ
brj-24403	116	22	,	,	PUNCT
brj-24403	116	23	orally	orally	ADV
brj-24403	116	24	)	)	PUNCT
brj-24403	116	25	,	,	PUNCT
brj-24403	116	26	flumazenil	flumazenil	NOUN
brj-24403	116	27	(	(	PUNCT
brj-24403	116	28	flum	flum	PROPN
brj-24403	116	29	,	,	PUNCT
brj-24403	116	30	i.p	i.p	PROPN
brj-24403	116	31	.	.	PROPN
brj-24403	116	32	)	)	PUNCT
brj-24403	116	33	,	,	PUNCT
brj-24403	116	34	or	or	CCONJ
brj-24403	116	35	nimodipine	nimodipine	ADJ
brj-24403	116	36	(	(	PUNCT
brj-24403	116	37	nimo	nimo	ADJ
brj-24403	116	38	,	,	PUNCT
brj-24403	116	39	orally	orally	ADV
brj-24403	116	40	)	)	PUNCT
brj-24403	116	41	were	be	AUX
brj-24403	116	42	administered	administer	VERB
brj-24403	116	43	15	15	NUM
brj-24403	116	44	min	min	NOUN
brj-24403	116	45	prior	prior	ADV
brj-24403	116	46	to	to	ADP
brj-24403	116	47	the	the	DET
brj-24403	116	48	cnc	cnc	ADJ
brj-24403	116	49	extract	extract	NOUN
brj-24403	116	50	injection	injection	NOUN
brj-24403	116	51	(	(	PUNCT
brj-24403	116	52	i.p	i.p	PROPN
brj-24403	116	53	.	.	PUNCT
brj-24403	116	54	)	)	PUNCT
brj-24403	116	55	.	.	PUNCT
brj-24403	117	1	this	this	DET
brj-24403	117	2	timing	timing	NOUN
brj-24403	117	3	ensured	ensure	VERB
brj-24403	117	4	that	that	SCONJ
brj-24403	117	5	these	these	DET
brj-24403	117	6	agents	agent	NOUN
brj-24403	117	7	were	be	AUX
brj-24403	117	8	introduced	introduce	VERB
brj-24403	117	9	45	45	NUM
brj-24403	117	10	min	min	NOUN
brj-24403	117	11	prior	prior	ADV
brj-24403	117	12	to	to	ADP
brj-24403	117	13	the	the	DET
brj-24403	117	14	pilo	pilo	ADJ
brj-24403	117	15	injection	injection	NOUN
brj-24403	117	16	(	(	PUNCT
brj-24403	117	17	i.p	i.p	PROPN
brj-24403	117	18	.	.	PROPN
brj-24403	117	19	)	)	PUNCT
brj-24403	117	20	,	,	PUNCT
brj-24403	117	21	allowing	allow	VERB
brj-24403	117	22	adequate	adequate	ADJ
brj-24403	117	23	pharmacodynamic	pharmacodynamic	ADJ
brj-24403	117	24	interactions	interaction	NOUN
brj-24403	117	25	to	to	PART
brj-24403	117	26	occur	occur	VERB
brj-24403	117	27	.	.	PUNCT
brj-24403	118	1	the	the	DET
brj-24403	118	2	design	design	NOUN
brj-24403	118	3	of	of	ADP
brj-24403	118	4	this	this	DET
brj-24403	118	5	protocol	protocol	NOUN
brj-24403	118	6	enabled	enable	VERB
brj-24403	118	7	the	the	DET
brj-24403	118	8	assessment	assessment	NOUN
brj-24403	118	9	of	of	ADP
brj-24403	118	10	both	both	CCONJ
brj-24403	118	11	the	the	DET
brj-24403	118	12	individual	individual	ADJ
brj-24403	118	13	and	and	CCONJ
brj-24403	118	14	combined	combined	ADJ
brj-24403	118	15	effects	effect	NOUN
brj-24403	118	16	of	of	ADP
brj-24403	118	17	cnc	cnc	ADJ
brj-24403	118	18	extract	extract	NOUN
brj-24403	118	19	and	and	CCONJ
brj-24403	118	20	these	these	DET
brj-24403	118	21	agents	agent	NOUN
brj-24403	118	22	on	on	ADP
brj-24403	118	23	the	the	DET
brj-24403	118	24	pilo	pilo	ADV
brj-24403	118	25	-	-	PUNCT
brj-24403	118	26	induced	induce	VERB
brj-24403	118	27	seizure	seizure	NOUN
brj-24403	118	28	model	model	NOUN
brj-24403	118	29	,	,	PUNCT
brj-24403	118	30	providing	provide	VERB
brj-24403	118	31	valuable	valuable	ADJ
brj-24403	118	32	insights	insight	NOUN
brj-24403	118	33	into	into	ADP
brj-24403	118	34	their	their	PRON
brj-24403	118	35	potential	potential	ADJ
brj-24403	118	36	therapeutic	therapeutic	ADJ
brj-24403	118	37	or	or	CCONJ
brj-24403	118	38	synergistic	synergistic	ADJ
brj-24403	118	39	roles	role	NOUN
brj-24403	118	40	.	.	PUNCT
brj-24403	119	1	behavioural	behavioural	ADJ
brj-24403	119	2	testing	testing	NOUN
brj-24403	119	3	mice	mouse	NOUN
brj-24403	119	4	were	be	AUX
brj-24403	119	5	distributed	distribute	VERB
brj-24403	119	6	into	into	ADP
brj-24403	119	7	the	the	DET
brj-24403	119	8	following	follow	VERB
brj-24403	119	9	groups	group	NOUN
brj-24403	119	10	:	:	PUNCT
brj-24403	119	11	group	group	NOUN
brj-24403	119	12	1	1	NUM
brj-24403	119	13	:	:	PUNCT
brj-24403	119	14	pilocarpine	pilocarpine	NOUN
brj-24403	119	15	(	(	PUNCT
brj-24403	119	16	pilo	pilo	NOUN
brj-24403	119	17	:	:	PUNCT
brj-24403	119	18	350	350	NUM
brj-24403	119	19	mg	mg	PROPN
brj-24403	119	20	/	/	SYM
brj-24403	119	21	kg	kg	PROPN
brj-24403	119	22	,	,	PUNCT
brj-24403	119	23	i.p	i.p	PROPN
brj-24403	119	24	.	.	PROPN
brj-24403	119	25	)	)	PUNCT
brj-24403	119	26	group	group	NOUN
brj-24403	119	27	2	2	NUM
brj-24403	119	28	:	:	PUNCT
brj-24403	119	29	cnc+pilo	cnc+pilo	PROPN
brj-24403	119	30	(	(	PUNCT
brj-24403	119	31	cnc	cnc	ADJ
brj-24403	119	32	:	:	PUNCT
brj-24403	119	33	25	25	NUM
brj-24403	119	34	,	,	PUNCT
brj-24403	119	35	50	50	NUM
brj-24403	119	36	,	,	PUNCT
brj-24403	119	37	100	100	NUM
brj-24403	119	38	mg	mg	NUM
brj-24403	119	39	/	/	SYM
brj-24403	119	40	kg	kg	PROPN
brj-24403	119	41	,	,	PUNCT
brj-24403	119	42	i.p	i.p	PROPN
brj-24403	119	43	.	.	PROPN
brj-24403	119	44	)	)	PUNCT
brj-24403	119	45	followed	follow	VERB
brj-24403	119	46	by	by	ADP
brj-24403	119	47	pilocarpine	pilocarpine	PROPN
brj-24403	119	48	administration	administration	NOUN
brj-24403	119	49	(	(	PUNCT
brj-24403	119	50	350	350	NUM
brj-24403	119	51	mg	mg	PROPN
brj-24403	119	52	/	/	SYM
brj-24403	119	53	kg	kg	PROPN
brj-24403	119	54	)	)	PUNCT
brj-24403	119	55	,	,	PUNCT
brj-24403	119	56	30	30	NUM
brj-24403	119	57	min	min	NOUN
brj-24403	119	58	later	later	ADV
brj-24403	119	59	.	.	PUNCT
brj-24403	120	1	the	the	DET
brj-24403	120	2	details	detail	NOUN
brj-24403	120	3	of	of	ADP
brj-24403	120	4	combination	combination	NOUN
brj-24403	120	5	experiments	experiment	NOUN
brj-24403	120	6	were	be	AUX
brj-24403	120	7	as	as	SCONJ
brj-24403	120	8	follows	follow	VERB
brj-24403	120	9	(	(	PUNCT
brj-24403	120	10	the	the	DET
brj-24403	120	11	number	number	NOUN
brj-24403	120	12	given	give	VERB
brj-24403	120	13	in	in	ADP
brj-24403	120	14	front	front	NOUN
brj-24403	120	15	of	of	ADP
brj-24403	120	16	cnc	cnc	PROPN
brj-24403	120	17	represent	represent	NOUN
brj-24403	120	18	dose	dose	VERB
brj-24403	120	19	in	in	ADP
brj-24403	120	20	mg	mg	PROPN
brj-24403	120	21	/	/	SYM
brj-24403	120	22	kg	kg	PROPN
brj-24403	120	23	):	):	PUNCT
brj-24403	120	24	1	1	NUM
brj-24403	120	25	.	.	X
brj-24403	120	26	atrp1+cnc50	atrp1+cnc50	PROPN
brj-24403	120	27	;	;	PUNCT
brj-24403	120	28	atrp10+cnc100	atrp10+cnc100	PROPN
brj-24403	120	29	;	;	PUNCT
brj-24403	120	30	2	2	NUM
brj-24403	120	31	.	.	X
brj-24403	121	1	mem2+cnc100	mem2+cnc100	NUM
brj-24403	121	2	3	3	X
brj-24403	121	3	.	.	PUNCT
brj-24403	122	1	dzp0.2+cnc50	dzp0.2+cnc50	PROPN
brj-24403	122	2	;	;	PUNCT
brj-24403	122	3	dzp0.5+cnc100	dzp0.5+cnc100	NUM
brj-24403	122	4	;	;	PUNCT
brj-24403	122	5	after	after	SCONJ
brj-24403	122	6	the	the	DET
brj-24403	122	7	pilo	pilo	ADJ
brj-24403	122	8	injection	injection	NOUN
brj-24403	122	9	was	be	AUX
brj-24403	122	10	administered	administer	VERB
brj-24403	122	11	,	,	PUNCT
brj-24403	122	12	the	the	DET
brj-24403	122	13	animals	animal	NOUN
brj-24403	122	14	exhibited	exhibit	VERB
brj-24403	122	15	signs	sign	NOUN
brj-24403	122	16	of	of	ADP
brj-24403	122	17	reduced	reduced	ADJ
brj-24403	122	18	activity	activity	NOUN
brj-24403	122	19	(	(	PUNCT
brj-24403	122	20	hypoactivity	hypoactivity	NOUN
brj-24403	122	21	)	)	PUNCT
brj-24403	122	22	and	and	CCONJ
brj-24403	122	23	specific	specific	ADJ
brj-24403	122	24	physical	physical	ADJ
brj-24403	122	25	behaviours	behaviour	NOUN
brj-24403	122	26	,	,	PUNCT
brj-24403	122	27	including	include	VERB
brj-24403	122	28	oro	oro	X
brj-24403	122	29	-	-	PUNCT
brj-24403	122	30	facial	facial	ADJ
brj-24403	122	31	motions	motion	NOUN
brj-24403	122	32	,	,	PUNCT
brj-24403	122	33	profuse	profuse	NOUN
brj-24403	122	34	salivation	salivation	NOUN
brj-24403	122	35	,	,	PUNCT
brj-24403	122	36	eye	eye	NOUN
brj-24403	122	37	squinting	squinting	NOUN
brj-24403	122	38	,	,	PUNCT
brj-24403	122	39	quivering	quiver	VERB
brj-24403	122	40	of	of	ADP
brj-24403	122	41	their	their	PRON
brj-24403	122	42	vibrissae	vibrissa	NOUN
brj-24403	122	43	(	(	PUNCT
brj-24403	122	44	whiskers	whisker	NOUN
brj-24403	122	45	)	)	PUNCT
brj-24403	122	46	,	,	PUNCT
brj-24403	122	47	and	and	CCONJ
brj-24403	122	48	yawning	yawn	VERB
brj-24403	122	49	,	,	PUNCT
brj-24403	122	50	approximately	approximately	ADV
brj-24403	122	51	30	30	NUM
brj-24403	122	52	min	min	NOUN
brj-24403	122	53	later	later	ADV
brj-24403	122	54	.	.	PUNCT
brj-24403	123	1	generalized	generalized	ADJ
brj-24403	123	2	seizures	seizure	NOUN
brj-24403	123	3	and	and	CCONJ
brj-24403	123	4	indications	indication	NOUN
brj-24403	123	5	of	of	ADP
brj-24403	123	6	limbic	limbic	ADJ
brj-24403	123	7	status	status	NOUN
brj-24403	123	8	epilepticus	epilepticus	NOUN
brj-24403	123	9	were	be	AUX
brj-24403	123	10	noted	note	VERB
brj-24403	123	11	40	40	NUM
brj-24403	123	12	to	to	PART
brj-24403	123	13	80	80	NUM
brj-24403	123	14	min	min	NOUN
brj-24403	123	15	post	post	NOUN
brj-24403	123	16	-	-	NOUN
brj-24403	123	17	injection	injection	NOUN
brj-24403	123	18	.	.	PUNCT
brj-24403	124	1	the	the	DET
brj-24403	124	2	main	main	ADJ
brj-24403	124	3	characteristics	characteristic	NOUN
brj-24403	124	4	evaluated	evaluate	VERB
brj-24403	124	5	during	during	ADP
brj-24403	124	6	this	this	DET
brj-24403	124	7	period	period	NOUN
brj-24403	124	8	were	be	AUX
brj-24403	124	9	the	the	DET
brj-24403	124	10	latency	latency	NOUN
brj-24403	124	11	to	to	ADP
brj-24403	124	12	the	the	DET
brj-24403	124	13	first	first	ADJ
brj-24403	124	14	convulsion	convulsion	NOUN
brj-24403	124	15	and	and	CCONJ
brj-24403	124	16	the	the	DET
brj-24403	124	17	total	total	ADJ
brj-24403	124	18	survival	survival	NOUN
brj-24403	124	19	duration	duration	NOUN
brj-24403	124	20	,	,	PUNCT
brj-24403	124	21	recorded	record	VERB
brj-24403	124	22	up	up	ADP
brj-24403	124	23	to	to	ADP
brj-24403	124	24	a	a	DET
brj-24403	124	25	maximum	maximum	NOUN
brj-24403	124	26	of	of	ADP
brj-24403	124	27	2	2	NUM
brj-24403	124	28	h.	h.	NOUN
brj-24403	124	29	furthermore	furthermore	ADV
brj-24403	124	30	,	,	PUNCT
brj-24403	124	31	the	the	DET
brj-24403	124	32	quantity	quantity	NOUN
brj-24403	124	33	of	of	ADP
brj-24403	124	34	animals	animal	NOUN
brj-24403	124	35	that	that	PRON
brj-24403	124	36	endured	endure	VERB
brj-24403	124	37	during	during	ADP
brj-24403	124	38	a	a	DET
brj-24403	124	39	24	24	NUM
brj-24403	124	40	-	-	PUNCT
brj-24403	124	41	h	h	NOUN
brj-24403	124	42	observation	observation	NOUN
brj-24403	124	43	period	period	NOUN
brj-24403	124	44	was	be	AUX
brj-24403	124	45	documented	document	VERB
brj-24403	124	46	.	.	PUNCT
brj-24403	125	1	in	in	ADP
brj-24403	125	2	tests	test	NOUN
brj-24403	125	3	examining	examine	VERB
brj-24403	125	4	monoamine	monoamine	NOUN
brj-24403	125	5	and	and	CCONJ
brj-24403	125	6	amino	amino	ADJ
brj-24403	125	7	acid	acid	NOUN
brj-24403	125	8	concentrations	concentration	NOUN
brj-24403	125	9	,	,	PUNCT
brj-24403	125	10	the	the	DET
brj-24403	125	11	animals	animal	NOUN
brj-24403	125	12	were	be	AUX
brj-24403	125	13	euthanized	euthanize	VERB
brj-24403	125	14	by	by	ADP
brj-24403	125	15	decapitation	decapitation	NOUN
brj-24403	125	16	immediately	immediately	ADV
brj-24403	125	17	after	after	ADP
brj-24403	125	18	their	their	PRON
brj-24403	125	19	initial	initial	ADJ
brj-24403	125	20	convulsion	convulsion	NOUN
brj-24403	125	21	.	.	PUNCT
brj-24403	126	1	in	in	ADP
brj-24403	126	2	the	the	DET
brj-24403	126	3	pilo	pilo	ADJ
brj-24403	126	4	-	-	PUNCT
brj-24403	126	5	only	only	ADJ
brj-24403	126	6	group	group	NOUN
brj-24403	126	7	,	,	PUNCT
brj-24403	126	8	this	this	PRON
brj-24403	126	9	generally	generally	ADV
brj-24403	126	10	ensued	ensue	VERB
brj-24403	126	11	within	within	ADP
brj-24403	126	12	30	30	NUM
brj-24403	126	13	min	min	NOUN
brj-24403	126	14	,	,	PUNCT
brj-24403	126	15	as	as	SCONJ
brj-24403	126	16	subjects	subject	NOUN
brj-24403	126	17	in	in	ADP
brj-24403	126	18	this	this	DET
brj-24403	126	19	cohort	cohort	NOUN
brj-24403	126	20	rarely	rarely	ADV
brj-24403	126	21	endured	endure	VERB
brj-24403	126	22	beyond	beyond	ADP
brj-24403	126	23	that	that	DET
brj-24403	126	24	duration	duration	NOUN
brj-24403	126	25	.	.	PUNCT
brj-24403	127	1	conversely	conversely	ADV
brj-24403	127	2	,	,	PUNCT
brj-24403	127	3	in	in	ADP
brj-24403	127	4	groups	group	NOUN
brj-24403	127	5	pretreated	pretreate	VERB
brj-24403	127	6	with	with	ADP
brj-24403	127	7	cnc	cnc	PROPN
brj-24403	127	8	prior	prior	ADV
brj-24403	127	9	to	to	ADP
brj-24403	127	10	pilo	pilo	PROPN
brj-24403	127	11	administration	administration	NOUN
brj-24403	127	12	,	,	PUNCT
brj-24403	127	13	animals	animal	NOUN
brj-24403	127	14	were	be	AUX
brj-24403	127	15	killed	kill	VERB
brj-24403	127	16	either	either	CCONJ
brj-24403	127	17	2	2	NUM
brj-24403	127	18	h	h	NOUN
brj-24403	127	19	after	after	ADP
brj-24403	127	20	their	their	PRON
brj-24403	127	21	initial	initial	ADJ
brj-24403	127	22	convulsion	convulsion	NOUN
brj-24403	127	23	or	or	CCONJ
brj-24403	127	24	at	at	ADP
brj-24403	127	25	the	the	DET
brj-24403	127	26	2	2	NUM
brj-24403	127	27	-	-	PUNCT
brj-24403	127	28	h	h	NOUN
brj-24403	127	29	interval	interval	NOUN
brj-24403	127	30	if	if	SCONJ
brj-24403	127	31	they	they	PRON
brj-24403	127	32	survived	survive	VERB
brj-24403	127	33	that	that	DET
brj-24403	127	34	duration	duration	NOUN
brj-24403	127	35	.	.	PUNCT
brj-24403	128	1	the	the	DET
brj-24403	128	2	selected	select	VERB
brj-24403	128	3	time	time	NOUN
brj-24403	128	4	points	point	NOUN
brj-24403	128	5	were	be	AUX
brj-24403	128	6	meticulously	meticulously	ADV
brj-24403	128	7	aligned	align	VERB
brj-24403	128	8	with	with	ADP
brj-24403	128	9	the	the	DET
brj-24403	128	10	survival	survival	NOUN
brj-24403	128	11	trends	trend	NOUN
brj-24403	128	12	identified	identify	VERB
brj-24403	128	13	in	in	ADP
brj-24403	128	14	each	each	DET
brj-24403	128	15	group	group	NOUN
brj-24403	128	16	.	.	PUNCT
brj-24403	129	1	following	follow	VERB
brj-24403	129	2	euthanasia	euthanasia	PROPN
brj-24403	129	3	,	,	PUNCT
brj-24403	129	4	the	the	DET
brj-24403	129	5	brains	brain	NOUN
brj-24403	129	6	of	of	ADP
brj-24403	129	7	the	the	DET
brj-24403	129	8	animals	animal	NOUN
brj-24403	129	9	were	be	AUX
brj-24403	129	10	dissected	dissect	VERB
brj-24403	129	11	to	to	PART
brj-24403	129	12	extract	extract	VERB
brj-24403	129	13	the	the	DET
brj-24403	129	14	striata	striata	NOUN
brj-24403	129	15	.	.	PUNCT
brj-24403	130	1	the	the	DET
brj-24403	130	2	aforementioned	aforementioned	ADJ
brj-24403	130	3	brain	brain	NOUN
brj-24403	130	4	areas	area	NOUN
brj-24403	130	5	were	be	AUX
brj-24403	130	6	utilized	utilize	VERB
brj-24403	130	7	to	to	PART
brj-24403	130	8	create	create	VERB
brj-24403	130	9	homogenates	homogenate	NOUN
brj-24403	130	10	for	for	ADP
brj-24403	130	11	the	the	DET
brj-24403	130	12	quantification	quantification	NOUN
brj-24403	130	13	of	of	ADP
brj-24403	130	14	monoamine	monoamine	NOUN
brj-24403	130	15	and	and	CCONJ
brj-24403	130	16	amino	amino	ADJ
brj-24403	130	17	acid	acid	NOUN
brj-24403	130	18	concentrations	concentration	NOUN
brj-24403	130	19	.	.	PUNCT
brj-24403	131	1	this	this	DET
brj-24403	131	2	methodology	methodology	NOUN
brj-24403	131	3	guaranteed	guarantee	VERB
brj-24403	131	4	accurate	accurate	ADJ
brj-24403	131	5	biochemical	biochemical	ADJ
brj-24403	131	6	analysis	analysis	NOUN
brj-24403	131	7	pertinent	pertinent	ADJ
brj-24403	131	8	to	to	ADP
brj-24403	131	9	the	the	DET
brj-24403	131	10	study	study	NOUN
brj-24403	131	11	’s	’s	PART
brj-24403	131	12	aims	aim	NOUN
brj-24403	131	13	.	.	PUNCT
brj-24403	132	1	monoamine	monoamine	ADJ
brj-24403	132	2	level	level	NOUN
brj-24403	132	3	determination	determination	NOUN
brj-24403	132	4	to	to	PART
brj-24403	132	5	test	test	VERB
brj-24403	132	6	dopamine	dopamine	NOUN
brj-24403	132	7	and	and	CCONJ
brj-24403	132	8	its	its	PRON
brj-24403	132	9	metabolite	metabolite	NOUN
brj-24403	132	10	3,4	3,4	NUM
brj-24403	132	11	-	-	PUNCT
brj-24403	132	12	dihydroxyphenylacetic	dihydroxyphenylacetic	ADJ
brj-24403	132	13	acid	acid	NOUN
brj-24403	132	14	(	(	PUNCT
brj-24403	132	15	dopac	dopac	PROPN
brj-24403	132	16	)	)	PUNCT
brj-24403	132	17	,	,	PUNCT
brj-24403	132	18	10	10	NUM
brj-24403	132	19	%	%	NOUN
brj-24403	132	20	homogenates	homogenate	NOUN
brj-24403	132	21	were	be	AUX
brj-24403	132	22	prepared	prepare	VERB
brj-24403	132	23	using	use	VERB
brj-24403	132	24	the	the	DET
brj-24403	132	25	striata	striata	NOUN
brj-24403	132	26	from	from	ADP
brj-24403	132	27	all	all	PRON
brj-24403	132	28	of	of	ADP
brj-24403	132	29	the	the	DET
brj-24403	132	30	groups	group	NOUN
brj-24403	132	31	that	that	PRON
brj-24403	132	32	had	have	VERB
brj-24403	132	33	either	either	CCONJ
brj-24403	132	34	peer	peer	NOUN
brj-24403	132	35	-	-	PUNCT
brj-24403	132	36	reviewed	review	VERB
brj-24403	132	37	article	article	NOUN
brj-24403	132	38	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	132	39	li	li	PROPN
brj-24403	132	40	et	et	PROPN
brj-24403	132	41	al	al	PROPN
brj-24403	132	42	.	.	PROPN
brj-24403	133	1	(	(	PUNCT
brj-24403	133	2	2025	2025	NUM
brj-24403	133	3	)	)	PUNCT
brj-24403	133	4	.	.	PUNCT
brj-24403	134	1	“	"	PUNCT
brj-24403	134	2	herbal	herbal	ADJ
brj-24403	134	3	anti	anti	ADJ
brj-24403	134	4	-	-	ADJ
brj-24403	134	5	epileptic	epileptic	ADJ
brj-24403	134	6	extract	extract	NOUN
brj-24403	134	7	,	,	PUNCT
brj-24403	134	8	”	"	PUNCT
brj-24403	134	9	bioresources	bioresource	NOUN
brj-24403	134	10	20(2	20(2	NUM
brj-24403	134	11	)	)	PUNCT
brj-24403	134	12	,	,	PUNCT
brj-24403	134	13	4701	4701	NUM
brj-24403	134	14	-	-	SYM
brj-24403	134	15	4719	4719	NUM
brj-24403	134	16	.	.	PUNCT
brj-24403	135	1	4707	4707	NUM
brj-24403	135	2	been	be	AUX
brj-24403	135	3	treated	treat	VERB
brj-24403	135	4	with	with	ADP
brj-24403	135	5	pilo	pilo	NOUN
brj-24403	135	6	or	or	CCONJ
brj-24403	135	7	pretreated	pretreate	VERB
brj-24403	135	8	with	with	ADP
brj-24403	135	9	cnc	cnc	PROPN
brj-24403	135	10	.	.	PUNCT
brj-24403	136	1	this	this	DET
brj-24403	136	2	process	process	NOUN
brj-24403	136	3	was	be	AUX
brj-24403	136	4	followed	follow	VERB
brj-24403	136	5	,	,	PUNCT
brj-24403	136	6	with	with	ADP
brj-24403	136	7	some	some	DET
brj-24403	136	8	minor	minor	ADJ
brj-24403	136	9	adjustments	adjustment	NOUN
brj-24403	136	10	,	,	PUNCT
brj-24403	136	11	in	in	ADP
brj-24403	136	12	accordance	accordance	NOUN
brj-24403	136	13	with	with	ADP
brj-24403	136	14	a	a	DET
brj-24403	136	15	procedure	procedure	NOUN
brj-24403	136	16	that	that	PRON
brj-24403	136	17	had	have	AUX
brj-24403	136	18	been	be	AUX
brj-24403	136	19	described	describe	VERB
brj-24403	136	20	earlier	early	ADV
brj-24403	136	21	.	.	PUNCT
brj-24403	137	1	oxidative	oxidative	ADJ
brj-24403	137	2	stress	stress	NOUN
brj-24403	137	3	markers	marker	NOUN
brj-24403	137	4	in	in	ADP
brj-24403	137	5	brain	brain	NOUN
brj-24403	137	6	the	the	DET
brj-24403	137	7	effect	effect	NOUN
brj-24403	137	8	of	of	ADP
brj-24403	137	9	cnc	cnc	PROPN
brj-24403	137	10	on	on	ADP
brj-24403	137	11	lipid	lipid	NOUN
brj-24403	137	12	and	and	CCONJ
brj-24403	137	13	protein	protein	NOUN
brj-24403	137	14	oxidative	oxidative	ADJ
brj-24403	137	15	damage	damage	NOUN
brj-24403	137	16	was	be	AUX
brj-24403	137	17	performed	perform	VERB
brj-24403	137	18	by	by	ADP
brj-24403	137	19	the	the	DET
brj-24403	137	20	estimating	estimate	VERB
brj-24403	137	21	the	the	DET
brj-24403	137	22	concentration	concentration	NOUN
brj-24403	137	23	of	of	ADP
brj-24403	137	24	tbars	tbar	NOUN
brj-24403	137	25	,	,	PUNCT
brj-24403	137	26	carbonyl	carbonyl	NOUN
brj-24403	137	27	protein	protein	NOUN
brj-24403	137	28	,	,	PUNCT
brj-24403	137	29	nitric	nitric	ADJ
brj-24403	137	30	oxide	oxide	NOUN
brj-24403	137	31	levels	level	NOUN
brj-24403	137	32	,	,	PUNCT
brj-24403	137	33	sulfhydryl	sulfhydryl	ADJ
brj-24403	137	34	protein	protein	NOUN
brj-24403	137	35	,	,	PUNCT
brj-24403	137	36	and	and	CCONJ
brj-24403	137	37	activity	activity	NOUN
brj-24403	137	38	of	of	ADP
brj-24403	137	39	the	the	DET
brj-24403	137	40	antioxidant	antioxidant	ADJ
brj-24403	137	41	enzymes	enzyme	NOUN
brj-24403	137	42	superoxide	superoxide	NOUN
brj-24403	137	43	dismutase	dismutase	NOUN
brj-24403	137	44	(	(	PUNCT
brj-24403	137	45	sod	sod	NOUN
brj-24403	137	46	)	)	PUNCT
brj-24403	137	47	and	and	CCONJ
brj-24403	137	48	catalase	catalase	NOUN
brj-24403	137	49	(	(	PUNCT
brj-24403	137	50	cat	cat	NOUN
brj-24403	137	51	)	)	PUNCT
brj-24403	137	52	were	be	AUX
brj-24403	137	53	quantified	quantify	VERB
brj-24403	137	54	following	follow	VERB
brj-24403	137	55	previously	previously	ADV
brj-24403	137	56	reported	report	VERB
brj-24403	137	57	procedures	procedure	NOUN
brj-24403	137	58	.	.	PUNCT
brj-24403	138	1	statistical	statistical	ADJ
brj-24403	138	2	analysis	analysis	NOUN
brj-24403	138	3	the	the	DET
brj-24403	138	4	data	datum	NOUN
brj-24403	138	5	for	for	ADP
brj-24403	138	6	latencies	latency	NOUN
brj-24403	138	7	to	to	ADP
brj-24403	138	8	the	the	DET
brj-24403	138	9	1st	1st	ADJ
brj-24403	138	10	convulsion	convulsion	NOUN
brj-24403	138	11	and	and	CCONJ
brj-24403	138	12	to	to	ADP
brj-24403	138	13	death	death	NOUN
brj-24403	138	14	were	be	AUX
brj-24403	138	15	analyzed	analyze	VERB
brj-24403	138	16	by	by	ADP
brj-24403	138	17	the	the	DET
brj-24403	138	18	nonparametric	nonparametric	NOUN
brj-24403	138	19	kruskal	kruskal	PROPN
brj-24403	138	20	–	–	PUNCT
brj-24403	138	21	wallis	wallis	PROPN
brj-24403	138	22	test	test	NOUN
brj-24403	138	23	,	,	PUNCT
brj-24403	138	24	followed	follow	VERB
brj-24403	138	25	by	by	ADP
brj-24403	138	26	the	the	DET
brj-24403	138	27	dunn	dunn	PROPN
brj-24403	138	28	’s	’	VERB
brj-24403	138	29	as	as	ADP
brj-24403	138	30	a	a	DET
brj-24403	138	31	post	post	X
brj-24403	138	32	hoc	hoc	X
brj-24403	138	33	multiple	multiple	ADJ
brj-24403	138	34	comparisons	comparison	NOUN
brj-24403	138	35	test	test	NOUN
brj-24403	138	36	,	,	PUNCT
brj-24403	138	37	and	and	CCONJ
brj-24403	138	38	the	the	DET
brj-24403	138	39	frequency	frequency	NOUN
brj-24403	138	40	to	to	ADP
brj-24403	138	41	death	death	NOUN
brj-24403	138	42	by	by	ADP
brj-24403	138	43	the	the	DET
brj-24403	138	44	log	log	NOUN
brj-24403	138	45	-	-	PUNCT
brj-24403	138	46	rank	rank	NOUN
brj-24403	138	47	(	(	PUNCT
brj-24403	138	48	mantel	mantel	NOUN
brj-24403	138	49	–	–	PUNCT
brj-24403	138	50	cox	cox	NOUN
brj-24403	138	51	)	)	PUNCT
brj-24403	138	52	test	test	NOUN
brj-24403	138	53	.	.	PUNCT
brj-24403	139	1	two	two	NUM
brj-24403	139	2	-	-	PUNCT
brj-24403	139	3	way	way	NOUN
brj-24403	139	4	anova	anova	X
brj-24403	139	5	(	(	PUNCT
brj-24403	139	6	figures	figure	NOUN
brj-24403	139	7	from	from	ADP
brj-24403	139	8	graphpad	graphpad	NOUN
brj-24403	139	9	prism	prism	NOUN
brj-24403	139	10	5	5	NUM
brj-24403	139	11	)	)	PUNCT
brj-24403	139	12	,	,	PUNCT
brj-24403	139	13	followed	follow	VERB
brj-24403	139	14	by	by	ADP
brj-24403	139	15	the	the	DET
brj-24403	139	16	mack	mack	PROPN
brj-24403	139	17	–	–	PUNCT
brj-24403	139	18	skillings	skilling	NOUN
brj-24403	139	19	statistical	statistical	ADJ
brj-24403	139	20	test	test	NOUN
brj-24403	139	21	(	(	PUNCT
brj-24403	139	22	a	a	DET
brj-24403	139	23	nonparametric	nonparametric	NOUN
brj-24403	139	24	two	two	NUM
brj-24403	139	25	-	-	PUNCT
brj-24403	139	26	way	way	NOUN
brj-24403	139	27	anova	anova	PROPN
brj-24403	139	28	used	use	VERB
brj-24403	139	29	for	for	ADP
brj-24403	139	30	incomplete	incomplete	ADJ
brj-24403	139	31	block	block	NOUN
brj-24403	139	32	designs	design	NOUN
brj-24403	139	33	)	)	PUNCT
brj-24403	139	34	and	and	CCONJ
brj-24403	139	35	by	by	ADP
brj-24403	139	36	the	the	DET
brj-24403	139	37	dwass	dwass	NOUN
brj-24403	139	38	–	–	PUNCT
brj-24403	139	39	steel	steel	NOUN
brj-24403	139	40	–	–	PUNCT
brj-24403	139	41	critchlow	critchlow	ADJ
brj-24403	139	42	–	–	PUNCT
brj-24403	139	43	fligner	fligner	NOUN
brj-24403	139	44	test	test	NOUN
brj-24403	139	45	for	for	ADP
brj-24403	139	46	multiple	multiple	ADJ
brj-24403	139	47	comparisons	comparison	NOUN
brj-24403	139	48	were	be	AUX
brj-24403	139	49	used	use	VERB
brj-24403	139	50	(	(	PUNCT
brj-24403	139	51	xlstat	xlstat	PROPN
brj-24403	139	52	)	)	PUNCT
brj-24403	139	53	,	,	PUNCT
brj-24403	139	54	for	for	ADP
brj-24403	139	55	the	the	DET
brj-24403	139	56	association	association	NOUN
brj-24403	139	57	experiments	experiment	NOUN
brj-24403	139	58	with	with	ADP
brj-24403	139	59	two	two	NUM
brj-24403	139	60	or	or	CCONJ
brj-24403	139	61	more	more	ADJ
brj-24403	139	62	drugs	drug	NOUN
brj-24403	139	63	.	.	PUNCT
brj-24403	140	1	all	all	DET
brj-24403	140	2	other	other	ADJ
brj-24403	140	3	cases	case	NOUN
brj-24403	140	4	were	be	AUX
brj-24403	140	5	analyzed	analyze	VERB
brj-24403	140	6	with	with	ADP
brj-24403	140	7	oneway	oneway	PROPN
brj-24403	140	8	anova	anova	PROPN
brj-24403	140	9	,	,	PUNCT
brj-24403	140	10	followed	follow	VERB
brj-24403	140	11	by	by	ADP
brj-24403	140	12	the	the	DET
brj-24403	140	13	student	student	NOUN
brj-24403	140	14	–	–	PUNCT
brj-24403	140	15	newman	newman	PROPN
brj-24403	140	16	–	–	PUNCT
brj-24403	140	17	keuls	keuls	PROPN
brj-24403	140	18	as	as	ADP
brj-24403	140	19	the	the	DET
brj-24403	140	20	test	test	NOUN
brj-24403	140	21	post	post	X
brj-24403	140	22	hoc	hoc	X
brj-24403	140	23	.	.	PUNCT
brj-24403	141	1	the	the	DET
brj-24403	141	2	results	result	NOUN
brj-24403	141	3	were	be	AUX
brj-24403	141	4	considered	consider	VERB
brj-24403	141	5	significant	significant	ADJ
brj-24403	141	6	at	at	ADP
brj-24403	141	7	p<0.05	p<0.05	NOUN
brj-24403	141	8	.	.	PUNCT
brj-24403	142	1	results	result	NOUN
brj-24403	142	2	and	and	CCONJ
brj-24403	142	3	discussion	discussion	NOUN
brj-24403	142	4	there	there	PRON
brj-24403	142	5	have	have	AUX
brj-24403	142	6	been	be	AUX
brj-24403	142	7	countless	countless	ADJ
brj-24403	142	8	maladies	malady	NOUN
brj-24403	142	9	that	that	PRON
brj-24403	142	10	have	have	AUX
brj-24403	142	11	been	be	AUX
brj-24403	142	12	treated	treat	VERB
brj-24403	142	13	with	with	ADP
brj-24403	142	14	plant	plant	NOUN
brj-24403	142	15	-	-	PUNCT
brj-24403	142	16	based	base	VERB
brj-24403	142	17	medicines	medicine	NOUN
brj-24403	142	18	ever	ever	ADV
brj-24403	142	19	since	since	SCONJ
brj-24403	142	20	the	the	DET
brj-24403	142	21	beginning	beginning	NOUN
brj-24403	142	22	of	of	ADP
brj-24403	142	23	folklore	folklore	NOUN
brj-24403	142	24	(	(	PUNCT
brj-24403	142	25	saklani	saklani	NOUN
brj-24403	142	26	and	and	CCONJ
brj-24403	142	27	kutty	kutty	PROPN
brj-24403	142	28	2008	2008	NUM
brj-24403	142	29	)	)	PUNCT
brj-24403	142	30	.	.	PUNCT
brj-24403	143	1	there	there	PRON
brj-24403	143	2	have	have	AUX
brj-24403	143	3	been	be	AUX
brj-24403	143	4	a	a	DET
brj-24403	143	5	number	number	NOUN
brj-24403	143	6	of	of	ADP
brj-24403	143	7	studies	study	NOUN
brj-24403	143	8	that	that	PRON
brj-24403	143	9	have	have	AUX
brj-24403	143	10	demonstrated	demonstrate	VERB
brj-24403	143	11	their	their	PRON
brj-24403	143	12	great	great	ADJ
brj-24403	143	13	efficacy	efficacy	NOUN
brj-24403	143	14	against	against	ADP
brj-24403	143	15	non	non	ADJ
brj-24403	143	16	-	-	ADJ
brj-24403	143	17	infectious	infectious	ADJ
brj-24403	143	18	diseases	disease	NOUN
brj-24403	143	19	as	as	ADV
brj-24403	143	20	well	well	ADV
brj-24403	143	21	as	as	ADP
brj-24403	143	22	infectious	infectious	ADJ
brj-24403	143	23	diseases	disease	NOUN
brj-24403	143	24	,	,	PUNCT
brj-24403	143	25	which	which	PRON
brj-24403	143	26	includes	include	VERB
brj-24403	143	27	neurological	neurological	ADJ
brj-24403	143	28	problems	problem	NOUN
brj-24403	143	29	(	(	PUNCT
brj-24403	143	30	balunas	baluna	NOUN
brj-24403	143	31	and	and	CCONJ
brj-24403	143	32	kinghorn	kinghorn	ADJ
brj-24403	143	33	2005	2005	NUM
brj-24403	143	34	)	)	PUNCT
brj-24403	143	35	.	.	PUNCT
brj-24403	144	1	the	the	DET
brj-24403	144	2	use	use	NOUN
brj-24403	144	3	of	of	ADP
brj-24403	144	4	these	these	DET
brj-24403	144	5	phytochemicals	phytochemical	NOUN
brj-24403	144	6	,	,	PUNCT
brj-24403	144	7	which	which	PRON
brj-24403	144	8	target	target	VERB
brj-24403	144	9	specific	specific	ADJ
brj-24403	144	10	receptors	receptor	NOUN
brj-24403	144	11	,	,	PUNCT
brj-24403	144	12	provides	provide	VERB
brj-24403	144	13	relief	relief	NOUN
brj-24403	144	14	from	from	ADP
brj-24403	144	15	the	the	DET
brj-24403	144	16	disease	disease	NOUN
brj-24403	144	17	while	while	SCONJ
brj-24403	144	18	causing	cause	VERB
brj-24403	144	19	less	less	ADV
brj-24403	144	20	adverse	adverse	ADJ
brj-24403	144	21	effects	effect	NOUN
brj-24403	144	22	than	than	ADP
brj-24403	144	23	the	the	DET
brj-24403	144	24	standard	standard	ADJ
brj-24403	144	25	medicines	medicine	NOUN
brj-24403	144	26	.	.	PUNCT
brj-24403	145	1	epilepsy	epilepsy	NOUN
brj-24403	145	2	,	,	PUNCT
brj-24403	145	3	particularly	particularly	ADV
brj-24403	145	4	in	in	ADP
brj-24403	145	5	cases	case	NOUN
brj-24403	145	6	involving	involve	VERB
brj-24403	145	7	convulsive	convulsive	ADJ
brj-24403	145	8	seizures	seizure	NOUN
brj-24403	145	9	,	,	PUNCT
brj-24403	145	10	has	have	VERB
brj-24403	145	11	a	a	DET
brj-24403	145	12	profound	profound	ADJ
brj-24403	145	13	effect	effect	NOUN
brj-24403	145	14	on	on	ADP
brj-24403	145	15	behavioral	behavioral	ADJ
brj-24403	145	16	patterns	pattern	NOUN
brj-24403	145	17	,	,	PUNCT
brj-24403	145	18	resulting	result	VERB
brj-24403	145	19	in	in	ADP
brj-24403	145	20	cognitive	cognitive	ADJ
brj-24403	145	21	,	,	PUNCT
brj-24403	145	22	emotional	emotional	ADJ
brj-24403	145	23	,	,	PUNCT
brj-24403	145	24	and	and	CCONJ
brj-24403	145	25	social	social	ADJ
brj-24403	145	26	difficulties	difficulty	NOUN
brj-24403	145	27	(	(	PUNCT
brj-24403	145	28	engelborghs	engelborghs	VERB
brj-24403	145	29	et	et	PROPN
brj-24403	145	30	al	al	PROPN
brj-24403	145	31	.	.	PROPN
brj-24403	145	32	2000	2000	NUM
brj-24403	145	33	;	;	PUNCT
brj-24403	145	34	fisher	fisher	PROPN
brj-24403	145	35	et	et	PROPN
brj-24403	145	36	al	al	PROPN
brj-24403	145	37	.	.	PROPN
brj-24403	145	38	2005	2005	NUM
brj-24403	145	39	;	;	PUNCT
brj-24403	145	40	scharfman	scharfman	NOUN
brj-24403	145	41	2007	2007	NUM
brj-24403	145	42	)	)	PUNCT
brj-24403	145	43	.	.	PUNCT
brj-24403	146	1	convulsions	convulsion	NOUN
brj-24403	146	2	interfere	interfere	VERB
brj-24403	146	3	with	with	ADP
brj-24403	146	4	neuronal	neuronal	ADJ
brj-24403	146	5	activity	activity	NOUN
brj-24403	146	6	,	,	PUNCT
brj-24403	146	7	resulting	result	VERB
brj-24403	146	8	in	in	ADP
brj-24403	146	9	postictal	postictal	ADJ
brj-24403	146	10	confusion	confusion	NOUN
brj-24403	146	11	,	,	PUNCT
brj-24403	146	12	aggression	aggression	NOUN
brj-24403	146	13	,	,	PUNCT
brj-24403	146	14	or	or	CCONJ
brj-24403	146	15	lethargy	lethargy	NOUN
brj-24403	146	16	.	.	PUNCT
brj-24403	147	1	chronic	chronic	ADJ
brj-24403	147	2	seizures	seizure	NOUN
brj-24403	147	3	are	be	AUX
brj-24403	147	4	associated	associate	VERB
brj-24403	147	5	with	with	ADP
brj-24403	147	6	anxiety	anxiety	NOUN
brj-24403	147	7	,	,	PUNCT
brj-24403	147	8	depression	depression	NOUN
brj-24403	147	9	,	,	PUNCT
brj-24403	147	10	irritability	irritability	NOUN
brj-24403	147	11	,	,	PUNCT
brj-24403	147	12	and	and	CCONJ
brj-24403	147	13	memory	memory	NOUN
brj-24403	147	14	impairments	impairment	NOUN
brj-24403	147	15	.	.	PUNCT
brj-24403	148	1	in	in	ADP
brj-24403	148	2	children	child	NOUN
brj-24403	148	3	,	,	PUNCT
brj-24403	148	4	epilepsy	epilepsy	NOUN
brj-24403	148	5	frequently	frequently	ADV
brj-24403	148	6	presents	present	VERB
brj-24403	148	7	as	as	ADP
brj-24403	148	8	hyperactivity	hyperactivity	NOUN
brj-24403	148	9	or	or	CCONJ
brj-24403	148	10	social	social	ADJ
brj-24403	148	11	withdrawal	withdrawal	NOUN
brj-24403	148	12	,	,	PUNCT
brj-24403	148	13	whereas	whereas	SCONJ
brj-24403	148	14	adults	adult	NOUN
brj-24403	148	15	may	may	AUX
brj-24403	148	16	encounter	encounter	VERB
brj-24403	148	17	reduced	reduced	ADJ
brj-24403	148	18	cognitive	cognitive	ADJ
brj-24403	148	19	flexibility	flexibility	NOUN
brj-24403	148	20	and	and	CCONJ
brj-24403	148	21	heightened	heighten	VERB
brj-24403	148	22	emotional	emotional	ADJ
brj-24403	148	23	instability	instability	NOUN
brj-24403	148	24	.	.	PUNCT
brj-24403	149	1	the	the	DET
brj-24403	149	2	unpredictable	unpredictable	ADJ
brj-24403	149	3	nature	nature	NOUN
brj-24403	149	4	of	of	ADP
brj-24403	149	5	seizures	seizure	NOUN
brj-24403	149	6	increases	increase	VERB
brj-24403	149	7	psychological	psychological	ADJ
brj-24403	149	8	stress	stress	NOUN
brj-24403	149	9	and	and	CCONJ
brj-24403	149	10	social	social	ADJ
brj-24403	149	11	stigma	stigma	NOUN
brj-24403	149	12	,	,	PUNCT
brj-24403	149	13	adversely	adversely	ADV
brj-24403	149	14	impacting	impact	VERB
brj-24403	149	15	quality	quality	NOUN
brj-24403	149	16	of	of	ADP
brj-24403	149	17	life	life	NOUN
brj-24403	149	18	.	.	PUNCT
brj-24403	150	1	however	however	ADV
brj-24403	150	2	,	,	PUNCT
brj-24403	150	3	despite	despite	SCONJ
brj-24403	150	4	of	of	ADP
brj-24403	150	5	the	the	DET
brj-24403	150	6	advances	advance	NOUN
brj-24403	150	7	in	in	ADP
brj-24403	150	8	therapeutic	therapeutic	ADJ
brj-24403	150	9	options	option	NOUN
brj-24403	150	10	,	,	PUNCT
brj-24403	150	11	still	still	ADV
brj-24403	150	12	the	the	DET
brj-24403	150	13	patients	patient	NOUN
brj-24403	150	14	of	of	ADP
brj-24403	150	15	epilepsy	epilepsy	NOUN
brj-24403	150	16	are	be	AUX
brj-24403	150	17	non	non	ADJ
brj-24403	150	18	-	-	ADJ
brj-24403	150	19	responsive	responsive	ADJ
brj-24403	150	20	to	to	ADP
brj-24403	150	21	conventional	conventional	ADJ
brj-24403	150	22	pharmacotherapy	pharmacotherapy	NOUN
brj-24403	150	23	due	due	ADJ
brj-24403	150	24	to	to	ADP
brj-24403	150	25	poor	poor	ADJ
brj-24403	150	26	blood	blood	NOUN
brj-24403	150	27	-	-	PUNCT
brj-24403	150	28	brain	brain	NOUN
brj-24403	150	29	barrier	barrier	NOUN
brj-24403	150	30	penetrability	penetrability	NOUN
brj-24403	150	31	,	,	PUNCT
brj-24403	150	32	and	and	CCONJ
brj-24403	150	33	serious	serious	ADJ
brj-24403	150	34	side	side	NOUN
brj-24403	150	35	-	-	PUNCT
brj-24403	150	36	effects	effect	NOUN
brj-24403	150	37	due	due	ADJ
brj-24403	150	38	to	to	ADP
brj-24403	150	39	long	long	ADJ
brj-24403	150	40	term	term	NOUN
brj-24403	150	41	usage	usage	NOUN
brj-24403	150	42	(	(	PUNCT
brj-24403	150	43	moosa	moosa	PROPN
brj-24403	150	44	2019	2019	NUM
brj-24403	150	45	;	;	PUNCT
brj-24403	150	46	löscher	löscher	X
brj-24403	150	47	et	et	PROPN
brj-24403	150	48	al	al	PROPN
brj-24403	150	49	.	.	PROPN
brj-24403	150	50	2020	2020	NUM
brj-24403	150	51	)	)	PUNCT
brj-24403	150	52	.	.	PUNCT
brj-24403	151	1	thus	thus	ADV
brj-24403	151	2	,	,	PUNCT
brj-24403	151	3	it	it	PRON
brj-24403	151	4	is	be	AUX
brj-24403	151	5	important	important	ADJ
brj-24403	151	6	to	to	PART
brj-24403	151	7	find	find	VERB
brj-24403	151	8	new	new	ADJ
brj-24403	151	9	and	and	CCONJ
brj-24403	151	10	efficacious	efficacious	ADJ
brj-24403	151	11	therapeutic	therapeutic	ADJ
brj-24403	151	12	agents	agent	NOUN
brj-24403	151	13	.	.	PUNCT
brj-24403	152	1	therefore	therefore	ADV
brj-24403	152	2	,	,	PUNCT
brj-24403	152	3	in	in	ADP
brj-24403	152	4	the	the	DET
brj-24403	152	5	present	present	ADJ
brj-24403	152	6	study	study	NOUN
brj-24403	152	7	,	,	PUNCT
brj-24403	152	8	the	the	DET
brj-24403	152	9	goal	goal	NOUN
brj-24403	152	10	was	be	AUX
brj-24403	152	11	to	to	PART
brj-24403	152	12	investigate	investigate	VERB
brj-24403	152	13	the	the	DET
brj-24403	152	14	impact	impact	NOUN
brj-24403	152	15	that	that	PRON
brj-24403	152	16	callicarpa	callicarpa	VERB
brj-24403	152	17	kwangtungensis	kwangtungensis	NOUN
brj-24403	152	18	chun	chun	PROPN
brj-24403	152	19	.	.	PUNCT
brj-24403	153	1	(	(	PUNCT
brj-24403	153	2	ckc	ckc	NOUN
brj-24403	153	3	)	)	PUNCT
brj-24403	153	4	has	have	VERB
brj-24403	153	5	on	on	ADP
brj-24403	153	6	the	the	DET
brj-24403	153	7	development	development	NOUN
brj-24403	153	8	of	of	ADP
brj-24403	153	9	epilepsy	epilepsy	NOUN
brj-24403	153	10	in	in	ADP
brj-24403	153	11	mice	mouse	NOUN
brj-24403	153	12	that	that	PRON
brj-24403	153	13	has	have	AUX
brj-24403	153	14	been	be	AUX
brj-24403	153	15	caused	cause	VERB
brj-24403	153	16	by	by	ADP
brj-24403	153	17	pilocarpine	pilocarpine	NOUN
brj-24403	153	18	(	(	PUNCT
brj-24403	153	19	pilo	pilo	PROPN
brj-24403	153	20	)	)	PUNCT
brj-24403	153	21	.	.	PUNCT
brj-24403	154	1	the	the	DET
brj-24403	154	2	petroleum	petroleum	NOUN
brj-24403	154	3	ether	ether	NOUN
brj-24403	154	4	extraction	extraction	NOUN
brj-24403	154	5	of	of	ADP
brj-24403	154	6	the	the	DET
brj-24403	154	7	dried	dry	VERB
brj-24403	154	8	whole	whole	ADJ
brj-24403	154	9	plant	plant	NOUN
brj-24403	154	10	material	material	NOUN
brj-24403	154	11	of	of	ADP
brj-24403	154	12	ckc	ckc	PROPN
brj-24403	154	13	yielded	yield	VERB
brj-24403	154	14	25	25	NUM
brj-24403	154	15	g	g	NOUN
brj-24403	154	16	of	of	ADP
brj-24403	154	17	concentrated	concentrated	ADJ
brj-24403	154	18	crude	crude	ADJ
brj-24403	154	19	extract	extract	NOUN
brj-24403	154	20	from	from	ADP
brj-24403	154	21	500	500	NUM
brj-24403	154	22	g	g	NOUN
brj-24403	154	23	of	of	ADP
brj-24403	154	24	powdered	powdered	ADJ
brj-24403	154	25	plant	plant	NOUN
brj-24403	154	26	material	material	NOUN
brj-24403	154	27	,	,	PUNCT
brj-24403	154	28	corresponding	correspond	VERB
brj-24403	154	29	to	to	ADP
brj-24403	154	30	an	an	DET
brj-24403	154	31	extraction	extraction	NOUN
brj-24403	154	32	yield	yield	NOUN
brj-24403	154	33	of	of	ADP
brj-24403	154	34	5	5	NUM
brj-24403	154	35	%	%	NOUN
brj-24403	154	36	(	(	PUNCT
brj-24403	154	37	w	w	NOUN
brj-24403	154	38	/	/	SYM
brj-24403	154	39	w	w	NOUN
brj-24403	154	40	)	)	PUNCT
brj-24403	154	41	.	.	PUNCT
brj-24403	155	1	the	the	DET
brj-24403	155	2	extract	extract	NOUN
brj-24403	155	3	was	be	AUX
brj-24403	155	4	obtained	obtain	VERB
brj-24403	155	5	as	as	ADP
brj-24403	155	6	a	a	DET
brj-24403	155	7	semi	semi	ADJ
brj-24403	155	8	-	-	ADJ
brj-24403	155	9	solid	solid	ADJ
brj-24403	155	10	,	,	PUNCT
brj-24403	155	11	dark	dark	ADJ
brj-24403	155	12	green	green	ADJ
brj-24403	155	13	to	to	ADP
brj-24403	155	14	brownish	brownish	ADJ
brj-24403	155	15	mass	mass	NOUN
brj-24403	155	16	with	with	ADP
brj-24403	155	17	an	an	DET
brj-24403	155	18	oily	oily	ADJ
brj-24403	155	19	texture	texture	NOUN
brj-24403	155	20	and	and	CCONJ
brj-24403	155	21	characteristic	characteristic	ADJ
brj-24403	155	22	odor	odor	NOUN
brj-24403	155	23	,	,	PUNCT
brj-24403	155	24	typical	typical	ADJ
brj-24403	155	25	of	of	ADP
brj-24403	155	26	non	non	ADJ
brj-24403	155	27	-	-	ADJ
brj-24403	155	28	polar	polar	ADJ
brj-24403	155	29	peer	peer	NOUN
brj-24403	155	30	-	-	PUNCT
brj-24403	155	31	reviewed	review	VERB
brj-24403	155	32	article	article	NOUN
brj-24403	155	33	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	155	34	li	li	PROPN
brj-24403	155	35	et	et	PROPN
brj-24403	155	36	al	al	PROPN
brj-24403	155	37	.	.	PROPN
brj-24403	156	1	(	(	PUNCT
brj-24403	156	2	2025	2025	NUM
brj-24403	156	3	)	)	PUNCT
brj-24403	156	4	.	.	PUNCT
brj-24403	157	1	“	"	PUNCT
brj-24403	157	2	herbal	herbal	ADJ
brj-24403	157	3	anti	anti	ADJ
brj-24403	157	4	-	-	ADJ
brj-24403	157	5	epileptic	epileptic	ADJ
brj-24403	157	6	extract	extract	NOUN
brj-24403	157	7	,	,	PUNCT
brj-24403	157	8	”	"	PUNCT
brj-24403	157	9	bioresources	bioresource	NOUN
brj-24403	157	10	20(2	20(2	NUM
brj-24403	157	11	)	)	PUNCT
brj-24403	157	12	,	,	PUNCT
brj-24403	157	13	4701	4701	NUM
brj-24403	157	14	-	-	SYM
brj-24403	157	15	4719	4719	NUM
brj-24403	157	16	.	.	PUNCT
brj-24403	158	1	4708	4708	NUM
brj-24403	158	2	phytochemical	phytochemical	ADJ
brj-24403	158	3	-	-	PUNCT
brj-24403	158	4	rich	rich	ADJ
brj-24403	158	5	fractions	fraction	NOUN
brj-24403	158	6	.	.	PUNCT
brj-24403	159	1	preliminary	preliminary	ADJ
brj-24403	159	2	phytochemical	phytochemical	ADJ
brj-24403	159	3	screening	screening	NOUN
brj-24403	159	4	revealed	reveal	VERB
brj-24403	159	5	the	the	DET
brj-24403	159	6	presence	presence	NOUN
brj-24403	159	7	of	of	ADP
brj-24403	159	8	phytosterols	phytosterol	NOUN
brj-24403	159	9	,	,	PUNCT
brj-24403	159	10	terpenoids	terpenoid	NOUN
brj-24403	159	11	,	,	PUNCT
brj-24403	159	12	and	and	CCONJ
brj-24403	159	13	fixed	fix	VERB
brj-24403	159	14	oils	oil	NOUN
brj-24403	159	15	,	,	PUNCT
brj-24403	159	16	while	while	SCONJ
brj-24403	159	17	alkaloids	alkaloid	NOUN
brj-24403	159	18	,	,	PUNCT
brj-24403	159	19	flavonoids	flavonoid	NOUN
brj-24403	159	20	,	,	PUNCT
brj-24403	159	21	tannins	tannin	NOUN
brj-24403	159	22	,	,	PUNCT
brj-24403	159	23	saponins	saponin	NOUN
brj-24403	159	24	,	,	PUNCT
brj-24403	159	25	and	and	CCONJ
brj-24403	159	26	glycosides	glycoside	NOUN
brj-24403	159	27	were	be	AUX
brj-24403	159	28	absent	absent	ADJ
brj-24403	159	29	.	.	PUNCT
brj-24403	160	1	these	these	DET
brj-24403	160	2	results	result	NOUN
brj-24403	160	3	are	be	AUX
brj-24403	160	4	consistent	consistent	ADJ
brj-24403	160	5	with	with	ADP
brj-24403	160	6	the	the	DET
brj-24403	160	7	non	non	ADJ
brj-24403	160	8	-	-	ADJ
brj-24403	160	9	polar	polar	ADJ
brj-24403	160	10	nature	nature	NOUN
brj-24403	160	11	of	of	ADP
brj-24403	160	12	petroleum	petroleum	NOUN
brj-24403	160	13	ether	ether	NOUN
brj-24403	160	14	,	,	PUNCT
brj-24403	160	15	which	which	PRON
brj-24403	160	16	preferentially	preferentially	ADV
brj-24403	160	17	extracts	extract	VERB
brj-24403	160	18	lipophilic	lipophilic	ADJ
brj-24403	160	19	constituents	constituent	NOUN
brj-24403	160	20	such	such	ADJ
brj-24403	160	21	as	as	ADP
brj-24403	160	22	fatty	fatty	NOUN
brj-24403	160	23	acids	acid	NOUN
brj-24403	160	24	,	,	PUNCT
brj-24403	160	25	sterols	sterol	NOUN
brj-24403	160	26	,	,	PUNCT
brj-24403	160	27	and	and	CCONJ
brj-24403	160	28	terpenoids	terpenoid	NOUN
brj-24403	160	29	.	.	PUNCT
brj-24403	161	1	the	the	DET
brj-24403	161	2	presence	presence	NOUN
brj-24403	161	3	of	of	ADP
brj-24403	161	4	these	these	DET
brj-24403	161	5	non	non	ADJ
brj-24403	161	6	-	-	ADJ
brj-24403	161	7	polar	polar	ADJ
brj-24403	161	8	bioactive	bioactive	ADJ
brj-24403	161	9	compounds	compound	NOUN
brj-24403	161	10	is	be	AUX
brj-24403	161	11	consistent	consistent	ADJ
brj-24403	161	12	with	with	ADP
brj-24403	161	13	previous	previous	ADJ
brj-24403	161	14	reports	report	NOUN
brj-24403	161	15	on	on	ADP
brj-24403	161	16	callicarpa	callicarpa	ADJ
brj-24403	161	17	species	specie	NOUN
brj-24403	161	18	,	,	PUNCT
brj-24403	161	19	which	which	PRON
brj-24403	161	20	have	have	AUX
brj-24403	161	21	been	be	AUX
brj-24403	161	22	shown	show	VERB
brj-24403	161	23	to	to	PART
brj-24403	161	24	possess	possess	VERB
brj-24403	161	25	neuropharmacological	neuropharmacological	ADJ
brj-24403	161	26	activities	activity	NOUN
brj-24403	161	27	attributed	attribute	VERB
brj-24403	161	28	to	to	ADP
brj-24403	161	29	their	their	PRON
brj-24403	161	30	sterols	sterol	NOUN
brj-24403	161	31	and	and	CCONJ
brj-24403	161	32	terpenoids	terpenoid	NOUN
brj-24403	161	33	(	(	PUNCT
brj-24403	161	34	li	li	PROPN
brj-24403	161	35	et	et	PROPN
brj-24403	161	36	al	al	PROPN
brj-24403	161	37	.	.	PROPN
brj-24403	161	38	2016	2016	NUM
brj-24403	161	39	;	;	PUNCT
brj-24403	161	40	wang	wang	PROPN
brj-24403	161	41	et	et	PROPN
brj-24403	161	42	al	al	PROPN
brj-24403	161	43	.	.	PROPN
brj-24403	161	44	2018	2018	NUM
brj-24403	161	45	)	)	PUNCT
brj-24403	161	46	.	.	PUNCT
brj-24403	162	1	the	the	DET
brj-24403	162	2	moderate	moderate	ADJ
brj-24403	162	3	extraction	extraction	NOUN
brj-24403	162	4	yield	yield	NOUN
brj-24403	162	5	and	and	CCONJ
brj-24403	162	6	phytochemical	phytochemical	ADJ
brj-24403	162	7	profile	profile	NOUN
brj-24403	162	8	obtained	obtain	VERB
brj-24403	162	9	in	in	ADP
brj-24403	162	10	this	this	DET
brj-24403	162	11	study	study	NOUN
brj-24403	162	12	support	support	VERB
brj-24403	162	13	the	the	DET
brj-24403	162	14	rationale	rationale	NOUN
brj-24403	162	15	for	for	ADP
brj-24403	162	16	selecting	select	VERB
brj-24403	162	17	petroleum	petroleum	NOUN
brj-24403	162	18	ether	ether	NOUN
brj-24403	162	19	as	as	ADP
brj-24403	162	20	the	the	DET
brj-24403	162	21	solvent	solvent	NOUN
brj-24403	162	22	,	,	PUNCT
brj-24403	162	23	as	as	SCONJ
brj-24403	162	24	it	it	PRON
brj-24403	162	25	effectively	effectively	ADV
brj-24403	162	26	enriched	enrich	VERB
brj-24403	162	27	the	the	DET
brj-24403	162	28	extract	extract	NOUN
brj-24403	162	29	with	with	ADP
brj-24403	162	30	bioactive	bioactive	ADJ
brj-24403	162	31	non	non	ADJ
brj-24403	162	32	-	-	ADJ
brj-24403	162	33	polar	polar	ADJ
brj-24403	162	34	secondary	secondary	ADJ
brj-24403	162	35	metabolites	metabolite	NOUN
brj-24403	162	36	.	.	PUNCT
brj-24403	163	1	the	the	DET
brj-24403	163	2	dried	dry	VERB
brj-24403	163	3	extract	extract	NOUN
brj-24403	163	4	was	be	AUX
brj-24403	163	5	subsequently	subsequently	ADV
brj-24403	163	6	used	use	VERB
brj-24403	163	7	for	for	ADP
brj-24403	163	8	bioassay	bioassay	NOUN
brj-24403	163	9	evaluation	evaluation	NOUN
brj-24403	163	10	to	to	PART
brj-24403	163	11	investigate	investigate	VERB
brj-24403	163	12	its	its	PRON
brj-24403	163	13	potential	potential	ADJ
brj-24403	163	14	pharmacological	pharmacological	ADJ
brj-24403	163	15	properties	property	NOUN
brj-24403	163	16	.	.	PUNCT
brj-24403	164	1	animal	animal	NOUN
brj-24403	164	2	models	model	NOUN
brj-24403	164	3	,	,	PUNCT
brj-24403	164	4	such	such	ADJ
brj-24403	164	5	as	as	ADP
brj-24403	164	6	pilocarpine	pilocarpine	NOUN
brj-24403	164	7	-	-	PUNCT
brj-24403	164	8	induced	induce	VERB
brj-24403	164	9	epilepsy	epilepsy	NOUN
brj-24403	164	10	in	in	ADP
brj-24403	164	11	mice	mouse	NOUN
brj-24403	164	12	,	,	PUNCT
brj-24403	164	13	provide	provide	VERB
brj-24403	164	14	a	a	DET
brj-24403	164	15	valuable	valuable	ADJ
brj-24403	164	16	tool	tool	NOUN
brj-24403	164	17	for	for	ADP
brj-24403	164	18	understanding	understand	VERB
brj-24403	164	19	these	these	DET
brj-24403	164	20	behavioral	behavioral	ADJ
brj-24403	164	21	effects	effect	NOUN
brj-24403	164	22	(	(	PUNCT
brj-24403	164	23	löscher	löscher	NOUN
brj-24403	164	24	2002	2002	NUM
brj-24403	164	25	;	;	PUNCT
brj-24403	164	26	grone	grone	NOUN
brj-24403	164	27	and	and	CCONJ
brj-24403	164	28	baraban	baraban	PROPN
brj-24403	164	29	2015	2015	NUM
brj-24403	164	30	)	)	PUNCT
brj-24403	164	31	.	.	PUNCT
brj-24403	165	1	pilocarpine	pilocarpine	PROPN
brj-24403	165	2	,	,	PUNCT
brj-24403	165	3	a	a	DET
brj-24403	165	4	cholinergic	cholinergic	ADJ
brj-24403	165	5	agonist	agonist	NOUN
brj-24403	165	6	,	,	PUNCT
brj-24403	165	7	induces	induce	VERB
brj-24403	165	8	status	status	NOUN
brj-24403	165	9	epilepticus	epilepticus	NOUN
brj-24403	165	10	and	and	CCONJ
brj-24403	165	11	chronic	chronic	ADJ
brj-24403	165	12	epilepsy	epilepsy	NOUN
brj-24403	165	13	,	,	PUNCT
brj-24403	165	14	closely	closely	ADV
brj-24403	165	15	mimicking	mimic	VERB
brj-24403	165	16	human	human	ADJ
brj-24403	165	17	temporal	temporal	ADJ
brj-24403	165	18	lobe	lobe	NOUN
brj-24403	165	19	epilepsy	epilepsy	NOUN
brj-24403	165	20	.	.	PUNCT
brj-24403	166	1	this	this	DET
brj-24403	166	2	model	model	NOUN
brj-24403	166	3	offers	offer	VERB
brj-24403	166	4	several	several	ADJ
brj-24403	166	5	advantages	advantage	NOUN
brj-24403	166	6	,	,	PUNCT
brj-24403	166	7	including	include	VERB
brj-24403	166	8	reproducibility	reproducibility	NOUN
brj-24403	166	9	,	,	PUNCT
brj-24403	166	10	the	the	DET
brj-24403	166	11	ability	ability	NOUN
brj-24403	166	12	to	to	PART
brj-24403	166	13	study	study	VERB
brj-24403	166	14	the	the	DET
brj-24403	166	15	progression	progression	NOUN
brj-24403	166	16	of	of	ADP
brj-24403	166	17	seizures	seizure	NOUN
brj-24403	166	18	,	,	PUNCT
brj-24403	166	19	and	and	CCONJ
brj-24403	166	20	the	the	DET
brj-24403	166	21	assessment	assessment	NOUN
brj-24403	166	22	of	of	ADP
brj-24403	166	23	postictal	postictal	ADJ
brj-24403	166	24	behavioral	behavioral	ADJ
brj-24403	166	25	changes	change	NOUN
brj-24403	166	26	.	.	PUNCT
brj-24403	167	1	mice	mouse	NOUN
brj-24403	167	2	subjected	subject	VERB
brj-24403	167	3	to	to	AUX
brj-24403	167	4	pilocarpine	pilocarpine	NOUN
brj-24403	167	5	-	-	PUNCT
brj-24403	167	6	induced	induce	VERB
brj-24403	167	7	seizures	seizure	NOUN
brj-24403	167	8	exhibit	exhibit	VERB
brj-24403	167	9	anxiety	anxiety	NOUN
brj-24403	167	10	-	-	PUNCT
brj-24403	167	11	like	like	ADJ
brj-24403	167	12	behaviors	behavior	NOUN
brj-24403	167	13	,	,	PUNCT
brj-24403	167	14	cognitive	cognitive	ADJ
brj-24403	167	15	deficits	deficit	NOUN
brj-24403	167	16	,	,	PUNCT
brj-24403	167	17	and	and	CCONJ
brj-24403	167	18	hyperactivity	hyperactivity	NOUN
brj-24403	167	19	,	,	PUNCT
brj-24403	167	20	reflecting	reflect	VERB
brj-24403	167	21	the	the	DET
brj-24403	167	22	behavioral	behavioral	ADJ
brj-24403	167	23	patterns	pattern	NOUN
brj-24403	167	24	observed	observe	VERB
brj-24403	167	25	in	in	ADP
brj-24403	167	26	human	human	ADJ
brj-24403	167	27	epilepsy	epilepsy	NOUN
brj-24403	167	28	.	.	PUNCT
brj-24403	168	1	these	these	DET
brj-24403	168	2	models	model	NOUN
brj-24403	168	3	are	be	AUX
brj-24403	168	4	instrumental	instrumental	ADJ
brj-24403	168	5	in	in	ADP
brj-24403	168	6	exploring	explore	VERB
brj-24403	168	7	the	the	DET
brj-24403	168	8	underlying	underlie	VERB
brj-24403	168	9	mechanisms	mechanism	NOUN
brj-24403	168	10	of	of	ADP
brj-24403	168	11	epilepsy	epilepsy	NOUN
brj-24403	168	12	-	-	PUNCT
brj-24403	168	13	induced	induce	VERB
brj-24403	168	14	behavioral	behavioral	ADJ
brj-24403	168	15	changes	change	NOUN
brj-24403	168	16	and	and	CCONJ
brj-24403	168	17	in	in	ADP
brj-24403	168	18	evaluating	evaluate	VERB
brj-24403	168	19	potential	potential	ADJ
brj-24403	168	20	therapeutic	therapeutic	ADJ
brj-24403	168	21	interventions	intervention	NOUN
brj-24403	168	22	.	.	PUNCT
brj-24403	169	1	by	by	ADP
brj-24403	169	2	bridging	bridge	VERB
brj-24403	169	3	the	the	DET
brj-24403	169	4	gap	gap	NOUN
brj-24403	169	5	between	between	ADP
brj-24403	169	6	preclinical	preclinical	ADJ
brj-24403	169	7	findings	finding	NOUN
brj-24403	169	8	and	and	CCONJ
brj-24403	169	9	clinical	clinical	ADJ
brj-24403	169	10	outcomes	outcome	NOUN
brj-24403	169	11	,	,	PUNCT
brj-24403	169	12	pilocarpine	pilocarpine	NOUN
brj-24403	169	13	models	model	NOUN
brj-24403	169	14	contribute	contribute	VERB
brj-24403	169	15	to	to	ADP
brj-24403	169	16	the	the	DET
brj-24403	169	17	development	development	NOUN
brj-24403	169	18	of	of	ADP
brj-24403	169	19	targeted	target	VERB
brj-24403	169	20	therapies	therapy	NOUN
brj-24403	169	21	addressing	address	VERB
brj-24403	169	22	both	both	DET
brj-24403	169	23	seizures	seizure	NOUN
brj-24403	169	24	and	and	CCONJ
brj-24403	169	25	associated	associate	VERB
brj-24403	169	26	behavioral	behavioral	ADJ
brj-24403	169	27	impairments	impairment	NOUN
brj-24403	169	28	.	.	PUNCT
brj-24403	170	1	results	result	NOUN
brj-24403	170	2	of	of	ADP
brj-24403	170	3	the	the	DET
brj-24403	170	4	study	study	NOUN
brj-24403	170	5	,	,	PUNCT
brj-24403	170	6	showed	show	VERB
brj-24403	170	7	that	that	SCONJ
brj-24403	170	8	,	,	PUNCT
brj-24403	170	9	ckc	ckc	NOUN
brj-24403	170	10	through	through	ADP
brj-24403	170	11	its	its	PRON
brj-24403	170	12	multi	multi	ADJ
brj-24403	170	13	-	-	ADJ
brj-24403	170	14	target	target	NOUN
brj-24403	170	15	activity	activity	NOUN
brj-24403	170	16	,	,	PUNCT
brj-24403	170	17	exhibit	exhibit	VERB
brj-24403	170	18	significant	significant	ADJ
brj-24403	170	19	pharmacological	pharmacological	ADJ
brj-24403	170	20	advantage	advantage	NOUN
brj-24403	170	21	in	in	ADP
brj-24403	170	22	alleviating	alleviate	VERB
brj-24403	170	23	the	the	DET
brj-24403	170	24	effects	effect	NOUN
brj-24403	170	25	of	of	ADP
brj-24403	170	26	epilepsy	epilepsy	NOUN
brj-24403	170	27	in	in	ADP
brj-24403	170	28	mice	mouse	NOUN
brj-24403	170	29	.	.	PUNCT
brj-24403	171	1	initially	initially	ADV
brj-24403	171	2	,	,	PUNCT
brj-24403	171	3	an	an	DET
brj-24403	171	4	investigation	investigation	NOUN
brj-24403	171	5	was	be	AUX
brj-24403	171	6	carried	carry	VERB
brj-24403	171	7	out	out	ADP
brj-24403	171	8	to	to	PART
brj-24403	171	9	assess	assess	VERB
brj-24403	171	10	the	the	DET
brj-24403	171	11	impact	impact	NOUN
brj-24403	171	12	of	of	ADP
brj-24403	171	13	cnc	cnc	PROPN
brj-24403	171	14	on	on	ADP
brj-24403	171	15	the	the	DET
brj-24403	171	16	behavioral	behavioral	ADJ
brj-24403	171	17	patterns	pattern	NOUN
brj-24403	171	18	of	of	ADP
brj-24403	171	19	experimental	experimental	ADJ
brj-24403	171	20	mice	mouse	NOUN
brj-24403	171	21	.	.	PUNCT
brj-24403	172	1	as	as	SCONJ
brj-24403	172	2	shown	show	VERB
brj-24403	172	3	in	in	ADP
brj-24403	172	4	table	table	NOUN
brj-24403	172	5	1	1	NUM
brj-24403	172	6	,	,	PUNCT
brj-24403	172	7	the	the	DET
brj-24403	172	8	administration	administration	NOUN
brj-24403	172	9	of	of	ADP
brj-24403	172	10	cnc	cnc	PROPN
brj-24403	172	11	caused	cause	VERB
brj-24403	172	12	reduction	reduction	NOUN
brj-24403	172	13	in	in	ADP
brj-24403	172	14	the	the	DET
brj-24403	172	15	percent	percent	NOUN
brj-24403	172	16	of	of	ADP
brj-24403	172	17	mice	mouse	NOUN
brj-24403	172	18	that	that	PRON
brj-24403	172	19	convulsed	convulse	VERB
brj-24403	172	20	from	from	ADP
brj-24403	172	21	94	94	NUM
brj-24403	172	22	%	%	NOUN
brj-24403	172	23	(	(	PUNCT
brj-24403	172	24	p350	p350	PROPN
brj-24403	172	25	group	group	NOUN
brj-24403	172	26	)	)	PUNCT
brj-24403	172	27	to	to	ADP
brj-24403	172	28	80	80	NUM
brj-24403	172	29	%	%	NOUN
brj-24403	172	30	in	in	ADP
brj-24403	172	31	the	the	PRON
brj-24403	172	32	100	100	NUM
brj-24403	172	33	mg	mg	PROPN
brj-24403	172	34	/	/	SYM
brj-24403	172	35	kg	kg	PROPN
brj-24403	172	36	treated	treat	VERB
brj-24403	172	37	group	group	NOUN
brj-24403	172	38	.	.	PUNCT
brj-24403	173	1	it	it	PRON
brj-24403	173	2	also	also	ADV
brj-24403	173	3	led	lead	VERB
brj-24403	173	4	to	to	ADP
brj-24403	173	5	an	an	DET
brj-24403	173	6	increase	increase	NOUN
brj-24403	173	7	in	in	ADP
brj-24403	173	8	percentage	percentage	NOUN
brj-24403	173	9	of	of	ADP
brj-24403	173	10	survivals	survival	NOUN
brj-24403	173	11	24	24	NUM
brj-24403	173	12	h	h	NOUN
brj-24403	173	13	after	after	ADP
brj-24403	173	14	the	the	DET
brj-24403	173	15	1st	1st	ADJ
brj-24403	173	16	convulsion	convulsion	NOUN
brj-24403	173	17	in	in	ADP
brj-24403	173	18	a	a	DET
brj-24403	173	19	dose	dose	NOUN
brj-24403	173	20	-	-	PUNCT
brj-24403	173	21	dependent	dependent	ADJ
brj-24403	173	22	manner	manner	NOUN
brj-24403	173	23	.	.	PUNCT
brj-24403	174	1	thus	thus	ADV
brj-24403	174	2	,	,	PUNCT
brj-24403	174	3	it	it	PRON
brj-24403	174	4	was	be	AUX
brj-24403	174	5	suggested	suggest	VERB
brj-24403	174	6	that	that	SCONJ
brj-24403	174	7	the	the	DET
brj-24403	174	8	administration	administration	NOUN
brj-24403	174	9	of	of	ADP
brj-24403	174	10	cnc	cnc	PROPN
brj-24403	174	11	considerably	considerably	ADV
brj-24403	174	12	extended	extend	VERB
brj-24403	174	13	both	both	CCONJ
brj-24403	174	14	the	the	DET
brj-24403	174	15	latency	latency	NOUN
brj-24403	174	16	to	to	ADP
brj-24403	174	17	the	the	DET
brj-24403	174	18	first	first	ADJ
brj-24403	174	19	convulsion	convulsion	NOUN
brj-24403	174	20	and	and	CCONJ
brj-24403	174	21	the	the	DET
brj-24403	174	22	time	time	NOUN
brj-24403	174	23	to	to	ADP
brj-24403	174	24	death	death	NOUN
brj-24403	174	25	in	in	ADP
brj-24403	174	26	comparison	comparison	NOUN
brj-24403	174	27	to	to	ADP
brj-24403	174	28	the	the	DET
brj-24403	174	29	group	group	NOUN
brj-24403	174	30	that	that	PRON
brj-24403	174	31	was	be	AUX
brj-24403	174	32	given	give	VERB
brj-24403	174	33	pilocarpine	pilocarpine	NOUN
brj-24403	174	34	with	with	ADP
brj-24403	174	35	no	no	DET
brj-24403	174	36	drug	drug	NOUN
brj-24403	174	37	.	.	PUNCT
brj-24403	175	1	table	table	NOUN
brj-24403	175	2	1	1	NUM
brj-24403	175	3	.	.	PUNCT
brj-24403	175	4	ratios	ratio	NOUN
brj-24403	175	5	and	and	CCONJ
brj-24403	175	6	percentages	percentage	NOUN
brj-24403	175	7	of	of	ADP
brj-24403	175	8	development	development	NOUN
brj-24403	175	9	of	of	ADP
brj-24403	175	10	convulsions	convulsion	NOUN
brj-24403	175	11	and	and	CCONJ
brj-24403	175	12	survivals	survival	NOUN
brj-24403	175	13	,	,	PUNCT
brj-24403	175	14	after	after	ADP
brj-24403	175	15	pilocarpine	pilocarpine	NOUN
brj-24403	175	16	-	-	PUNCT
brj-24403	175	17	induced	induced	ADJ
brj-24403	175	18	(	(	PUNCT
brj-24403	175	19	pilo	pilo	ADJ
brj-24403	175	20	)	)	PUNCT
brj-24403	175	21	convulsions	convulsion	NOUN
brj-24403	175	22	,	,	PUNCT
brj-24403	175	23	in	in	ADP
brj-24403	175	24	mice	mouse	NOUN
brj-24403	175	25	pretreated	pretreate	VERB
brj-24403	175	26	with	with	ADP
brj-24403	175	27	cnc	cnc	PROPN
brj-24403	175	28	observation	observation	NOUN
brj-24403	175	29	treatment	treatment	NOUN
brj-24403	175	30	before	before	ADP
brj-24403	175	31	p350	p350	PROPN
brj-24403	175	32	pilo	pilo	ADJ
brj-24403	175	33	cnc25	cnc25	PROPN
brj-24403	175	34	cnc50	cnc50	PROPN
brj-24403	175	35	cnc100	cnc100	ADJ
brj-24403	175	36	number	number	NOUN
brj-24403	175	37	of	of	ADP
brj-24403	175	38	convulsed	convulsed	ADJ
brj-24403	175	39	animals	animal	NOUN
brj-24403	175	40	up	up	ADP
brj-24403	175	41	to	to	PART
brj-24403	175	42	90	90	NUM
brj-24403	175	43	min	min	NOUN
brj-24403	175	44	after	after	ADP
brj-24403	175	45	p350	p350	PROPN
brj-24403	175	46	33/35	33/35	NUM
brj-24403	175	47	(	(	PUNCT
brj-24403	175	48	94	94	NUM
brj-24403	175	49	%	%	NOUN
brj-24403	175	50	)	)	PUNCT
brj-24403	176	1	25/25	25/25	NUM
brj-24403	176	2	(	(	PUNCT
brj-24403	176	3	100	100	NUM
brj-24403	176	4	)	)	PUNCT
brj-24403	176	5	22/25	22/25	NUM
brj-24403	176	6	(	(	PUNCT
brj-24403	176	7	88	88	NUM
brj-24403	176	8	%	%	NOUN
brj-24403	176	9	)	)	PUNCT
brj-24403	176	10	20/25	20/25	NUM
brj-24403	176	11	(	(	PUNCT
brj-24403	176	12	80	80	NUM
brj-24403	176	13	)	)	PUNCT
brj-24403	176	14	survivors	survivor	NOUN
brj-24403	176	15	up	up	ADV
brj-24403	176	16	to	to	PART
brj-24403	176	17	24	24	NUM
brj-24403	176	18	h	h	NOUN
brj-24403	176	19	after	after	ADP
brj-24403	176	20	p350	p350	PROPN
brj-24403	176	21	-	-	PUNCT
brj-24403	176	22	induced	induce	VERB
brj-24403	176	23	convulsions	convulsion	NOUN
brj-24403	176	24	2/33	2/33	NUM
brj-24403	176	25	4/25	4/25	NUM
brj-24403	176	26	6/25	6/25	NUM
brj-24403	176	27	8/25	8/25	NUM
brj-24403	176	28	latency	latency	NOUN
brj-24403	176	29	to	to	ADP
brj-24403	176	30	1st	1st	ADJ
brj-24403	176	31	convulsion	convulsion	NOUN
brj-24403	176	32	(	(	PUNCT
brj-24403	176	33	seconds	second	NOUN
brj-24403	176	34	)	)	PUNCT
brj-24403	176	35	678.2±12.2	678.2±12.2	ADJ
brj-24403	177	1	734.5±15.3	734.5±15.3	NOUN
brj-24403	177	2	*	*	PROPN
brj-24403	177	3	*	*	PUNCT
brj-24403	177	4	965.3±19.2	965.3±19.2	NUM
brj-24403	177	5	*	*	PUNCT
brj-24403	177	6	*	*	PUNCT
brj-24403	177	7	*	*	PUNCT
brj-24403	177	8	1012.5±24.1	1012.5±24.1	PROPN
brj-24403	177	9	*	*	PUNCT
brj-24403	177	10	*	*	PUNCT
brj-24403	177	11	*	*	ADJ
brj-24403	177	12	survival	survival	NOUN
brj-24403	177	13	(	(	PUNCT
brj-24403	177	14	seconds	second	NOUN
brj-24403	177	15	)	)	PUNCT
brj-24403	177	16	1167±27.5	1167±27.5	NUM
brj-24403	177	17	1422±34.2	1422±34.2	NUM
brj-24403	177	18	*	*	NOUN
brj-24403	177	19	1603±42.5	1603±42.5	NUM
brj-24403	177	20	*	*	SYM
brj-24403	177	21	*	*	NOUN
brj-24403	177	22	1892±51.3	1892±51.3	NUM
brj-24403	177	23	*	*	PUNCT
brj-24403	177	24	*	*	PUNCT
brj-24403	177	25	*	*	PUNCT
brj-24403	177	26	note	note	NOUN
brj-24403	177	27	:	:	PUNCT
brj-24403	177	28	latencies	latency	NOUN
brj-24403	177	29	to	to	ADP
brj-24403	177	30	the	the	DET
brj-24403	177	31	1st	1st	ADJ
brj-24403	177	32	convulsion	convulsion	NOUN
brj-24403	177	33	and	and	CCONJ
brj-24403	177	34	to	to	ADP
brj-24403	177	35	death	death	NOUN
brj-24403	177	36	are	be	AUX
brj-24403	177	37	represented	represent	VERB
brj-24403	177	38	by	by	ADP
brj-24403	177	39	means±s.e.m	means±s.e.m	PROPN
brj-24403	177	40	.	.	PUNCT
brj-24403	178	1	(	(	PUNCT
brj-24403	178	2	seconds	second	NOUN
brj-24403	178	3	)	)	PUNCT
brj-24403	178	4	,	,	PUNCT
brj-24403	178	5	after	after	ADP
brj-24403	178	6	p350	p350	PROPN
brj-24403	178	7	administration	administration	NOUN
brj-24403	178	8	,	,	PUNCT
brj-24403	178	9	and	and	CCONJ
brj-24403	178	10	analyzed	analyze	VERB
brj-24403	178	11	by	by	ADP
brj-24403	178	12	kruskal	kruskal	PROPN
brj-24403	178	13	–	–	PUNCT
brj-24403	178	14	wallis	wallis	PROPN
brj-24403	178	15	,	,	PUNCT
brj-24403	178	16	followed	follow	VERB
brj-24403	178	17	by	by	ADP
brj-24403	178	18	the	the	DET
brj-24403	178	19	dunn	dunn	PROPN
brj-24403	178	20	's	's	PART
brj-24403	178	21	multiple	multiple	ADJ
brj-24403	178	22	comparison	comparison	NOUN
brj-24403	178	23	test	test	NOUN
brj-24403	178	24	.	.	PUNCT
brj-24403	179	1	latency	latency	NOUN
brj-24403	179	2	to	to	ADP
brj-24403	179	3	1st	1st	ADJ
brj-24403	179	4	convulsion	convulsion	NOUN
brj-24403	179	5	:	:	PUNCT
brj-24403	180	1	*	*	PUNCT
brj-24403	180	2	*	*	PUNCT
brj-24403	180	3	p<0.01	p<0.01	PROPN
brj-24403	180	4	and	and	CCONJ
brj-24403	180	5	*	*	PUNCT
brj-24403	180	6	*	*	PUNCT
brj-24403	180	7	*	*	PUNCT
brj-24403	180	8	p<0.001	p<0.001	X
brj-24403	180	9	vs.	vs.	ADP
brj-24403	180	10	p350	p350	PROPN
brj-24403	180	11	.	.	PUNCT
brj-24403	181	1	latency	latency	NOUN
brj-24403	181	2	to	to	ADP
brj-24403	181	3	death	death	NOUN
brj-24403	181	4	:	:	PUNCT
brj-24403	181	5	*	*	PUNCT
brj-24403	181	6	p<0.05	p<0.05	NOUN
brj-24403	181	7	,	,	PUNCT
brj-24403	181	8	*	*	PUNCT
brj-24403	181	9	*	*	PUNCT
brj-24403	181	10	p<0.01	p<0.01	ADJ
brj-24403	181	11	and	and	CCONJ
brj-24403	181	12	*	*	PUNCT
brj-24403	181	13	*	*	PUNCT
brj-24403	181	14	*	*	PUNCT
brj-24403	181	15	p<0.001	p<0.001	X
brj-24403	181	16	vs.	vs.	ADP
brj-24403	181	17	p350	p350	PROPN
brj-24403	181	18	.	.	PUNCT
brj-24403	182	1	data	datum	NOUN
brj-24403	182	2	on	on	ADP
brj-24403	182	3	survivors	survivor	NOUN
brj-24403	182	4	were	be	AUX
brj-24403	182	5	analyzed	analyze	VERB
brj-24403	182	6	by	by	ADP
brj-24403	182	7	the	the	DET
brj-24403	182	8	nonparametric	nonparametric	NOUN
brj-24403	182	9	log	log	NOUN
brj-24403	182	10	-	-	PUNCT
brj-24403	182	11	rank	rank	NOUN
brj-24403	182	12	(	(	PUNCT
brj-24403	182	13	mantel	mantel	NOUN
brj-24403	182	14	–	–	PUNCT
brj-24403	182	15	cox	cox	NOUN
brj-24403	182	16	)	)	PUNCT
brj-24403	182	17	test	test	NOUN
brj-24403	182	18	(	(	PUNCT
brj-24403	182	19	comparison	comparison	NOUN
brj-24403	182	20	of	of	ADP
brj-24403	182	21	each	each	DET
brj-24403	182	22	survival	survival	NOUN
brj-24403	182	23	curve	curve	NOUN
brj-24403	182	24	to	to	ADP
brj-24403	182	25	p350	p350	PROPN
brj-24403	182	26	)	)	PUNCT
brj-24403	182	27	.	.	PUNCT
brj-24403	183	1	peer	peer	NOUN
brj-24403	183	2	-	-	PUNCT
brj-24403	183	3	reviewed	review	VERB
brj-24403	183	4	article	article	NOUN
brj-24403	183	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	183	6	li	li	PROPN
brj-24403	183	7	et	et	PROPN
brj-24403	183	8	al	al	PROPN
brj-24403	183	9	.	.	PROPN
brj-24403	184	1	(	(	PUNCT
brj-24403	184	2	2025	2025	NUM
brj-24403	184	3	)	)	PUNCT
brj-24403	184	4	.	.	PUNCT
brj-24403	185	1	“	"	PUNCT
brj-24403	185	2	herbal	herbal	ADJ
brj-24403	185	3	anti	anti	ADJ
brj-24403	185	4	-	-	ADJ
brj-24403	185	5	epileptic	epileptic	ADJ
brj-24403	185	6	extract	extract	NOUN
brj-24403	185	7	,	,	PUNCT
brj-24403	185	8	”	"	PUNCT
brj-24403	185	9	bioresources	bioresource	NOUN
brj-24403	185	10	20(2	20(2	NUM
brj-24403	185	11	)	)	PUNCT
brj-24403	185	12	,	,	PUNCT
brj-24403	185	13	4701	4701	NUM
brj-24403	185	14	-	-	SYM
brj-24403	185	15	4719	4719	NUM
brj-24403	185	16	.	.	PUNCT
brj-24403	186	1	4709	4709	NUM
brj-24403	186	2	the	the	DET
brj-24403	186	3	percentage	percentage	NOUN
brj-24403	186	4	of	of	ADP
brj-24403	186	5	animals	animal	NOUN
brj-24403	186	6	that	that	PRON
brj-24403	186	7	did	do	AUX
brj-24403	186	8	not	not	PART
brj-24403	186	9	exhibit	exhibit	VERB
brj-24403	186	10	convulsions	convulsion	NOUN
brj-24403	186	11	was	be	AUX
brj-24403	186	12	also	also	ADV
brj-24403	186	13	significantly	significantly	ADV
brj-24403	186	14	raised	raise	VERB
brj-24403	186	15	as	as	ADP
brj-24403	186	16	a	a	DET
brj-24403	186	17	result	result	NOUN
brj-24403	186	18	of	of	ADP
brj-24403	186	19	cnc	cnc	PROPN
brj-24403	186	20	,	,	PUNCT
brj-24403	186	21	which	which	PRON
brj-24403	186	22	also	also	ADV
brj-24403	186	23	significantly	significantly	ADV
brj-24403	186	24	increased	increase	VERB
brj-24403	186	25	the	the	DET
brj-24403	186	26	survival	survival	NOUN
brj-24403	186	27	rates	rate	NOUN
brj-24403	186	28	of	of	ADP
brj-24403	186	29	the	the	DET
brj-24403	186	30	animals	animal	NOUN
brj-24403	186	31	.	.	PUNCT
brj-24403	187	1	these	these	DET
brj-24403	187	2	findings	finding	NOUN
brj-24403	187	3	indicate	indicate	VERB
brj-24403	187	4	that	that	SCONJ
brj-24403	187	5	cnc	cnc	PROPN
brj-24403	187	6	exhibited	exhibit	VERB
brj-24403	187	7	significant	significant	ADJ
brj-24403	187	8	anti	anti	ADJ
brj-24403	187	9	-	-	ADJ
brj-24403	187	10	convulsive	convulsive	ADJ
brj-24403	187	11	activity	activity	NOUN
brj-24403	187	12	.	.	PUNCT
brj-24403	188	1	this	this	PRON
brj-24403	188	2	may	may	AUX
brj-24403	188	3	be	be	AUX
brj-24403	188	4	attributed	attribute	VERB
brj-24403	188	5	to	to	ADP
brj-24403	188	6	the	the	DET
brj-24403	188	7	bioactive	bioactive	ADJ
brj-24403	188	8	phytosterols	phytosterol	NOUN
brj-24403	188	9	and	and	CCONJ
brj-24403	188	10	terpenoids	terpenoid	NOUN
brj-24403	188	11	present	present	ADJ
brj-24403	188	12	in	in	ADP
brj-24403	188	13	the	the	DET
brj-24403	188	14	extract	extract	NOUN
brj-24403	188	15	,	,	PUNCT
brj-24403	188	16	which	which	PRON
brj-24403	188	17	have	have	AUX
brj-24403	188	18	been	be	AUX
brj-24403	188	19	reported	report	VERB
brj-24403	188	20	to	to	PART
brj-24403	188	21	exert	exert	VERB
brj-24403	188	22	neuroprotective	neuroprotective	ADJ
brj-24403	188	23	and	and	CCONJ
brj-24403	188	24	membrane	membrane	NOUN
brj-24403	188	25	-	-	PUNCT
brj-24403	188	26	stabilizing	stabilize	VERB
brj-24403	188	27	effects	effect	NOUN
brj-24403	188	28	(	(	PUNCT
brj-24403	188	29	ghosh	ghosh	PROPN
brj-24403	188	30	et	et	PROPN
brj-24403	188	31	al	al	PROPN
brj-24403	188	32	.	.	PROPN
brj-24403	188	33	2014	2014	NUM
brj-24403	188	34	;	;	PUNCT
brj-24403	188	35	kim	kim	PROPN
brj-24403	188	36	et	et	PROPN
brj-24403	188	37	al	al	PROPN
brj-24403	188	38	.	.	PROPN
brj-24403	188	39	2015	2015	NUM
brj-24403	188	40	)	)	PUNCT
brj-24403	188	41	.	.	PUNCT
brj-24403	189	1	the	the	DET
brj-24403	189	2	next	next	ADJ
brj-24403	189	3	part	part	NOUN
brj-24403	189	4	of	of	ADP
brj-24403	189	5	the	the	DET
brj-24403	189	6	study	study	NOUN
brj-24403	189	7	was	be	AUX
brj-24403	189	8	conducted	conduct	VERB
brj-24403	189	9	to	to	PART
brj-24403	189	10	elucidate	elucidate	VERB
brj-24403	189	11	the	the	DET
brj-24403	189	12	possible	possible	ADJ
brj-24403	189	13	mechanism	mechanism	NOUN
brj-24403	189	14	of	of	ADP
brj-24403	189	15	action	action	NOUN
brj-24403	189	16	of	of	ADP
brj-24403	189	17	cnc	cnc	PROPN
brj-24403	189	18	.	.	PUNCT
brj-24403	190	1	thus	thus	ADV
brj-24403	190	2	,	,	PUNCT
brj-24403	190	3	the	the	DET
brj-24403	190	4	effect	effect	NOUN
brj-24403	190	5	of	of	ADP
brj-24403	190	6	cnc	cnc	PROPN
brj-24403	190	7	(	(	PUNCT
brj-24403	190	8	50	50	NUM
brj-24403	190	9	mg	mg	PROPN
brj-24403	190	10	/	/	SYM
brj-24403	190	11	kg	kg	PROPN
brj-24403	190	12	and	and	CCONJ
brj-24403	190	13	100	100	NUM
brj-24403	190	14	mg	mg	NUM
brj-24403	190	15	/	/	SYM
brj-24403	190	16	kg	kg	PROPN
brj-24403	190	17	)	)	PUNCT
brj-24403	190	18	was	be	AUX
brj-24403	190	19	estimated	estimate	VERB
brj-24403	190	20	in	in	ADP
brj-24403	190	21	combination	combination	NOUN
brj-24403	190	22	with	with	ADP
brj-24403	190	23	atropine	atropine	NOUN
brj-24403	190	24	(	(	PUNCT
brj-24403	190	25	atrp	atrp	PROPN
brj-24403	190	26	,	,	PUNCT
brj-24403	190	27	a	a	DET
brj-24403	190	28	muscarinic	muscarinic	ADJ
brj-24403	190	29	antagonist	antagonist	NOUN
brj-24403	190	30	)	)	PUNCT
brj-24403	190	31	,	,	PUNCT
brj-24403	190	32	memantine	memantine	NOUN
brj-24403	190	33	(	(	PUNCT
brj-24403	190	34	mem	mem	PROPN
brj-24403	190	35	,	,	PUNCT
brj-24403	190	36	a	a	DET
brj-24403	190	37	nmdatype	nmdatype	ADJ
brj-24403	190	38	glutamate	glutamate	ADJ
brj-24403	190	39	receptor	receptor	NOUN
brj-24403	190	40	blocker	blocker	NOUN
brj-24403	190	41	)	)	PUNCT
brj-24403	190	42	,	,	PUNCT
brj-24403	190	43	diazepam	diazepam	NOUN
brj-24403	190	44	(	(	PUNCT
brj-24403	190	45	dzp	dzp	PROPN
brj-24403	190	46	,	,	PUNCT
brj-24403	190	47	a	a	DET
brj-24403	190	48	drug	drug	NOUN
brj-24403	190	49	which	which	PRON
brj-24403	190	50	binds	bind	VERB
brj-24403	190	51	to	to	ADP
brj-24403	190	52	a	a	DET
brj-24403	190	53	specific	specific	ADJ
brj-24403	190	54	subunit	subunit	NOUN
brj-24403	190	55	of	of	ADP
brj-24403	190	56	the	the	DET
brj-24403	190	57	gabaa	gabaa	NOUN
brj-24403	190	58	receptor	receptor	NOUN
brj-24403	190	59	)	)	PUNCT
brj-24403	190	60	.	.	PUNCT
brj-24403	191	1	some	some	DET
brj-24403	191	2	drugs	drug	NOUN
brj-24403	191	3	,	,	PUNCT
brj-24403	191	4	such	such	ADJ
brj-24403	191	5	as	as	ADP
brj-24403	191	6	atropine	atropine	NOUN
brj-24403	191	7	,	,	PUNCT
brj-24403	191	8	that	that	PRON
brj-24403	191	9	block	block	VERB
brj-24403	191	10	muscarinic	muscarinic	ADJ
brj-24403	191	11	acetylcholine	acetylcholine	NOUN
brj-24403	191	12	receptors	receptor	NOUN
brj-24403	191	13	may	may	AUX
brj-24403	191	14	help	help	VERB
brj-24403	191	15	treat	treat	VERB
brj-24403	191	16	epilepsy	epilepsy	NOUN
brj-24403	191	17	by	by	ADP
brj-24403	191	18	slowing	slow	VERB
brj-24403	191	19	down	down	ADP
brj-24403	191	20	the	the	DET
brj-24403	191	21	brain	brain	NOUN
brj-24403	191	22	activity	activity	NOUN
brj-24403	191	23	that	that	PRON
brj-24403	191	24	leads	lead	VERB
brj-24403	191	25	to	to	ADP
brj-24403	191	26	seizures	seizure	NOUN
brj-24403	191	27	.	.	PUNCT
brj-24403	192	1	this	this	PRON
brj-24403	192	2	is	be	AUX
brj-24403	192	3	done	do	VERB
brj-24403	192	4	by	by	ADP
brj-24403	192	5	lowering	lower	VERB
brj-24403	192	6	the	the	DET
brj-24403	192	7	number	number	NOUN
brj-24403	192	8	of	of	ADP
brj-24403	192	9	wrong	wrong	ADJ
brj-24403	192	10	brain	brain	NOUN
brj-24403	192	11	messages	message	NOUN
brj-24403	192	12	that	that	PRON
brj-24403	192	13	could	could	AUX
brj-24403	192	14	cause	cause	VERB
brj-24403	192	15	seizures	seizure	NOUN
brj-24403	192	16	,	,	PUNCT
brj-24403	192	17	i.e.	i.e.	X
brj-24403	192	18	by	by	ADP
brj-24403	192	19	lowering	lower	VERB
brj-24403	192	20	the	the	DET
brj-24403	192	21	activity	activity	NOUN
brj-24403	192	22	of	of	ADP
brj-24403	192	23	these	these	DET
brj-24403	192	24	receptors	receptor	NOUN
brj-24403	192	25	(	(	PUNCT
brj-24403	192	26	aldossary	aldossary	ADJ
brj-24403	192	27	2022a	2022a	NUM
brj-24403	192	28	)	)	PUNCT
brj-24403	192	29	.	.	PUNCT
brj-24403	193	1	for	for	ADP
brj-24403	193	2	the	the	DET
brj-24403	193	3	present	present	ADJ
brj-24403	193	4	study	study	NOUN
brj-24403	193	5	,	,	PUNCT
brj-24403	193	6	the	the	DET
brj-24403	193	7	mice	mouse	NOUN
brj-24403	193	8	were	be	AUX
brj-24403	193	9	given	give	VERB
brj-24403	193	10	atropine	atropine	NOUN
brj-24403	193	11	(	(	PUNCT
brj-24403	193	12	atrp	atrp	NOUN
brj-24403	193	13	)	)	PUNCT
brj-24403	193	14	before	before	ADP
brj-24403	193	15	giving	give	VERB
brj-24403	193	16	them	they	PRON
brj-24403	193	17	pilocarpine	pilocarpine	NOUN
brj-24403	193	18	,	,	PUNCT
brj-24403	193	19	a	a	DET
brj-24403	193	20	drug	drug	NOUN
brj-24403	193	21	that	that	PRON
brj-24403	193	22	is	be	AUX
brj-24403	193	23	known	know	VERB
brj-24403	193	24	to	to	PART
brj-24403	193	25	make	make	VERB
brj-24403	193	26	cholinergic	cholinergic	ADJ
brj-24403	193	27	neurons	neuron	NOUN
brj-24403	193	28	work	work	VERB
brj-24403	193	29	.	.	PUNCT
brj-24403	194	1	in	in	ADP
brj-24403	194	2	an	an	DET
brj-24403	194	3	earlier	early	ADJ
brj-24403	194	4	study	study	NOUN
brj-24403	194	5	,	,	PUNCT
brj-24403	194	6	a	a	DET
brj-24403	194	7	strong	strong	ADJ
brj-24403	194	8	link	link	NOUN
brj-24403	194	9	was	be	AUX
brj-24403	194	10	found	find	VERB
brj-24403	194	11	between	between	ADP
brj-24403	194	12	cholinergic	cholinergic	ADJ
brj-24403	194	13	activity	activity	NOUN
brj-24403	194	14	and	and	CCONJ
brj-24403	194	15	the	the	DET
brj-24403	194	16	start	start	NOUN
brj-24403	194	17	of	of	ADP
brj-24403	194	18	these	these	DET
brj-24403	194	19	seizures	seizure	NOUN
brj-24403	194	20	.	.	PUNCT
brj-24403	195	1	this	this	PRON
brj-24403	195	2	was	be	AUX
brj-24403	195	3	demonstrated	demonstrate	VERB
brj-24403	195	4	when	when	SCONJ
brj-24403	195	5	methylscopolamine	methylscopolamine	PROPN
brj-24403	195	6	,	,	PUNCT
brj-24403	195	7	another	another	DET
brj-24403	195	8	muscarinic	muscarinic	ADJ
brj-24403	195	9	blocker	blocker	NOUN
brj-24403	195	10	,	,	PUNCT
brj-24403	195	11	was	be	AUX
brj-24403	195	12	given	give	VERB
brj-24403	195	13	before	before	ADP
brj-24403	195	14	pilocarpine	pilocarpine	NOUN
brj-24403	195	15	treatment	treatment	NOUN
brj-24403	195	16	and	and	CCONJ
brj-24403	195	17	effectively	effectively	ADV
brj-24403	195	18	weakened	weaken	VERB
brj-24403	195	19	most	most	ADJ
brj-24403	195	20	of	of	ADP
brj-24403	195	21	its	its	PRON
brj-24403	195	22	effects	effect	NOUN
brj-24403	195	23	(	(	PUNCT
brj-24403	195	24	marchi	marchi	PROPN
brj-24403	195	25	et	et	PROPN
brj-24403	195	26	al	al	PROPN
brj-24403	195	27	.	.	PROPN
brj-24403	195	28	2007a	2007a	NUM
brj-24403	195	29	)	)	PUNCT
brj-24403	195	30	.	.	PUNCT
brj-24403	196	1	fig	fig	NOUN
brj-24403	196	2	.	.	PUNCT
brj-24403	197	1	1	1	X
brj-24403	197	2	.	.	X
brj-24403	197	3	effect	effect	NOUN
brj-24403	197	4	of	of	ADP
brj-24403	197	5	cnc	cnc	PROPN
brj-24403	197	6	in	in	ADP
brj-24403	197	7	combination	combination	NOUN
brj-24403	197	8	with	with	ADP
brj-24403	197	9	atrp	atrp	NOUN
brj-24403	197	10	.	.	PUNCT
brj-24403	198	1	the	the	DET
brj-24403	198	2	data	datum	NOUN
brj-24403	198	3	represent	represent	VERB
brj-24403	198	4	means±s.e.m	means±s.e.m	NOUN
brj-24403	198	5	.	.	PUNCT
brj-24403	199	1	for	for	ADP
brj-24403	199	2	latency	latency	NOUN
brj-24403	199	3	to	to	ADP
brj-24403	199	4	the	the	DET
brj-24403	199	5	1st	1st	ADJ
brj-24403	199	6	convulsion	convulsion	NOUN
brj-24403	199	7	and	and	CCONJ
brj-24403	199	8	death	death	NOUN
brj-24403	199	9	.	.	PUNCT
brj-24403	200	1	no	no	DET
brj-24403	200	2	significant	significant	ADJ
brj-24403	200	3	differences	difference	NOUN
brj-24403	200	4	among	among	ADP
brj-24403	200	5	treatments	treatment	NOUN
brj-24403	200	6	were	be	AUX
brj-24403	200	7	observed	observe	VERB
brj-24403	200	8	(	(	PUNCT
brj-24403	200	9	skillings	skilling	NOUN
brj-24403	200	10	–	–	PUNCT
brj-24403	200	11	mack	mack	PROPN
brj-24403	200	12	non	non	ADJ
brj-24403	200	13	-	-	ADJ
brj-24403	200	14	parametric	parametric	ADJ
brj-24403	200	15	two	two	NUM
brj-24403	200	16	-	-	PUNCT
brj-24403	200	17	way	way	NOUN
brj-24403	200	18	anova	anova	PROPN
brj-24403	200	19	,	,	PUNCT
brj-24403	200	20	followed	follow	VERB
brj-24403	200	21	by	by	ADP
brj-24403	200	22	the	the	DET
brj-24403	200	23	dwass	dwass	NOUN
brj-24403	200	24	–	–	PUNCT
brj-24403	200	25	steel	steel	NOUN
brj-24403	200	26	–	–	PUNCT
brj-24403	200	27	critchlow	critchlow	ADJ
brj-24403	200	28	–	–	PUNCT
brj-24403	200	29	fligner	fligner	NOUN
brj-24403	200	30	test	test	NOUN
brj-24403	200	31	for	for	ADP
brj-24403	200	32	multiple	multiple	ADJ
brj-24403	200	33	comparisons	comparison	NOUN
brj-24403	200	34	)	)	PUNCT
brj-24403	200	35	.	.	PUNCT
brj-24403	201	1	as	as	SCONJ
brj-24403	201	2	shown	show	VERB
brj-24403	201	3	in	in	ADP
brj-24403	201	4	fig	fig	NOUN
brj-24403	201	5	.	.	PUNCT
brj-24403	202	1	1a	1a	NOUN
brj-24403	202	2	,	,	PUNCT
brj-24403	202	3	an	an	DET
brj-24403	202	4	increase	increase	NOUN
brj-24403	202	5	in	in	ADP
brj-24403	202	6	latency	latency	NOUN
brj-24403	202	7	to	to	ADP
brj-24403	202	8	the	the	DET
brj-24403	202	9	first	first	ADJ
brj-24403	202	10	convulsion	convulsion	NOUN
brj-24403	202	11	was	be	AUX
brj-24403	202	12	observed	observe	VERB
brj-24403	202	13	in	in	ADP
brj-24403	202	14	p350	p350	PROPN
brj-24403	202	15	group	group	NOUN
brj-24403	202	16	pre	pre	VERB
brj-24403	202	17	-	-	VERB
brj-24403	202	18	treated	treat	VERB
brj-24403	202	19	with	with	ADP
brj-24403	202	20	cnc100	cnc100	PROPN
brj-24403	202	21	,	,	PUNCT
brj-24403	202	22	or	or	CCONJ
brj-24403	202	23	atrp10	atrp10	PROPN
brj-24403	202	24	or	or	CCONJ
brj-24403	202	25	in	in	ADP
brj-24403	202	26	the	the	DET
brj-24403	202	27	combination	combination	NOUN
brj-24403	202	28	of	of	ADP
brj-24403	202	29	cnc100+atrp10	cnc100+atrp10	PROPN
brj-24403	202	30	in	in	ADP
brj-24403	202	31	comparison	comparison	NOUN
brj-24403	202	32	to	to	ADP
brj-24403	202	33	p350	p350	PROPN
brj-24403	202	34	group	group	NOUN
brj-24403	202	35	.	.	PUNCT
brj-24403	203	1	however	however	ADV
brj-24403	203	2	,	,	PUNCT
brj-24403	203	3	no	no	DET
brj-24403	203	4	significant	significant	ADJ
brj-24403	203	5	difference	difference	NOUN
brj-24403	203	6	was	be	AUX
brj-24403	203	7	observed	observe	VERB
brj-24403	203	8	in	in	ADP
brj-24403	203	9	the	the	DET
brj-24403	203	10	cnc50	cnc50	PROPN
brj-24403	203	11	,	,	PUNCT
brj-24403	203	12	atrp2	atrp2	PROPN
brj-24403	203	13	,	,	PUNCT
brj-24403	203	14	or	or	CCONJ
brj-24403	203	15	a	a	DET
brj-24403	203	16	combination	combination	NOUN
brj-24403	203	17	of	of	ADP
brj-24403	203	18	these	these	PRON
brj-24403	203	19	.	.	PUNCT
brj-24403	204	1	thus	thus	ADV
brj-24403	204	2	,	,	PUNCT
brj-24403	204	3	it	it	PRON
brj-24403	204	4	was	be	AUX
brj-24403	204	5	suggested	suggest	VERB
brj-24403	204	6	that	that	SCONJ
brj-24403	204	7	atrp	atrp	NOUN
brj-24403	204	8	helped	helped	AUX
brj-24403	204	9	avoid	avoid	VERB
brj-24403	204	10	seizures	seizure	NOUN
brj-24403	204	11	a	a	DET
brj-24403	204	12	little	little	ADJ
brj-24403	204	13	bit	bit	NOUN
brj-24403	204	14	,	,	PUNCT
brj-24403	204	15	but	but	CCONJ
brj-24403	204	16	when	when	SCONJ
brj-24403	204	17	it	it	PRON
brj-24403	204	18	was	be	AUX
brj-24403	204	19	mixed	mix	VERB
brj-24403	204	20	with	with	ADP
brj-24403	204	21	another	another	DET
brj-24403	204	22	drug	drug	NOUN
brj-24403	204	23	(	(	PUNCT
brj-24403	204	24	cnc	cnc	PROPN
brj-24403	204	25	)	)	PUNCT
brj-24403	204	26	,	,	PUNCT
brj-24403	204	27	it	it	PRON
brj-24403	204	28	did	do	AUX
brj-24403	204	29	n’t	not	PART
brj-24403	204	30	make	make	VERB
brj-24403	204	31	cnc	cnc	ADJ
brj-24403	204	32	work	work	NOUN
brj-24403	204	33	better	well	ADV
brj-24403	204	34	at	at	ADP
brj-24403	204	35	stopping	stop	VERB
brj-24403	204	36	seizures	seizure	NOUN
brj-24403	204	37	.	.	PUNCT
brj-24403	205	1	atropine	atropine	NOUN
brj-24403	205	2	can	can	AUX
brj-24403	205	3	stop	stop	VERB
brj-24403	205	4	seizures	seizure	NOUN
brj-24403	205	5	caused	cause	VERB
brj-24403	205	6	by	by	ADP
brj-24403	205	7	pilocarpine	pilocarpine	NOUN
brj-24403	205	8	by	by	ADP
brj-24403	205	9	connecting	connect	VERB
brj-24403	205	10	to	to	ADP
brj-24403	205	11	m1	m1	NOUN
brj-24403	205	12	muscarinic	muscarinic	ADJ
brj-24403	205	13	receptors	receptor	NOUN
brj-24403	205	14	,	,	PUNCT
brj-24403	205	15	as	as	SCONJ
brj-24403	205	16	shown	show	VERB
brj-24403	205	17	in	in	ADP
brj-24403	205	18	earlier	early	ADJ
brj-24403	205	19	research	research	NOUN
brj-24403	205	20	(	(	PUNCT
brj-24403	205	21	hamilton	hamilton	PROPN
brj-24403	205	22	et	et	PROPN
brj-24403	205	23	al	al	PROPN
brj-24403	205	24	.	.	PROPN
brj-24403	205	25	1997	1997	NUM
brj-24403	205	26	)	)	PUNCT
brj-24403	205	27	.	.	PUNCT
brj-24403	206	1	it	it	PRON
brj-24403	206	2	is	be	AUX
brj-24403	206	3	thought	think	VERB
brj-24403	206	4	that	that	SCONJ
brj-24403	206	5	these	these	DET
brj-24403	206	6	receptors	receptor	NOUN
brj-24403	206	7	are	be	AUX
brj-24403	206	8	the	the	DET
brj-24403	206	9	main	main	ADJ
brj-24403	206	10	cause	cause	NOUN
brj-24403	206	11	of	of	ADP
brj-24403	206	12	seizures	seizure	NOUN
brj-24403	206	13	.	.	PUNCT
brj-24403	207	1	previous	previous	ADJ
brj-24403	207	2	studies	study	NOUN
brj-24403	207	3	have	have	AUX
brj-24403	207	4	shown	show	VERB
brj-24403	207	5	that	that	SCONJ
brj-24403	207	6	muscarinic	muscarinic	ADJ
brj-24403	207	7	receptor	receptor	NOUN
brj-24403	207	8	blockade	blockade	NOUN
brj-24403	207	9	attenuates	attenuate	NOUN
brj-24403	207	10	pilocarpineinduced	pilocarpineinduce	VERB
brj-24403	207	11	seizures	seizure	NOUN
brj-24403	207	12	(	(	PUNCT
brj-24403	207	13	marchi	marchi	PROPN
brj-24403	207	14	et	et	PROPN
brj-24403	207	15	al	al	PROPN
brj-24403	207	16	.	.	PROPN
brj-24403	207	17	2007b	2007b	NUM
brj-24403	207	18	;	;	PUNCT
brj-24403	207	19	aldossary	aldossary	ADJ
brj-24403	207	20	2022b	2022b	NUM
brj-24403	207	21	)	)	PUNCT
brj-24403	207	22	.	.	PUNCT
brj-24403	208	1	however	however	ADV
brj-24403	208	2	,	,	PUNCT
brj-24403	208	3	the	the	DET
brj-24403	208	4	present	present	ADJ
brj-24403	208	5	research	research	NOUN
brj-24403	208	6	peer	peer	NOUN
brj-24403	208	7	-	-	PUNCT
brj-24403	208	8	reviewed	review	VERB
brj-24403	208	9	article	article	NOUN
brj-24403	208	10	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	208	11	li	li	PROPN
brj-24403	208	12	et	et	PROPN
brj-24403	208	13	al	al	PROPN
brj-24403	208	14	.	.	PROPN
brj-24403	209	1	(	(	PUNCT
brj-24403	209	2	2025	2025	NUM
brj-24403	209	3	)	)	PUNCT
brj-24403	209	4	.	.	PUNCT
brj-24403	210	1	“	"	PUNCT
brj-24403	210	2	herbal	herbal	ADJ
brj-24403	210	3	anti	anti	ADJ
brj-24403	210	4	-	-	ADJ
brj-24403	210	5	epileptic	epileptic	ADJ
brj-24403	210	6	extract	extract	NOUN
brj-24403	210	7	,	,	PUNCT
brj-24403	210	8	”	"	PUNCT
brj-24403	210	9	bioresources	bioresource	NOUN
brj-24403	210	10	20(2	20(2	NUM
brj-24403	210	11	)	)	PUNCT
brj-24403	210	12	,	,	PUNCT
brj-24403	210	13	4701	4701	NUM
brj-24403	210	14	-	-	SYM
brj-24403	210	15	4719	4719	NUM
brj-24403	210	16	.	.	PUNCT
brj-24403	211	1	4710	4710	NUM
brj-24403	211	2	showed	show	VERB
brj-24403	211	3	that	that	SCONJ
brj-24403	211	4	muscarinic	muscarinic	ADJ
brj-24403	211	5	receptor	receptor	NOUN
brj-24403	211	6	activation	activation	NOUN
brj-24403	211	7	was	be	AUX
brj-24403	211	8	not	not	PART
brj-24403	211	9	the	the	DET
brj-24403	211	10	only	only	ADJ
brj-24403	211	11	criterion	criterion	NOUN
brj-24403	211	12	controlling	control	VERB
brj-24403	211	13	the	the	DET
brj-24403	211	14	antiseizure	antiseizure	NOUN
brj-24403	211	15	effects	effect	NOUN
brj-24403	211	16	of	of	ADP
brj-24403	211	17	cnc	cnc	PROPN
brj-24403	211	18	.	.	PUNCT
brj-24403	212	1	thus	thus	ADV
brj-24403	212	2	,	,	PUNCT
brj-24403	212	3	to	to	PART
brj-24403	212	4	further	far	ADV
brj-24403	212	5	explore	explore	VERB
brj-24403	212	6	the	the	DET
brj-24403	212	7	possible	possible	ADJ
brj-24403	212	8	mechanism	mechanism	NOUN
brj-24403	212	9	of	of	ADP
brj-24403	212	10	action	action	NOUN
brj-24403	212	11	of	of	ADP
brj-24403	212	12	cnc	cnc	PROPN
brj-24403	212	13	,	,	PUNCT
brj-24403	212	14	the	the	DET
brj-24403	212	15	pharmacological	pharmacological	ADJ
brj-24403	212	16	activity	activity	NOUN
brj-24403	212	17	cnc	cnc	NOUN
brj-24403	212	18	was	be	AUX
brj-24403	212	19	tested	test	VERB
brj-24403	212	20	in	in	ADP
brj-24403	212	21	combination	combination	NOUN
brj-24403	212	22	with	with	ADP
brj-24403	212	23	mem	mem	PROPN
brj-24403	212	24	(	(	PUNCT
brj-24403	212	25	mcshane	mcshane	PROPN
brj-24403	212	26	et	et	PROPN
brj-24403	212	27	al	al	PROPN
brj-24403	212	28	.	.	PROPN
brj-24403	212	29	2019	2019	NUM
brj-24403	212	30	)	)	PUNCT
brj-24403	212	31	,	,	PUNCT
brj-24403	212	32	to	to	PART
brj-24403	212	33	identify	identify	VERB
brj-24403	212	34	the	the	DET
brj-24403	212	35	role	role	NOUN
brj-24403	212	36	of	of	ADP
brj-24403	212	37	glutaminergic	glutaminergic	NOUN
brj-24403	212	38	receptor	receptor	NOUN
brj-24403	212	39	in	in	ADP
brj-24403	212	40	anticonvulsive	anticonvulsive	ADJ
brj-24403	212	41	action	action	NOUN
brj-24403	212	42	of	of	ADP
brj-24403	212	43	cnc	cnc	PROPN
brj-24403	212	44	.	.	PROPN
brj-24403	213	1	as	as	SCONJ
brj-24403	213	2	shown	show	VERB
brj-24403	213	3	in	in	ADP
brj-24403	213	4	fig	fig	NOUN
brj-24403	213	5	.	.	PUNCT
brj-24403	214	1	2	2	NUM
brj-24403	214	2	,	,	PUNCT
brj-24403	214	3	no	no	DET
brj-24403	214	4	significant	significant	ADJ
brj-24403	214	5	increase	increase	NOUN
brj-24403	214	6	in	in	ADP
brj-24403	214	7	latency	latency	NOUN
brj-24403	214	8	to	to	ADP
brj-24403	214	9	the	the	DET
brj-24403	214	10	1st	1st	ADJ
brj-24403	214	11	convulsion	convulsion	NOUN
brj-24403	214	12	was	be	AUX
brj-24403	214	13	observed	observe	VERB
brj-24403	214	14	in	in	ADP
brj-24403	214	15	the	the	DET
brj-24403	214	16	mem2+cnc50	mem2+cnc50	PROPN
brj-24403	214	17	combination	combination	NOUN
brj-24403	214	18	group	group	NOUN
brj-24403	214	19	,	,	PUNCT
brj-24403	214	20	suggesting	suggest	VERB
brj-24403	214	21	the	the	DET
brj-24403	214	22	memantine	memantine	NOUN
brj-24403	214	23	was	be	AUX
brj-24403	214	24	not	not	PART
brj-24403	214	25	able	able	ADJ
brj-24403	214	26	to	to	PART
brj-24403	214	27	prevent	prevent	VERB
brj-24403	214	28	pilocarpine	pilocarpine	NOUN
brj-24403	214	29	induced	induce	VERB
brj-24403	214	30	convulsion	convulsion	NOUN
brj-24403	214	31	in	in	ADP
brj-24403	214	32	comparison	comparison	NOUN
brj-24403	214	33	to	to	ADP
brj-24403	214	34	p350	p350	PROPN
brj-24403	214	35	treated	treat	VERB
brj-24403	214	36	group	group	NOUN
brj-24403	214	37	.	.	PUNCT
brj-24403	215	1	studies	study	NOUN
brj-24403	215	2	showed	show	VERB
brj-24403	215	3	that	that	SCONJ
brj-24403	215	4	seizures	seizure	NOUN
brj-24403	215	5	begin	begin	VERB
brj-24403	215	6	and	and	CCONJ
brj-24403	215	7	progress	progress	VERB
brj-24403	215	8	with	with	ADP
brj-24403	215	9	glutamate	glutamate	NOUN
brj-24403	215	10	,	,	PUNCT
brj-24403	215	11	and	and	CCONJ
brj-24403	215	12	research	research	NOUN
brj-24403	215	13	shows	show	VERB
brj-24403	215	14	that	that	SCONJ
brj-24403	215	15	aberrant	aberrant	ADJ
brj-24403	215	16	glutamate	glutamate	NOUN
brj-24403	215	17	release	release	NOUN
brj-24403	215	18	activates	activate	VERB
brj-24403	215	19	many	many	ADJ
brj-24403	215	20	neuronal	neuronal	ADJ
brj-24403	215	21	populations	population	NOUN
brj-24403	215	22	at	at	ADP
brj-24403	215	23	once	once	ADV
brj-24403	215	24	,	,	PUNCT
brj-24403	215	25	causing	cause	VERB
brj-24403	215	26	seizures	seizure	NOUN
brj-24403	215	27	(	(	PUNCT
brj-24403	215	28	during	during	ADP
brj-24403	215	29	and	and	CCONJ
brj-24403	215	30	spencer	spencer	PROPN
brj-24403	215	31	1993	1993	NUM
brj-24403	215	32	;	;	PUNCT
brj-24403	215	33	barker	barker	NOUN
brj-24403	215	34	-	-	PUNCT
brj-24403	215	35	haliski	haliski	PROPN
brj-24403	215	36	and	and	CCONJ
brj-24403	215	37	steve	steve	PROPN
brj-24403	215	38	white	white	PROPN
brj-24403	215	39	2015	2015	NUM
brj-24403	215	40	)	)	PUNCT
brj-24403	215	41	.	.	PUNCT
brj-24403	216	1	one	one	NUM
brj-24403	216	2	possible	possible	ADJ
brj-24403	216	3	element	element	NOUN
brj-24403	216	4	in	in	ADP
brj-24403	216	5	the	the	DET
brj-24403	216	6	epileptogenic	epileptogenic	ADJ
brj-24403	216	7	process	process	NOUN
brj-24403	216	8	and	and	CCONJ
brj-24403	216	9	the	the	DET
brj-24403	216	10	origin	origin	NOUN
brj-24403	216	11	of	of	ADP
brj-24403	216	12	seizures	seizure	NOUN
brj-24403	216	13	is	be	AUX
brj-24403	216	14	changes	change	NOUN
brj-24403	216	15	in	in	ADP
brj-24403	216	16	glutamatergic	glutamatergic	ADJ
brj-24403	216	17	transmission	transmission	NOUN
brj-24403	216	18	via	via	ADP
brj-24403	216	19	the	the	DET
brj-24403	216	20	perforant	perforant	ADJ
brj-24403	216	21	route	route	NOUN
brj-24403	216	22	.	.	PUNCT
brj-24403	217	1	enhanced	enhance	VERB
brj-24403	217	2	glutamatergic	glutamatergic	ADJ
brj-24403	217	3	transmission	transmission	NOUN
brj-24403	217	4	helped	help	VERB
brj-24403	217	5	reduce	reduce	VERB
brj-24403	217	6	the	the	DET
brj-24403	217	7	seizure	seizure	NOUN
brj-24403	217	8	threshold	threshold	NOUN
brj-24403	217	9	,	,	PUNCT
brj-24403	217	10	according	accord	VERB
brj-24403	217	11	to	to	ADP
brj-24403	217	12	patch	patch	ADJ
brj-24403	217	13	-	-	PUNCT
brj-24403	217	14	clamp	clamp	NOUN
brj-24403	217	15	recordings	recording	NOUN
brj-24403	217	16	in	in	ADP
brj-24403	217	17	rat	rat	NOUN
brj-24403	217	18	hippocampus	hippocampus	NOUN
brj-24403	217	19	slices	slice	NOUN
brj-24403	217	20	taken	take	VERB
brj-24403	217	21	after	after	ADP
brj-24403	217	22	pilocarpine	pilocarpine	NOUN
brj-24403	217	23	-	-	PUNCT
brj-24403	217	24	induced	induce	VERB
brj-24403	217	25	status	status	NOUN
brj-24403	217	26	epilepticus	epilepticus	NOUN
brj-24403	217	27	(	(	PUNCT
brj-24403	217	28	jakubs	jakub	NOUN
brj-24403	217	29	et	et	PROPN
brj-24403	217	30	al	al	PROPN
brj-24403	217	31	.	.	PROPN
brj-24403	217	32	2006	2006	NUM
brj-24403	217	33	;	;	PUNCT
brj-24403	217	34	amakhin	amakhin	ADP
brj-24403	217	35	et	et	PROPN
brj-24403	217	36	al	al	PROPN
brj-24403	217	37	.	.	PROPN
brj-24403	217	38	2018a	2018a	NUM
brj-24403	217	39	)	)	PUNCT
brj-24403	217	40	.	.	PUNCT
brj-24403	218	1	in	in	ADP
brj-24403	218	2	the	the	DET
brj-24403	218	3	current	current	ADJ
brj-24403	218	4	study	study	NOUN
brj-24403	218	5	,	,	PUNCT
brj-24403	218	6	neither	neither	CCONJ
brj-24403	218	7	the	the	DET
brj-24403	218	8	use	use	NOUN
brj-24403	218	9	of	of	ADP
brj-24403	218	10	pilocarpine	pilocarpine	NOUN
brj-24403	218	11	nor	nor	CCONJ
brj-24403	218	12	the	the	DET
brj-24403	218	13	combination	combination	NOUN
brj-24403	218	14	of	of	ADP
brj-24403	218	15	the	the	DET
brj-24403	218	16	nmda	nmda	ADJ
brj-24403	218	17	receptor	receptor	NOUN
brj-24403	218	18	antagonist	antagonist	NOUN
brj-24403	218	19	memantine	memantine	VERB
brj-24403	218	20	with	with	ADP
brj-24403	218	21	the	the	DET
brj-24403	218	22	cnc	cnc	PROPN
brj-24403	218	23	increased	increase	VERB
brj-24403	218	24	the	the	DET
brj-24403	218	25	effectiveness	effectiveness	NOUN
brj-24403	218	26	of	of	ADP
brj-24403	218	27	the	the	DET
brj-24403	218	28	latter	latter	ADJ
brj-24403	218	29	.	.	PUNCT
brj-24403	219	1	this	this	PRON
brj-24403	219	2	indicates	indicate	VERB
brj-24403	219	3	that	that	SCONJ
brj-24403	219	4	the	the	DET
brj-24403	219	5	anti	anti	ADJ
brj-24403	219	6	-	-	ADJ
brj-24403	219	7	convulsive	convulsive	ADJ
brj-24403	219	8	action	action	NOUN
brj-24403	219	9	of	of	ADP
brj-24403	219	10	cnc	cnc	PROPN
brj-24403	219	11	is	be	AUX
brj-24403	219	12	not	not	PART
brj-24403	219	13	mediated	mediate	VERB
brj-24403	219	14	via	via	ADP
brj-24403	219	15	nmda	nmda	ADJ
brj-24403	219	16	-	-	PUNCT
brj-24403	219	17	type	type	NOUN
brj-24403	219	18	glutamatergic	glutamatergic	ADJ
brj-24403	219	19	receptor	receptor	NOUN
brj-24403	219	20	antagonism	antagonism	NOUN
brj-24403	219	21	,	,	PUNCT
brj-24403	219	22	which	which	PRON
brj-24403	219	23	is	be	AUX
brj-24403	219	24	consistent	consistent	ADJ
brj-24403	219	25	with	with	ADP
brj-24403	219	26	literature	literature	NOUN
brj-24403	219	27	reporting	report	VERB
brj-24403	219	28	limited	limited	ADJ
brj-24403	219	29	efficacy	efficacy	NOUN
brj-24403	219	30	of	of	ADP
brj-24403	219	31	nmda	nmda	ADJ
brj-24403	219	32	antagonists	antagonist	NOUN
brj-24403	219	33	in	in	ADP
brj-24403	219	34	this	this	DET
brj-24403	219	35	model	model	NOUN
brj-24403	219	36	(	(	PUNCT
brj-24403	219	37	during	during	ADP
brj-24403	219	38	and	and	CCONJ
brj-24403	219	39	spencer	spencer	PROPN
brj-24403	219	40	1993	1993	NUM
brj-24403	219	41	;	;	PUNCT
brj-24403	219	42	amakhin	amakhin	ADP
brj-24403	219	43	et	et	PROPN
brj-24403	219	44	al	al	PROPN
brj-24403	219	45	.	.	PROPN
brj-24403	219	46	2018b	2018b	NUM
brj-24403	219	47	)	)	PUNCT
brj-24403	219	48	.	.	PUNCT
brj-24403	220	1	fig	fig	NOUN
brj-24403	220	2	.	.	PUNCT
brj-24403	221	1	2	2	X
brj-24403	221	2	.	.	X
brj-24403	221	3	effect	effect	NOUN
brj-24403	221	4	of	of	ADP
brj-24403	221	5	cnc	cnc	PROPN
brj-24403	221	6	in	in	ADP
brj-24403	221	7	combination	combination	NOUN
brj-24403	221	8	with	with	ADP
brj-24403	221	9	mem	mem	PROPN
brj-24403	221	10	.	.	PUNCT
brj-24403	222	1	the	the	DET
brj-24403	222	2	data	datum	NOUN
brj-24403	222	3	represent	represent	VERB
brj-24403	222	4	means±s.e.m	means±s.e.m	NOUN
brj-24403	222	5	.	.	PUNCT
brj-24403	223	1	for	for	ADP
brj-24403	223	2	latencies	latency	NOUN
brj-24403	223	3	to	to	ADP
brj-24403	223	4	the	the	DET
brj-24403	223	5	1st	1st	ADJ
brj-24403	223	6	convulsion	convulsion	NOUN
brj-24403	223	7	and	and	CCONJ
brj-24403	223	8	to	to	ADP
brj-24403	223	9	death	death	NOUN
brj-24403	223	10	.	.	PUNCT
brj-24403	224	1	no	no	DET
brj-24403	224	2	significant	significant	ADJ
brj-24403	224	3	differences	difference	NOUN
brj-24403	224	4	among	among	ADP
brj-24403	224	5	treatments	treatment	NOUN
brj-24403	224	6	were	be	AUX
brj-24403	224	7	observed	observe	VERB
brj-24403	224	8	(	(	PUNCT
brj-24403	224	9	skillings	skilling	NOUN
brj-24403	224	10	–	–	PUNCT
brj-24403	224	11	mack	mack	PROPN
brj-24403	224	12	non	non	ADJ
brj-24403	224	13	-	-	ADJ
brj-24403	224	14	parametric	parametric	ADJ
brj-24403	224	15	two	two	NUM
brj-24403	224	16	-	-	PUNCT
brj-24403	224	17	way	way	NOUN
brj-24403	224	18	anova	anova	PROPN
brj-24403	224	19	,	,	PUNCT
brj-24403	224	20	followed	follow	VERB
brj-24403	224	21	by	by	ADP
brj-24403	224	22	the	the	DET
brj-24403	224	23	dwass	dwass	NOUN
brj-24403	224	24	–	–	PUNCT
brj-24403	224	25	steel	steel	NOUN
brj-24403	224	26	–	–	PUNCT
brj-24403	224	27	critchlow	critchlow	ADJ
brj-24403	224	28	–	–	PUNCT
brj-24403	224	29	fligner	fligner	NOUN
brj-24403	224	30	test	test	NOUN
brj-24403	224	31	for	for	ADP
brj-24403	224	32	multiple	multiple	ADJ
brj-24403	224	33	comparisons	comparison	NOUN
brj-24403	224	34	)	)	PUNCT
brj-24403	224	35	.	.	PUNCT
brj-24403	225	1	the	the	DET
brj-24403	225	2	last	last	ADJ
brj-24403	225	3	combination	combination	NOUN
brj-24403	225	4	of	of	ADP
brj-24403	225	5	cnc	cnc	PROPN
brj-24403	225	6	was	be	AUX
brj-24403	225	7	performed	perform	VERB
brj-24403	225	8	with	with	ADP
brj-24403	225	9	dzp	dzp	NOUN
brj-24403	225	10	to	to	PART
brj-24403	225	11	find	find	VERB
brj-24403	225	12	out	out	ADP
brj-24403	225	13	the	the	DET
brj-24403	225	14	relation	relation	NOUN
brj-24403	225	15	of	of	ADP
brj-24403	225	16	bdz	bdz	PROPN
brj-24403	225	17	receptor	receptor	NOUN
brj-24403	225	18	on	on	ADP
brj-24403	225	19	the	the	DET
brj-24403	225	20	anticonvulsive	anticonvulsive	ADJ
brj-24403	225	21	action	action	NOUN
brj-24403	225	22	of	of	ADP
brj-24403	225	23	cnc	cnc	PROPN
brj-24403	225	24	.	.	PROPN
brj-24403	226	1	as	as	SCONJ
brj-24403	226	2	shown	show	VERB
brj-24403	226	3	in	in	ADP
brj-24403	226	4	fig	fig	NOUN
brj-24403	226	5	.	.	PUNCT
brj-24403	227	1	3	3	NUM
brj-24403	227	2	,	,	PUNCT
brj-24403	227	3	in	in	ADP
brj-24403	227	4	comparison	comparison	NOUN
brj-24403	227	5	to	to	ADP
brj-24403	227	6	p350	p350	PROPN
brj-24403	227	7	untreated	untreated	ADJ
brj-24403	227	8	group	group	NOUN
brj-24403	227	9	,	,	PUNCT
brj-24403	227	10	the	the	DET
brj-24403	227	11	p350	p350	PROPN
brj-24403	227	12	pre	pre	VERB
brj-24403	227	13	-	-	VERB
brj-24403	227	14	treated	treat	VERB
brj-24403	227	15	alone	alone	ADJ
brj-24403	227	16	and	and	CCONJ
brj-24403	227	17	combination	combination	NOUN
brj-24403	227	18	group	group	NOUN
brj-24403	227	19	(	(	PUNCT
brj-24403	227	20	cnc50	cnc50	PROPN
brj-24403	227	21	,	,	PUNCT
brj-24403	227	22	cnc100	cnc100	PROPN
brj-24403	227	23	,	,	PUNCT
brj-24403	227	24	dzp0.2	dzp0.2	PROPN
brj-24403	227	25	,	,	PUNCT
brj-24403	227	26	dzp0.2+cnc50	dzp0.2+cnc50	PROPN
brj-24403	227	27	,	,	PUNCT
brj-24403	227	28	dzp0.5	dzp0.5	PROPN
brj-24403	227	29	,	,	PUNCT
brj-24403	227	30	and	and	CCONJ
brj-24403	227	31	dzp0.5+cnc100	dzp0.5+cnc100	NUM
brj-24403	227	32	)	)	PUNCT
brj-24403	227	33	showed	show	VERB
brj-24403	227	34	significant	significant	ADJ
brj-24403	227	35	improvement	improvement	NOUN
brj-24403	227	36	in	in	ADP
brj-24403	227	37	the	the	DET
brj-24403	227	38	latency	latency	NOUN
brj-24403	227	39	to	to	ADP
brj-24403	227	40	the	the	DET
brj-24403	227	41	1st	1st	ADJ
brj-24403	227	42	convulsion	convulsion	NOUN
brj-24403	227	43	.	.	PUNCT
brj-24403	228	1	the	the	DET
brj-24403	228	2	latency	latency	NOUN
brj-24403	228	3	to	to	ADP
brj-24403	228	4	death	death	NOUN
brj-24403	228	5	,	,	PUNCT
brj-24403	228	6	on	on	ADP
brj-24403	228	7	the	the	DET
brj-24403	228	8	other	other	ADJ
brj-24403	228	9	hand	hand	NOUN
brj-24403	228	10	,	,	PUNCT
brj-24403	228	11	did	do	AUX
brj-24403	228	12	not	not	PART
brj-24403	228	13	show	show	VERB
brj-24403	228	14	any	any	DET
brj-24403	228	15	significant	significant	ADJ
brj-24403	228	16	differences	difference	NOUN
brj-24403	228	17	between	between	ADP
brj-24403	228	18	the	the	DET
brj-24403	228	19	groups	group	NOUN
brj-24403	228	20	.	.	PUNCT
brj-24403	229	1	this	this	PRON
brj-24403	229	2	is	be	AUX
brj-24403	229	3	most	most	ADV
brj-24403	229	4	likely	likely	ADJ
brj-24403	229	5	because	because	SCONJ
brj-24403	229	6	the	the	DET
brj-24403	229	7	majority	majority	NOUN
brj-24403	229	8	of	of	ADP
brj-24403	229	9	the	the	DET
brj-24403	229	10	animals	animal	NOUN
brj-24403	229	11	did	do	AUX
brj-24403	229	12	not	not	PART
brj-24403	229	13	experience	experience	VERB
brj-24403	229	14	convulsions	convulsion	NOUN
brj-24403	229	15	or	or	CCONJ
brj-24403	229	16	die	die	VERB
brj-24403	229	17	when	when	SCONJ
brj-24403	229	18	the	the	DET
brj-24403	229	19	cnc	cnc	ADJ
brj-24403	229	20	and	and	CCONJ
brj-24403	229	21	dzp	dzp	NOUN
brj-24403	229	22	were	be	AUX
brj-24403	229	23	combined	combine	VERB
brj-24403	229	24	.	.	PUNCT
brj-24403	230	1	it	it	PRON
brj-24403	230	2	has	have	AUX
brj-24403	230	3	been	be	AUX
brj-24403	230	4	suggested	suggest	VERB
brj-24403	230	5	that	that	SCONJ
brj-24403	230	6	the	the	DET
brj-24403	230	7	extract	extract	NOUN
brj-24403	230	8	may	may	AUX
brj-24403	230	9	enhance	enhance	VERB
brj-24403	230	10	gabaergic	gabaergic	ADJ
brj-24403	230	11	transmission	transmission	NOUN
brj-24403	230	12	,	,	PUNCT
brj-24403	230	13	possibly	possibly	ADV
brj-24403	230	14	due	due	ADP
brj-24403	230	15	to	to	ADP
brj-24403	230	16	phytosterols	phytosterol	NOUN
brj-24403	230	17	,	,	PUNCT
brj-24403	230	18	which	which	PRON
brj-24403	230	19	are	be	AUX
brj-24403	230	20	known	know	VERB
brj-24403	230	21	to	to	PART
brj-24403	230	22	modulate	modulate	VERB
brj-24403	230	23	gaba	gaba	NOUN
brj-24403	230	24	-	-	PUNCT
brj-24403	230	25	a	a	DET
brj-24403	230	26	receptor	receptor	NOUN
brj-24403	230	27	activity	activity	NOUN
brj-24403	230	28	(	(	PUNCT
brj-24403	230	29	zavvari	zavvari	X
brj-24403	230	30	et	et	PROPN
brj-24403	230	31	al	al	PROPN
brj-24403	230	32	.	.	PROPN
brj-24403	230	33	2018	2018	NUM
brj-24403	230	34	)	)	PUNCT
brj-24403	230	35	peer	peer	NOUN
brj-24403	230	36	-	-	PUNCT
brj-24403	230	37	reviewed	review	VERB
brj-24403	230	38	article	article	NOUN
brj-24403	230	39	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	230	40	li	li	PROPN
brj-24403	230	41	et	et	PROPN
brj-24403	230	42	al	al	PROPN
brj-24403	230	43	.	.	PROPN
brj-24403	231	1	(	(	PUNCT
brj-24403	231	2	2025	2025	NUM
brj-24403	231	3	)	)	PUNCT
brj-24403	231	4	.	.	PUNCT
brj-24403	232	1	“	"	PUNCT
brj-24403	232	2	herbal	herbal	ADJ
brj-24403	232	3	anti	anti	ADJ
brj-24403	232	4	-	-	ADJ
brj-24403	232	5	epileptic	epileptic	ADJ
brj-24403	232	6	extract	extract	NOUN
brj-24403	232	7	,	,	PUNCT
brj-24403	232	8	”	"	PUNCT
brj-24403	232	9	bioresources	bioresource	NOUN
brj-24403	232	10	20(2	20(2	NUM
brj-24403	232	11	)	)	PUNCT
brj-24403	232	12	,	,	PUNCT
brj-24403	232	13	4701	4701	NUM
brj-24403	232	14	-	-	SYM
brj-24403	232	15	4719	4719	NUM
brj-24403	232	16	.	.	PUNCT
brj-24403	233	1	4711	4711	NUM
brj-24403	233	2	fig	fig	NOUN
brj-24403	233	3	.	.	PUNCT
brj-24403	234	1	3	3	X
brj-24403	234	2	.	.	X
brj-24403	234	3	effect	effect	NOUN
brj-24403	234	4	of	of	ADP
brj-24403	234	5	cnc	cnc	PROPN
brj-24403	234	6	in	in	ADP
brj-24403	234	7	combination	combination	NOUN
brj-24403	234	8	with	with	ADP
brj-24403	234	9	dzp	dzp	NOUN
brj-24403	234	10	.	.	PUNCT
brj-24403	235	1	the	the	DET
brj-24403	235	2	data	datum	NOUN
brj-24403	235	3	represent	represent	VERB
brj-24403	235	4	means±s.e.m	means±s.e.m	NOUN
brj-24403	235	5	.	.	PUNCT
brj-24403	236	1	for	for	ADP
brj-24403	236	2	latency	latency	NOUN
brj-24403	236	3	to	to	ADP
brj-24403	236	4	1st	1st	ADJ
brj-24403	236	5	convulsion	convulsion	NOUN
brj-24403	236	6	and	and	CCONJ
brj-24403	236	7	death	death	NOUN
brj-24403	236	8	.	.	PUNCT
brj-24403	237	1	latency	latency	NOUN
brj-24403	237	2	to	to	ADP
brj-24403	237	3	the	the	DET
brj-24403	237	4	1st	1st	ADJ
brj-24403	237	5	convulsion	convulsion	NOUN
brj-24403	237	6	:	:	PUNCT
brj-24403	237	7	*	*	PUNCT
brj-24403	237	8	p>0.004	p>0.004	VERB
brj-24403	237	9	to	to	ADP
brj-24403	237	10	0.010	0.010	NUM
brj-24403	237	11	vs.	vs.	ADP
brj-24403	237	12	p350	p350	PROPN
brj-24403	237	13	(	(	PUNCT
brj-24403	237	14	skillings	skilling	NOUN
brj-24403	237	15	–	–	PUNCT
brj-24403	237	16	mack	mack	PROPN
brj-24403	237	17	non	non	ADJ
brj-24403	237	18	-	-	ADJ
brj-24403	237	19	parametric	parametric	ADJ
brj-24403	237	20	two	two	NUM
brj-24403	237	21	-	-	PUNCT
brj-24403	237	22	way	way	NOUN
brj-24403	237	23	anova	anova	PROPN
brj-24403	237	24	,	,	PUNCT
brj-24403	237	25	followed	follow	VERB
brj-24403	237	26	by	by	ADP
brj-24403	237	27	the	the	DET
brj-24403	237	28	dwass	dwass	NOUN
brj-24403	237	29	–	–	PUNCT
brj-24403	237	30	steel	steel	NOUN
brj-24403	237	31	–	–	PUNCT
brj-24403	237	32	critchlow	critchlow	ADJ
brj-24403	237	33	–	–	PUNCT
brj-24403	237	34	fligner	fligner	NOUN
brj-24403	237	35	test	test	NOUN
brj-24403	237	36	for	for	ADP
brj-24403	237	37	multiple	multiple	ADJ
brj-24403	237	38	comparisons	comparison	NOUN
brj-24403	237	39	)	)	PUNCT
brj-24403	237	40	.	.	PUNCT
brj-24403	238	1	dopaminergic	dopaminergic	ADJ
brj-24403	238	2	receptors	receptor	NOUN
brj-24403	238	3	are	be	AUX
brj-24403	238	4	the	the	DET
brj-24403	238	5	mechanism	mechanism	NOUN
brj-24403	238	6	by	by	ADP
brj-24403	238	7	which	which	PRON
brj-24403	238	8	dopamine	dopamine	NOUN
brj-24403	238	9	functions	function	NOUN
brj-24403	238	10	to	to	PART
brj-24403	238	11	exert	exert	VERB
brj-24403	238	12	an	an	DET
brj-24403	238	13	influence	influence	NOUN
brj-24403	238	14	on	on	ADP
brj-24403	238	15	both	both	CCONJ
brj-24403	238	16	inhibitory	inhibitory	ADJ
brj-24403	238	17	and	and	CCONJ
brj-24403	238	18	excitatory	excitatory	ADJ
brj-24403	238	19	pathways	pathway	NOUN
brj-24403	238	20	,	,	PUNCT
brj-24403	238	21	hence	hence	ADV
brj-24403	238	22	contributing	contribute	VERB
brj-24403	238	23	to	to	ADP
brj-24403	238	24	the	the	DET
brj-24403	238	25	susceptibility	susceptibility	NOUN
brj-24403	238	26	to	to	ADP
brj-24403	238	27	and	and	CCONJ
brj-24403	238	28	propagation	propagation	NOUN
brj-24403	238	29	of	of	ADP
brj-24403	238	30	seizures	seizure	NOUN
brj-24403	238	31	(	(	PUNCT
brj-24403	238	32	jakubs	jakub	NOUN
brj-24403	238	33	et	et	PROPN
brj-24403	238	34	al	al	PROPN
brj-24403	238	35	.	.	PROPN
brj-24403	238	36	2006	2006	NUM
brj-24403	238	37	;	;	PUNCT
brj-24403	238	38	kasica	kasica	PROPN
brj-24403	238	39	et	et	PROPN
brj-24403	238	40	al	al	PROPN
brj-24403	238	41	.	.	PROPN
brj-24403	238	42	2022	2022	NUM
brj-24403	238	43	)	)	PUNCT
brj-24403	238	44	.	.	PUNCT
brj-24403	239	1	in	in	ADP
brj-24403	239	2	this	this	DET
brj-24403	239	3	process	process	NOUN
brj-24403	239	4	,	,	PUNCT
brj-24403	239	5	dopamine	dopamine	NOUN
brj-24403	239	6	(	(	PUNCT
brj-24403	239	7	da	da	NOUN
brj-24403	239	8	)	)	PUNCT
brj-24403	239	9	and	and	CCONJ
brj-24403	239	10	its	its	PRON
brj-24403	239	11	metabolite	metabolite	NOUN
brj-24403	239	12	,	,	PUNCT
brj-24403	239	13	3,4	3,4	NUM
brj-24403	239	14	-	-	ADJ
brj-24403	239	15	dihydroxyphenylacetic	dihydroxyphenylacetic	ADJ
brj-24403	239	16	acid	acid	NOUN
brj-24403	239	17	(	(	PUNCT
brj-24403	239	18	dopac	dopac	PROPN
brj-24403	239	19	)	)	PUNCT
brj-24403	239	20	,	,	PUNCT
brj-24403	239	21	play	play	VERB
brj-24403	239	22	significant	significant	ADJ
brj-24403	239	23	roles	role	NOUN
brj-24403	239	24	in	in	ADP
brj-24403	239	25	the	the	DET
brj-24403	239	26	pathophysiology	pathophysiology	NOUN
brj-24403	239	27	of	of	ADP
brj-24403	239	28	epilepsy	epilepsy	NOUN
brj-24403	239	29	by	by	ADP
brj-24403	239	30	modifying	modify	VERB
brj-24403	239	31	neuronal	neuronal	ADJ
brj-24403	239	32	excitability	excitability	NOUN
brj-24403	239	33	and	and	CCONJ
brj-24403	239	34	neurotransmission	neurotransmission	NOUN
brj-24403	239	35	.	.	PUNCT
brj-24403	240	1	it	it	PRON
brj-24403	240	2	has	have	AUX
brj-24403	240	3	been	be	AUX
brj-24403	240	4	established	establish	VERB
brj-24403	240	5	that	that	SCONJ
brj-24403	240	6	decreased	decrease	VERB
brj-24403	240	7	levels	level	NOUN
brj-24403	240	8	of	of	ADP
brj-24403	240	9	da	da	PROPN
brj-24403	240	10	are	be	AUX
brj-24403	240	11	associated	associate	VERB
brj-24403	240	12	with	with	ADP
brj-24403	240	13	increased	increase	VERB
brj-24403	240	14	seizure	seizure	NOUN
brj-24403	240	15	activity	activity	NOUN
brj-24403	240	16	,	,	PUNCT
brj-24403	240	17	whereas	whereas	SCONJ
brj-24403	240	18	the	the	DET
brj-24403	240	19	restoration	restoration	NOUN
brj-24403	240	20	of	of	ADP
brj-24403	240	21	da	da	PROPN
brj-24403	240	22	may	may	AUX
brj-24403	240	23	have	have	VERB
brj-24403	240	24	anticonvulsive	anticonvulsive	ADJ
brj-24403	240	25	effects	effect	NOUN
brj-24403	240	26	(	(	PUNCT
brj-24403	240	27	chen	chen	PROPN
brj-24403	240	28	2006	2006	NUM
brj-24403	240	29	)	)	PUNCT
brj-24403	240	30	.	.	PUNCT
brj-24403	241	1	dopac	dopac	PROPN
brj-24403	241	2	,	,	PUNCT
brj-24403	241	3	which	which	PRON
brj-24403	241	4	is	be	AUX
brj-24403	241	5	a	a	DET
brj-24403	241	6	measure	measure	NOUN
brj-24403	241	7	of	of	ADP
brj-24403	241	8	da	da	ADJ
brj-24403	241	9	metabolism	metabolism	NOUN
brj-24403	241	10	,	,	PUNCT
brj-24403	241	11	is	be	AUX
brj-24403	241	12	a	a	DET
brj-24403	241	13	reflection	reflection	NOUN
brj-24403	241	14	of	of	ADP
brj-24403	241	15	dopaminergic	dopaminergic	ADJ
brj-24403	241	16	activity	activity	NOUN
brj-24403	241	17	and	and	CCONJ
brj-24403	241	18	turnover	turnover	NOUN
brj-24403	241	19	.	.	PUNCT
brj-24403	242	1	changes	change	NOUN
brj-24403	242	2	in	in	ADP
brj-24403	242	3	its	its	PRON
brj-24403	242	4	levels	level	NOUN
brj-24403	242	5	have	have	AUX
brj-24403	242	6	been	be	AUX
brj-24403	242	7	seen	see	VERB
brj-24403	242	8	after	after	ADP
brj-24403	242	9	seizures	seizure	NOUN
brj-24403	242	10	(	(	PUNCT
brj-24403	242	11	sanz	sanz	PROPN
brj-24403	242	12	-	-	PUNCT
brj-24403	242	13	novo	novo	NOUN
brj-24403	242	14	et	et	PROPN
brj-24403	242	15	al	al	PROPN
brj-24403	242	16	.	.	PROPN
brj-24403	242	17	2023	2023	NUM
brj-24403	242	18	)	)	PUNCT
brj-24403	242	19	.	.	PUNCT
brj-24403	243	1	it	it	PRON
brj-24403	243	2	is	be	AUX
brj-24403	243	3	possible	possible	ADJ
brj-24403	243	4	that	that	SCONJ
brj-24403	243	5	anticonvulsant	anticonvulsant	ADJ
brj-24403	243	6	medications	medication	NOUN
brj-24403	243	7	,	,	PUNCT
brj-24403	243	8	such	such	ADJ
brj-24403	243	9	as	as	ADP
brj-24403	243	10	levetiracetam	levetiracetam	NOUN
brj-24403	243	11	and	and	CCONJ
brj-24403	243	12	valproate	valproate	ADJ
brj-24403	243	13	,	,	PUNCT
brj-24403	243	14	can	can	AUX
brj-24403	243	15	restore	restore	VERB
brj-24403	243	16	dopaminergic	dopaminergic	ADJ
brj-24403	243	17	balance	balance	NOUN
brj-24403	243	18	and	and	CCONJ
brj-24403	243	19	reduce	reduce	VERB
brj-24403	243	20	hyperexcitability	hyperexcitability	NOUN
brj-24403	243	21	by	by	ADP
brj-24403	243	22	modulating	modulate	VERB
brj-24403	243	23	the	the	DET
brj-24403	243	24	amounts	amount	NOUN
brj-24403	243	25	of	of	ADP
brj-24403	243	26	dopamine	dopamine	NOUN
brj-24403	243	27	and	and	CCONJ
brj-24403	243	28	dopamine	dopamine	NOUN
brj-24403	243	29	-	-	PUNCT
brj-24403	243	30	related	relate	VERB
brj-24403	243	31	peptides	peptide	NOUN
brj-24403	243	32	(	(	PUNCT
brj-24403	243	33	da	da	X
brj-24403	243	34	and	and	CCONJ
brj-24403	243	35	dopac	dopac	PROPN
brj-24403	243	36	)	)	PUNCT
brj-24403	244	1	(	(	PUNCT
brj-24403	244	2	cengiz	cengiz	NOUN
brj-24403	244	3	et	et	PROPN
brj-24403	244	4	al	al	PROPN
brj-24403	244	5	.	.	PROPN
brj-24403	244	6	2024	2024	NUM
brj-24403	244	7	)	)	PUNCT
brj-24403	244	8	.	.	PUNCT
brj-24403	245	1	studies	study	NOUN
brj-24403	245	2	have	have	AUX
brj-24403	245	3	shown	show	VERB
brj-24403	245	4	,	,	PUNCT
brj-24403	245	5	for	for	ADP
brj-24403	245	6	example	example	NOUN
brj-24403	245	7	,	,	PUNCT
brj-24403	245	8	that	that	SCONJ
brj-24403	245	9	these	these	DET
brj-24403	245	10	medications	medication	NOUN
brj-24403	245	11	can	can	AUX
brj-24403	245	12	either	either	CCONJ
brj-24403	245	13	boost	boost	VERB
brj-24403	245	14	the	the	DET
brj-24403	245	15	release	release	NOUN
brj-24403	245	16	of	of	ADP
brj-24403	245	17	dopamine	dopamine	NOUN
brj-24403	245	18	(	(	PUNCT
brj-24403	245	19	da	da	NOUN
brj-24403	245	20	)	)	PUNCT
brj-24403	245	21	or	or	CCONJ
brj-24403	245	22	limit	limit	VERB
brj-24403	245	23	the	the	DET
brj-24403	245	24	breakdown	breakdown	NOUN
brj-24403	245	25	of	of	ADP
brj-24403	245	26	da	da	NOUN
brj-24403	245	27	,	,	PUNCT
brj-24403	245	28	which	which	PRON
brj-24403	245	29	is	be	AUX
brj-24403	245	30	correlated	correlate	VERB
brj-24403	245	31	with	with	ADP
brj-24403	245	32	greater	great	ADJ
brj-24403	245	33	seizure	seizure	NOUN
brj-24403	245	34	management	management	NOUN
brj-24403	245	35	.	.	PUNCT
brj-24403	246	1	keeping	keep	VERB
brj-24403	246	2	an	an	DET
brj-24403	246	3	eye	eye	NOUN
brj-24403	246	4	on	on	ADP
brj-24403	246	5	the	the	DET
brj-24403	246	6	levels	level	NOUN
brj-24403	246	7	of	of	ADP
brj-24403	246	8	da	da	PROPN
brj-24403	246	9	and	and	CCONJ
brj-24403	246	10	dopac	dopac	PROPN
brj-24403	246	11	could	could	AUX
brj-24403	246	12	provide	provide	VERB
brj-24403	246	13	valuable	valuable	ADJ
brj-24403	246	14	information	information	NOUN
brj-24403	246	15	regarding	regard	VERB
brj-24403	246	16	the	the	DET
brj-24403	246	17	effectiveness	effectiveness	NOUN
brj-24403	246	18	of	of	ADP
brj-24403	246	19	antiepileptic	antiepileptic	ADJ
brj-24403	246	20	treatments	treatment	NOUN
brj-24403	246	21	and	and	CCONJ
brj-24403	246	22	the	the	DET
brj-24403	246	23	dopaminergic	dopaminergic	ADJ
brj-24403	246	24	mechanisms	mechanism	NOUN
brj-24403	246	25	that	that	PRON
brj-24403	246	26	are	be	AUX
brj-24403	246	27	responsible	responsible	ADJ
brj-24403	246	28	for	for	ADP
brj-24403	246	29	the	the	DET
brj-24403	246	30	management	management	NOUN
brj-24403	246	31	of	of	ADP
brj-24403	246	32	epilepsy	epilepsy	NOUN
brj-24403	246	33	.	.	PUNCT
brj-24403	247	1	thus	thus	ADV
brj-24403	247	2	,	,	PUNCT
brj-24403	247	3	next	next	ADJ
brj-24403	247	4	part	part	NOUN
brj-24403	247	5	of	of	ADP
brj-24403	247	6	the	the	DET
brj-24403	247	7	study	study	NOUN
brj-24403	247	8	aimed	aim	VERB
brj-24403	247	9	at	at	ADP
brj-24403	247	10	determining	determine	VERB
brj-24403	247	11	the	the	DET
brj-24403	247	12	level	level	NOUN
brj-24403	247	13	of	of	ADP
brj-24403	247	14	monoamines	monoamine	NOUN
brj-24403	247	15	,	,	PUNCT
brj-24403	247	16	such	such	ADJ
brj-24403	247	17	as	as	ADP
brj-24403	247	18	dopamine	dopamine	NOUN
brj-24403	247	19	(	(	PUNCT
brj-24403	247	20	da	da	NOUN
brj-24403	247	21	)	)	PUNCT
brj-24403	247	22	and	and	CCONJ
brj-24403	247	23	dopac	dopac	ADJ
brj-24403	247	24	(	(	PUNCT
brj-24403	247	25	3,4	3,4	NUM
brj-24403	247	26	-	-	ADJ
brj-24403	247	27	dihydroxyphenylacetic	dihydroxyphenylacetic	ADJ
brj-24403	247	28	acid	acid	NOUN
brj-24403	247	29	)	)	PUNCT
brj-24403	247	30	in	in	ADP
brj-24403	247	31	the	the	DET
brj-24403	247	32	mice	mice	NOUN
brj-24403	247	33	striata	striata	NOUN
brj-24403	247	34	.	.	PUNCT
brj-24403	248	1	as	as	SCONJ
brj-24403	248	2	shown	show	VERB
brj-24403	248	3	in	in	ADP
brj-24403	248	4	fig	fig	NOUN
brj-24403	248	5	.	.	PUNCT
brj-24403	249	1	4	4	NUM
brj-24403	249	2	,	,	PUNCT
brj-24403	249	3	the	the	DET
brj-24403	249	4	level	level	NOUN
brj-24403	249	5	of	of	ADP
brj-24403	249	6	both	both	CCONJ
brj-24403	249	7	da	da	NOUN
brj-24403	249	8	and	and	CCONJ
brj-24403	249	9	dopac	dopac	PROPN
brj-24403	249	10	was	be	AUX
brj-24403	249	11	found	find	VERB
brj-24403	249	12	significantly	significantly	ADV
brj-24403	249	13	reduced	reduce	VERB
brj-24403	249	14	in	in	ADP
brj-24403	249	15	p350	p350	PROPN
brj-24403	249	16	treated	treat	VERB
brj-24403	249	17	group	group	NOUN
brj-24403	249	18	.	.	PUNCT
brj-24403	250	1	however	however	ADV
brj-24403	250	2	,	,	PUNCT
brj-24403	250	3	upon	upon	SCONJ
brj-24403	250	4	administration	administration	NOUN
brj-24403	250	5	of	of	ADP
brj-24403	250	6	cnc	cnc	PROPN
brj-24403	250	7	,	,	PUNCT
brj-24403	250	8	a	a	DET
brj-24403	250	9	dose	dose	NOUN
brj-24403	250	10	-	-	PUNCT
brj-24403	250	11	dependent	dependent	ADJ
brj-24403	250	12	increase	increase	NOUN
brj-24403	250	13	in	in	ADP
brj-24403	250	14	both	both	CCONJ
brj-24403	250	15	da	da	NOUN
brj-24403	250	16	and	and	CCONJ
brj-24403	250	17	dopac	dopac	PROPN
brj-24403	250	18	was	be	AUX
brj-24403	250	19	observed	observe	VERB
brj-24403	250	20	.	.	PUNCT
brj-24403	251	1	thus	thus	ADV
brj-24403	251	2	,	,	PUNCT
brj-24403	251	3	it	it	PRON
brj-24403	251	4	was	be	AUX
brj-24403	251	5	suggested	suggest	VERB
brj-24403	251	6	that	that	SCONJ
brj-24403	251	7	anticonvulsive	anticonvulsive	ADJ
brj-24403	251	8	action	action	NOUN
brj-24403	251	9	of	of	ADP
brj-24403	251	10	cnc	cnc	PROPN
brj-24403	251	11	might	might	AUX
brj-24403	251	12	be	be	AUX
brj-24403	251	13	due	due	ADJ
brj-24403	251	14	to	to	ADP
brj-24403	251	15	modulation	modulation	NOUN
brj-24403	251	16	of	of	ADP
brj-24403	251	17	da	da	NOUN
brj-24403	251	18	generation	generation	NOUN
brj-24403	251	19	and	and	CCONJ
brj-24403	251	20	prevention	prevention	NOUN
brj-24403	251	21	of	of	ADP
brj-24403	251	22	its	its	PRON
brj-24403	251	23	metabolism	metabolism	NOUN
brj-24403	251	24	which	which	PRON
brj-24403	251	25	cause	cause	VERB
brj-24403	251	26	increase	increase	NOUN
brj-24403	251	27	in	in	ADP
brj-24403	251	28	striatal	striatal	ADJ
brj-24403	251	29	da	da	NOUN
brj-24403	251	30	level	level	NOUN
brj-24403	251	31	.	.	PUNCT
brj-24403	252	1	previous	previous	ADJ
brj-24403	252	2	studies	study	NOUN
brj-24403	252	3	have	have	AUX
brj-24403	252	4	implicated	implicate	VERB
brj-24403	252	5	dopaminergic	dopaminergic	ADJ
brj-24403	252	6	imbalance	imbalance	NOUN
brj-24403	252	7	in	in	ADP
brj-24403	252	8	epilepsy	epilepsy	NOUN
brj-24403	252	9	pathophysiology	pathophysiology	NOUN
brj-24403	252	10	,	,	PUNCT
brj-24403	252	11	with	with	ADP
brj-24403	252	12	restoration	restoration	NOUN
brj-24403	252	13	of	of	ADP
brj-24403	252	14	da	da	PROPN
brj-24403	252	15	levels	level	NOUN
brj-24403	252	16	shown	show	VERB
brj-24403	252	17	to	to	PART
brj-24403	252	18	reduce	reduce	VERB
brj-24403	252	19	seizure	seizure	NOUN
brj-24403	252	20	susceptibility	susceptibility	NOUN
brj-24403	252	21	(	(	PUNCT
brj-24403	252	22	chen	chen	PROPN
brj-24403	252	23	2006	2006	NUM
brj-24403	252	24	;	;	PUNCT
brj-24403	252	25	sanznovo	sanznovo	PROPN
brj-24403	252	26	et	et	PROPN
brj-24403	252	27	al	al	PROPN
brj-24403	252	28	.	.	PROPN
brj-24403	252	29	2023	2023	NUM
brj-24403	252	30	)	)	PUNCT
brj-24403	252	31	peer	peer	NOUN
brj-24403	252	32	-	-	PUNCT
brj-24403	252	33	reviewed	review	VERB
brj-24403	252	34	article	article	NOUN
brj-24403	252	35	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	252	36	li	li	PROPN
brj-24403	252	37	et	et	PROPN
brj-24403	252	38	al	al	PROPN
brj-24403	252	39	.	.	PROPN
brj-24403	253	1	(	(	PUNCT
brj-24403	253	2	2025	2025	NUM
brj-24403	253	3	)	)	PUNCT
brj-24403	253	4	.	.	PUNCT
brj-24403	254	1	“	"	PUNCT
brj-24403	254	2	herbal	herbal	ADJ
brj-24403	254	3	anti	anti	ADJ
brj-24403	254	4	-	-	ADJ
brj-24403	254	5	epileptic	epileptic	ADJ
brj-24403	254	6	extract	extract	NOUN
brj-24403	254	7	,	,	PUNCT
brj-24403	254	8	”	"	PUNCT
brj-24403	254	9	bioresources	bioresource	NOUN
brj-24403	254	10	20(2	20(2	NUM
brj-24403	254	11	)	)	PUNCT
brj-24403	254	12	,	,	PUNCT
brj-24403	254	13	4701	4701	NUM
brj-24403	254	14	-	-	SYM
brj-24403	254	15	4719	4719	NUM
brj-24403	254	16	.	.	PUNCT
brj-24403	254	17	4712	4712	NUM
brj-24403	254	18	fig	fig	NOUN
brj-24403	254	19	.	.	PUNCT
brj-24403	255	1	4	4	X
brj-24403	255	2	.	.	X
brj-24403	255	3	effect	effect	NOUN
brj-24403	255	4	of	of	ADP
brj-24403	255	5	cnc	cnc	PROPN
brj-24403	255	6	on	on	ADP
brj-24403	255	7	the	the	DET
brj-24403	255	8	dopamine	dopamine	NOUN
brj-24403	255	9	(	(	PUNCT
brj-24403	255	10	da	da	NOUN
brj-24403	255	11	)	)	PUNCT
brj-24403	255	12	and	and	CCONJ
brj-24403	255	13	dopac	dopac	PROPN
brj-24403	255	14	.	.	PUNCT
brj-24403	256	1	the	the	DET
brj-24403	256	2	data	datum	NOUN
brj-24403	256	3	represent	represent	VERB
brj-24403	256	4	means±s.e.m	means±s.e.m	PROPN
brj-24403	256	5	.	.	PROPN
brj-24403	256	6	,	,	PUNCT
brj-24403	256	7	analyzed	analyze	VERB
brj-24403	256	8	by	by	ADP
brj-24403	256	9	one	one	NUM
brj-24403	256	10	-	-	PUNCT
brj-24403	256	11	way	way	NOUN
brj-24403	256	12	anova	anova	X
brj-24403	256	13	with	with	ADP
brj-24403	256	14	the	the	DET
brj-24403	256	15	student	student	NOUN
brj-24403	256	16	–	–	PUNCT
brj-24403	256	17	newman	newman	PROPN
brj-24403	256	18	–	–	PUNCT
brj-24403	256	19	keuls	keuls	PROPN
brj-24403	256	20	as	as	ADP
brj-24403	256	21	a	a	DET
brj-24403	256	22	post	post	ADJ
brj-24403	256	23	-	-	ADJ
brj-24403	256	24	hoc	hoc	ADJ
brj-24403	256	25	test	test	NOUN
brj-24403	256	26	.	.	PUNCT
brj-24403	257	1	da	da	ADJ
brj-24403	257	2	:	:	PUNCT
brj-24403	257	3	*	*	PUNCT
brj-24403	257	4	*	*	PUNCT
brj-24403	257	5	*	*	PUNCT
brj-24403	257	6	p>0.001	p>0.001	NOUN
brj-24403	257	7	vs.	vs.	ADP
brj-24403	257	8	normal	normal	ADJ
brj-24403	257	9	controls	control	NOUN
brj-24403	257	10	;	;	PUNCT
brj-24403	257	11	dopac	dopac	ADJ
brj-24403	257	12	:	:	PUNCT
brj-24403	258	1	*	*	PUNCT
brj-24403	258	2	*	*	PUNCT
brj-24403	258	3	p>0.01	p>0.01	PRON
brj-24403	258	4	vs.	vs.	ADP
brj-24403	258	5	normal	normal	ADJ
brj-24403	258	6	control	control	NOUN
brj-24403	258	7	.	.	PUNCT
brj-24403	259	1	oxidative	oxidative	ADJ
brj-24403	259	2	stress	stress	NOUN
brj-24403	259	3	is	be	AUX
brj-24403	259	4	a	a	DET
brj-24403	259	5	hallmark	hallmark	NOUN
brj-24403	259	6	of	of	ADP
brj-24403	259	7	epilepsy	epilepsy	NOUN
brj-24403	259	8	and	and	CCONJ
brj-24403	259	9	a	a	DET
brj-24403	259	10	key	key	ADJ
brj-24403	259	11	contributor	contributor	NOUN
brj-24403	259	12	to	to	ADP
brj-24403	259	13	the	the	DET
brj-24403	259	14	onset	onset	NOUN
brj-24403	259	15	of	of	ADP
brj-24403	259	16	seizures	seizure	NOUN
brj-24403	259	17	and	and	CCONJ
brj-24403	259	18	subsequent	subsequent	ADJ
brj-24403	259	19	brain	brain	NOUN
brj-24403	259	20	damage	damage	NOUN
brj-24403	259	21	.	.	PUNCT
brj-24403	260	1	this	this	DET
brj-24403	260	2	disorder	disorder	NOUN
brj-24403	260	3	is	be	AUX
brj-24403	260	4	caused	cause	VERB
brj-24403	260	5	by	by	ADP
brj-24403	260	6	an	an	DET
brj-24403	260	7	imbalance	imbalance	NOUN
brj-24403	260	8	between	between	ADP
brj-24403	260	9	the	the	DET
brj-24403	260	10	brain	brain	NOUN
brj-24403	260	11	’s	’s	PART
brj-24403	260	12	antioxidant	antioxidant	ADJ
brj-24403	260	13	defence	defence	NOUN
brj-24403	260	14	and	and	CCONJ
brj-24403	260	15	the	the	DET
brj-24403	260	16	generation	generation	NOUN
brj-24403	260	17	of	of	ADP
brj-24403	260	18	reactive	reactive	ADJ
brj-24403	260	19	oxygen	oxygen	NOUN
brj-24403	260	20	species	specie	NOUN
brj-24403	260	21	(	(	PUNCT
brj-24403	260	22	ros	ros	PROPN
brj-24403	260	23	)	)	PUNCT
brj-24403	260	24	(	(	PUNCT
brj-24403	260	25	aguiar	aguiar	NOUN
brj-24403	260	26	et	et	PROPN
brj-24403	260	27	al	al	PROPN
brj-24403	260	28	.	.	PROPN
brj-24403	260	29	2012	2012	NUM
brj-24403	260	30	)	)	PUNCT
brj-24403	260	31	.	.	PUNCT
brj-24403	261	1	a	a	DET
brj-24403	261	2	rise	rise	NOUN
brj-24403	261	3	in	in	ADP
brj-24403	261	4	mitochondrial	mitochondrial	ADJ
brj-24403	261	5	reactive	reactive	ADJ
brj-24403	261	6	oxygen	oxygen	NOUN
brj-24403	261	7	species	specie	NOUN
brj-24403	261	8	(	(	PUNCT
brj-24403	261	9	ros	ros	PROPN
brj-24403	261	10	)	)	PUNCT
brj-24403	261	11	and	and	CCONJ
brj-24403	261	12	subsequent	subsequent	ADJ
brj-24403	261	13	oxidative	oxidative	ADJ
brj-24403	261	14	damage	damage	NOUN
brj-24403	261	15	to	to	ADP
brj-24403	261	16	dna	dna	PROPN
brj-24403	261	17	,	,	PUNCT
brj-24403	261	18	lipids	lipid	NOUN
brj-24403	261	19	,	,	PUNCT
brj-24403	261	20	and	and	CCONJ
brj-24403	261	21	proteins	protein	NOUN
brj-24403	261	22	occurs	occur	VERB
brj-24403	261	23	during	during	ADP
brj-24403	261	24	seizures	seizure	NOUN
brj-24403	261	25	due	due	ADP
brj-24403	261	26	to	to	ADP
brj-24403	261	27	the	the	DET
brj-24403	261	28	abnormally	abnormally	ADV
brj-24403	261	29	high	high	ADJ
brj-24403	261	30	levels	level	NOUN
brj-24403	261	31	of	of	ADP
brj-24403	261	32	neuronal	neuronal	ADJ
brj-24403	261	33	activity	activity	NOUN
brj-24403	261	34	that	that	PRON
brj-24403	261	35	seizures	seizure	NOUN
brj-24403	261	36	induce	induce	VERB
brj-24403	261	37	.	.	PUNCT
brj-24403	262	1	epilepsy	epilepsy	PROPN
brj-24403	262	2	thrives	thrive	VERB
brj-24403	262	3	in	in	ADP
brj-24403	262	4	damaged	damage	VERB
brj-24403	262	5	brain	brain	NOUN
brj-24403	262	6	areas	area	NOUN
brj-24403	262	7	because	because	SCONJ
brj-24403	262	8	it	it	PRON
brj-24403	262	9	messes	mess	VERB
brj-24403	262	10	with	with	ADP
brj-24403	262	11	ion	ion	NOUN
brj-24403	262	12	channels	channel	NOUN
brj-24403	262	13	,	,	PUNCT
brj-24403	262	14	neurotransmitter	neurotransmitter	NOUN
brj-24403	262	15	release	release	NOUN
brj-24403	262	16	,	,	PUNCT
brj-24403	262	17	and	and	CCONJ
brj-24403	262	18	neuronal	neuronal	ADJ
brj-24403	262	19	signaling	signaling	NOUN
brj-24403	262	20	.	.	PUNCT
brj-24403	263	1	there	there	PRON
brj-24403	263	2	is	be	VERB
brj-24403	263	3	a	a	DET
brj-24403	263	4	vicious	vicious	ADJ
brj-24403	263	5	cycle	cycle	NOUN
brj-24403	263	6	of	of	ADP
brj-24403	263	7	neuronal	neuronal	ADJ
brj-24403	263	8	hyperexcitability	hyperexcitability	NOUN
brj-24403	263	9	and	and	CCONJ
brj-24403	263	10	injury	injury	NOUN
brj-24403	263	11	that	that	PRON
brj-24403	263	12	begins	begin	VERB
brj-24403	263	13	with	with	ADP
brj-24403	263	14	oxidative	oxidative	ADJ
brj-24403	263	15	stress	stress	NOUN
brj-24403	263	16	and	and	CCONJ
brj-24403	263	17	continues	continue	VERB
brj-24403	263	18	with	with	ADP
brj-24403	263	19	mitochondrial	mitochondrial	ADJ
brj-24403	263	20	dysfunction	dysfunction	NOUN
brj-24403	263	21	,	,	PUNCT
brj-24403	263	22	which	which	PRON
brj-24403	263	23	worsens	worsen	VERB
brj-24403	263	24	energy	energy	NOUN
brj-24403	263	25	deficiencies	deficiency	NOUN
brj-24403	263	26	and	and	CCONJ
brj-24403	263	27	keeps	keep	VERB
brj-24403	263	28	ros	ros	PROPN
brj-24403	263	29	generation	generation	NOUN
brj-24403	263	30	going	go	VERB
brj-24403	263	31	(	(	PUNCT
brj-24403	263	32	waldbaum	waldbaum	ADV
brj-24403	263	33	and	and	CCONJ
brj-24403	263	34	patel	patel	NOUN
brj-24403	263	35	2010	2010	NUM
brj-24403	263	36	)	)	PUNCT
brj-24403	263	37	.	.	PUNCT
brj-24403	264	1	the	the	DET
brj-24403	264	2	oxidative	oxidative	ADJ
brj-24403	264	3	stress	stress	NOUN
brj-24403	264	4	that	that	PRON
brj-24403	264	5	results	result	VERB
brj-24403	264	6	from	from	ADP
brj-24403	264	7	and	and	CCONJ
brj-24403	264	8	contributes	contribute	VERB
brj-24403	264	9	to	to	ADP
brj-24403	264	10	the	the	DET
brj-24403	264	11	development	development	NOUN
brj-24403	264	12	of	of	ADP
brj-24403	264	13	epilepsy	epilepsy	NOUN
brj-24403	264	14	is	be	AUX
brj-24403	264	15	brought	bring	VERB
brj-24403	264	16	to	to	ADP
brj-24403	264	17	light	light	NOUN
brj-24403	264	18	by	by	ADP
brj-24403	264	19	this	this	DET
brj-24403	264	20	process	process	NOUN
brj-24403	264	21	.	.	PUNCT
brj-24403	265	1	in	in	ADP
brj-24403	265	2	this	this	DET
brj-24403	265	3	regard	regard	NOUN
brj-24403	265	4	,	,	PUNCT
brj-24403	265	5	it	it	PRON
brj-24403	265	6	is	be	AUX
brj-24403	265	7	worthwhile	worthwhile	ADJ
brj-24403	265	8	to	to	PART
brj-24403	265	9	assess	assess	VERB
brj-24403	265	10	the	the	DET
brj-24403	265	11	effect	effect	NOUN
brj-24403	265	12	of	of	ADP
brj-24403	265	13	cnc	cnc	PROPN
brj-24403	265	14	on	on	ADP
brj-24403	265	15	the	the	DET
brj-24403	265	16	oxidative	oxidative	ADJ
brj-24403	265	17	stress	stress	NOUN
brj-24403	265	18	in	in	ADP
brj-24403	265	19	the	the	DET
brj-24403	265	20	pilo	pilo	ADJ
brj-24403	265	21	induced	induce	VERB
brj-24403	265	22	mice	mouse	NOUN
brj-24403	265	23	.	.	PUNCT
brj-24403	266	1	thus	thus	ADV
brj-24403	266	2	,	,	PUNCT
brj-24403	266	3	in	in	ADP
brj-24403	266	4	the	the	DET
brj-24403	266	5	next	next	ADJ
brj-24403	266	6	part	part	NOUN
brj-24403	266	7	,	,	PUNCT
brj-24403	266	8	the	the	DET
brj-24403	266	9	level	level	NOUN
brj-24403	266	10	of	of	ADP
brj-24403	266	11	various	various	ADJ
brj-24403	266	12	oxidative	oxidative	ADJ
brj-24403	266	13	stress	stress	NOUN
brj-24403	266	14	biomarkers	biomarker	NOUN
brj-24403	266	15	was	be	AUX
brj-24403	266	16	determined	determine	VERB
brj-24403	266	17	,	,	PUNCT
brj-24403	266	18	such	such	ADJ
brj-24403	266	19	as	as	ADP
brj-24403	266	20	mda	mda	PROPN
brj-24403	266	21	,	,	PUNCT
brj-24403	266	22	sod	sod	NOUN
brj-24403	266	23	and	and	CCONJ
brj-24403	266	24	cat	cat	NOUN
brj-24403	266	25	in	in	ADP
brj-24403	266	26	the	the	DET
brj-24403	266	27	brain	brain	NOUN
brj-24403	266	28	cortex	cortex	NOUN
brj-24403	266	29	and	and	CCONJ
brj-24403	266	30	in	in	ADP
brj-24403	266	31	the	the	DET
brj-24403	266	32	blood	blood	NOUN
brj-24403	266	33	(	(	PUNCT
brj-24403	266	34	aguiar	aguiar	NOUN
brj-24403	266	35	et	et	PROPN
brj-24403	266	36	al	al	PROPN
brj-24403	266	37	.	.	PROPN
brj-24403	266	38	2012	2012	NUM
brj-24403	266	39	)	)	PUNCT
brj-24403	266	40	.	.	PUNCT
brj-24403	267	1	in	in	ADP
brj-24403	267	2	epilepsy	epilepsy	PROPN
brj-24403	267	3	,	,	PUNCT
brj-24403	267	4	elevated	elevated	ADJ
brj-24403	267	5	thiobarbituric	thiobarbituric	ADJ
brj-24403	267	6	acid	acid	NOUN
brj-24403	267	7	reactive	reactive	ADJ
brj-24403	267	8	substances	substance	NOUN
brj-24403	267	9	(	(	PUNCT
brj-24403	267	10	tbars	tbar	NOUN
brj-24403	267	11	)	)	PUNCT
brj-24403	267	12	indicate	indicate	VERB
brj-24403	267	13	increased	increase	VERB
brj-24403	267	14	lipid	lipid	NOUN
brj-24403	267	15	peroxidation	peroxidation	NOUN
brj-24403	267	16	due	due	ADP
brj-24403	267	17	to	to	ADP
brj-24403	267	18	oxidative	oxidative	ADJ
brj-24403	267	19	stress	stress	NOUN
brj-24403	267	20	caused	cause	VERB
brj-24403	267	21	by	by	ADP
brj-24403	267	22	recurrent	recurrent	ADJ
brj-24403	267	23	seizures	seizure	NOUN
brj-24403	267	24	.	.	PUNCT
brj-24403	268	1	this	this	DET
brj-24403	268	2	oxidative	oxidative	ADJ
brj-24403	268	3	damage	damage	NOUN
brj-24403	268	4	contributes	contribute	VERB
brj-24403	268	5	to	to	ADP
brj-24403	268	6	neuronal	neuronal	ADJ
brj-24403	268	7	dysfunction	dysfunction	NOUN
brj-24403	268	8	and	and	CCONJ
brj-24403	268	9	hyperexcitability	hyperexcitability	NOUN
brj-24403	268	10	,	,	PUNCT
brj-24403	268	11	worsening	worsen	VERB
brj-24403	268	12	seizure	seizure	NOUN
brj-24403	268	13	pathology	pathology	NOUN
brj-24403	268	14	(	(	PUNCT
brj-24403	268	15	gluck	gluck	PROPN
brj-24403	268	16	et	et	PROPN
brj-24403	268	17	al	al	PROPN
brj-24403	268	18	.	.	PROPN
brj-24403	268	19	2000	2000	NUM
brj-24403	268	20	)	)	PUNCT
brj-24403	268	21	.	.	PUNCT
brj-24403	269	1	monitoring	monitor	VERB
brj-24403	269	2	tbars	tbar	NOUN
brj-24403	269	3	levels	level	NOUN
brj-24403	269	4	helps	help	VERB
brj-24403	269	5	evaluate	evaluate	VERB
brj-24403	269	6	oxidative	oxidative	ADJ
brj-24403	269	7	stress	stress	NOUN
brj-24403	269	8	in	in	ADP
brj-24403	269	9	epilepsy	epilepsy	NOUN
brj-24403	269	10	,	,	PUNCT
brj-24403	269	11	providing	provide	VERB
brj-24403	269	12	insights	insight	NOUN
brj-24403	269	13	into	into	ADP
brj-24403	269	14	disease	disease	NOUN
brj-24403	269	15	progression	progression	NOUN
brj-24403	269	16	and	and	CCONJ
brj-24403	269	17	the	the	DET
brj-24403	269	18	potential	potential	ADJ
brj-24403	269	19	antioxidant	antioxidant	ADJ
brj-24403	269	20	effects	effect	NOUN
brj-24403	269	21	of	of	ADP
brj-24403	269	22	antiepileptic	antiepileptic	ADJ
brj-24403	269	23	drugs	drug	NOUN
brj-24403	269	24	in	in	ADP
brj-24403	269	25	reducing	reduce	VERB
brj-24403	269	26	neuronal	neuronal	ADJ
brj-24403	269	27	injury	injury	NOUN
brj-24403	269	28	.	.	PUNCT
brj-24403	270	1	carbonyl	carbonyl	NOUN
brj-24403	270	2	protein	protein	NOUN
brj-24403	270	3	levels	level	NOUN
brj-24403	270	4	serve	serve	VERB
brj-24403	270	5	as	as	ADP
brj-24403	270	6	a	a	DET
brj-24403	270	7	marker	marker	NOUN
brj-24403	270	8	of	of	ADP
brj-24403	270	9	oxidative	oxidative	ADJ
brj-24403	270	10	stress	stress	NOUN
brj-24403	270	11	in	in	ADP
brj-24403	270	12	epilepsy	epilepsy	NOUN
brj-24403	270	13	,	,	PUNCT
brj-24403	270	14	reflecting	reflect	VERB
brj-24403	270	15	protein	protein	NOUN
brj-24403	270	16	oxidation	oxidation	NOUN
brj-24403	270	17	caused	cause	VERB
brj-24403	270	18	by	by	ADP
brj-24403	270	19	reactive	reactive	ADJ
brj-24403	270	20	oxygen	oxygen	NOUN
brj-24403	270	21	species	specie	NOUN
brj-24403	270	22	(	(	PUNCT
brj-24403	270	23	ros	ros	PROPN
brj-24403	270	24	)	)	PUNCT
brj-24403	270	25	.	.	PUNCT
brj-24403	271	1	elevated	elevated	ADJ
brj-24403	271	2	carbonyl	carbonyl	NOUN
brj-24403	271	3	proteins	protein	NOUN
brj-24403	271	4	are	be	AUX
brj-24403	271	5	commonly	commonly	ADV
brj-24403	271	6	observed	observe	VERB
brj-24403	271	7	in	in	ADP
brj-24403	271	8	epilepsy	epilepsy	NOUN
brj-24403	271	9	,	,	PUNCT
brj-24403	271	10	particularly	particularly	ADV
brj-24403	271	11	after	after	ADP
brj-24403	271	12	seizures	seizure	NOUN
brj-24403	271	13	,	,	PUNCT
brj-24403	271	14	due	due	ADJ
brj-24403	271	15	to	to	ADP
brj-24403	271	16	increased	increase	VERB
brj-24403	271	17	ros	ros	PROPN
brj-24403	271	18	production	production	NOUN
brj-24403	271	19	and	and	CCONJ
brj-24403	271	20	impaired	impaired	ADJ
brj-24403	271	21	antioxidant	antioxidant	ADJ
brj-24403	271	22	defences	defence	NOUN
brj-24403	271	23	.	.	PUNCT
brj-24403	272	1	oxidative	oxidative	ADJ
brj-24403	272	2	modification	modification	NOUN
brj-24403	272	3	of	of	ADP
brj-24403	272	4	proteins	protein	NOUN
brj-24403	272	5	disrupts	disrupt	VERB
brj-24403	272	6	their	their	PRON
brj-24403	272	7	structure	structure	NOUN
brj-24403	272	8	and	and	CCONJ
brj-24403	272	9	function	function	NOUN
brj-24403	272	10	,	,	PUNCT
brj-24403	272	11	contributing	contribute	VERB
brj-24403	272	12	to	to	ADP
brj-24403	272	13	neuronal	neuronal	ADJ
brj-24403	272	14	damage	damage	NOUN
brj-24403	272	15	,	,	PUNCT
brj-24403	272	16	synaptic	synaptic	ADJ
brj-24403	272	17	dysfunction	dysfunction	NOUN
brj-24403	272	18	,	,	PUNCT
brj-24403	272	19	and	and	CCONJ
brj-24403	272	20	seizure	seizure	NOUN
brj-24403	272	21	progression	progression	NOUN
brj-24403	272	22	.	.	PUNCT
brj-24403	273	1	sulfhydryl	sulfhydryl	ADJ
brj-24403	273	2	proteins	protein	NOUN
brj-24403	273	3	,	,	PUNCT
brj-24403	273	4	nitric	nitric	ADJ
brj-24403	273	5	oxide	oxide	NOUN
brj-24403	273	6	(	(	PUNCT
brj-24403	273	7	no	no	NOUN
brj-24403	273	8	)	)	PUNCT
brj-24403	273	9	,	,	PUNCT
brj-24403	273	10	superoxide	superoxide	NOUN
brj-24403	273	11	dismutase	dismutase	NOUN
brj-24403	273	12	(	(	PUNCT
brj-24403	273	13	sod	sod	NOUN
brj-24403	273	14	)	)	PUNCT
brj-24403	273	15	,	,	PUNCT
brj-24403	273	16	and	and	CCONJ
brj-24403	273	17	catalase	catalase	NOUN
brj-24403	273	18	(	(	PUNCT
brj-24403	273	19	cat	cat	NOUN
brj-24403	273	20	)	)	PUNCT
brj-24403	273	21	play	play	VERB
brj-24403	273	22	critical	critical	ADJ
brj-24403	273	23	roles	role	NOUN
brj-24403	273	24	in	in	ADP
brj-24403	273	25	the	the	DET
brj-24403	273	26	pathophysiology	pathophysiology	NOUN
brj-24403	273	27	of	of	ADP
brj-24403	273	28	epilepsy	epilepsy	NOUN
brj-24403	273	29	by	by	ADP
brj-24403	273	30	modulating	modulate	VERB
brj-24403	273	31	oxidative	oxidative	ADJ
brj-24403	273	32	stress	stress	NOUN
brj-24403	273	33	and	and	CCONJ
brj-24403	273	34	neuronal	neuronal	ADJ
brj-24403	273	35	integrity	integrity	NOUN
brj-24403	273	36	(	(	PUNCT
brj-24403	273	37	nobre	nobre	PROPN
brj-24403	273	38	et	et	PROPN
brj-24403	273	39	al	al	PROPN
brj-24403	273	40	.	.	PROPN
brj-24403	273	41	2009	2009	NUM
brj-24403	273	42	;	;	PUNCT
brj-24403	273	43	shehta	shehta	VERB
brj-24403	273	44	et	et	PROPN
brj-24403	273	45	al	al	PROPN
brj-24403	273	46	.	.	PROPN
brj-24403	273	47	2022	2022	NUM
brj-24403	273	48	)	)	PUNCT
brj-24403	273	49	.	.	PUNCT
brj-24403	274	1	sulfhydryl	sulfhydryl	ADJ
brj-24403	274	2	groups	group	NOUN
brj-24403	274	3	in	in	ADP
brj-24403	274	4	proteins	protein	NOUN
brj-24403	274	5	are	be	AUX
brj-24403	274	6	essential	essential	ADJ
brj-24403	274	7	for	for	ADP
brj-24403	274	8	maintaining	maintain	VERB
brj-24403	274	9	their	their	PRON
brj-24403	274	10	structure	structure	NOUN
brj-24403	274	11	and	and	CCONJ
brj-24403	274	12	function	function	NOUN
brj-24403	274	13	.	.	PUNCT
brj-24403	275	1	however	however	ADV
brj-24403	275	2	,	,	PUNCT
brj-24403	275	3	seizures	seizure	NOUN
brj-24403	275	4	generate	generate	VERB
brj-24403	275	5	excessive	excessive	ADJ
brj-24403	275	6	reactive	reactive	ADJ
brj-24403	275	7	oxygen	oxygen	NOUN
brj-24403	275	8	species	specie	NOUN
brj-24403	275	9	(	(	PUNCT
brj-24403	275	10	ros	ros	PROPN
brj-24403	275	11	)	)	PUNCT
brj-24403	275	12	,	,	PUNCT
brj-24403	275	13	leading	lead	VERB
brj-24403	275	14	to	to	ADP
brj-24403	275	15	the	the	DET
brj-24403	275	16	oxidation	oxidation	NOUN
brj-24403	275	17	of	of	ADP
brj-24403	275	18	sulfhydryl	sulfhydryl	ADJ
brj-24403	275	19	groups	group	NOUN
brj-24403	275	20	,	,	PUNCT
brj-24403	275	21	disrupting	disrupt	VERB
brj-24403	275	22	protein	protein	NOUN
brj-24403	275	23	function	function	NOUN
brj-24403	275	24	,	,	PUNCT
brj-24403	275	25	and	and	CCONJ
brj-24403	275	26	contributing	contribute	VERB
brj-24403	275	27	to	to	ADP
brj-24403	275	28	neuronal	neuronal	ADJ
brj-24403	275	29	damage	damage	NOUN
brj-24403	275	30	(	(	PUNCT
brj-24403	275	31	rodrigues	rodrigue	NOUN
brj-24403	275	32	et	et	PROPN
brj-24403	275	33	al	al	PROPN
brj-24403	275	34	.	.	PROPN
brj-24403	275	35	2012	2012	NUM
brj-24403	275	36	,	,	PUNCT
brj-24403	275	37	2013	2013	NUM
brj-24403	275	38	)	)	PUNCT
brj-24403	275	39	.	.	PUNCT
brj-24403	276	1	no	no	INTJ
brj-24403	276	2	,	,	PUNCT
brj-24403	276	3	a	a	DET
brj-24403	276	4	neuromodulator	neuromodulator	NOUN
brj-24403	276	5	,	,	PUNCT
brj-24403	276	6	becomes	become	VERB
brj-24403	276	7	neurotoxic	neurotoxic	ADJ
brj-24403	276	8	during	during	ADP
brj-24403	276	9	seizures	seizure	NOUN
brj-24403	276	10	when	when	SCONJ
brj-24403	276	11	produced	produce	VERB
brj-24403	276	12	in	in	ADP
brj-24403	276	13	excess	excess	ADJ
brj-24403	276	14	,	,	PUNCT
brj-24403	276	15	forming	form	VERB
brj-24403	276	16	reactive	reactive	ADJ
brj-24403	276	17	nitrogen	nitrogen	NOUN
brj-24403	276	18	species	specie	NOUN
brj-24403	276	19	(	(	PUNCT
brj-24403	276	20	rns	rn	NOUN
brj-24403	276	21	)	)	PUNCT
brj-24403	276	22	like	like	ADP
brj-24403	276	23	peroxynitrite	peroxynitrite	ADJ
brj-24403	276	24	,	,	PUNCT
brj-24403	276	25	peer	peer	NOUN
brj-24403	276	26	-	-	PUNCT
brj-24403	276	27	reviewed	review	VERB
brj-24403	276	28	article	article	NOUN
brj-24403	276	29	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	276	30	li	li	PROPN
brj-24403	276	31	et	et	PROPN
brj-24403	276	32	al	al	PROPN
brj-24403	276	33	.	.	PROPN
brj-24403	277	1	(	(	PUNCT
brj-24403	277	2	2025	2025	NUM
brj-24403	277	3	)	)	PUNCT
brj-24403	277	4	.	.	PUNCT
brj-24403	278	1	“	"	PUNCT
brj-24403	278	2	herbal	herbal	ADJ
brj-24403	278	3	anti	anti	ADJ
brj-24403	278	4	-	-	ADJ
brj-24403	278	5	epileptic	epileptic	ADJ
brj-24403	278	6	extract	extract	NOUN
brj-24403	278	7	,	,	PUNCT
brj-24403	278	8	”	"	PUNCT
brj-24403	278	9	bioresources	bioresource	NOUN
brj-24403	278	10	20(2	20(2	NUM
brj-24403	278	11	)	)	PUNCT
brj-24403	278	12	,	,	PUNCT
brj-24403	278	13	4701	4701	NUM
brj-24403	278	14	-	-	SYM
brj-24403	278	15	4719	4719	NUM
brj-24403	278	16	.	.	PUNCT
brj-24403	279	1	4713	4713	NUM
brj-24403	279	2	which	which	PRON
brj-24403	279	3	exacerbates	exacerbate	VERB
brj-24403	279	4	neuronal	neuronal	ADJ
brj-24403	279	5	excitability	excitability	NOUN
brj-24403	279	6	and	and	CCONJ
brj-24403	279	7	injury	injury	NOUN
brj-24403	279	8	.	.	PUNCT
brj-24403	280	1	sod	sod	NOUN
brj-24403	280	2	,	,	PUNCT
brj-24403	280	3	an	an	DET
brj-24403	280	4	antioxidant	antioxidant	ADJ
brj-24403	280	5	enzyme	enzyme	NOUN
brj-24403	280	6	,	,	PUNCT
brj-24403	280	7	neutralizes	neutralize	VERB
brj-24403	280	8	superoxide	superoxide	NOUN
brj-24403	280	9	radicals	radical	NOUN
brj-24403	280	10	,	,	PUNCT
brj-24403	280	11	but	but	CCONJ
brj-24403	280	12	its	its	PRON
brj-24403	280	13	impaired	impaired	ADJ
brj-24403	280	14	or	or	CCONJ
brj-24403	280	15	overwhelmed	overwhelmed	ADJ
brj-24403	280	16	activity	activity	NOUN
brj-24403	280	17	in	in	ADP
brj-24403	280	18	epilepsy	epilepsy	NOUN
brj-24403	280	19	allows	allow	VERB
brj-24403	280	20	ros	ros	PROPN
brj-24403	280	21	accumulation	accumulation	NOUN
brj-24403	280	22	,	,	PUNCT
brj-24403	280	23	intensifying	intensify	VERB
brj-24403	280	24	oxidative	oxidative	ADJ
brj-24403	280	25	stress	stress	NOUN
brj-24403	280	26	.	.	PUNCT
brj-24403	281	1	similarly	similarly	ADV
brj-24403	281	2	,	,	PUNCT
brj-24403	281	3	reduced	reduce	VERB
brj-24403	281	4	catalase	catalase	NOUN
brj-24403	281	5	(	(	PUNCT
brj-24403	281	6	cat	cat	NOUN
brj-24403	281	7	)	)	PUNCT
brj-24403	281	8	activity	activity	NOUN
brj-24403	281	9	during	during	ADP
brj-24403	281	10	seizures	seizure	NOUN
brj-24403	281	11	fails	fail	VERB
brj-24403	281	12	to	to	PART
brj-24403	281	13	detoxify	detoxify	VERB
brj-24403	281	14	hydrogen	hydrogen	NOUN
brj-24403	281	15	peroxide	peroxide	NOUN
brj-24403	281	16	,	,	PUNCT
brj-24403	281	17	further	far	ADV
brj-24403	281	18	amplifying	amplify	VERB
brj-24403	281	19	neuronal	neuronal	ADJ
brj-24403	281	20	damage	damage	NOUN
brj-24403	281	21	.	.	PUNCT
brj-24403	282	1	monitoring	monitor	VERB
brj-24403	282	2	these	these	DET
brj-24403	282	3	biomarkers	biomarker	NOUN
brj-24403	282	4	highlights	highlight	VERB
brj-24403	282	5	the	the	DET
brj-24403	282	6	oxidative	oxidative	ADJ
brj-24403	282	7	stress	stress	NOUN
brj-24403	282	8	burden	burden	NOUN
brj-24403	282	9	in	in	ADP
brj-24403	282	10	epilepsy	epilepsy	NOUN
brj-24403	282	11	and	and	CCONJ
brj-24403	282	12	offers	offer	VERB
brj-24403	282	13	insights	insight	NOUN
brj-24403	282	14	into	into	ADP
brj-24403	282	15	potential	potential	ADJ
brj-24403	282	16	therapeutic	therapeutic	ADJ
brj-24403	282	17	strategies	strategy	NOUN
brj-24403	282	18	,	,	PUNCT
brj-24403	282	19	particularly	particularly	ADV
brj-24403	282	20	antioxidant	antioxidant	NOUN
brj-24403	282	21	-	-	PUNCT
brj-24403	282	22	based	base	VERB
brj-24403	282	23	treatments	treatment	NOUN
brj-24403	282	24	,	,	PUNCT
brj-24403	282	25	to	to	PART
brj-24403	282	26	mitigate	mitigate	VERB
brj-24403	282	27	seizure	seizure	NOUN
brj-24403	282	28	-	-	PUNCT
brj-24403	282	29	induced	induce	VERB
brj-24403	282	30	neurodegeneration	neurodegeneration	NOUN
brj-24403	282	31	(	(	PUNCT
brj-24403	282	32	sudha	sudha	NOUN
brj-24403	282	33	et	et	PROPN
brj-24403	282	34	al	al	PROPN
brj-24403	282	35	.	.	PROPN
brj-24403	282	36	2001	2001	NUM
brj-24403	282	37	)	)	PUNCT
brj-24403	282	38	.	.	PUNCT
brj-24403	283	1	according	accord	VERB
brj-24403	283	2	to	to	ADP
brj-24403	283	3	the	the	DET
brj-24403	283	4	findings	finding	NOUN
brj-24403	283	5	of	of	ADP
brj-24403	283	6	the	the	DET
brj-24403	283	7	current	current	ADJ
brj-24403	283	8	investigation	investigation	NOUN
brj-24403	283	9	(	(	PUNCT
brj-24403	283	10	fig	fig	NOUN
brj-24403	283	11	.	.	PUNCT
brj-24403	283	12	5	5	NUM
brj-24403	283	13	)	)	PUNCT
brj-24403	283	14	,	,	PUNCT
brj-24403	283	15	the	the	DET
brj-24403	283	16	levels	level	NOUN
brj-24403	283	17	of	of	ADP
brj-24403	283	18	tabars	tabar	NOUN
brj-24403	283	19	,	,	PUNCT
brj-24403	283	20	carbonyl	carbonyl	NOUN
brj-24403	283	21	protein	protein	NOUN
brj-24403	283	22	,	,	PUNCT
brj-24403	283	23	and	and	CCONJ
brj-24403	283	24	nitric	nitric	ADJ
brj-24403	283	25	oxide	oxide	NOUN
brj-24403	283	26	were	be	AUX
brj-24403	283	27	found	find	VERB
brj-24403	283	28	to	to	PART
brj-24403	283	29	have	have	AUX
brj-24403	283	30	greatly	greatly	ADV
brj-24403	283	31	increased	increase	VERB
brj-24403	283	32	,	,	PUNCT
brj-24403	283	33	whereas	whereas	SCONJ
brj-24403	283	34	the	the	DET
brj-24403	283	35	levels	level	NOUN
brj-24403	283	36	of	of	ADP
brj-24403	283	37	sulfhydryl	sulfhydryl	ADJ
brj-24403	283	38	protein	protein	NOUN
brj-24403	283	39	,	,	PUNCT
brj-24403	283	40	sod	sod	NOUN
brj-24403	283	41	,	,	PUNCT
brj-24403	283	42	and	and	CCONJ
brj-24403	283	43	cat	cat	NOUN
brj-24403	283	44	were	be	AUX
brj-24403	283	45	found	find	VERB
brj-24403	283	46	to	to	PART
brj-24403	283	47	have	have	AUX
brj-24403	283	48	decreased	decrease	VERB
brj-24403	283	49	in	in	ADP
brj-24403	283	50	the	the	DET
brj-24403	283	51	pilo	pilo	ADJ
brj-24403	283	52	group	group	NOUN
brj-24403	283	53	.	.	PUNCT
brj-24403	284	1	after	after	ADP
brj-24403	284	2	the	the	DET
brj-24403	284	3	administration	administration	NOUN
brj-24403	284	4	of	of	ADP
brj-24403	284	5	cnc	cnc	PROPN
brj-24403	284	6	,	,	PUNCT
brj-24403	284	7	the	the	DET
brj-24403	284	8	levels	level	NOUN
brj-24403	284	9	of	of	ADP
brj-24403	284	10	these	these	DET
brj-24403	284	11	biomarkers	biomarker	NOUN
brj-24403	284	12	were	be	AUX
brj-24403	284	13	dramatically	dramatically	ADV
brj-24403	284	14	restored	restore	VERB
brj-24403	284	15	to	to	ADP
brj-24403	284	16	normal	normal	ADJ
brj-24403	284	17	levels	level	NOUN
brj-24403	284	18	,	,	PUNCT
brj-24403	284	19	with	with	ADP
brj-24403	284	20	the	the	DET
brj-24403	284	21	group	group	NOUN
brj-24403	284	22	that	that	PRON
brj-24403	284	23	was	be	AUX
brj-24403	284	24	treated	treat	VERB
brj-24403	284	25	with	with	ADP
brj-24403	284	26	100	100	NUM
brj-24403	284	27	mg	mg	NUM
brj-24403	284	28	/	/	SYM
brj-24403	284	29	kg	kg	PROPN
brj-24403	284	30	of	of	ADP
brj-24403	284	31	cnc	cnc	PROPN
brj-24403	284	32	reporting	report	VERB
brj-24403	284	33	the	the	DET
brj-24403	284	34	highest	high	ADJ
brj-24403	284	35	activity	activity	NOUN
brj-24403	284	36	in	in	ADP
brj-24403	284	37	comparison	comparison	NOUN
brj-24403	284	38	to	to	PART
brj-24403	284	39	pilo	pilo	VERB
brj-24403	284	40	untreated	untreated	ADJ
brj-24403	284	41	-	-	PUNCT
brj-24403	284	42	group	group	NOUN
brj-24403	284	43	.	.	PUNCT
brj-24403	285	1	this	this	DET
brj-24403	285	2	antioxidant	antioxidant	ADJ
brj-24403	285	3	effect	effect	NOUN
brj-24403	285	4	may	may	AUX
brj-24403	285	5	be	be	AUX
brj-24403	285	6	attributed	attribute	VERB
brj-24403	285	7	to	to	ADP
brj-24403	285	8	the	the	DET
brj-24403	285	9	presence	presence	NOUN
brj-24403	285	10	of	of	ADP
brj-24403	285	11	terpenoids	terpenoid	NOUN
brj-24403	285	12	and	and	CCONJ
brj-24403	285	13	phytosterols	phytosterol	NOUN
brj-24403	285	14	in	in	ADP
brj-24403	285	15	the	the	DET
brj-24403	285	16	extract	extract	NOUN
brj-24403	285	17	,	,	PUNCT
brj-24403	285	18	which	which	PRON
brj-24403	285	19	have	have	AUX
brj-24403	285	20	been	be	AUX
brj-24403	285	21	reported	report	VERB
brj-24403	285	22	to	to	PART
brj-24403	285	23	scavenge	scavenge	VERB
brj-24403	285	24	free	free	ADJ
brj-24403	285	25	radicals	radical	NOUN
brj-24403	285	26	and	and	CCONJ
brj-24403	285	27	inhibit	inhibit	VERB
brj-24403	285	28	oxidative	oxidative	ADJ
brj-24403	285	29	damage	damage	NOUN
brj-24403	285	30	(	(	PUNCT
brj-24403	285	31	aguiar	aguiar	NOUN
brj-24403	285	32	et	et	PROPN
brj-24403	285	33	al	al	PROPN
brj-24403	285	34	.	.	PROPN
brj-24403	285	35	2012	2012	NUM
brj-24403	285	36	;	;	PUNCT
brj-24403	285	37	sudha	sudha	PROPN
brj-24403	285	38	et	et	PROPN
brj-24403	285	39	al	al	PROPN
brj-24403	285	40	.	.	PROPN
brj-24403	285	41	2001	2001	NUM
brj-24403	285	42	)	)	PUNCT
brj-24403	285	43	fig	fig	NOUN
brj-24403	285	44	.	.	PUNCT
brj-24403	286	1	5	5	X
brj-24403	286	2	.	.	X
brj-24403	286	3	effect	effect	NOUN
brj-24403	286	4	of	of	ADP
brj-24403	286	5	cnc	cnc	PROPN
brj-24403	286	6	on	on	ADP
brj-24403	286	7	the	the	DET
brj-24403	286	8	oxidative	oxidative	ADJ
brj-24403	286	9	stress	stress	NOUN
brj-24403	286	10	biomarkers	biomarker	NOUN
brj-24403	286	11	.	.	PUNCT
brj-24403	287	1	the	the	DET
brj-24403	287	2	data	datum	NOUN
brj-24403	287	3	are	be	AUX
brj-24403	287	4	mean±s.e.m	mean±s.e.m	ADJ
brj-24403	287	5	.	.	PUNCT
brj-24403	288	1	*	*	PUNCT
brj-24403	288	2	p	p	X
brj-24403	288	3	<	<	X
brj-24403	288	4	0.05	0.05	NUM
brj-24403	288	5	vs	vs	ADP
brj-24403	288	6	control	control	NOUN
brj-24403	288	7	(	(	PUNCT
brj-24403	288	8	one	one	NUM
brj-24403	288	9	-	-	PUNCT
brj-24403	288	10	way	way	NOUN
brj-24403	288	11	anova	anova	X
brj-24403	288	12	with	with	ADP
brj-24403	288	13	the	the	DET
brj-24403	288	14	student	student	NOUN
brj-24403	288	15	–	–	PUNCT
brj-24403	288	16	newman	newman	PROPN
brj-24403	288	17	–	–	PUNCT
brj-24403	288	18	keuls	keuls	PROPN
brj-24403	288	19	as	as	ADP
brj-24403	288	20	a	a	DET
brj-24403	288	21	post	post	ADJ
brj-24403	288	22	-	-	ADJ
brj-24403	288	23	hoc	hoc	ADJ
brj-24403	288	24	test	test	NOUN
brj-24403	288	25	)	)	PUNCT
brj-24403	288	26	.	.	PUNCT
brj-24403	289	1	conclusions	conclusion	NOUN
brj-24403	289	2	1	1	X
brj-24403	289	3	.	.	PUNCT
brj-24403	290	1	the	the	DET
brj-24403	290	2	callicarpa	callicarpa	PROPN
brj-24403	290	3	kwangtungensis	kwangtungensis	PROPN
brj-24403	290	4	chun	chun	PROPN
brj-24403	290	5	(	(	PUNCT
brj-24403	290	6	cnc	cnc	PROPN
brj-24403	290	7	)	)	PUNCT
brj-24403	290	8	extract	extract	NOUN
brj-24403	290	9	was	be	AUX
brj-24403	290	10	found	find	VERB
brj-24403	290	11	to	to	PART
brj-24403	290	12	possesses	possess	VERB
brj-24403	290	13	significant	significant	ADJ
brj-24403	290	14	antiepileptic	antiepileptic	ADJ
brj-24403	290	15	potential	potential	NOUN
brj-24403	290	16	in	in	ADP
brj-24403	290	17	pilocarpine	pilocarpine	NOUN
brj-24403	290	18	(	(	PUNCT
brj-24403	290	19	pilo)-induced	pilo)-induce	VERB
brj-24403	290	20	epilepsy	epilepsy	NOUN
brj-24403	290	21	in	in	ADP
brj-24403	290	22	mice	mouse	NOUN
brj-24403	290	23	.	.	PUNCT
brj-24403	291	1	2	2	X
brj-24403	291	2	.	.	X
brj-24403	291	3	one	one	NUM
brj-24403	291	4	possible	possible	ADJ
brj-24403	291	5	explanation	explanation	NOUN
brj-24403	291	6	for	for	ADP
brj-24403	291	7	the	the	DET
brj-24403	291	8	pharmacological	pharmacological	ADJ
brj-24403	291	9	effects	effect	NOUN
brj-24403	291	10	of	of	ADP
brj-24403	291	11	cnc	cnc	PROPN
brj-24403	291	12	was	be	AUX
brj-24403	291	13	its	its	PRON
brj-24403	291	14	role	role	NOUN
brj-24403	291	15	in	in	ADP
brj-24403	291	16	the	the	DET
brj-24403	291	17	gabaergic	gabaergic	ADJ
brj-24403	291	18	and	and	CCONJ
brj-24403	291	19	daergic	daergic	ADJ
brj-24403	291	20	signaling	signal	VERB
brj-24403	291	21	pathways	pathway	NOUN
brj-24403	291	22	interacting	interact	VERB
brj-24403	291	23	with	with	ADP
brj-24403	291	24	one	one	NUM
brj-24403	291	25	another	another	DET
brj-24403	291	26	.	.	PUNCT
brj-24403	292	1	additionally	additionally	ADV
brj-24403	292	2	,	,	PUNCT
brj-24403	292	3	it	it	PRON
brj-24403	292	4	showed	show	VERB
brj-24403	292	5	a	a	DET
brj-24403	292	6	great	great	ADJ
brj-24403	292	7	deal	deal	NOUN
brj-24403	292	8	of	of	ADP
brj-24403	292	9	antioxidant	antioxidant	ADJ
brj-24403	292	10	efficacy	efficacy	NOUN
brj-24403	292	11	in	in	ADP
brj-24403	292	12	mice	mouse	NOUN
brj-24403	292	13	.	.	PUNCT
brj-24403	293	1	peer	peer	NOUN
brj-24403	293	2	-	-	PUNCT
brj-24403	293	3	reviewed	review	VERB
brj-24403	293	4	article	article	NOUN
brj-24403	293	5	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	293	6	li	li	PROPN
brj-24403	293	7	et	et	PROPN
brj-24403	293	8	al	al	PROPN
brj-24403	293	9	.	.	PROPN
brj-24403	294	1	(	(	PUNCT
brj-24403	294	2	2025	2025	NUM
brj-24403	294	3	)	)	PUNCT
brj-24403	294	4	.	.	PUNCT
brj-24403	295	1	“	"	PUNCT
brj-24403	295	2	herbal	herbal	ADJ
brj-24403	295	3	anti	anti	ADJ
brj-24403	295	4	-	-	ADJ
brj-24403	295	5	epileptic	epileptic	ADJ
brj-24403	295	6	extract	extract	NOUN
brj-24403	295	7	,	,	PUNCT
brj-24403	295	8	”	"	PUNCT
brj-24403	295	9	bioresources	bioresource	NOUN
brj-24403	295	10	20(2	20(2	NUM
brj-24403	295	11	)	)	PUNCT
brj-24403	295	12	,	,	PUNCT
brj-24403	295	13	4701	4701	NUM
brj-24403	295	14	-	-	SYM
brj-24403	295	15	4719	4719	NUM
brj-24403	295	16	.	.	PUNCT
brj-24403	295	17	4714	4714	NUM
brj-24403	296	1	3	3	X
brj-24403	296	2	.	.	PUNCT
brj-24403	296	3	further	further	ADJ
brj-24403	296	4	investigation	investigation	NOUN
brj-24403	296	5	into	into	ADP
brj-24403	296	6	cnc	cnc	PROPN
brj-24403	296	7	’s	’s	PART
brj-24403	296	8	effects	effect	NOUN
brj-24403	296	9	on	on	ADP
brj-24403	296	10	other	other	ADJ
brj-24403	296	11	receptors	receptor	NOUN
brj-24403	296	12	,	,	PUNCT
brj-24403	296	13	neuronal	neuronal	ADJ
brj-24403	296	14	apoptosis	apoptosis	NOUN
brj-24403	296	15	,	,	PUNCT
brj-24403	296	16	and	and	CCONJ
brj-24403	296	17	the	the	DET
brj-24403	296	18	biochemical	biochemical	ADJ
brj-24403	296	19	mediators	mediator	NOUN
brj-24403	296	20	of	of	ADP
brj-24403	296	21	apoptosis	apoptosis	NOUN
brj-24403	296	22	is	be	AUX
brj-24403	296	23	necessary	necessary	ADJ
brj-24403	296	24	to	to	PART
brj-24403	296	25	support	support	VERB
brj-24403	296	26	cnc	cnc	PROPN
brj-24403	296	27	as	as	ADP
brj-24403	296	28	a	a	DET
brj-24403	296	29	prospective	prospective	ADJ
brj-24403	296	30	therapeutic	therapeutic	ADJ
brj-24403	296	31	candidate	candidate	NOUN
brj-24403	296	32	.	.	PUNCT
brj-24403	297	1	author	author	NOUN
brj-24403	297	2	’s	’s	PART
brj-24403	297	3	contribution	contribution	NOUN
brj-24403	297	4	shiqing	shiqe	VERB
brj-24403	297	5	li	li	PROPN
brj-24403	297	6	,	,	PUNCT
brj-24403	297	7	meizhi	meizhi	PROPN
brj-24403	297	8	li	li	PROPN
brj-24403	297	9	:	:	PUNCT
brj-24403	297	10	design	design	NOUN
brj-24403	297	11	research	research	NOUN
brj-24403	297	12	plan	plan	NOUN
brj-24403	297	13	,	,	PUNCT
brj-24403	297	14	implement	implement	VERB
brj-24403	297	15	research	research	NOUN
brj-24403	297	16	process	process	NOUN
brj-24403	297	17	,	,	PUNCT
brj-24403	297	18	thesis	thesis	NOUN
brj-24403	297	19	writing	writing	NOUN
brj-24403	297	20	;	;	PUNCT
brj-24403	297	21	rutong	rutong	PROPN
brj-24403	297	22	wei	wei	PROPN
brj-24403	297	23	:	:	PUNCT
brj-24403	297	24	put	put	VERB
brj-24403	297	25	forward	forward	ADV
brj-24403	297	26	research	research	NOUN
brj-24403	297	27	ideas	idea	NOUN
brj-24403	297	28	,	,	PUNCT
brj-24403	297	29	paper	paper	NOUN
brj-24403	297	30	review	review	NOUN
brj-24403	297	31	;	;	PUNCT
brj-24403	297	32	huawen	huawen	PROPN
brj-24403	297	33	liu	liu	PROPN
brj-24403	297	34	:	:	PUNCT
brj-24403	297	35	implementation	implementation	NOUN
brj-24403	297	36	of	of	ADP
brj-24403	297	37	the	the	DET
brj-24403	297	38	research	research	NOUN
brj-24403	297	39	process	process	NOUN
brj-24403	297	40	,	,	PUNCT
brj-24403	297	41	analysis	analysis	NOUN
brj-24403	297	42	of	of	ADP
brj-24403	297	43	experimental	experimental	ADJ
brj-24403	297	44	data	datum	NOUN
brj-24403	297	45	;	;	PUNCT
brj-24403	297	46	erwei	erwei	NOUN
brj-24403	297	47	hu	hu	PROPN
brj-24403	297	48	and	and	CCONJ
brj-24403	297	49	zhibing	zhibe	VERB
brj-24403	297	50	zhou	zhou	PROPN
brj-24403	297	51	:	:	PUNCT
brj-24403	297	52	implementation	implementation	NOUN
brj-24403	297	53	of	of	ADP
brj-24403	297	54	the	the	DET
brj-24403	297	55	research	research	NOUN
brj-24403	297	56	process	process	NOUN
brj-24403	297	57	,	,	PUNCT
brj-24403	297	58	thesis	thesis	NOUN
brj-24403	297	59	revision	revision	NOUN
brj-24403	297	60	.	.	PUNCT
brj-24403	298	1	references	reference	NOUN
brj-24403	298	2	cited	cite	VERB
brj-24403	298	3	aguiar	aguiar	PROPN
brj-24403	298	4	,	,	PUNCT
brj-24403	298	5	c.	c.	PROPN
brj-24403	298	6	c.	c.	PROPN
brj-24403	298	7	t.	t.	PROPN
brj-24403	298	8	,	,	PUNCT
brj-24403	298	9	almeida	almeida	PROPN
brj-24403	298	10	,	,	PUNCT
brj-24403	298	11	a.	a.	PROPN
brj-24403	298	12	b.	b.	PROPN
brj-24403	298	13	,	,	PUNCT
brj-24403	298	14	arajo	arajo	ADP
brj-24403	298	15	,	,	PUNCT
brj-24403	298	16	p.	p.	NOUN
brj-24403	298	17	v.	v.	PROPN
brj-24403	299	1	p.	p.	PROPN
brj-24403	299	2	,	,	PUNCT
brj-24403	299	3	abreu	abreu	PROPN
brj-24403	299	4	,	,	PUNCT
brj-24403	299	5	r.	r.	PROPN
brj-24403	299	6	n.	n.	PROPN
brj-24403	299	7	d.	d.	PROPN
brj-24403	299	8	c.	c.	PROPN
brj-24403	299	9	de	de	PROPN
brj-24403	299	10	,	,	PUNCT
brj-24403	299	11	chaves	chave	NOUN
brj-24403	299	12	,	,	PUNCT
brj-24403	299	13	e.	e.	PROPN
brj-24403	299	14	m.	m.	PROPN
brj-24403	299	15	c.	c.	PROPN
brj-24403	299	16	,	,	PUNCT
brj-24403	299	17	vale	vale	NOUN
brj-24403	299	18	,	,	PUNCT
brj-24403	299	19	o.	o.	PROPN
brj-24403	299	20	c.	c.	PROPN
brj-24403	299	21	do	do	VERB
brj-24403	299	22	,	,	PUNCT
brj-24403	299	23	macêdo	macêdo	PROPN
brj-24403	299	24	,	,	PUNCT
brj-24403	299	25	d.	d.	PROPN
brj-24403	299	26	s.	s.	PROPN
brj-24403	299	27	,	,	PUNCT
brj-24403	299	28	woods	woods	PROPN
brj-24403	299	29	,	,	PUNCT
brj-24403	299	30	d.	d.	PROPN
brj-24403	299	31	j.	j.	PROPN
brj-24403	299	32	,	,	PUNCT
brj-24403	299	33	fonteles	fontele	NOUN
brj-24403	299	34	,	,	PUNCT
brj-24403	299	35	m.	m.	NOUN
brj-24403	299	36	m.	m.	PROPN
brj-24403	299	37	d.	d.	PROPN
brj-24403	299	38	f.	f.	PROPN
brj-24403	299	39	,	,	PUNCT
brj-24403	299	40	and	and	CCONJ
brj-24403	299	41	vasconcelos	vasconcelos	PROPN
brj-24403	299	42	,	,	PUNCT
brj-24403	299	43	s.	s.	PROPN
brj-24403	299	44	m.	m.	PROPN
brj-24403	299	45	m.	m.	PROPN
brj-24403	299	46	(	(	PUNCT
brj-24403	299	47	2012	2012	NUM
brj-24403	299	48	)	)	PUNCT
brj-24403	299	49	.	.	PUNCT
brj-24403	300	1	“	"	PUNCT
brj-24403	300	2	oxidative	oxidative	ADJ
brj-24403	300	3	stress	stress	NOUN
brj-24403	300	4	and	and	CCONJ
brj-24403	300	5	epilepsy	epilepsy	NOUN
brj-24403	300	6	:	:	PUNCT
brj-24403	300	7	literature	literature	PROPN
brj-24403	300	8	review	review	PROPN
brj-24403	300	9	,	,	PUNCT
brj-24403	300	10	”	"	PUNCT
brj-24403	300	11	oxidative	oxidative	ADJ
brj-24403	300	12	medicine	medicine	NOUN
brj-24403	300	13	and	and	CCONJ
brj-24403	300	14	cellular	cellular	ADJ
brj-24403	300	15	longevity	longevity	NOUN
brj-24403	300	16	2012	2012	NUM
brj-24403	300	17	,	,	PUNCT
brj-24403	300	18	article	article	NOUN
brj-24403	300	19	795259	795259	NUM
brj-24403	300	20	.	.	PUNCT
brj-24403	301	1	doi	doi	NOUN
brj-24403	301	2	:	:	PUNCT
brj-24403	301	3	10.1155/2012/795259	10.1155/2012/795259	NUM
brj-24403	301	4	aldossary	aldossary	ADJ
brj-24403	301	5	,	,	PUNCT
brj-24403	301	6	s.	s.	PROPN
brj-24403	301	7	a.	a.	PROPN
brj-24403	301	8	(	(	PUNCT
brj-24403	301	9	2022a	2022a	NUM
brj-24403	301	10	)	)	PUNCT
brj-24403	301	11	.	.	PUNCT
brj-24403	302	1	“	"	PUNCT
brj-24403	302	2	targeting	target	VERB
brj-24403	302	3	muscarinic	muscarinic	ADJ
brj-24403	302	4	acetylcholine	acetylcholine	NOUN
brj-24403	302	5	receptors	receptor	NOUN
brj-24403	302	6	in	in	ADP
brj-24403	302	7	epilepsy	epilepsy	NOUN
brj-24403	302	8	:	:	PUNCT
brj-24403	302	9	current	current	ADJ
brj-24403	302	10	status	status	NOUN
brj-24403	302	11	and	and	CCONJ
brj-24403	302	12	future	future	ADJ
brj-24403	302	13	perspectives	perspective	NOUN
brj-24403	302	14	,	,	PUNCT
brj-24403	302	15	”	"	PUNCT
brj-24403	302	16	current	current	ADJ
brj-24403	302	17	neuropharmacology	neuropharmacology	NOUN
brj-24403	302	18	20(1	20(1	NOUN
brj-24403	302	19	)	)	PUNCT
brj-24403	302	20	,	,	PUNCT
brj-24403	302	21	110	110	NUM
brj-24403	302	22	-	-	SYM
brj-24403	302	23	123	123	NUM
brj-24403	302	24	.	.	PUNCT
brj-24403	303	1	doi	doi	NOUN
brj-24403	303	2	:	:	PUNCT
brj-24403	303	3	10.2174/1570159x19666210615130801	10.2174/1570159x19666210615130801	NUM
brj-24403	303	4	aldossary	aldossary	ADJ
brj-24403	303	5	,	,	PUNCT
brj-24403	303	6	s.	s.	PROPN
brj-24403	303	7	a.	a.	PROPN
brj-24403	303	8	(	(	PUNCT
brj-24403	303	9	2022b	2022b	NUM
brj-24403	303	10	)	)	PUNCT
brj-24403	303	11	.	.	PUNCT
brj-24403	304	1	“	"	PUNCT
brj-24403	304	2	review	review	NOUN
brj-24403	304	3	on	on	ADP
brj-24403	304	4	pharmacology	pharmacology	NOUN
brj-24403	304	5	of	of	ADP
brj-24403	304	6	atropine	atropine	NOUN
brj-24403	304	7	,	,	PUNCT
brj-24403	304	8	clinical	clinical	ADJ
brj-24403	304	9	use	use	NOUN
brj-24403	304	10	and	and	CCONJ
brj-24403	304	11	toxicity	toxicity	NOUN
brj-24403	304	12	,	,	PUNCT
brj-24403	304	13	”	"	PUNCT
brj-24403	304	14	biomedical	biomedical	ADJ
brj-24403	304	15	and	and	CCONJ
brj-24403	304	16	pharmacology	pharmacology	NOUN
brj-24403	304	17	journal	journal	NOUN
brj-24403	304	18	15(2	15(2	NUM
brj-24403	304	19	)	)	PUNCT
brj-24403	304	20	,	,	PUNCT
brj-24403	304	21	article	article	NOUN
brj-24403	304	22	2408	2408	NUM
brj-24403	304	23	.	.	PUNCT
brj-24403	305	1	doi	doi	NOUN
brj-24403	305	2	:	:	PUNCT
brj-24403	305	3	10.13005	10.13005	NUM
brj-24403	305	4	/	/	SYM
brj-24403	305	5	bpj/2408	bpj/2408	X
brj-24403	305	6	amakhin	amakhin	PROPN
brj-24403	305	7	,	,	PUNCT
brj-24403	305	8	d.	d.	PROPN
brj-24403	305	9	v.	v.	PROPN
brj-24403	305	10	,	,	PUNCT
brj-24403	305	11	taranov	taranov	PROPN
brj-24403	305	12	,	,	PUNCT
brj-24403	305	13	a.	a.	PROPN
brj-24403	305	14	s.	s.	PROPN
brj-24403	305	15	,	,	PUNCT
brj-24403	305	16	sitdikova	sitdikova	PROPN
brj-24403	305	17	,	,	PUNCT
brj-24403	305	18	g.	g.	PROPN
brj-24403	305	19	f.	f.	PROPN
brj-24403	305	20	,	,	PUNCT
brj-24403	305	21	and	and	CCONJ
brj-24403	305	22	zaitsev	zaitsev	NOUN
brj-24403	305	23	,	,	PUNCT
brj-24403	305	24	a.	a.	NOUN
brj-24403	305	25	v.	v.	PROPN
brj-24403	305	26	(	(	PUNCT
brj-24403	305	27	2018a	2018a	NUM
brj-24403	305	28	)	)	PUNCT
brj-24403	305	29	.	.	PUNCT
brj-24403	306	1	“	"	PUNCT
brj-24403	306	2	recurrent	recurrent	ADJ
brj-24403	306	3	seizures	seizure	NOUN
brj-24403	306	4	induce	induce	VERB
brj-24403	306	5	long	long	ADJ
brj-24403	306	6	-	-	PUNCT
brj-24403	306	7	term	term	NOUN
brj-24403	306	8	changes	change	NOUN
brj-24403	306	9	in	in	ADP
brj-24403	306	10	synaptic	synaptic	ADJ
brj-24403	306	11	glutamate	glutamate	NOUN
brj-24403	306	12	signaling	signal	VERB
brj-24403	306	13	in	in	ADP
brj-24403	306	14	the	the	DET
brj-24403	306	15	entorhinal	entorhinal	ADJ
brj-24403	306	16	cortex	cortex	NOUN
brj-24403	306	17	of	of	ADP
brj-24403	306	18	immature	immature	ADJ
brj-24403	306	19	rats	rat	NOUN
brj-24403	306	20	,	,	PUNCT
brj-24403	306	21	”	"	PUNCT
brj-24403	306	22	frontiers	frontier	NOUN
brj-24403	306	23	in	in	ADP
brj-24403	306	24	cellular	cellular	ADJ
brj-24403	306	25	neuroscience	neuroscience	NOUN
brj-24403	306	26	12	12	NUM
brj-24403	306	27	,	,	PUNCT
brj-24403	306	28	article	article	NOUN
brj-24403	306	29	198	198	NUM
brj-24403	306	30	.	.	PUNCT
brj-24403	307	1	doi	doi	NOUN
brj-24403	307	2	:	:	PUNCT
brj-24403	307	3	10.3389	10.3389	NUM
brj-24403	307	4	/	/	SYM
brj-24403	307	5	fncel.2018.00198	fncel.2018.00198	NOUN
brj-24403	307	6	amakhin	amakhin	ADJ
brj-24403	307	7	,	,	PUNCT
brj-24403	307	8	d.	d.	PROPN
brj-24403	307	9	v.	v.	PROPN
brj-24403	307	10	,	,	PUNCT
brj-24403	307	11	soboleva	soboleva	PROPN
brj-24403	307	12	,	,	PUNCT
brj-24403	307	13	e.	e.	PROPN
brj-24403	307	14	b.	b.	PROPN
brj-24403	307	15	,	,	PUNCT
brj-24403	307	16	ergina	ergina	PROPN
brj-24403	307	17	,	,	PUNCT
brj-24403	307	18	j.	j.	PROPN
brj-24403	307	19	l.	l.	PROPN
brj-24403	307	20	,	,	PUNCT
brj-24403	307	21	malkin	malkin	PROPN
brj-24403	307	22	,	,	PUNCT
brj-24403	307	23	s.	s.	PROPN
brj-24403	307	24	l.	l.	PROPN
brj-24403	307	25	,	,	PUNCT
brj-24403	307	26	chizhov	chizhov	PROPN
brj-24403	307	27	,	,	PUNCT
brj-24403	307	28	a.	a.	NOUN
brj-24403	307	29	v.	v.	ADV
brj-24403	307	30	,	,	PUNCT
brj-24403	307	31	and	and	CCONJ
brj-24403	307	32	zaitsev	zaitsev	NOUN
brj-24403	307	33	,	,	PUNCT
brj-24403	307	34	a.	a.	NOUN
brj-24403	307	35	v.	v.	PROPN
brj-24403	307	36	(	(	PUNCT
brj-24403	307	37	2018b	2018b	NUM
brj-24403	307	38	)	)	PUNCT
brj-24403	307	39	.	.	PUNCT
brj-24403	308	1	“	"	PUNCT
brj-24403	308	2	seizure	seizure	VERB
brj-24403	308	3	-	-	PUNCT
brj-24403	308	4	induced	induce	VERB
brj-24403	308	5	potentiation	potentiation	NOUN
brj-24403	308	6	of	of	ADP
brj-24403	308	7	ampa	ampa	NOUN
brj-24403	308	8	receptor	receptor	NOUN
brj-24403	308	9	-	-	PUNCT
brj-24403	308	10	mediated	mediate	VERB
brj-24403	308	11	synaptic	synaptic	ADJ
brj-24403	308	12	transmission	transmission	NOUN
brj-24403	308	13	in	in	ADP
brj-24403	308	14	the	the	DET
brj-24403	308	15	entorhinal	entorhinal	ADJ
brj-24403	308	16	cortex	cortex	NOUN
brj-24403	308	17	,	,	PUNCT
brj-24403	308	18	”	"	PUNCT
brj-24403	308	19	frontiers	frontier	NOUN
brj-24403	308	20	in	in	ADP
brj-24403	308	21	cellular	cellular	ADJ
brj-24403	308	22	neuroscience	neuroscience	NOUN
brj-24403	308	23	12	12	NUM
brj-24403	308	24	,	,	PUNCT
brj-24403	308	25	article	article	NOUN
brj-24403	308	26	486	486	NUM
brj-24403	308	27	.	.	PUNCT
brj-24403	309	1	doi	doi	NOUN
brj-24403	309	2	:	:	PUNCT
brj-24403	309	3	10.3389	10.3389	NUM
brj-24403	309	4	/	/	SYM
brj-24403	309	5	fncel.2018.00486	fncel.2018.00486	VERB
brj-24403	309	6	balunas	baluna	NOUN
brj-24403	309	7	,	,	PUNCT
brj-24403	309	8	m.	m.	NOUN
brj-24403	309	9	j.	j.	PROPN
brj-24403	309	10	,	,	PUNCT
brj-24403	309	11	and	and	CCONJ
brj-24403	309	12	kinghorn	kinghorn	PROPN
brj-24403	309	13	,	,	PUNCT
brj-24403	309	14	a.	a.	PROPN
brj-24403	309	15	d.	d.	PROPN
brj-24403	309	16	(	(	PUNCT
brj-24403	309	17	2005	2005	NUM
brj-24403	309	18	)	)	PUNCT
brj-24403	309	19	.	.	PUNCT
brj-24403	310	1	“	"	PUNCT
brj-24403	310	2	drug	drug	NOUN
brj-24403	310	3	discovery	discovery	NOUN
brj-24403	310	4	from	from	ADP
brj-24403	310	5	medicinal	medicinal	ADJ
brj-24403	310	6	plants	plant	NOUN
brj-24403	310	7	,	,	PUNCT
brj-24403	310	8	”	"	PUNCT
brj-24403	310	9	life	life	NOUN
brj-24403	310	10	sciences	science	NOUN
brj-24403	310	11	78(5	78(5	NOUN
brj-24403	310	12	)	)	PUNCT
brj-24403	310	13	,	,	PUNCT
brj-24403	310	14	431	431	NUM
brj-24403	310	15	-	-	SYM
brj-24403	310	16	441	441	NUM
brj-24403	310	17	.	.	PUNCT
brj-24403	311	1	doi	doi	NOUN
brj-24403	311	2	:	:	PUNCT
brj-24403	311	3	10.1016	10.1016	NUM
brj-24403	311	4	/	/	SYM
brj-24403	311	5	j.lfs.2005.09.012	j.lfs.2005.09.012	PROPN
brj-24403	311	6	barker	barker	PROPN
brj-24403	311	7	-	-	PUNCT
brj-24403	311	8	haliski	haliski	PROPN
brj-24403	311	9	,	,	PUNCT
brj-24403	311	10	m.	m.	NOUN
brj-24403	311	11	,	,	PUNCT
brj-24403	311	12	and	and	CCONJ
brj-24403	311	13	steve	steve	PROPN
brj-24403	311	14	white	white	PROPN
brj-24403	311	15	,	,	PUNCT
brj-24403	311	16	h.	h.	PROPN
brj-24403	311	17	(	(	PUNCT
brj-24403	311	18	2015	2015	NUM
brj-24403	311	19	)	)	PUNCT
brj-24403	311	20	.	.	PUNCT
brj-24403	312	1	“	"	PUNCT
brj-24403	312	2	glutamatergic	glutamatergic	ADJ
brj-24403	312	3	mechanisms	mechanism	NOUN
brj-24403	312	4	associated	associate	VERB
brj-24403	312	5	with	with	ADP
brj-24403	312	6	seizures	seizure	NOUN
brj-24403	312	7	and	and	CCONJ
brj-24403	312	8	epilepsy	epilepsy	NOUN
brj-24403	312	9	,	,	PUNCT
brj-24403	312	10	”	"	PUNCT
brj-24403	312	11	cold	cold	ADJ
brj-24403	312	12	spring	spring	NOUN
brj-24403	312	13	harbor	harbor	NOUN
brj-24403	312	14	perspectives	perspective	NOUN
brj-24403	312	15	in	in	ADP
brj-24403	312	16	medicine	medicine	NOUN
brj-24403	312	17	5(8	5(8	NUM
brj-24403	312	18	)	)	PUNCT
brj-24403	312	19	,	,	PUNCT
brj-24403	312	20	article	article	NOUN
brj-24403	312	21	22863	22863	NUM
brj-24403	312	22	.	.	PUNCT
brj-24403	313	1	doi	doi	NOUN
brj-24403	313	2	:	:	PUNCT
brj-24403	313	3	10.1101	10.1101	NUM
brj-24403	313	4	/	/	SYM
brj-24403	313	5	cshperspect.a022863	cshperspect.a022863	NOUN
brj-24403	313	6	beghi	beghi	PROPN
brj-24403	313	7	,	,	PUNCT
brj-24403	313	8	e.	e.	PROPN
brj-24403	313	9	(	(	PUNCT
brj-24403	313	10	2007	2007	NUM
brj-24403	313	11	)	)	PUNCT
brj-24403	313	12	.	.	PUNCT
brj-24403	314	1	“	"	PUNCT
brj-24403	314	2	epilepsy	epilepsy	NOUN
brj-24403	314	3	,	,	PUNCT
brj-24403	314	4	”	"	PUNCT
brj-24403	314	5	current	current	ADJ
brj-24403	314	6	opinion	opinion	NOUN
brj-24403	314	7	in	in	ADP
brj-24403	314	8	neurology	neurology	NOUN
brj-24403	314	9	20(2	20(2	NOUN
brj-24403	314	10	)	)	PUNCT
brj-24403	314	11	,	,	PUNCT
brj-24403	314	12	169	169	NUM
brj-24403	314	13	-	-	SYM
brj-24403	314	14	174	174	NUM
brj-24403	314	15	.	.	PUNCT
brj-24403	315	1	doi	doi	NOUN
brj-24403	315	2	:	:	PUNCT
brj-24403	315	3	10.1097	10.1097	NUM
brj-24403	315	4	/	/	SYM
brj-24403	315	5	wco.0b013e3280d646e4	wco.0b013e3280d646e4	NOUN
brj-24403	315	6	butler	butler	NOUN
brj-24403	315	7	,	,	PUNCT
brj-24403	315	8	m.	m.	NOUN
brj-24403	315	9	s.	s.	PROPN
brj-24403	315	10	,	,	PUNCT
brj-24403	315	11	robertson	robertson	PROPN
brj-24403	315	12	,	,	PUNCT
brj-24403	315	13	a.	a.	PROPN
brj-24403	315	14	a.	a.	PROPN
brj-24403	315	15	b.	b.	PROPN
brj-24403	315	16	,	,	PUNCT
brj-24403	315	17	and	and	CCONJ
brj-24403	315	18	cooper	cooper	PROPN
brj-24403	315	19	,	,	PUNCT
brj-24403	315	20	m.	m.	NOUN
brj-24403	315	21	a.	a.	PROPN
brj-24403	315	22	(	(	PUNCT
brj-24403	315	23	2014	2014	NUM
brj-24403	315	24	)	)	PUNCT
brj-24403	315	25	.	.	PUNCT
brj-24403	316	1	“	"	PUNCT
brj-24403	316	2	natural	natural	ADJ
brj-24403	316	3	product	product	NOUN
brj-24403	316	4	and	and	CCONJ
brj-24403	316	5	natural	natural	ADJ
brj-24403	316	6	product	product	NOUN
brj-24403	316	7	derived	derive	VERB
brj-24403	316	8	drugs	drug	NOUN
brj-24403	316	9	in	in	ADP
brj-24403	316	10	clinical	clinical	ADJ
brj-24403	316	11	trials	trial	NOUN
brj-24403	316	12	,	,	PUNCT
brj-24403	316	13	”	"	PUNCT
brj-24403	316	14	natural	natural	ADJ
brj-24403	316	15	product	product	NOUN
brj-24403	316	16	reports	report	VERB
brj-24403	316	17	31(11	31(11	NUM
brj-24403	316	18	)	)	PUNCT
brj-24403	316	19	,	,	PUNCT
brj-24403	316	20	1612	1612	NUM
brj-24403	316	21	-	-	SYM
brj-24403	316	22	1661	1661	NUM
brj-24403	316	23	.	.	PUNCT
brj-24403	317	1	doi	doi	NOUN
brj-24403	317	2	:	:	PUNCT
brj-24403	317	3	10.1039	10.1039	NUM
brj-24403	317	4	/	/	SYM
brj-24403	317	5	c4np00064a	c4np00064a	PROPN
brj-24403	317	6	cai	cai	PROPN
brj-24403	317	7	,	,	PUNCT
brj-24403	317	8	h.	h.	PROPN
brj-24403	317	9	,	,	PUNCT
brj-24403	317	10	xie	xie	PROPN
brj-24403	317	11	,	,	PUNCT
brj-24403	317	12	z.	z.	PROPN
brj-24403	317	13	,	,	PUNCT
brj-24403	317	14	liu	liu	PROPN
brj-24403	317	15	,	,	PUNCT
brj-24403	317	16	g.	g.	PROPN
brj-24403	317	17	,	,	PUNCT
brj-24403	317	18	sun	sun	NOUN
brj-24403	317	19	,	,	PUNCT
brj-24403	317	20	x.	x.	PROPN
brj-24403	317	21	,	,	PUNCT
brj-24403	317	22	peng	peng	PROPN
brj-24403	317	23	,	,	PUNCT
brj-24403	317	24	g.	g.	PROPN
brj-24403	317	25	,	,	PUNCT
brj-24403	317	26	lin	lin	PROPN
brj-24403	317	27	,	,	PUNCT
brj-24403	317	28	b.	b.	PROPN
brj-24403	317	29	,	,	PUNCT
brj-24403	317	30	and	and	CCONJ
brj-24403	317	31	liao	liao	PROPN
brj-24403	317	32	,	,	PUNCT
brj-24403	317	33	q.	q.	PROPN
brj-24403	317	34	(	(	PUNCT
brj-24403	317	35	2014	2014	NUM
brj-24403	317	36	)	)	PUNCT
brj-24403	317	37	.	.	PUNCT
brj-24403	318	1	“	"	PUNCT
brj-24403	318	2	isolation	isolation	NOUN
brj-24403	318	3	,	,	PUNCT
brj-24403	318	4	identification	identification	NOUN
brj-24403	318	5	and	and	CCONJ
brj-24403	318	6	activities	activity	NOUN
brj-24403	318	7	of	of	ADP
brj-24403	318	8	natural	natural	ADJ
brj-24403	318	9	antioxidants	antioxidant	NOUN
brj-24403	318	10	from	from	ADP
brj-24403	318	11	callicarpa	callicarpa	ADJ
brj-24403	318	12	kwangtungensis	kwangtungensis	PROPN
brj-24403	318	13	chun	chun	PROPN
brj-24403	318	14	,	,	PUNCT
brj-24403	318	15	”	"	PUNCT
brj-24403	318	16	plos	plos	PROPN
brj-24403	318	17	one	one	NUM
brj-24403	318	18	9(3	9(3	NUM
brj-24403	318	19	)	)	PUNCT
brj-24403	318	20	.	.	PUNCT
brj-24403	319	1	doi	doi	NOUN
brj-24403	319	2	:	:	PUNCT
brj-24403	319	3	10.1371	10.1371	NUM
brj-24403	319	4	/	/	SYM
brj-24403	319	5	journal.pone.0093000	journal.pone.0093000	PROPN
brj-24403	319	6	peer	peer	NOUN
brj-24403	319	7	-	-	PUNCT
brj-24403	319	8	reviewed	review	VERB
brj-24403	319	9	article	article	NOUN
brj-24403	319	10	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	319	11	li	li	PROPN
brj-24403	319	12	et	et	PROPN
brj-24403	319	13	al	al	PROPN
brj-24403	319	14	.	.	PROPN
brj-24403	320	1	(	(	PUNCT
brj-24403	320	2	2025	2025	NUM
brj-24403	320	3	)	)	PUNCT
brj-24403	320	4	.	.	PUNCT
brj-24403	321	1	“	"	PUNCT
brj-24403	321	2	herbal	herbal	ADJ
brj-24403	321	3	anti	anti	ADJ
brj-24403	321	4	-	-	ADJ
brj-24403	321	5	epileptic	epileptic	ADJ
brj-24403	321	6	extract	extract	NOUN
brj-24403	321	7	,	,	PUNCT
brj-24403	321	8	”	"	PUNCT
brj-24403	321	9	bioresources	bioresource	NOUN
brj-24403	321	10	20(2	20(2	NUM
brj-24403	321	11	)	)	PUNCT
brj-24403	321	12	,	,	PUNCT
brj-24403	321	13	4701	4701	NUM
brj-24403	321	14	-	-	SYM
brj-24403	321	15	4719	4719	NUM
brj-24403	321	16	.	.	PUNCT
brj-24403	322	1	4715	4715	NUM
brj-24403	322	2	catterall	catterall	PROPN
brj-24403	322	3	,	,	PUNCT
brj-24403	322	4	w.	w.	PROPN
brj-24403	322	5	a.	a.	PROPN
brj-24403	322	6	(	(	PUNCT
brj-24403	322	7	2014	2014	NUM
brj-24403	322	8	)	)	PUNCT
brj-24403	322	9	.	.	PUNCT
brj-24403	323	1	“	"	PUNCT
brj-24403	323	2	sodium	sodium	NOUN
brj-24403	323	3	channels	channel	NOUN
brj-24403	323	4	,	,	PUNCT
brj-24403	323	5	inherited	inherit	VERB
brj-24403	323	6	epilepsy	epilepsy	NOUN
brj-24403	323	7	,	,	PUNCT
brj-24403	323	8	and	and	CCONJ
brj-24403	323	9	antiepileptic	antiepileptic	ADJ
brj-24403	323	10	drugs	drug	NOUN
brj-24403	323	11	,	,	PUNCT
brj-24403	323	12	”	"	PUNCT
brj-24403	323	13	annual	annual	ADJ
brj-24403	323	14	review	review	NOUN
brj-24403	323	15	of	of	ADP
brj-24403	323	16	pharmacology	pharmacology	NOUN
brj-24403	323	17	and	and	CCONJ
brj-24403	323	18	toxicology	toxicology	NOUN
brj-24403	323	19	54	54	NUM
brj-24403	323	20	,	,	PUNCT
brj-24403	323	21	317	317	NUM
brj-24403	323	22	-	-	SYM
brj-24403	323	23	338	338	NUM
brj-24403	323	24	.	.	PUNCT
brj-24403	324	1	doi	doi	NOUN
brj-24403	324	2	:	:	PUNCT
brj-24403	324	3	10.1146	10.1146	NUM
brj-24403	324	4	/	/	SYM
brj-24403	324	5	annurev	annurev	ADJ
brj-24403	324	6	-	-	ADJ
brj-24403	324	7	pharmtox-011112	pharmtox-011112	ADJ
brj-24403	324	8	-	-	PUNCT
brj-24403	324	9	140232	140232	NUM
brj-24403	324	10	cavalheiro	cavalheiro	NOUN
brj-24403	324	11	,	,	PUNCT
brj-24403	324	12	e.	e.	PROPN
brj-24403	324	13	a.	a.	PROPN
brj-24403	324	14	,	,	PUNCT
brj-24403	324	15	turski	turski	PROPN
brj-24403	324	16	,	,	PUNCT
brj-24403	324	17	w.	w.	PROPN
brj-24403	324	18	a.	a.	PROPN
brj-24403	324	19	,	,	PUNCT
brj-24403	324	20	bortolotto	bortolotto	PROPN
brj-24403	324	21	,	,	PUNCT
brj-24403	324	22	z.	z.	PROPN
brj-24403	324	23	a.	a.	PROPN
brj-24403	324	24	,	,	PUNCT
brj-24403	324	25	and	and	CCONJ
brj-24403	324	26	mello	mello	PROPN
brj-24403	324	27	,	,	PUNCT
brj-24403	324	28	l.	l.	PROPN
brj-24403	324	29	g.	g.	PROPN
brj-24403	324	30	(	(	PUNCT
brj-24403	324	31	1987	1987	NUM
brj-24403	324	32	)	)	PUNCT
brj-24403	324	33	.	.	PUNCT
brj-24403	325	1	“	"	PUNCT
brj-24403	325	2	status	status	NOUN
brj-24403	325	3	epilepticus	epilepticus	NOUN
brj-24403	325	4	induced	induce	VERB
brj-24403	325	5	by	by	ADP
brj-24403	325	6	pilocarpine	pilocarpine	NOUN
brj-24403	325	7	in	in	ADP
brj-24403	325	8	laboratory	laboratory	NOUN
brj-24403	325	9	animals	animal	NOUN
brj-24403	325	10	:	:	PUNCT
brj-24403	325	11	a	a	DET
brj-24403	325	12	clinical	clinical	ADJ
brj-24403	325	13	model	model	NOUN
brj-24403	325	14	of	of	ADP
brj-24403	325	15	epilepsy	epilepsy	NOUN
brj-24403	325	16	,	,	PUNCT
brj-24403	325	17	”	"	PUNCT
brj-24403	325	18	epilepsia	epilepsia	NOUN
brj-24403	325	19	28	28	NUM
brj-24403	325	20	,	,	PUNCT
brj-24403	325	21	31	31	NUM
brj-24403	325	22	-	-	SYM
brj-24403	325	23	37	37	NUM
brj-24403	325	24	.	.	PUNCT
brj-24403	326	1	doi	doi	NOUN
brj-24403	326	2	:	:	PUNCT
brj-24403	326	3	10.1111	10.1111	NUM
brj-24403	326	4	/	/	SYM
brj-24403	326	5	j.1528	j.1528	X
brj-24403	326	6	-	-	PUNCT
brj-24403	326	7	1157.1987.tb03935.x	1157.1987.tb03935.x	NUM
brj-24403	326	8	.	.	PUNCT
brj-24403	327	1	cengiz	cengiz	PROPN
brj-24403	327	2	,	,	PUNCT
brj-24403	327	3	d.	d.	PROPN
brj-24403	327	4	u.	u.	PROPN
brj-24403	327	5	,	,	PUNCT
brj-24403	327	6	çolak	çolak	PROPN
brj-24403	327	7	,	,	PUNCT
brj-24403	327	8	s.	s.	PROPN
brj-24403	327	9	c.	c.	PROPN
brj-24403	327	10	,	,	PUNCT
brj-24403	327	11	özdemir	özdemir	NOUN
brj-24403	327	12	,	,	PUNCT
brj-24403	327	13	e.	e.	PROPN
brj-24403	327	14	a.	a.	PROPN
brj-24403	327	15	,	,	PUNCT
brj-24403	327	16	and	and	CCONJ
brj-24403	327	17	adıgüzel	adıgüzel	ADJ
brj-24403	327	18	,	,	PUNCT
brj-24403	327	19	a.	a.	NOUN
brj-24403	327	20	(	(	PUNCT
brj-24403	327	21	2024	2024	NUM
brj-24403	327	22	)	)	PUNCT
brj-24403	327	23	.	.	PUNCT
brj-24403	328	1	“	"	PUNCT
brj-24403	328	2	effects	effect	NOUN
brj-24403	328	3	of	of	ADP
brj-24403	328	4	valproic	valproic	ADJ
brj-24403	328	5	acid	acid	NOUN
brj-24403	328	6	and	and	CCONJ
brj-24403	328	7	levetiracetam	levetiracetam	NOUN
brj-24403	328	8	monotherapy	monotherapy	NOUN
brj-24403	328	9	on	on	ADP
brj-24403	328	10	balance	balance	NOUN
brj-24403	328	11	functions	function	NOUN
brj-24403	328	12	in	in	ADP
brj-24403	328	13	patients	patient	NOUN
brj-24403	328	14	with	with	ADP
brj-24403	328	15	generalized	generalized	ADJ
brj-24403	328	16	epilepsy	epilepsy	NOUN
brj-24403	328	17	,	,	PUNCT
brj-24403	328	18	”	"	PUNCT
brj-24403	328	19	epilepsy	epilepsy	NOUN
brj-24403	328	20	and	and	CCONJ
brj-24403	328	21	behavior	behavior	NOUN
brj-24403	328	22	151	151	NUM
brj-24403	328	23	,	,	PUNCT
brj-24403	328	24	article	article	NOUN
brj-24403	328	25	109622	109622	NUM
brj-24403	328	26	.	.	PUNCT
brj-24403	329	1	doi	doi	NOUN
brj-24403	329	2	:	:	PUNCT
brj-24403	329	3	10.1016	10.1016	NUM
brj-24403	329	4	/	/	SYM
brj-24403	329	5	j.yebeh.2024.109622	j.yebeh.2024.109622	PROPN
brj-24403	329	6	chen	chen	PROPN
brj-24403	329	7	,	,	PUNCT
brj-24403	329	8	j.	j.	PROPN
brj-24403	329	9	w.	w.	PROPN
brj-24403	329	10	(	(	PUNCT
brj-24403	329	11	2006	2006	NUM
brj-24403	329	12	)	)	PUNCT
brj-24403	329	13	.	.	PUNCT
brj-24403	330	1	“	"	PUNCT
brj-24403	330	2	dopaminergic	dopaminergic	ADJ
brj-24403	330	3	mechanisms	mechanism	NOUN
brj-24403	330	4	of	of	ADP
brj-24403	330	5	epileptogenesis	epileptogenesis	NOUN
brj-24403	330	6	,	,	PUNCT
brj-24403	330	7	”	"	PUNCT
brj-24403	330	8	acta	acta	PROPN
brj-24403	330	9	neurologica	neurologica	PROPN
brj-24403	330	10	taiwanica	taiwanica	PROPN
brj-24403	330	11	15(4	15(4	NUM
brj-24403	330	12	)	)	PUNCT
brj-24403	330	13	,	,	PUNCT
brj-24403	330	14	185	185	NUM
brj-24403	330	15	-	-	SYM
brj-24403	330	16	190	190	NUM
brj-24403	330	17	.	.	PUNCT
brj-24403	331	1	chen	chen	PROPN
brj-24403	331	2	,	,	PUNCT
brj-24403	331	3	s.	s.	PROPN
brj-24403	331	4	c.	c.	PROPN
brj-24403	331	5	(	(	PUNCT
brj-24403	331	6	2006	2006	NUM
brj-24403	331	7	)	)	PUNCT
brj-24403	331	8	.	.	PUNCT
brj-24403	332	1	“	"	PUNCT
brj-24403	332	2	epilepsy	epilepsy	NOUN
brj-24403	332	3	and	and	CCONJ
brj-24403	332	4	migraine	migraine	NOUN
brj-24403	332	5	:	:	PUNCT
brj-24403	332	6	the	the	DET
brj-24403	332	7	dopamine	dopamine	NOUN
brj-24403	332	8	hypotheses	hypothesis	NOUN
brj-24403	332	9	,	,	PUNCT
brj-24403	332	10	”	"	PUNCT
brj-24403	332	11	medical	medical	ADJ
brj-24403	332	12	hypotheses	hypothesis	NOUN
brj-24403	332	13	66(3	66(3	NOUN
brj-24403	332	14	)	)	PUNCT
brj-24403	332	15	,	,	PUNCT
brj-24403	332	16	466	466	NUM
brj-24403	332	17	-	-	SYM
brj-24403	332	18	472	472	NUM
brj-24403	332	19	.	.	PUNCT
brj-24403	333	1	doi	doi	NOUN
brj-24403	333	2	:	:	PUNCT
brj-24403	333	3	10.1016	10.1016	NUM
brj-24403	333	4	/	/	SYM
brj-24403	333	5	j.mehy.2005.09.045	j.mehy.2005.09.045	PROPN
brj-24403	333	6	chen	chen	PROPN
brj-24403	333	7	,	,	PUNCT
brj-24403	333	8	x.	x.	NOUN
brj-24403	333	9	,	,	PUNCT
brj-24403	333	10	song	song	NOUN
brj-24403	333	11	,	,	PUNCT
brj-24403	333	12	w.	w.	PROPN
brj-24403	333	13	,	,	PUNCT
brj-24403	333	14	zhou	zhou	PROPN
brj-24403	333	15	,	,	PUNCT
brj-24403	333	16	q.	q.	PROPN
brj-24403	333	17	,	,	PUNCT
brj-24403	333	18	song	song	NOUN
brj-24403	333	19	,	,	PUNCT
brj-24403	333	20	q.	q.	PROPN
brj-24403	333	21	,	,	PUNCT
brj-24403	333	22	zou	zou	PROPN
brj-24403	333	23	,	,	PUNCT
brj-24403	333	24	z.	z.	PROPN
brj-24403	333	25	,	,	PUNCT
brj-24403	333	26	liu	liu	PROPN
brj-24403	333	27	,	,	PUNCT
brj-24403	333	28	l.	l.	PROPN
brj-24403	333	29	,	,	PUNCT
brj-24403	333	30	hu	hu	PROPN
brj-24403	333	31	,	,	PUNCT
brj-24403	333	32	l.	l.	PROPN
brj-24403	333	33	,	,	PUNCT
brj-24403	333	34	wei	wei	PROPN
brj-24403	333	35	,	,	PUNCT
brj-24403	333	36	q.	q.	PROPN
brj-24403	333	37	,	,	PUNCT
brj-24403	333	38	yan	yan	PROPN
brj-24403	333	39	,	,	PUNCT
brj-24403	333	40	j.	j.	PROPN
brj-24403	333	41	,	,	PUNCT
brj-24403	333	42	and	and	CCONJ
brj-24403	333	43	ahemaiti	ahemaiti	NOUN
brj-24403	333	44	,	,	PUNCT
brj-24403	333	45	d.	d.	PROPN
brj-24403	333	46	(	(	PUNCT
brj-24403	333	47	2020	2020	NUM
brj-24403	333	48	)	)	PUNCT
brj-24403	333	49	.	.	PUNCT
brj-24403	334	1	“	"	PUNCT
brj-24403	334	2	effects	effect	NOUN
brj-24403	334	3	of	of	ADP
brj-24403	334	4	callicarpa	callicarpa	ADJ
brj-24403	334	5	kwangtungensis	kwangtungensis	NOUN
brj-24403	334	6	chun	chun	PROPN
brj-24403	334	7	.	.	PUNCT
brj-24403	335	1	extract	extract	VERB
brj-24403	335	2	on	on	ADP
brj-24403	335	3	reproductive	reproductive	ADJ
brj-24403	335	4	performance	performance	NOUN
brj-24403	335	5	,	,	PUNCT
brj-24403	335	6	immune	immune	ADJ
brj-24403	335	7	function	function	NOUN
brj-24403	335	8	,	,	PUNCT
brj-24403	335	9	antioxidant	antioxidant	ADJ
brj-24403	335	10	capacity	capacity	NOUN
brj-24403	335	11	and	and	CCONJ
brj-24403	335	12	intestinal	intestinal	ADJ
brj-24403	335	13	flora	flora	NOUN
brj-24403	335	14	of	of	ADP
brj-24403	335	15	sows	sow	NOUN
brj-24403	335	16	,	,	PUNCT
brj-24403	335	17	”	"	PUNCT
brj-24403	335	18	zhejiang	zhejiang	PROPN
brj-24403	335	19	daxue	daxue	PROPN
brj-24403	335	20	xuebao	xuebao	PROPN
brj-24403	336	1	(	(	PUNCT
brj-24403	336	2	nongye	nongye	PROPN
brj-24403	336	3	yu	yu	PROPN
brj-24403	336	4	shengming	shengme	VERB
brj-24403	336	5	kexue	kexue	PROPN
brj-24403	336	6	ban)/journal	ban)/journal	ADJ
brj-24403	336	7	of	of	ADP
brj-24403	336	8	the	the	DET
brj-24403	336	9	zhejiang	zhejiang	PROPN
brj-24403	336	10	university	university	PROPN
brj-24403	336	11	agriculture	agriculture	NOUN
brj-24403	336	12	and	and	CCONJ
brj-24403	336	13	life	life	NOUN
brj-24403	336	14	science	science	NOUN
brj-24403	336	15	46(3	46(3	PROPN
brj-24403	336	16	)	)	PUNCT
brj-24403	336	17	.	.	PUNCT
brj-24403	337	1	doi	doi	NOUN
brj-24403	337	2	:	:	PUNCT
brj-24403	337	3	10.3785	10.3785	NUM
brj-24403	337	4	/	/	SYM
brj-24403	337	5	j.issn.10089209.2019.06.210	j.issn.10089209.2019.06.210	NOUN
brj-24403	337	6	copmans	copman	NOUN
brj-24403	337	7	,	,	PUNCT
brj-24403	337	8	d.	d.	PROPN
brj-24403	337	9	,	,	PUNCT
brj-24403	337	10	kildgaard	kildgaard	PROPN
brj-24403	337	11	,	,	PUNCT
brj-24403	337	12	s.	s.	PROPN
brj-24403	337	13	,	,	PUNCT
brj-24403	337	14	rasmussen	rasmussen	PROPN
brj-24403	337	15	,	,	PUNCT
brj-24403	337	16	s.	s.	PROPN
brj-24403	337	17	a.	a.	PROPN
brj-24403	337	18	,	,	PUNCT
brj-24403	337	19	ślezak	ślezak	ADV
brj-24403	337	20	,	,	PUNCT
brj-24403	337	21	m.	m.	NOUN
brj-24403	337	22	,	,	PUNCT
brj-24403	337	23	dirkx	dirkx	PROPN
brj-24403	337	24	,	,	PUNCT
brj-24403	337	25	n.	n.	NOUN
brj-24403	337	26	,	,	PUNCT
brj-24403	337	27	partoens	partoen	NOUN
brj-24403	337	28	,	,	PUNCT
brj-24403	337	29	m.	m.	NOUN
brj-24403	337	30	,	,	PUNCT
brj-24403	337	31	esguerra	esguerra	PROPN
brj-24403	337	32	,	,	PUNCT
brj-24403	337	33	c.	c.	PROPN
brj-24403	337	34	v.	v.	PROPN
brj-24403	337	35	,	,	PUNCT
brj-24403	337	36	crawford	crawford	PROPN
brj-24403	337	37	,	,	PUNCT
brj-24403	337	38	a.	a.	PROPN
brj-24403	337	39	d.	d.	PROPN
brj-24403	337	40	,	,	PUNCT
brj-24403	337	41	larsen	larsen	PROPN
brj-24403	337	42	,	,	PUNCT
brj-24403	337	43	t.	t.	PROPN
brj-24403	337	44	o.	o.	PROPN
brj-24403	337	45	,	,	PUNCT
brj-24403	337	46	and	and	CCONJ
brj-24403	337	47	de	de	X
brj-24403	337	48	witte	witte	NOUN
brj-24403	337	49	,	,	PUNCT
brj-24403	337	50	p.	p.	NOUN
brj-24403	337	51	a.	a.	NOUN
brj-24403	337	52	m.	m.	NOUN
brj-24403	337	53	(	(	PUNCT
brj-24403	337	54	2019	2019	NUM
brj-24403	337	55	)	)	PUNCT
brj-24403	337	56	.	.	PUNCT
brj-24403	338	1	“	"	PUNCT
brj-24403	338	2	zebrafish	zebrafish	ADJ
brj-24403	338	3	-	-	PUNCT
brj-24403	338	4	based	base	VERB
brj-24403	338	5	discovery	discovery	NOUN
brj-24403	338	6	of	of	ADP
brj-24403	338	7	antiseizure	antiseizure	NOUN
brj-24403	338	8	compounds	compound	VERB
brj-24403	338	9	from	from	ADP
brj-24403	338	10	the	the	DET
brj-24403	338	11	north	north	PROPN
brj-24403	338	12	sea	sea	PROPN
brj-24403	338	13	:	:	PUNCT
brj-24403	338	14	isoquinoline	isoquinoline	ADJ
brj-24403	338	15	alkaloids	alkaloid	NOUN
brj-24403	338	16	tmc-120a	tmc-120a	NOUN
brj-24403	338	17	and	and	CCONJ
brj-24403	338	18	tmc-120b	tmc-120b	PROPN
brj-24403	338	19	,	,	PUNCT
brj-24403	338	20	”	"	PUNCT
brj-24403	338	21	marine	marine	ADJ
brj-24403	338	22	drugs	drug	NOUN
brj-24403	338	23	17(11	17(11	NUM
brj-24403	338	24	)	)	PUNCT
brj-24403	338	25	,	,	PUNCT
brj-24403	338	26	article	article	NOUN
brj-24403	338	27	607	607	NUM
brj-24403	338	28	.	.	PUNCT
brj-24403	339	1	doi	doi	NOUN
brj-24403	339	2	:	:	PUNCT
brj-24403	339	3	10.3390	10.3390	NUM
brj-24403	339	4	/	/	SYM
brj-24403	339	5	md17110607	md17110607	ADJ
brj-24403	339	6	cragg	cragg	PROPN
brj-24403	339	7	,	,	PUNCT
brj-24403	339	8	g.	g.	PROPN
brj-24403	339	9	m.	m.	PROPN
brj-24403	339	10	,	,	PUNCT
brj-24403	339	11	newman	newman	PROPN
brj-24403	339	12	,	,	PUNCT
brj-24403	339	13	d.	d.	PROPN
brj-24403	339	14	j.	j.	PROPN
brj-24403	339	15	,	,	PUNCT
brj-24403	339	16	and	and	CCONJ
brj-24403	339	17	snader	snader	NOUN
brj-24403	339	18	,	,	PUNCT
brj-24403	339	19	k.	k.	PROPN
brj-24403	339	20	m.	m.	PROPN
brj-24403	339	21	(	(	PUNCT
brj-24403	339	22	1997	1997	NUM
brj-24403	339	23	)	)	PUNCT
brj-24403	339	24	.	.	PUNCT
brj-24403	340	1	“	"	PUNCT
brj-24403	340	2	natural	natural	ADJ
brj-24403	340	3	products	product	NOUN
brj-24403	340	4	in	in	ADP
brj-24403	340	5	drug	drug	NOUN
brj-24403	340	6	discovery	discovery	NOUN
brj-24403	340	7	and	and	CCONJ
brj-24403	340	8	development	development	NOUN
brj-24403	340	9	,	,	PUNCT
brj-24403	340	10	”	"	PUNCT
brj-24403	340	11	journal	journal	NOUN
brj-24403	340	12	of	of	ADP
brj-24403	340	13	natural	natural	ADJ
brj-24403	340	14	products	product	NOUN
brj-24403	340	15	60(1	60(1	NUM
brj-24403	340	16	)	)	PUNCT
brj-24403	340	17	,	,	PUNCT
brj-24403	340	18	52	52	NUM
brj-24403	340	19	-	-	SYM
brj-24403	340	20	60	60	NUM
brj-24403	340	21	.	.	PUNCT
brj-24403	341	1	doi	doi	NOUN
brj-24403	341	2	:	:	PUNCT
brj-24403	341	3	10.1021	10.1021	NUM
brj-24403	341	4	/	/	SYM
brj-24403	341	5	np9604893	np9604893	PROPN
brj-24403	341	6	de	de	X
brj-24403	341	7	boer	boer	PROPN
brj-24403	341	8	,	,	PUNCT
brj-24403	341	9	h.	h.	PROPN
brj-24403	341	10	m.	m.	PROPN
brj-24403	341	11	,	,	PUNCT
brj-24403	341	12	mula	mula	PROPN
brj-24403	341	13	,	,	PUNCT
brj-24403	341	14	m.	m.	NOUN
brj-24403	341	15	,	,	PUNCT
brj-24403	341	16	and	and	CCONJ
brj-24403	341	17	sander	sander	NOUN
brj-24403	341	18	,	,	PUNCT
brj-24403	341	19	j.	j.	PROPN
brj-24403	341	20	w.	w.	PROPN
brj-24403	341	21	(	(	PUNCT
brj-24403	341	22	2008	2008	NUM
brj-24403	341	23	)	)	PUNCT
brj-24403	341	24	.	.	PUNCT
brj-24403	342	1	“	"	PUNCT
brj-24403	342	2	the	the	DET
brj-24403	342	3	global	global	ADJ
brj-24403	342	4	burden	burden	NOUN
brj-24403	342	5	and	and	CCONJ
brj-24403	342	6	stigma	stigma	NOUN
brj-24403	342	7	of	of	ADP
brj-24403	342	8	epilepsy	epilepsy	NOUN
brj-24403	342	9	,	,	PUNCT
brj-24403	342	10	”	"	PUNCT
brj-24403	342	11	epilepsy	epilepsy	NOUN
brj-24403	342	12	and	and	CCONJ
brj-24403	342	13	behavior	behavior	NOUN
brj-24403	342	14	12(4	12(4	NUM
brj-24403	342	15	)	)	PUNCT
brj-24403	342	16	,	,	PUNCT
brj-24403	342	17	540	540	NUM
brj-24403	342	18	-	-	SYM
brj-24403	342	19	546	546	NUM
brj-24403	342	20	.	.	PUNCT
brj-24403	343	1	doi	doi	NOUN
brj-24403	343	2	:	:	PUNCT
brj-24403	343	3	10.1016	10.1016	NUM
brj-24403	343	4	/	/	SYM
brj-24403	343	5	j.yebeh.2007.12.019	j.yebeh.2007.12.019	X
brj-24403	343	6	during	during	ADP
brj-24403	343	7	,	,	PUNCT
brj-24403	343	8	m.	m.	NOUN
brj-24403	343	9	j.	j.	PROPN
brj-24403	343	10	,	,	PUNCT
brj-24403	343	11	and	and	CCONJ
brj-24403	343	12	spencer	spencer	PROPN
brj-24403	343	13	,	,	PUNCT
brj-24403	343	14	d.	d.	PROPN
brj-24403	343	15	d.	d.	PROPN
brj-24403	343	16	(	(	PUNCT
brj-24403	343	17	1993	1993	NUM
brj-24403	343	18	)	)	PUNCT
brj-24403	343	19	.	.	PUNCT
brj-24403	344	1	“	"	PUNCT
brj-24403	344	2	extracellular	extracellular	ADJ
brj-24403	344	3	hippocampal	hippocampal	ADJ
brj-24403	344	4	glutamate	glutamate	NOUN
brj-24403	344	5	and	and	CCONJ
brj-24403	344	6	spontaneous	spontaneous	ADJ
brj-24403	344	7	seizure	seizure	NOUN
brj-24403	344	8	in	in	ADP
brj-24403	344	9	the	the	DET
brj-24403	344	10	conscious	conscious	ADJ
brj-24403	344	11	human	human	ADJ
brj-24403	344	12	brain	brain	NOUN
brj-24403	344	13	,	,	PUNCT
brj-24403	344	14	”	"	PUNCT
brj-24403	344	15	the	the	DET
brj-24403	344	16	lancet	lancet	PROPN
brj-24403	344	17	341(8861	341(8861	PROPN
brj-24403	344	18	)	)	PUNCT
brj-24403	344	19	16071610	16071610	NUM
brj-24403	344	20	.	.	PUNCT
brj-24403	345	1	doi	doi	NOUN
brj-24403	345	2	:	:	PUNCT
brj-24403	345	3	10.1016/0140	10.1016/0140	NUM
brj-24403	345	4	-	-	PUNCT
brj-24403	345	5	6736(93)90754	6736(93)90754	NUM
brj-24403	345	6	-	-	SYM
brj-24403	345	7	5	5	NUM
brj-24403	345	8	engelborghs	engelborgh	NOUN
brj-24403	345	9	,	,	PUNCT
brj-24403	345	10	s.	s.	PROPN
brj-24403	345	11	,	,	PUNCT
brj-24403	345	12	d’hooge	d’hooge	PROPN
brj-24403	345	13	,	,	PUNCT
brj-24403	345	14	r.	r.	PROPN
brj-24403	345	15	,	,	PUNCT
brj-24403	345	16	and	and	CCONJ
brj-24403	345	17	de	de	X
brj-24403	345	18	deyn	deyn	NOUN
brj-24403	345	19	,	,	PUNCT
brj-24403	345	20	p.	p.	NOUN
brj-24403	345	21	p.	p.	NOUN
brj-24403	346	1	(	(	PUNCT
brj-24403	346	2	2000	2000	NUM
brj-24403	346	3	)	)	PUNCT
brj-24403	346	4	.	.	PUNCT
brj-24403	347	1	“	"	PUNCT
brj-24403	347	2	pathophysiology	pathophysiology	NOUN
brj-24403	347	3	of	of	ADP
brj-24403	347	4	epilepsy	epilepsy	NOUN
brj-24403	347	5	,	,	PUNCT
brj-24403	347	6	”	"	PUNCT
brj-24403	347	7	acta	acta	PROPN
brj-24403	347	8	neurol	neurol	PROPN
brj-24403	347	9	.	.	PUNCT
brj-24403	348	1	belg	belg	PROPN
brj-24403	348	2	.	.	PUNCT
brj-24403	349	1	100	100	NUM
brj-24403	349	2	,	,	PUNCT
brj-24403	349	3	201	201	NUM
brj-24403	349	4	-	-	SYM
brj-24403	349	5	213	213	NUM
brj-24403	349	6	.	.	PUNCT
brj-24403	350	1	doi	doi	NOUN
brj-24403	350	2	:	:	PUNCT
brj-24403	350	3	10.1016/0013	10.1016/0013	NUM
brj-24403	350	4	-	-	SYM
brj-24403	350	5	4694(90)92089	4694(90)92089	NOUN
brj-24403	350	6	-	-	PUNCT
brj-24403	350	7	f	f	PROPN
brj-24403	350	8	fisher	fisher	PROPN
brj-24403	350	9	,	,	PUNCT
brj-24403	350	10	r.	r.	PROPN
brj-24403	350	11	s.	s.	PROPN
brj-24403	350	12	,	,	PUNCT
brj-24403	350	13	van	van	PROPN
brj-24403	350	14	emde	emde	NOUN
brj-24403	350	15	boas	boa	NOUN
brj-24403	350	16	,	,	PUNCT
brj-24403	350	17	w.	w.	PROPN
brj-24403	350	18	,	,	PUNCT
brj-24403	350	19	blume	blume	PROPN
brj-24403	350	20	,	,	PUNCT
brj-24403	350	21	w.	w.	PROPN
brj-24403	350	22	,	,	PUNCT
brj-24403	350	23	elger	elger	PROPN
brj-24403	350	24	,	,	PUNCT
brj-24403	350	25	c.	c.	PROPN
brj-24403	350	26	,	,	PUNCT
brj-24403	350	27	genton	genton	NOUN
brj-24403	350	28	,	,	PUNCT
brj-24403	350	29	p.	p.	PROPN
brj-24403	350	30	,	,	PUNCT
brj-24403	350	31	lee	lee	PROPN
brj-24403	350	32	,	,	PUNCT
brj-24403	350	33	p.	p.	PROPN
brj-24403	350	34	,	,	PUNCT
brj-24403	350	35	and	and	CCONJ
brj-24403	350	36	engel	engel	PROPN
brj-24403	350	37	,	,	PUNCT
brj-24403	350	38	j.	j.	PROPN
brj-24403	350	39	(	(	PUNCT
brj-24403	350	40	2005	2005	NUM
brj-24403	350	41	)	)	PUNCT
brj-24403	350	42	.	.	PUNCT
brj-24403	351	1	“	"	PUNCT
brj-24403	351	2	epileptic	epileptic	ADJ
brj-24403	351	3	seizures	seizure	NOUN
brj-24403	351	4	and	and	CCONJ
brj-24403	351	5	epilepsy	epilepsy	NOUN
brj-24403	351	6	:	:	PUNCT
brj-24403	351	7	definitions	definition	NOUN
brj-24403	351	8	proposed	propose	VERB
brj-24403	351	9	by	by	ADP
brj-24403	351	10	the	the	DET
brj-24403	351	11	international	international	PROPN
brj-24403	351	12	league	league	PROPN
brj-24403	351	13	against	against	ADP
brj-24403	351	14	epilepsy	epilepsy	NOUN
brj-24403	351	15	(	(	PUNCT
brj-24403	351	16	ilae	ilae	NOUN
brj-24403	351	17	)	)	PUNCT
brj-24403	351	18	and	and	CCONJ
brj-24403	351	19	the	the	DET
brj-24403	351	20	international	international	ADJ
brj-24403	351	21	bureau	bureau	NOUN
brj-24403	351	22	for	for	ADP
brj-24403	351	23	epilepsy	epilepsy	PROPN
brj-24403	351	24	(	(	PUNCT
brj-24403	351	25	ibe	ibe	PROPN
brj-24403	351	26	)	)	PUNCT
brj-24403	351	27	,	,	PUNCT
brj-24403	351	28	”	"	PUNCT
brj-24403	351	29	epilepsia	epilepsia	PROPN
brj-24403	351	30	46(4	46(4	NOUN
brj-24403	351	31	)	)	PUNCT
brj-24403	351	32	,	,	PUNCT
brj-24403	351	33	470	470	NUM
brj-24403	351	34	-	-	SYM
brj-24403	351	35	472	472	NUM
brj-24403	351	36	.	.	PUNCT
brj-24403	352	1	doi	doi	NOUN
brj-24403	352	2	:	:	PUNCT
brj-24403	352	3	10.1111	10.1111	NUM
brj-24403	352	4	/	/	SYM
brj-24403	352	5	j.0013	j.0013	PROPN
brj-24403	352	6	-	-	PUNCT
brj-24403	352	7	9580.2005.66104.x	9580.2005.66104.x	NUM
brj-24403	352	8	ghosh	ghosh	PROPN
brj-24403	352	9	,	,	PUNCT
brj-24403	352	10	c.	c.	PROPN
brj-24403	352	11	,	,	PUNCT
brj-24403	352	12	hossain	hossain	PROPN
brj-24403	352	13	,	,	PUNCT
brj-24403	352	14	m.	m.	NOUN
brj-24403	352	15	,	,	PUNCT
brj-24403	352	16	solanki	solanki	PROPN
brj-24403	352	17	,	,	PUNCT
brj-24403	352	18	j.	j.	PROPN
brj-24403	352	19	,	,	PUNCT
brj-24403	352	20	dadas	dadas	PROPN
brj-24403	352	21	,	,	PUNCT
brj-24403	352	22	a.	a.	NOUN
brj-24403	352	23	,	,	PUNCT
brj-24403	352	24	marchi	marchi	PROPN
brj-24403	352	25	,	,	PUNCT
brj-24403	352	26	n.	n.	NOUN
brj-24403	352	27	,	,	PUNCT
brj-24403	352	28	and	and	CCONJ
brj-24403	352	29	janigro	janigro	PROPN
brj-24403	352	30	,	,	PUNCT
brj-24403	352	31	d.	d.	PROPN
brj-24403	352	32	(	(	PUNCT
brj-24403	352	33	2014	2014	NUM
brj-24403	352	34	)	)	PUNCT
brj-24403	352	35	.	.	PUNCT
brj-24403	353	1	“	"	PUNCT
brj-24403	353	2	pathophysiological	pathophysiological	ADJ
brj-24403	353	3	mechanisms	mechanism	NOUN
brj-24403	353	4	of	of	ADP
brj-24403	353	5	blood	blood	NOUN
brj-24403	353	6	–	–	PUNCT
brj-24403	353	7	brain	brain	NOUN
brj-24403	353	8	barrier	barrier	NOUN
brj-24403	353	9	disruption	disruption	NOUN
brj-24403	353	10	in	in	ADP
brj-24403	353	11	epilepsy	epilepsy	NOUN
brj-24403	353	12	,	,	PUNCT
brj-24403	353	13	”	"	PUNCT
brj-24403	353	14	epilepsia	epilepsia	NOUN
brj-24403	353	15	55(6	55(6	NUM
brj-24403	353	16	)	)	PUNCT
brj-24403	353	17	,	,	PUNCT
brj-24403	353	18	876	876	NUM
brj-24403	353	19	-	-	SYM
brj-24403	353	20	886	886	NUM
brj-24403	353	21	.	.	PUNCT
brj-24403	354	1	doi	doi	NOUN
brj-24403	354	2	:	:	PUNCT
brj-24403	354	3	10.1111	10.1111	NUM
brj-24403	354	4	/	/	SYM
brj-24403	354	5	epi.12620	epi.12620	PROPN
brj-24403	354	6	gluck	gluck	NOUN
brj-24403	354	7	,	,	PUNCT
brj-24403	354	8	m.	m.	PROPN
brj-24403	354	9	r.	r.	PROPN
brj-24403	354	10	,	,	PUNCT
brj-24403	354	11	jayatilleke	jayatilleke	PROPN
brj-24403	354	12	,	,	PUNCT
brj-24403	354	13	e.	e.	PROPN
brj-24403	354	14	,	,	PUNCT
brj-24403	354	15	shaw	shaw	PROPN
brj-24403	354	16	,	,	PUNCT
brj-24403	354	17	s.	s.	PROPN
brj-24403	354	18	,	,	PUNCT
brj-24403	354	19	rowan	rowan	PROPN
brj-24403	354	20	,	,	PUNCT
brj-24403	354	21	a.	a.	PROPN
brj-24403	354	22	j.	j.	PROPN
brj-24403	354	23	,	,	PUNCT
brj-24403	354	24	and	and	CCONJ
brj-24403	354	25	haroutunian	haroutunian	ADJ
brj-24403	354	26	,	,	PUNCT
brj-24403	354	27	v.	v.	PROPN
brj-24403	354	28	(	(	PUNCT
brj-24403	354	29	2000	2000	NUM
brj-24403	354	30	)	)	PUNCT
brj-24403	354	31	.	.	PUNCT
brj-24403	355	1	“	"	PUNCT
brj-24403	355	2	cns	cns	PROPN
brj-24403	355	3	oxidative	oxidative	ADJ
brj-24403	355	4	stress	stress	NOUN
brj-24403	355	5	associated	associate	VERB
brj-24403	355	6	with	with	ADP
brj-24403	355	7	the	the	DET
brj-24403	355	8	kainic	kainic	ADJ
brj-24403	355	9	acid	acid	NOUN
brj-24403	355	10	rodent	rodent	NOUN
brj-24403	355	11	model	model	NOUN
brj-24403	355	12	of	of	ADP
brj-24403	355	13	experimental	experimental	ADJ
brj-24403	355	14	epilepsy	epilepsy	NOUN
brj-24403	355	15	,	,	PUNCT
brj-24403	355	16	”	"	PUNCT
brj-24403	355	17	epilepsy	epilepsy	ADJ
brj-24403	355	18	research	research	NOUN
brj-24403	355	19	39(1	39(1	NUM
brj-24403	355	20	)	)	PUNCT
brj-24403	355	21	.	.	PUNCT
brj-24403	356	1	doi	doi	NOUN
brj-24403	356	2	:	:	PUNCT
brj-24403	356	3	10.1016	10.1016	NUM
brj-24403	356	4	/	/	SYM
brj-24403	356	5	s0920	s0920	NOUN
brj-24403	356	6	-	-	PUNCT
brj-24403	356	7	1211(99)00111	1211(99)00111	NUM
brj-24403	356	8	-	-	SYM
brj-24403	356	9	4	4	NUM
brj-24403	356	10	grone	grone	NOUN
brj-24403	356	11	,	,	PUNCT
brj-24403	356	12	b.	b.	PROPN
brj-24403	356	13	p.	p.	PROPN
brj-24403	356	14	,	,	PUNCT
brj-24403	356	15	and	and	CCONJ
brj-24403	356	16	baraban	baraban	PROPN
brj-24403	356	17	,	,	PUNCT
brj-24403	356	18	s.	s.	PROPN
brj-24403	356	19	c.	c.	PROPN
brj-24403	356	20	(	(	PUNCT
brj-24403	356	21	2015	2015	NUM
brj-24403	356	22	)	)	PUNCT
brj-24403	356	23	.	.	PUNCT
brj-24403	357	1	“	"	PUNCT
brj-24403	357	2	animal	animal	NOUN
brj-24403	357	3	models	model	NOUN
brj-24403	357	4	in	in	ADP
brj-24403	357	5	epilepsy	epilepsy	ADJ
brj-24403	357	6	research	research	NOUN
brj-24403	357	7	:	:	PUNCT
brj-24403	357	8	legacies	legacy	NOUN
brj-24403	357	9	and	and	CCONJ
brj-24403	357	10	new	new	ADJ
brj-24403	357	11	directions	direction	NOUN
brj-24403	357	12	,	,	PUNCT
brj-24403	357	13	”	"	PUNCT
brj-24403	357	14	nature	nature	NOUN
brj-24403	357	15	neuroscience	neuroscience	NOUN
brj-24403	357	16	18(3	18(3	NUM
brj-24403	357	17	)	)	PUNCT
brj-24403	357	18	,	,	PUNCT
brj-24403	357	19	339	339	NUM
brj-24403	357	20	-	-	SYM
brj-24403	357	21	343	343	NUM
brj-24403	357	22	.	.	PUNCT
brj-24403	358	1	doi	doi	NOUN
brj-24403	358	2	:	:	PUNCT
brj-24403	358	3	10.1038	10.1038	NUM
brj-24403	358	4	/	/	SYM
brj-24403	358	5	nn.3934	nn.3934	PROPN
brj-24403	358	6	hamilton	hamilton	PROPN
brj-24403	358	7	,	,	PUNCT
brj-24403	358	8	s.	s.	PROPN
brj-24403	358	9	e.	e.	PROPN
brj-24403	358	10	,	,	PUNCT
brj-24403	358	11	loose	loose	ADJ
brj-24403	358	12	,	,	PUNCT
brj-24403	358	13	m.	m.	PROPN
brj-24403	358	14	d.	d.	PROPN
brj-24403	358	15	,	,	PUNCT
brj-24403	358	16	qi	qi	PROPN
brj-24403	358	17	,	,	PUNCT
brj-24403	358	18	m.	m.	NOUN
brj-24403	358	19	,	,	PUNCT
brj-24403	358	20	levey	levey	PROPN
brj-24403	358	21	,	,	PUNCT
brj-24403	358	22	a.	a.	NOUN
brj-24403	358	23	i.	i.	PROPN
brj-24403	358	24	,	,	PUNCT
brj-24403	358	25	hille	hille	PROPN
brj-24403	358	26	,	,	PUNCT
brj-24403	358	27	b.	b.	PROPN
brj-24403	358	28	,	,	PUNCT
brj-24403	358	29	mcknight	mcknight	PROPN
brj-24403	358	30	,	,	PUNCT
brj-24403	358	31	g.	g.	PROPN
brj-24403	358	32	s.	s.	PROPN
brj-24403	358	33	,	,	PUNCT
brj-24403	358	34	idzerda	idzerda	PROPN
brj-24403	358	35	,	,	PUNCT
brj-24403	358	36	peer	peer	NOUN
brj-24403	358	37	-	-	PUNCT
brj-24403	358	38	reviewed	review	VERB
brj-24403	358	39	article	article	NOUN
brj-24403	358	40	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	358	41	li	li	PROPN
brj-24403	358	42	et	et	PROPN
brj-24403	358	43	al	al	PROPN
brj-24403	358	44	.	.	PROPN
brj-24403	358	45	(	(	PUNCT
brj-24403	358	46	2025	2025	NUM
brj-24403	358	47	)	)	PUNCT
brj-24403	358	48	.	.	PUNCT
brj-24403	359	1	“	"	PUNCT
brj-24403	359	2	herbal	herbal	ADJ
brj-24403	359	3	anti	anti	ADJ
brj-24403	359	4	-	-	ADJ
brj-24403	359	5	epileptic	epileptic	ADJ
brj-24403	359	6	extract	extract	NOUN
brj-24403	359	7	,	,	PUNCT
brj-24403	359	8	”	"	PUNCT
brj-24403	359	9	bioresources	bioresource	NOUN
brj-24403	359	10	20(2	20(2	NUM
brj-24403	359	11	)	)	PUNCT
brj-24403	359	12	,	,	PUNCT
brj-24403	359	13	4701	4701	NUM
brj-24403	359	14	-	-	SYM
brj-24403	359	15	4719	4719	NUM
brj-24403	359	16	.	.	PUNCT
brj-24403	360	1	4716	4716	NUM
brj-24403	360	2	r.	r.	PROPN
brj-24403	360	3	l.	l.	PROPN
brj-24403	360	4	,	,	PUNCT
brj-24403	360	5	and	and	CCONJ
brj-24403	360	6	nathanson	nathanson	PROPN
brj-24403	360	7	,	,	PUNCT
brj-24403	360	8	n.	n.	NOUN
brj-24403	360	9	m.	m.	NOUN
brj-24403	360	10	(	(	PUNCT
brj-24403	360	11	1997	1997	NUM
brj-24403	360	12	)	)	PUNCT
brj-24403	360	13	.	.	PUNCT
brj-24403	361	1	“	"	PUNCT
brj-24403	361	2	disruption	disruption	NOUN
brj-24403	361	3	of	of	ADP
brj-24403	361	4	the	the	DET
brj-24403	361	5	m1	m1	PROPN
brj-24403	361	6	receptor	receptor	NOUN
brj-24403	361	7	gene	gene	NOUN
brj-24403	361	8	ablates	ablate	VERB
brj-24403	361	9	muscarinic	muscarinic	ADJ
brj-24403	361	10	receptor	receptor	NOUN
brj-24403	361	11	-	-	PUNCT
brj-24403	361	12	dependent	dependent	ADJ
brj-24403	361	13	m	m	VERB
brj-24403	361	14	current	current	ADJ
brj-24403	361	15	regulation	regulation	NOUN
brj-24403	361	16	and	and	CCONJ
brj-24403	361	17	seizure	seizure	NOUN
brj-24403	361	18	activity	activity	NOUN
brj-24403	361	19	in	in	ADP
brj-24403	361	20	mice	mouse	NOUN
brj-24403	361	21	,	,	PUNCT
brj-24403	361	22	”	"	PUNCT
brj-24403	361	23	proceedings	proceeding	NOUN
brj-24403	361	24	of	of	ADP
brj-24403	361	25	the	the	DET
brj-24403	361	26	national	national	PROPN
brj-24403	361	27	academy	academy	PROPN
brj-24403	361	28	of	of	ADP
brj-24403	361	29	sciences	sciences	PROPN
brj-24403	361	30	of	of	ADP
brj-24403	361	31	the	the	DET
brj-24403	361	32	united	united	PROPN
brj-24403	361	33	states	states	PROPN
brj-24403	361	34	of	of	ADP
brj-24403	361	35	america	america	PROPN
brj-24403	361	36	94(24	94(24	PROPN
brj-24403	361	37	)	)	PUNCT
brj-24403	361	38	,	,	PUNCT
brj-24403	361	39	article	article	NOUN
brj-24403	361	40	13311	13311	NUM
brj-24403	361	41	.	.	PUNCT
brj-24403	362	1	doi	doi	NOUN
brj-24403	362	2	:	:	PUNCT
brj-24403	362	3	10.1073	10.1073	NUM
brj-24403	362	4	/	/	SYM
brj-24403	362	5	pnas.94.24.13311	pnas.94.24.13311	NOUN
brj-24403	362	6	hassanzadeh	hassanzadeh	NOUN
brj-24403	362	7	,	,	PUNCT
brj-24403	362	8	m.	m.	NOUN
brj-24403	362	9	,	,	PUNCT
brj-24403	362	10	sharifi	sharifi	NOUN
brj-24403	362	11	,	,	PUNCT
brj-24403	362	12	n.	n.	NOUN
brj-24403	362	13	,	,	PUNCT
brj-24403	362	14	mahernia	mahernia	PROPN
brj-24403	362	15	,	,	PUNCT
brj-24403	362	16	s.	s.	PROPN
brj-24403	362	17	,	,	PUNCT
brj-24403	362	18	rahimi	rahimi	NOUN
brj-24403	362	19	,	,	PUNCT
brj-24403	362	20	n.	n.	NOUN
brj-24403	362	21	,	,	PUNCT
brj-24403	362	22	dehpour	dehpour	PROPN
brj-24403	362	23	,	,	PUNCT
brj-24403	362	24	a.	a.	PROPN
brj-24403	362	25	r.	r.	PROPN
brj-24403	362	26	,	,	PUNCT
brj-24403	362	27	and	and	CCONJ
brj-24403	362	28	amanlou	amanlou	ADV
brj-24403	362	29	,	,	PUNCT
brj-24403	362	30	m.	m.	NOUN
brj-24403	362	31	(	(	PUNCT
brj-24403	362	32	2021	2021	NUM
brj-24403	362	33	)	)	PUNCT
brj-24403	362	34	.	.	PUNCT
brj-24403	363	1	“	"	PUNCT
brj-24403	363	2	effects	effect	NOUN
brj-24403	363	3	of	of	ADP
brj-24403	363	4	onopordia	onopordia	NOUN
brj-24403	363	5	,	,	PUNCT
brj-24403	363	6	a	a	DET
brj-24403	363	7	novel	novel	NOUN
brj-24403	363	8	isolated	isolate	VERB
brj-24403	363	9	compound	compound	NOUN
brj-24403	363	10	from	from	ADP
brj-24403	363	11	onopordon	onopordon	ADJ
brj-24403	363	12	acanthium	acanthium	NOUN
brj-24403	363	13	,	,	PUNCT
brj-24403	363	14	on	on	ADP
brj-24403	363	15	pentylenetetrazole	pentylenetetrazole	NOUN
brj-24403	363	16	-	-	PUNCT
brj-24403	363	17	induced	induce	VERB
brj-24403	363	18	seizures	seizure	NOUN
brj-24403	363	19	in	in	ADP
brj-24403	363	20	mice	mouse	NOUN
brj-24403	363	21	:	:	PUNCT
brj-24403	363	22	possible	possible	ADJ
brj-24403	363	23	involvement	involvement	NOUN
brj-24403	363	24	of	of	ADP
brj-24403	363	25	nitric	nitric	ADJ
brj-24403	363	26	oxide	oxide	NOUN
brj-24403	363	27	pathway	pathway	NOUN
brj-24403	363	28	,	,	PUNCT
brj-24403	363	29	”	"	PUNCT
brj-24403	363	30	journal	journal	NOUN
brj-24403	363	31	of	of	ADP
brj-24403	363	32	traditional	traditional	ADJ
brj-24403	363	33	and	and	CCONJ
brj-24403	363	34	complementary	complementary	ADJ
brj-24403	363	35	medicine	medicine	NOUN
brj-24403	363	36	11(1	11(1	NUM
brj-24403	363	37	)	)	PUNCT
brj-24403	363	38	,	,	PUNCT
brj-24403	363	39	article	article	NOUN
brj-24403	363	40	5	5	NUM
brj-24403	363	41	.	.	PUNCT
brj-24403	363	42	doi	doi	NOUN
brj-24403	363	43	:	:	PUNCT
brj-24403	363	44	10.1016	10.1016	NUM
brj-24403	363	45	/	/	SYM
brj-24403	363	46	j.jtcme.2019.11.005	j.jtcme.2019.11.005	PROPN
brj-24403	363	47	he	he	PRON
brj-24403	363	48	,	,	PUNCT
brj-24403	363	49	x.	x.	PROPN
brj-24403	363	50	,	,	PUNCT
brj-24403	363	51	chen	chen	PROPN
brj-24403	363	52	,	,	PUNCT
brj-24403	363	53	x.	x.	PROPN
brj-24403	363	54	,	,	PUNCT
brj-24403	363	55	yang	yang	PROPN
brj-24403	363	56	,	,	PUNCT
brj-24403	363	57	y.	y.	PROPN
brj-24403	363	58	,	,	PUNCT
brj-24403	363	59	xie	xie	PROPN
brj-24403	363	60	,	,	PUNCT
brj-24403	363	61	y.	y.	PROPN
brj-24403	363	62	,	,	PUNCT
brj-24403	363	63	and	and	CCONJ
brj-24403	363	64	liu	liu	PROPN
brj-24403	363	65	,	,	PUNCT
brj-24403	363	66	y.	y.	PROPN
brj-24403	363	67	(	(	PUNCT
brj-24403	363	68	2024	2024	NUM
brj-24403	363	69	)	)	PUNCT
brj-24403	363	70	.	.	PUNCT
brj-24403	364	1	“	"	PUNCT
brj-24403	364	2	medicinal	medicinal	ADJ
brj-24403	364	3	plants	plant	NOUN
brj-24403	364	4	for	for	ADP
brj-24403	364	5	epileptic	epileptic	ADJ
brj-24403	364	6	seizures	seizure	NOUN
brj-24403	364	7	:	:	PUNCT
brj-24403	364	8	phytoconstituents	phytoconstituent	NOUN
brj-24403	364	9	,	,	PUNCT
brj-24403	364	10	pharmacology	pharmacology	NOUN
brj-24403	364	11	and	and	CCONJ
brj-24403	364	12	mechanisms	mechanism	NOUN
brj-24403	364	13	revisited	revisit	VERB
brj-24403	364	14	,	,	PUNCT
brj-24403	364	15	”	"	PUNCT
brj-24403	364	16	journal	journal	NOUN
brj-24403	364	17	of	of	ADP
brj-24403	364	18	ethnopharmacology	ethnopharmacology	NOUN
brj-24403	364	19	320	320	NUM
brj-24403	364	20	,	,	PUNCT
brj-24403	364	21	article	article	NOUN
brj-24403	364	22	117386	117386	NUM
brj-24403	364	23	.	.	PUNCT
brj-24403	365	1	doi	doi	NOUN
brj-24403	365	2	:	:	PUNCT
brj-24403	365	3	10.1016	10.1016	NUM
brj-24403	365	4	/	/	SYM
brj-24403	365	5	j.jep.2023.117386	j.jep.2023.117386	VERB
brj-24403	365	6	howard	howard	PROPN
brj-24403	365	7	,	,	PUNCT
brj-24403	365	8	p.	p.	NOUN
brj-24403	365	9	,	,	PUNCT
brj-24403	365	10	twycross	twycross	PROPN
brj-24403	365	11	,	,	PUNCT
brj-24403	365	12	r.	r.	PROPN
brj-24403	365	13	,	,	PUNCT
brj-24403	365	14	shuster	shuster	PROPN
brj-24403	365	15	,	,	PUNCT
brj-24403	365	16	j.	j.	PROPN
brj-24403	365	17	,	,	PUNCT
brj-24403	365	18	mihalyo	mihalyo	PROPN
brj-24403	365	19	,	,	PUNCT
brj-24403	365	20	m.	m.	NOUN
brj-24403	365	21	,	,	PUNCT
brj-24403	365	22	rémi	rémi	NOUN
brj-24403	365	23	,	,	PUNCT
brj-24403	365	24	j.	j.	PROPN
brj-24403	365	25	,	,	PUNCT
brj-24403	365	26	and	and	CCONJ
brj-24403	365	27	wilcock	wilcock	NOUN
brj-24403	365	28	,	,	PUNCT
brj-24403	365	29	a.	a.	NOUN
brj-24403	365	30	(	(	PUNCT
brj-24403	365	31	2011	2011	NUM
brj-24403	365	32	)	)	PUNCT
brj-24403	365	33	.	.	PUNCT
brj-24403	366	1	“	"	PUNCT
brj-24403	366	2	anti	anti	ADJ
brj-24403	366	3	-	-	ADJ
brj-24403	366	4	epileptic	epileptic	ADJ
brj-24403	366	5	drugs	drug	NOUN
brj-24403	366	6	,	,	PUNCT
brj-24403	366	7	”	"	PUNCT
brj-24403	366	8	journal	journal	NOUN
brj-24403	366	9	of	of	ADP
brj-24403	366	10	pain	pain	NOUN
brj-24403	366	11	and	and	CCONJ
brj-24403	366	12	symptom	symptom	NOUN
brj-24403	366	13	management	management	NOUN
brj-24403	366	14	42(5	42(5	NOUN
brj-24403	366	15	)	)	PUNCT
brj-24403	366	16	,	,	PUNCT
brj-24403	366	17	788	788	NUM
brj-24403	366	18	-	-	SYM
brj-24403	366	19	804	804	NUM
brj-24403	366	20	.	.	PUNCT
brj-24403	367	1	doi	doi	NOUN
brj-24403	367	2	:	:	PUNCT
brj-24403	367	3	10.1016	10.1016	NUM
brj-24403	367	4	/	/	SYM
brj-24403	367	5	j.jpainsymman.2011.10.007	j.jpainsymman.2011.10.007	PROPN
brj-24403	367	6	huang	huang	PROPN
brj-24403	367	7	,	,	PUNCT
brj-24403	367	8	y.	y.	PROPN
brj-24403	367	9	m.	m.	PROPN
brj-24403	367	10	,	,	PUNCT
brj-24403	367	11	yuan	yuan	PROPN
brj-24403	367	12	,	,	PUNCT
brj-24403	367	13	h.	h.	PROPN
brj-24403	367	14	,	,	PUNCT
brj-24403	367	15	chen	chen	PROPN
brj-24403	367	16	,	,	PUNCT
brj-24403	367	17	p.	p.	PROPN
brj-24403	367	18	,	,	PUNCT
brj-24403	367	19	wang	wang	PROPN
brj-24403	367	20	,	,	PUNCT
brj-24403	367	21	t.	t.	PROPN
brj-24403	367	22	,	,	PUNCT
brj-24403	367	23	peng	peng	PROPN
brj-24403	367	24	,	,	PUNCT
brj-24403	367	25	g.	g.	PROPN
brj-24403	367	26	t.	t.	PROPN
brj-24403	367	27	,	,	PUNCT
brj-24403	367	28	and	and	CCONJ
brj-24403	367	29	wu	wu	PROPN
brj-24403	367	30	,	,	PUNCT
brj-24403	367	31	a.	a.	PROPN
brj-24403	367	32	z.	z.	PROPN
brj-24403	367	33	(	(	PUNCT
brj-24403	367	34	2022	2022	NUM
brj-24403	367	35	)	)	PUNCT
brj-24403	367	36	.	.	PUNCT
brj-24403	368	1	“	"	PUNCT
brj-24403	368	2	terpenoids	terpenoid	NOUN
brj-24403	368	3	from	from	ADP
brj-24403	368	4	callicarpa	callicarpa	ADJ
brj-24403	368	5	kwangtungensis	kwangtungensis	NOUN
brj-24403	368	6	and	and	CCONJ
brj-24403	368	7	their	their	PRON
brj-24403	368	8	anti	anti	ADJ
brj-24403	368	9	-	-	ADJ
brj-24403	368	10	inflammatory	inflammatory	ADJ
brj-24403	368	11	activity	activity	NOUN
brj-24403	368	12	.	.	PUNCT
brj-24403	369	1	tianran	tianran	PROPN
brj-24403	369	2	chanwu	chanwu	PROPN
brj-24403	369	3	yanjiu	yanjiu	PROPN
brj-24403	369	4	yu	yu	PROPN
brj-24403	369	5	kaifa	kaifa	PROPN
brj-24403	369	6	,	,	PUNCT
brj-24403	369	7	34(1	34(1	NUM
brj-24403	369	8	)	)	PUNCT
brj-24403	369	9	,	,	PUNCT
brj-24403	369	10	article	article	NOUN
brj-24403	369	11	7	7	NUM
brj-24403	369	12	.	.	PUNCT
brj-24403	369	13	doi	doi	NOUN
brj-24403	369	14	:	:	PUNCT
brj-24403	369	15	10.16333	10.16333	NUM
brj-24403	369	16	/	/	SYM
brj-24403	369	17	j.10016880.2022.1.007	j.10016880.2022.1.007	NOUN
brj-24403	369	18	ioannou	ioannou	NOUN
brj-24403	369	19	,	,	PUNCT
brj-24403	369	20	p.	p.	PROPN
brj-24403	369	21	,	,	PUNCT
brj-24403	369	22	foster	foster	PROPN
brj-24403	369	23	,	,	PUNCT
brj-24403	369	24	d.	d.	PROPN
brj-24403	369	25	l.	l.	PROPN
brj-24403	369	26	,	,	PUNCT
brj-24403	369	27	sander	sander	PROPN
brj-24403	369	28	,	,	PUNCT
brj-24403	369	29	j.	j.	PROPN
brj-24403	369	30	w.	w.	PROPN
brj-24403	369	31	,	,	PUNCT
brj-24403	369	32	dupont	dupont	PROPN
brj-24403	369	33	,	,	PUNCT
brj-24403	369	34	s.	s.	PROPN
brj-24403	369	35	,	,	PUNCT
brj-24403	369	36	gil	gil	PROPN
brj-24403	369	37	-	-	PUNCT
brj-24403	369	38	nagel	nagel	PROPN
brj-24403	369	39	,	,	PUNCT
brj-24403	369	40	a.	a.	PROPN
brj-24403	369	41	,	,	PUNCT
brj-24403	369	42	drogon	drogon	PROPN
brj-24403	369	43	o’flaherty	o’flaherty	PROPN
brj-24403	369	44	,	,	PUNCT
brj-24403	369	45	e.	e.	PROPN
brj-24403	369	46	,	,	PUNCT
brj-24403	369	47	alvarez	alvarez	PROPN
brj-24403	369	48	-	-	PUNCT
brj-24403	369	49	baron	baron	NOUN
brj-24403	369	50	,	,	PUNCT
brj-24403	369	51	e.	e.	PROPN
brj-24403	369	52	,	,	PUNCT
brj-24403	369	53	and	and	CCONJ
brj-24403	369	54	medjedovic	medjedovic	PROPN
brj-24403	369	55	,	,	PUNCT
brj-24403	369	56	j.	j.	PROPN
brj-24403	369	57	(	(	PUNCT
brj-24403	369	58	2022	2022	NUM
brj-24403	369	59	)	)	PUNCT
brj-24403	369	60	.	.	PUNCT
brj-24403	370	1	“	"	PUNCT
brj-24403	370	2	the	the	DET
brj-24403	370	3	burden	burden	NOUN
brj-24403	370	4	of	of	ADP
brj-24403	370	5	epilepsy	epilepsy	NOUN
brj-24403	370	6	and	and	CCONJ
brj-24403	370	7	unmet	unmet	NOUN
brj-24403	370	8	need	need	VERB
brj-24403	370	9	in	in	ADP
brj-24403	370	10	people	people	NOUN
brj-24403	370	11	with	with	ADP
brj-24403	370	12	focal	focal	ADJ
brj-24403	370	13	seizures	seizure	NOUN
brj-24403	370	14	,	,	PUNCT
brj-24403	370	15	”	"	PUNCT
brj-24403	370	16	brain	brain	NOUN
brj-24403	370	17	and	and	CCONJ
brj-24403	370	18	behavior	behavior	NOUN
brj-24403	370	19	12(9	12(9	NUM
brj-24403	370	20	)	)	PUNCT
brj-24403	370	21	,	,	PUNCT
brj-24403	370	22	article	article	NOUN
brj-24403	370	23	2589	2589	NUM
brj-24403	370	24	.	.	PUNCT
brj-24403	371	1	doi	doi	NOUN
brj-24403	371	2	:	:	PUNCT
brj-24403	371	3	10.1002	10.1002	NUM
brj-24403	371	4	/	/	SYM
brj-24403	371	5	brb3.2589	brb3.2589	PROPN
brj-24403	371	6	jakubs	jakubs	PROPN
brj-24403	371	7	,	,	PUNCT
brj-24403	371	8	k.	k.	PROPN
brj-24403	371	9	,	,	PUNCT
brj-24403	371	10	nanobashvili	nanobashvili	PROPN
brj-24403	371	11	,	,	PUNCT
brj-24403	371	12	a.	a.	PROPN
brj-24403	371	13	,	,	PUNCT
brj-24403	371	14	bonde	bonde	PROPN
brj-24403	371	15	,	,	PUNCT
brj-24403	371	16	s.	s.	PROPN
brj-24403	371	17	,	,	PUNCT
brj-24403	371	18	ekdahl	ekdahl	PROPN
brj-24403	371	19	,	,	PUNCT
brj-24403	371	20	c.	c.	PROPN
brj-24403	371	21	t.	t.	PROPN
brj-24403	371	22	,	,	PUNCT
brj-24403	371	23	kokaia	kokaia	PROPN
brj-24403	371	24	,	,	PUNCT
brj-24403	371	25	z.	z.	PROPN
brj-24403	371	26	,	,	PUNCT
brj-24403	371	27	kokaia	kokaia	PROPN
brj-24403	371	28	,	,	PUNCT
brj-24403	371	29	m.	m.	NOUN
brj-24403	371	30	,	,	PUNCT
brj-24403	371	31	and	and	CCONJ
brj-24403	371	32	lindvall	lindvall	PROPN
brj-24403	371	33	,	,	PUNCT
brj-24403	371	34	o.	o.	PROPN
brj-24403	371	35	(	(	PUNCT
brj-24403	371	36	2006	2006	NUM
brj-24403	371	37	)	)	PUNCT
brj-24403	371	38	.	.	PUNCT
brj-24403	372	1	“	"	PUNCT
brj-24403	372	2	environment	environment	NOUN
brj-24403	372	3	matters	matter	VERB
brj-24403	372	4	:	:	PUNCT
brj-24403	372	5	synaptic	synaptic	ADJ
brj-24403	372	6	properties	property	NOUN
brj-24403	372	7	of	of	ADP
brj-24403	372	8	neurons	neuron	NOUN
brj-24403	372	9	born	bear	VERB
brj-24403	372	10	in	in	ADP
brj-24403	372	11	the	the	DET
brj-24403	372	12	epileptic	epileptic	ADJ
brj-24403	372	13	adult	adult	NOUN
brj-24403	372	14	brain	brain	NOUN
brj-24403	372	15	develop	develop	VERB
brj-24403	372	16	to	to	PART
brj-24403	372	17	reduce	reduce	VERB
brj-24403	372	18	excitability	excitability	NOUN
brj-24403	372	19	,	,	PUNCT
brj-24403	372	20	”	"	PUNCT
brj-24403	372	21	neuron	neuron	NOUN
brj-24403	372	22	52(6	52(6	NUM
brj-24403	372	23	)	)	PUNCT
brj-24403	372	24	.	.	PUNCT
brj-24403	373	1	doi	doi	NOUN
brj-24403	373	2	:	:	PUNCT
brj-24403	373	3	10.1016	10.1016	NUM
brj-24403	373	4	/	/	SYM
brj-24403	373	5	j.neuron.2006.11.004	j.neuron.2006.11.004	PROPN
brj-24403	373	6	kasica	kasica	PROPN
brj-24403	373	7	,	,	PUNCT
brj-24403	373	8	n.	n.	NOUN
brj-24403	373	9	,	,	PUNCT
brj-24403	373	10	święch	święch	PROPN
brj-24403	373	11	,	,	PUNCT
brj-24403	373	12	a.	a.	PROPN
brj-24403	373	13	,	,	PUNCT
brj-24403	373	14	saładziak	saładziak	PROPN
brj-24403	373	15	,	,	PUNCT
brj-24403	373	16	k.	k.	PROPN
brj-24403	373	17	,	,	PUNCT
brj-24403	373	18	mackiewicz	mackiewicz	VERB
brj-24403	373	19	,	,	PUNCT
brj-24403	373	20	j.	j.	PROPN
brj-24403	373	21	,	,	PUNCT
brj-24403	373	22	and	and	CCONJ
brj-24403	373	23	osęka	osęka	NOUN
brj-24403	373	24	,	,	PUNCT
brj-24403	373	25	m.	m.	NOUN
brj-24403	373	26	(	(	PUNCT
brj-24403	373	27	2022	2022	NUM
brj-24403	373	28	)	)	PUNCT
brj-24403	373	29	.	.	PUNCT
brj-24403	374	1	“	"	PUNCT
brj-24403	374	2	the	the	DET
brj-24403	374	3	inhibitory	inhibitory	ADJ
brj-24403	374	4	effect	effect	NOUN
brj-24403	374	5	of	of	ADP
brj-24403	374	6	selected	select	VERB
brj-24403	374	7	d2	d2	ADJ
brj-24403	374	8	dopaminergic	dopaminergic	ADJ
brj-24403	374	9	receptor	receptor	NOUN
brj-24403	374	10	agonists	agonist	NOUN
brj-24403	374	11	on	on	ADP
brj-24403	374	12	vegf	vegf	PROPN
brj-24403	374	13	-	-	PUNCT
brj-24403	374	14	dependent	dependent	ADJ
brj-24403	374	15	neovascularization	neovascularization	NOUN
brj-24403	374	16	in	in	ADP
brj-24403	374	17	zebrafish	zebrafish	ADJ
brj-24403	374	18	larvae	larvae	NOUN
brj-24403	374	19	:	:	PUNCT
brj-24403	374	20	potential	potential	ADJ
brj-24403	374	21	new	new	ADJ
brj-24403	374	22	therapy	therapy	NOUN
brj-24403	374	23	in	in	ADP
brj-24403	374	24	ophthalmic	ophthalmic	ADJ
brj-24403	374	25	diseases	disease	NOUN
brj-24403	374	26	,	,	PUNCT
brj-24403	374	27	”	"	PUNCT
brj-24403	374	28	cells	cell	NOUN
brj-24403	374	29	11(7	11(7	NUM
brj-24403	374	30	)	)	PUNCT
brj-24403	374	31	,	,	PUNCT
brj-24403	374	32	article	article	NOUN
brj-24403	374	33	1202	1202	NUM
brj-24403	374	34	.	.	PUNCT
brj-24403	375	1	doi	doi	NOUN
brj-24403	375	2	:	:	PUNCT
brj-24403	375	3	10.3390	10.3390	NUM
brj-24403	375	4	/	/	SYM
brj-24403	375	5	cells11071202	cells11071202	PROPN
brj-24403	375	6	kim	kim	PROPN
brj-24403	375	7	,	,	PUNCT
brj-24403	375	8	e.	e.	PROPN
brj-24403	375	9	n.	n.	PROPN
brj-24403	375	10	,	,	PUNCT
brj-24403	375	11	lee	lee	PROPN
brj-24403	375	12	,	,	PUNCT
brj-24403	375	13	h.	h.	PROPN
brj-24403	375	14	s.	s.	PROPN
brj-24403	375	15	,	,	PUNCT
brj-24403	375	16	and	and	CCONJ
brj-24403	375	17	jeong	jeong	PROPN
brj-24403	375	18	,	,	PUNCT
brj-24403	375	19	g.	g.	PROPN
brj-24403	375	20	s.	s.	PROPN
brj-24403	375	21	(	(	PUNCT
brj-24403	375	22	2022	2022	NUM
brj-24403	375	23	)	)	PUNCT
brj-24403	375	24	.	.	PUNCT
brj-24403	376	1	“	"	PUNCT
brj-24403	376	2	callicarpa	callicarpa	ADJ
brj-24403	376	3	dichotoma	dichotoma	NOUN
brj-24403	376	4	leaf	leaf	NOUN
brj-24403	376	5	extract	extract	NOUN
brj-24403	376	6	alleviates	alleviate	VERB
brj-24403	376	7	atopic	atopic	NOUN
brj-24403	376	8	dermatitis	dermatitis	NOUN
brj-24403	376	9	through	through	ADP
brj-24403	376	10	the	the	DET
brj-24403	376	11	suppression	suppression	NOUN
brj-24403	376	12	of	of	ADP
brj-24403	376	13	t	t	NOUN
brj-24403	376	14	cells	cell	NOUN
brj-24403	376	15	and	and	CCONJ
brj-24403	376	16	keratinocytes	keratinocyte	VERB
brj-24403	376	17	activation	activation	NOUN
brj-24403	376	18	,	,	PUNCT
brj-24403	376	19	”	"	PUNCT
brj-24403	376	20	pharmaceuticals	pharmaceutical	NOUN
brj-24403	376	21	15(10	15(10	NUM
brj-24403	376	22	)	)	PUNCT
brj-24403	376	23	,	,	PUNCT
brj-24403	376	24	article	article	NOUN
brj-24403	376	25	1280	1280	NUM
brj-24403	376	26	.	.	PUNCT
brj-24403	377	1	doi	doi	NOUN
brj-24403	377	2	:	:	PUNCT
brj-24403	377	3	10.3390	10.3390	NUM
brj-24403	377	4	/	/	SYM
brj-24403	377	5	ph15101280	ph15101280	ADJ
brj-24403	377	6	kim	kim	PROPN
brj-24403	377	7	,	,	PUNCT
brj-24403	377	8	h.	h.	PROPN
brj-24403	377	9	j.	j.	PROPN
brj-24403	377	10	,	,	PUNCT
brj-24403	377	11	park	park	PROPN
brj-24403	377	12	,	,	PUNCT
brj-24403	377	13	h.	h.	PROPN
brj-24403	377	14	j.	j.	PROPN
brj-24403	377	15	,	,	PUNCT
brj-24403	377	16	kim	kim	PROPN
brj-24403	377	17	,	,	PUNCT
brj-24403	377	18	k.	k.	PROPN
brj-24403	377	19	w.	w.	PROPN
brj-24403	377	20	,	,	PUNCT
brj-24403	377	21	and	and	CCONJ
brj-24403	377	22	park	park	NOUN
brj-24403	377	23	,	,	PUNCT
brj-24403	377	24	s.	s.	PROPN
brj-24403	377	25	j.	j.	PROPN
brj-24403	377	26	(	(	PUNCT
brj-24403	377	27	2015	2015	NUM
brj-24403	377	28	)	)	PUNCT
brj-24403	377	29	.	.	PUNCT
brj-24403	378	1	“	"	PUNCT
brj-24403	378	2	protective	protective	ADJ
brj-24403	378	3	effects	effect	NOUN
brj-24403	378	4	of	of	ADP
brj-24403	378	5	phytosterols	phytosterol	NOUN
brj-24403	378	6	on	on	ADP
brj-24403	378	7	oxidative	oxidative	ADJ
brj-24403	378	8	stress	stress	NOUN
brj-24403	378	9	-	-	PUNCT
brj-24403	378	10	induced	induce	VERB
brj-24403	378	11	neuronal	neuronal	ADJ
brj-24403	378	12	cell	cell	NOUN
brj-24403	378	13	death	death	NOUN
brj-24403	378	14	in	in	ADP
brj-24403	378	15	vitro	vitro	X
brj-24403	378	16	,	,	PUNCT
brj-24403	378	17	”	"	PUNCT
brj-24403	378	18	molecules	molecule	NOUN
brj-24403	378	19	20(6	20(6	NOUN
brj-24403	378	20	)	)	PUNCT
brj-24403	378	21	,	,	PUNCT
brj-24403	378	22	10833	10833	NUM
brj-24403	378	23	-	-	SYM
brj-24403	378	24	10845	10845	NUM
brj-24403	378	25	.	.	PUNCT
brj-24403	379	1	doi	doi	NOUN
brj-24403	379	2	:	:	PUNCT
brj-24403	379	3	10.3390	10.3390	NUM
brj-24403	379	4	/	/	SYM
brj-24403	379	5	molecules200610833	molecules200610833	PROPN
brj-24403	379	6	li	li	PROPN
brj-24403	379	7	,	,	PUNCT
brj-24403	379	8	y.	y.	PROPN
brj-24403	379	9	,	,	PUNCT
brj-24403	379	10	yang	yang	PROPN
brj-24403	379	11	,	,	PUNCT
brj-24403	379	12	y.	y.	PROPN
brj-24403	379	13	,	,	PUNCT
brj-24403	379	14	kang	kang	PROPN
brj-24403	379	15	,	,	PUNCT
brj-24403	379	16	x.	x.	PROPN
brj-24403	379	17	,	,	PUNCT
brj-24403	379	18	li	li	PROPN
brj-24403	379	19	,	,	PUNCT
brj-24403	379	20	x.	x.	PROPN
brj-24403	379	21	,	,	PUNCT
brj-24403	379	22	wu	wu	PROPN
brj-24403	379	23	,	,	PUNCT
brj-24403	379	24	y.	y.	PROPN
brj-24403	379	25	,	,	PUNCT
brj-24403	379	26	xiao	xiao	PROPN
brj-24403	379	27	,	,	PUNCT
brj-24403	379	28	j.	j.	PROPN
brj-24403	379	29	,	,	PUNCT
brj-24403	379	30	ye	ye	PROPN
brj-24403	379	31	,	,	PUNCT
brj-24403	379	32	y.	y.	PROPN
brj-24403	379	33	,	,	PUNCT
brj-24403	379	34	yang	yang	PROPN
brj-24403	379	35	,	,	PUNCT
brj-24403	379	36	j.	j.	PROPN
brj-24403	379	37	,	,	PUNCT
brj-24403	379	38	yang	yang	PROPN
brj-24403	379	39	,	,	PUNCT
brj-24403	379	40	y.	y.	PROPN
brj-24403	379	41	,	,	PUNCT
brj-24403	379	42	and	and	CCONJ
brj-24403	379	43	liu	liu	PROPN
brj-24403	379	44	,	,	PUNCT
brj-24403	379	45	h.	h.	PROPN
brj-24403	379	46	(	(	PUNCT
brj-24403	379	47	2022	2022	NUM
brj-24403	379	48	)	)	PUNCT
brj-24403	379	49	.	.	PUNCT
brj-24403	380	1	“	"	PUNCT
brj-24403	380	2	study	study	VERB
brj-24403	380	3	on	on	ADP
brj-24403	380	4	the	the	DET
brj-24403	380	5	anti	anti	ADJ
brj-24403	380	6	-	-	ADJ
brj-24403	380	7	inflammatory	inflammatory	ADJ
brj-24403	380	8	effects	effect	NOUN
brj-24403	380	9	of	of	ADP
brj-24403	380	10	callicarpa	callicarpa	ADJ
brj-24403	380	11	nudiflora	nudiflora	NOUN
brj-24403	380	12	based	base	VERB
brj-24403	380	13	on	on	ADP
brj-24403	380	14	the	the	DET
brj-24403	380	15	spectrum	spectrum	NOUN
brj-24403	380	16	–	–	PUNCT
brj-24403	380	17	effect	effect	NOUN
brj-24403	380	18	relationship	relationship	NOUN
brj-24403	380	19	,	,	PUNCT
brj-24403	380	20	”	"	PUNCT
brj-24403	380	21	frontiers	frontier	NOUN
brj-24403	380	22	in	in	ADP
brj-24403	380	23	pharmacology	pharmacology	NOUN
brj-24403	380	24	12	12	NUM
brj-24403	380	25	,	,	PUNCT
brj-24403	380	26	article	article	NOUN
brj-24403	380	27	806808	806808	NUM
brj-24403	380	28	.	.	PUNCT
brj-24403	381	1	doi	doi	NOUN
brj-24403	381	2	:	:	PUNCT
brj-24403	381	3	10.3389	10.3389	NUM
brj-24403	381	4	/	/	SYM
brj-24403	381	5	fphar.2021.806808	fphar.2021.806808	NOUN
brj-24403	381	6	li	li	PROPN
brj-24403	381	7	,	,	PUNCT
brj-24403	381	8	z.	z.	PROPN
brj-24403	381	9	,	,	PUNCT
brj-24403	381	10	wang	wang	PROPN
brj-24403	381	11	,	,	PUNCT
brj-24403	381	12	x.	x.	PROPN
brj-24403	381	13	,	,	PUNCT
brj-24403	381	14	chen	chen	PROPN
brj-24403	381	15	,	,	PUNCT
brj-24403	381	16	l.	l.	PROPN
brj-24403	381	17	,	,	PUNCT
brj-24403	381	18	yang	yang	PROPN
brj-24403	381	19	,	,	PUNCT
brj-24403	381	20	f.	f.	PROPN
brj-24403	381	21	,	,	PUNCT
brj-24403	381	22	and	and	CCONJ
brj-24403	381	23	wu	wu	PROPN
brj-24403	381	24	,	,	PUNCT
brj-24403	381	25	y.	y.	PROPN
brj-24403	381	26	(	(	PUNCT
brj-24403	381	27	2016	2016	NUM
brj-24403	381	28	)	)	PUNCT
brj-24403	381	29	.	.	PUNCT
brj-24403	382	1	“	"	PUNCT
brj-24403	382	2	chemical	chemical	ADJ
brj-24403	382	3	constituents	constituent	NOUN
brj-24403	382	4	and	and	CCONJ
brj-24403	382	5	bioactivities	bioactivitie	NOUN
brj-24403	382	6	of	of	ADP
brj-24403	382	7	plants	plant	NOUN
brj-24403	382	8	from	from	ADP
brj-24403	382	9	the	the	DET
brj-24403	382	10	genus	genus	NOUN
brj-24403	382	11	callicarpa	callicarpa	VERB
brj-24403	382	12	,	,	PUNCT
brj-24403	382	13	”	"	PUNCT
brj-24403	382	14	chemistry	chemistry	NOUN
brj-24403	382	15	&	&	CCONJ
brj-24403	382	16	biodiversity	biodiversity	NOUN
brj-24403	382	17	13(7	13(7	NUM
brj-24403	382	18	)	)	PUNCT
brj-24403	382	19	,	,	PUNCT
brj-24403	382	20	955	955	NUM
brj-24403	382	21	-	-	SYM
brj-24403	382	22	975	975	NUM
brj-24403	382	23	.	.	PUNCT
brj-24403	383	1	doi	doi	NOUN
brj-24403	383	2	:	:	PUNCT
brj-24403	383	3	10.1002	10.1002	NUM
brj-24403	383	4	/	/	SYM
brj-24403	383	5	cbdv.201500315	cbdv.201500315	PROPN
brj-24403	383	6	löscher	löscher	NOUN
brj-24403	383	7	,	,	PUNCT
brj-24403	383	8	w.	w.	PROPN
brj-24403	383	9	(	(	PUNCT
brj-24403	383	10	2002	2002	NUM
brj-24403	383	11	)	)	PUNCT
brj-24403	383	12	.	.	PUNCT
brj-24403	384	1	“	"	PUNCT
brj-24403	384	2	animal	animal	NOUN
brj-24403	384	3	models	model	NOUN
brj-24403	384	4	of	of	ADP
brj-24403	384	5	epilepsy	epilepsy	NOUN
brj-24403	384	6	for	for	ADP
brj-24403	384	7	the	the	DET
brj-24403	384	8	development	development	NOUN
brj-24403	384	9	of	of	ADP
brj-24403	384	10	antiepileptogenic	antiepileptogenic	ADJ
brj-24403	384	11	and	and	CCONJ
brj-24403	384	12	disease	disease	NOUN
brj-24403	384	13	-	-	PUNCT
brj-24403	384	14	modifying	modify	VERB
brj-24403	384	15	drugs	drug	NOUN
brj-24403	384	16	.	.	PUNCT
brj-24403	385	1	a	a	DET
brj-24403	385	2	comparison	comparison	NOUN
brj-24403	385	3	of	of	ADP
brj-24403	385	4	the	the	DET
brj-24403	385	5	pharmacology	pharmacology	NOUN
brj-24403	385	6	of	of	ADP
brj-24403	385	7	kindling	kindling	NOUN
brj-24403	385	8	and	and	CCONJ
brj-24403	385	9	post	post	ADJ
brj-24403	385	10	-	-	ADJ
brj-24403	385	11	status	status	ADJ
brj-24403	385	12	epilepticus	epilepticus	NOUN
brj-24403	385	13	models	model	NOUN
brj-24403	385	14	of	of	ADP
brj-24403	385	15	temporal	temporal	ADJ
brj-24403	385	16	lobe	lobe	NOUN
brj-24403	385	17	epilepsy	epilepsy	NOUN
brj-24403	385	18	,	,	PUNCT
brj-24403	385	19	”	"	PUNCT
brj-24403	385	20	epilepsy	epilepsy	NOUN
brj-24403	385	21	research	research	NOUN
brj-24403	385	22	50(1	50(1	PROPN
brj-24403	385	23	-	-	PUNCT
brj-24403	385	24	2	2	NUM
brj-24403	385	25	)	)	PUNCT
brj-24403	385	26	,	,	PUNCT
brj-24403	385	27	105	105	NUM
brj-24403	385	28	-	-	SYM
brj-24403	385	29	123	123	NUM
brj-24403	385	30	.	.	PUNCT
brj-24403	386	1	doi	doi	NOUN
brj-24403	386	2	:	:	PUNCT
brj-24403	386	3	10.1016	10.1016	NUM
brj-24403	386	4	/	/	SYM
brj-24403	386	5	s0920	s0920	NOUN
brj-24403	386	6	-	-	PUNCT
brj-24403	386	7	1211(02)00073	1211(02)00073	NUM
brj-24403	386	8	-	-	SYM
brj-24403	386	9	6	6	NUM
brj-24403	386	10	peer	peer	NOUN
brj-24403	386	11	-	-	PUNCT
brj-24403	386	12	reviewed	review	VERB
brj-24403	386	13	article	article	NOUN
brj-24403	386	14	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	386	15	li	li	PROPN
brj-24403	386	16	et	et	PROPN
brj-24403	386	17	al	al	PROPN
brj-24403	386	18	.	.	PROPN
brj-24403	387	1	(	(	PUNCT
brj-24403	387	2	2025	2025	NUM
brj-24403	387	3	)	)	PUNCT
brj-24403	387	4	.	.	PUNCT
brj-24403	388	1	“	"	PUNCT
brj-24403	388	2	herbal	herbal	ADJ
brj-24403	388	3	anti	anti	ADJ
brj-24403	388	4	-	-	ADJ
brj-24403	388	5	epileptic	epileptic	ADJ
brj-24403	388	6	extract	extract	NOUN
brj-24403	388	7	,	,	PUNCT
brj-24403	388	8	”	"	PUNCT
brj-24403	388	9	bioresources	bioresource	NOUN
brj-24403	388	10	20(2	20(2	NUM
brj-24403	388	11	)	)	PUNCT
brj-24403	388	12	,	,	PUNCT
brj-24403	388	13	4701	4701	NUM
brj-24403	388	14	-	-	SYM
brj-24403	388	15	4719	4719	NUM
brj-24403	388	16	.	.	PUNCT
brj-24403	389	1	4717	4717	NUM
brj-24403	389	2	löscher	löscher	NOUN
brj-24403	389	3	,	,	PUNCT
brj-24403	389	4	w.	w.	PROPN
brj-24403	389	5	,	,	PUNCT
brj-24403	389	6	potschka	potschka	PROPN
brj-24403	389	7	,	,	PUNCT
brj-24403	389	8	h.	h.	PROPN
brj-24403	389	9	,	,	PUNCT
brj-24403	389	10	sisodiya	sisodiya	PROPN
brj-24403	389	11	,	,	PUNCT
brj-24403	389	12	s.	s.	PROPN
brj-24403	389	13	m.	m.	PROPN
brj-24403	389	14	,	,	PUNCT
brj-24403	389	15	and	and	CCONJ
brj-24403	389	16	vezzani	vezzani	NOUN
brj-24403	389	17	,	,	PUNCT
brj-24403	389	18	a.	a.	NOUN
brj-24403	389	19	(	(	PUNCT
brj-24403	389	20	2020	2020	NUM
brj-24403	389	21	)	)	PUNCT
brj-24403	389	22	.	.	PUNCT
brj-24403	390	1	“	"	PUNCT
brj-24403	390	2	drug	drug	NOUN
brj-24403	390	3	resistance	resistance	NOUN
brj-24403	390	4	in	in	ADP
brj-24403	390	5	epilepsy	epilepsy	NOUN
brj-24403	390	6	:	:	PUNCT
brj-24403	390	7	clinical	clinical	ADJ
brj-24403	390	8	impact	impact	NOUN
brj-24403	390	9	,	,	PUNCT
brj-24403	390	10	potential	potential	ADJ
brj-24403	390	11	mechanisms	mechanism	NOUN
brj-24403	390	12	,	,	PUNCT
brj-24403	390	13	and	and	CCONJ
brj-24403	390	14	new	new	ADJ
brj-24403	390	15	innovative	innovative	ADJ
brj-24403	390	16	treatment	treatment	NOUN
brj-24403	390	17	options	option	NOUN
brj-24403	390	18	,	,	PUNCT
brj-24403	390	19	”	"	PUNCT
brj-24403	390	20	pharmacological	pharmacological	ADJ
brj-24403	390	21	reviews	review	NOUN
brj-24403	390	22	72(3	72(3	NUM
brj-24403	390	23	)	)	PUNCT
brj-24403	390	24	,	,	PUNCT
brj-24403	390	25	article	article	NOUN
brj-24403	390	26	019539	019539	NUM
brj-24403	390	27	.	.	PUNCT
brj-24403	391	1	doi	doi	NOUN
brj-24403	391	2	:	:	PUNCT
brj-24403	391	3	10.1124	10.1124	NUM
brj-24403	391	4	/	/	SYM
brj-24403	391	5	pr.120.019539	pr.120.019539	NOUN
brj-24403	391	6	luo	luo	PROPN
brj-24403	391	7	,	,	PUNCT
brj-24403	391	8	y.	y.	PROPN
brj-24403	391	9	,	,	PUNCT
brj-24403	391	10	cobb	cobb	PROPN
brj-24403	391	11	,	,	PUNCT
brj-24403	391	12	r.	r.	PROPN
brj-24403	391	13	e.	e.	PROPN
brj-24403	391	14	,	,	PUNCT
brj-24403	391	15	and	and	CCONJ
brj-24403	391	16	zhao	zhao	PROPN
brj-24403	391	17	,	,	PUNCT
brj-24403	391	18	h.	h.	PROPN
brj-24403	391	19	(	(	PUNCT
brj-24403	391	20	2014	2014	NUM
brj-24403	391	21	)	)	PUNCT
brj-24403	391	22	.	.	PUNCT
brj-24403	392	1	“	"	PUNCT
brj-24403	392	2	recent	recent	ADJ
brj-24403	392	3	advances	advance	NOUN
brj-24403	392	4	in	in	ADP
brj-24403	392	5	natural	natural	ADJ
brj-24403	392	6	product	product	NOUN
brj-24403	392	7	discovery	discovery	NOUN
brj-24403	392	8	,	,	PUNCT
brj-24403	392	9	”	"	PUNCT
brj-24403	392	10	current	current	ADJ
brj-24403	392	11	opinion	opinion	NOUN
brj-24403	392	12	in	in	ADP
brj-24403	392	13	biotechnology	biotechnology	NOUN
brj-24403	392	14	30	30	NUM
brj-24403	392	15	,	,	PUNCT
brj-24403	392	16	230	230	NUM
brj-24403	392	17	-	-	SYM
brj-24403	392	18	237	237	NUM
brj-24403	392	19	.	.	PUNCT
brj-24403	393	1	doi	doi	NOUN
brj-24403	393	2	:	:	PUNCT
brj-24403	393	3	10.1016	10.1016	NUM
brj-24403	393	4	/	/	SYM
brj-24403	393	5	j.copbio.2014.09.002	j.copbio.2014.09.002	PROPN
brj-24403	393	6	ma	ma	PROPN
brj-24403	393	7	,	,	PUNCT
brj-24403	393	8	y.	y.	PROPN
brj-24403	393	9	,	,	PUNCT
brj-24403	393	10	guo	guo	PROPN
brj-24403	393	11	,	,	PUNCT
brj-24403	393	12	l.	l.	PROPN
brj-24403	393	13	,	,	PUNCT
brj-24403	393	14	hou	hou	PROPN
brj-24403	393	15	,	,	PUNCT
brj-24403	393	16	w.	w.	PROPN
brj-24403	393	17	,	,	PUNCT
brj-24403	393	18	zhuo	zhuo	PROPN
brj-24403	393	19	,	,	PUNCT
brj-24403	393	20	j.	j.	PROPN
brj-24403	393	21	,	,	PUNCT
brj-24403	393	22	zhao	zhao	PROPN
brj-24403	393	23	,	,	PUNCT
brj-24403	393	24	m.	m.	NOUN
brj-24403	393	25	,	,	PUNCT
brj-24403	393	26	and	and	CCONJ
brj-24403	393	27	liu	liu	PROPN
brj-24403	393	28	,	,	PUNCT
brj-24403	393	29	y.	y.	PROPN
brj-24403	393	30	(	(	PUNCT
brj-24403	393	31	2022	2022	NUM
brj-24403	393	32	)	)	PUNCT
brj-24403	393	33	.	.	PUNCT
brj-24403	394	1	“	"	PUNCT
brj-24403	394	2	phytochemistry	phytochemistry	NOUN
brj-24403	394	3	,	,	PUNCT
brj-24403	394	4	bioactivities	bioactivitie	NOUN
brj-24403	394	5	,	,	PUNCT
brj-24403	394	6	and	and	CCONJ
brj-24403	394	7	future	future	ADJ
brj-24403	394	8	prospects	prospect	NOUN
brj-24403	394	9	of	of	ADP
brj-24403	394	10	callicarpa	callicarpa	ADJ
brj-24403	394	11	nudiflora	nudiflora	NOUN
brj-24403	394	12	:	:	PUNCT
brj-24403	394	13	a	a	DET
brj-24403	394	14	review	review	NOUN
brj-24403	394	15	,	,	PUNCT
brj-24403	394	16	”	"	PUNCT
brj-24403	394	17	medicinal	medicinal	ADJ
brj-24403	394	18	plant	plant	NOUN
brj-24403	394	19	biology	biology	NOUN
brj-24403	394	20	1(1	1(1	NUM
brj-24403	394	21	)	)	PUNCT
brj-24403	394	22	,	,	PUNCT
brj-24403	394	23	article	article	NOUN
brj-24403	394	24	5	5	NUM
brj-24403	394	25	.	.	PUNCT
brj-24403	394	26	doi	doi	NOUN
brj-24403	394	27	:	:	PUNCT
brj-24403	394	28	10.48130	10.48130	NUM
brj-24403	394	29	/	/	SYM
brj-24403	394	30	mpb-2022	mpb-2022	NOUN
brj-24403	394	31	-	-	PUNCT
brj-24403	394	32	0005	0005	NUM
brj-24403	394	33	marchi	marchi	PROPN
brj-24403	394	34	,	,	PUNCT
brj-24403	394	35	n.	n.	NOUN
brj-24403	394	36	,	,	PUNCT
brj-24403	394	37	granata	granata	PROPN
brj-24403	394	38	,	,	PUNCT
brj-24403	394	39	t.	t.	PROPN
brj-24403	394	40	,	,	PUNCT
brj-24403	394	41	ghosh	ghosh	PROPN
brj-24403	394	42	,	,	PUNCT
brj-24403	394	43	c.	c.	PROPN
brj-24403	394	44	,	,	PUNCT
brj-24403	394	45	and	and	CCONJ
brj-24403	394	46	janigro	janigro	PROPN
brj-24403	394	47	,	,	PUNCT
brj-24403	394	48	d.	d.	PROPN
brj-24403	394	49	(	(	PUNCT
brj-24403	394	50	2007a	2007a	NUM
brj-24403	394	51	)	)	PUNCT
brj-24403	394	52	.	.	PUNCT
brj-24403	395	1	“	"	PUNCT
brj-24403	395	2	blood	blood	NOUN
brj-24403	395	3	–	–	PUNCT
brj-24403	395	4	brain	brain	NOUN
brj-24403	395	5	barrier	barrier	NOUN
brj-24403	395	6	dysfunction	dysfunction	NOUN
brj-24403	395	7	and	and	CCONJ
brj-24403	395	8	epilepsy	epilepsy	NOUN
brj-24403	395	9	:	:	PUNCT
brj-24403	395	10	pathophysiologic	pathophysiologic	ADJ
brj-24403	395	11	role	role	NOUN
brj-24403	395	12	and	and	CCONJ
brj-24403	395	13	therapeutic	therapeutic	ADJ
brj-24403	395	14	approaches	approach	NOUN
brj-24403	395	15	,	,	PUNCT
brj-24403	395	16	”	"	PUNCT
brj-24403	395	17	epilepsia	epilepsia	NOUN
brj-24403	395	18	48(11	48(11	NUM
brj-24403	395	19	)	)	PUNCT
brj-24403	395	20	,	,	PUNCT
brj-24403	395	21	2136	2136	NUM
brj-24403	395	22	-	-	SYM
brj-24403	395	23	2147	2147	NUM
brj-24403	395	24	.	.	PUNCT
brj-24403	396	1	doi	doi	NOUN
brj-24403	396	2	:	:	PUNCT
brj-24403	396	3	10.1111	10.1111	NUM
brj-24403	396	4	/	/	SYM
brj-24403	396	5	j.1528	j.1528	X
brj-24403	396	6	-	-	SYM
brj-24403	396	7	1167.2007.01285.x	1167.2007.01285.x	NUM
brj-24403	396	8	marchi	marchi	PROPN
brj-24403	396	9	,	,	PUNCT
brj-24403	396	10	n.	n.	NOUN
brj-24403	396	11	,	,	PUNCT
brj-24403	396	12	oby	oby	PROPN
brj-24403	396	13	,	,	PUNCT
brj-24403	396	14	e.	e.	PROPN
brj-24403	396	15	,	,	PUNCT
brj-24403	396	16	batra	batra	PROPN
brj-24403	396	17	,	,	PUNCT
brj-24403	396	18	a.	a.	PROPN
brj-24403	396	19	,	,	PUNCT
brj-24403	396	20	uva	uva	PROPN
brj-24403	396	21	,	,	PUNCT
brj-24403	396	22	l.	l.	PROPN
brj-24403	396	23	,	,	PUNCT
brj-24403	396	24	de	de	PROPN
brj-24403	396	25	curtis	curtis	PROPN
brj-24403	396	26	,	,	PUNCT
brj-24403	396	27	m.	m.	NOUN
brj-24403	396	28	,	,	PUNCT
brj-24403	396	29	hernandez	hernandez	PROPN
brj-24403	396	30	,	,	PUNCT
brj-24403	396	31	n.	n.	PROPN
brj-24403	396	32	,	,	PUNCT
brj-24403	396	33	van	van	PROPN
brj-24403	396	34	boxeldezaire	boxeldezaire	NOUN
brj-24403	396	35	,	,	PUNCT
brj-24403	396	36	a.	a.	NOUN
brj-24403	396	37	,	,	PUNCT
brj-24403	396	38	najm	najm	ADJ
brj-24403	396	39	,	,	PUNCT
brj-24403	396	40	i.	i.	NOUN
brj-24403	396	41	,	,	PUNCT
brj-24403	396	42	and	and	CCONJ
brj-24403	396	43	janigro	janigro	PROPN
brj-24403	396	44	,	,	PUNCT
brj-24403	396	45	d.	d.	PROPN
brj-24403	396	46	(	(	PUNCT
brj-24403	396	47	2007b	2007b	NUM
brj-24403	396	48	)	)	PUNCT
brj-24403	396	49	.	.	PUNCT
brj-24403	397	1	“	"	PUNCT
brj-24403	397	2	in	in	ADP
brj-24403	397	3	vivo	vivo	NOUN
brj-24403	397	4	and	and	CCONJ
brj-24403	397	5	in	in	ADP
brj-24403	397	6	vitro	vitro	X
brj-24403	397	7	effects	effect	NOUN
brj-24403	397	8	of	of	ADP
brj-24403	397	9	pilocarpine	pilocarpine	NOUN
brj-24403	397	10	:	:	PUNCT
brj-24403	397	11	relevance	relevance	NOUN
brj-24403	397	12	to	to	ADP
brj-24403	397	13	ictogenesis	ictogenesis	NOUN
brj-24403	397	14	,	,	PUNCT
brj-24403	397	15	”	"	PUNCT
brj-24403	397	16	epilepsia	epilepsia	NOUN
brj-24403	397	17	48(10	48(10	NUM
brj-24403	397	18	)	)	PUNCT
brj-24403	397	19	.	.	PUNCT
brj-24403	398	1	doi	doi	NOUN
brj-24403	398	2	:	:	PUNCT
brj-24403	398	3	10.1111	10.1111	NUM
brj-24403	398	4	/	/	SYM
brj-24403	398	5	j.15281167.2007.01185.x	j.15281167.2007.01185.x	NOUN
brj-24403	398	6	mazarati	mazarati	PROPN
brj-24403	398	7	,	,	PUNCT
brj-24403	398	8	a.	a.	NOUN
brj-24403	398	9	m.	m.	NOUN
brj-24403	398	10	,	,	PUNCT
brj-24403	398	11	sankar	sankar	NOUN
brj-24403	398	12	,	,	PUNCT
brj-24403	398	13	r.	r.	PROPN
brj-24403	398	14	,	,	PUNCT
brj-24403	398	15	and	and	CCONJ
brj-24403	398	16	wasterlain	wasterlain	NOUN
brj-24403	398	17	,	,	PUNCT
brj-24403	398	18	c.	c.	PROPN
brj-24403	398	19	g.	g.	PROPN
brj-24403	398	20	(	(	PUNCT
brj-24403	398	21	1998	1998	NUM
brj-24403	398	22	)	)	PUNCT
brj-24403	398	23	.	.	PUNCT
brj-24403	399	1	“	"	PUNCT
brj-24403	399	2	electrophysiological	electrophysiological	ADJ
brj-24403	399	3	characteristics	characteristic	NOUN
brj-24403	399	4	of	of	ADP
brj-24403	399	5	pilocarpine	pilocarpine	NOUN
brj-24403	399	6	-	-	PUNCT
brj-24403	399	7	induced	induce	VERB
brj-24403	399	8	seizures	seizure	NOUN
brj-24403	399	9	in	in	ADP
brj-24403	399	10	rats	rat	NOUN
brj-24403	399	11	,	,	PUNCT
brj-24403	399	12	”	"	PUNCT
brj-24403	399	13	epilepsy	epilepsy	NOUN
brj-24403	399	14	research	research	NOUN
brj-24403	399	15	32	32	NUM
brj-24403	399	16	,	,	PUNCT
brj-24403	399	17	213220	213220	NUM
brj-24403	399	18	.	.	PUNCT
brj-24403	400	1	doi	doi	NOUN
brj-24403	400	2	:	:	PUNCT
brj-24403	400	3	10.1016	10.1016	NUM
brj-24403	400	4	/	/	SYM
brj-24403	400	5	s0920	s0920	NOUN
brj-24403	400	6	-	-	PUNCT
brj-24403	400	7	1211(98)00041	1211(98)00041	NUM
brj-24403	400	8	-	-	SYM
brj-24403	400	9	3	3	NUM
brj-24403	400	10	.	.	PUNCT
brj-24403	401	1	mcshane	mcshane	PROPN
brj-24403	401	2	,	,	PUNCT
brj-24403	401	3	r.	r.	PROPN
brj-24403	401	4	,	,	PUNCT
brj-24403	401	5	westby	westby	PROPN
brj-24403	401	6	,	,	PUNCT
brj-24403	401	7	m.	m.	PROPN
brj-24403	401	8	j.	j.	PROPN
brj-24403	401	9	,	,	PUNCT
brj-24403	401	10	roberts	roberts	PROPN
brj-24403	401	11	,	,	PUNCT
brj-24403	401	12	e.	e.	PROPN
brj-24403	401	13	,	,	PUNCT
brj-24403	401	14	minakaran	minakaran	VERB
brj-24403	401	15	,	,	PUNCT
brj-24403	401	16	n.	n.	NOUN
brj-24403	401	17	,	,	PUNCT
brj-24403	401	18	schneider	schneider	PROPN
brj-24403	401	19	,	,	PUNCT
brj-24403	401	20	l.	l.	PROPN
brj-24403	401	21	,	,	PUNCT
brj-24403	401	22	farrimond	farrimond	NOUN
brj-24403	401	23	,	,	PUNCT
brj-24403	401	24	l.	l.	PROPN
brj-24403	401	25	e.	e.	PROPN
brj-24403	401	26	,	,	PUNCT
brj-24403	401	27	maayan	maayan	PROPN
brj-24403	401	28	,	,	PUNCT
brj-24403	401	29	n.	n.	NOUN
brj-24403	401	30	,	,	PUNCT
brj-24403	401	31	ware	ware	PROPN
brj-24403	401	32	,	,	PUNCT
brj-24403	401	33	j.	j.	PROPN
brj-24403	401	34	,	,	PUNCT
brj-24403	401	35	and	and	CCONJ
brj-24403	401	36	debarros	debarros	PROPN
brj-24403	401	37	,	,	PUNCT
brj-24403	401	38	j.	j.	PROPN
brj-24403	401	39	(	(	PUNCT
brj-24403	401	40	2019	2019	NUM
brj-24403	401	41	)	)	PUNCT
brj-24403	401	42	.	.	PUNCT
brj-24403	402	1	“	"	PUNCT
brj-24403	402	2	memantine	memantine	NOUN
brj-24403	402	3	for	for	ADP
brj-24403	402	4	dementia	dementia	NOUN
brj-24403	402	5	,	,	PUNCT
brj-24403	402	6	”	"	PUNCT
brj-24403	402	7	cochrane	cochrane	NOUN
brj-24403	402	8	database	database	NOUN
brj-24403	402	9	of	of	ADP
brj-24403	402	10	systematic	systematic	ADJ
brj-24403	402	11	reviews	review	NOUN
brj-24403	402	12	2019(3	2019(3	NUM
brj-24403	402	13	)	)	PUNCT
brj-24403	402	14	.	.	PUNCT
brj-24403	403	1	doi	doi	NOUN
brj-24403	403	2	:	:	PUNCT
brj-24403	403	3	10.1002/14651858.cd003154.pub6	10.1002/14651858.cd003154.pub6	NUM
brj-24403	403	4	moosa	moosa	PROPN
brj-24403	403	5	,	,	PUNCT
brj-24403	403	6	a.	a.	PROPN
brj-24403	403	7	n.	n.	PROPN
brj-24403	403	8	v.	v.	PROPN
brj-24403	403	9	(	(	PUNCT
brj-24403	403	10	2019	2019	NUM
brj-24403	403	11	)	)	PUNCT
brj-24403	403	12	.	.	PUNCT
brj-24403	404	1	“	"	PUNCT
brj-24403	404	2	antiepileptic	antiepileptic	ADJ
brj-24403	404	3	drug	drug	NOUN
brj-24403	404	4	treatment	treatment	NOUN
brj-24403	404	5	of	of	ADP
brj-24403	404	6	epilepsy	epilepsy	NOUN
brj-24403	404	7	in	in	ADP
brj-24403	404	8	children	child	NOUN
brj-24403	404	9	,	,	PUNCT
brj-24403	404	10	”	"	PUNCT
brj-24403	404	11	continuum	continuum	ADJ
brj-24403	404	12	lifelong	lifelong	ADJ
brj-24403	404	13	learning	learning	NOUN
brj-24403	404	14	in	in	ADP
brj-24403	404	15	neurology	neurology	NOUN
brj-24403	404	16	25(2	25(2	NUM
brj-24403	404	17	)	)	PUNCT
brj-24403	404	18	,	,	PUNCT
brj-24403	404	19	381	381	NUM
brj-24403	404	20	-	-	SYM
brj-24403	404	21	407	407	NUM
brj-24403	404	22	.	.	PUNCT
brj-24403	405	1	doi	doi	NOUN
brj-24403	405	2	:	:	PUNCT
brj-24403	405	3	10.1212	10.1212	NUM
brj-24403	405	4	/	/	SYM
brj-24403	405	5	con.0000000000000712	con.0000000000000712	ADJ
brj-24403	405	6	nobre	nobre	X
brj-24403	405	7	,	,	PUNCT
brj-24403	405	8	h.	h.	PROPN
brj-24403	405	9	v.	v.	PROPN
brj-24403	405	10	,	,	PUNCT
brj-24403	405	11	fonteles	fontele	NOUN
brj-24403	405	12	,	,	PUNCT
brj-24403	405	13	m.	m.	NOUN
brj-24403	405	14	m.	m.	PROPN
brj-24403	405	15	d.	d.	PROPN
brj-24403	405	16	f.	f.	PROPN
brj-24403	405	17	,	,	PUNCT
brj-24403	405	18	and	and	CCONJ
brj-24403	405	19	de	de	ADP
brj-24403	405	20	freitas	freitas	PROPN
brj-24403	405	21	,	,	PUNCT
brj-24403	405	22	r.	r.	PROPN
brj-24403	405	23	m.	m.	PROPN
brj-24403	405	24	de	de	PROPN
brj-24403	405	25	.	.	PROPN
brj-24403	405	26	(	(	PUNCT
brj-24403	405	27	2009	2009	NUM
brj-24403	405	28	)	)	PUNCT
brj-24403	405	29	.	.	PUNCT
brj-24403	406	1	“	"	PUNCT
brj-24403	406	2	acute	acute	ADJ
brj-24403	406	3	seizure	seizure	NOUN
brj-24403	406	4	activity	activity	NOUN
brj-24403	406	5	promotes	promote	VERB
brj-24403	406	6	lipid	lipid	NOUN
brj-24403	406	7	peroxidation	peroxidation	NOUN
brj-24403	406	8	,	,	PUNCT
brj-24403	406	9	increased	increase	VERB
brj-24403	406	10	nitrite	nitrite	NOUN
brj-24403	406	11	levels	level	NOUN
brj-24403	406	12	and	and	CCONJ
brj-24403	406	13	adaptive	adaptive	ADJ
brj-24403	406	14	pathways	pathway	NOUN
brj-24403	406	15	against	against	ADP
brj-24403	406	16	oxidative	oxidative	ADJ
brj-24403	406	17	stress	stress	NOUN
brj-24403	406	18	in	in	ADP
brj-24403	406	19	the	the	DET
brj-24403	406	20	frontal	frontal	ADJ
brj-24403	406	21	cortex	cortex	NOUN
brj-24403	406	22	and	and	CCONJ
brj-24403	406	23	striatum	striatum	NOUN
brj-24403	406	24	,	,	PUNCT
brj-24403	406	25	”	"	PUNCT
brj-24403	406	26	oxidative	oxidative	ADJ
brj-24403	406	27	medicine	medicine	NOUN
brj-24403	406	28	and	and	CCONJ
brj-24403	406	29	cellular	cellular	ADJ
brj-24403	406	30	longevity	longevity	NOUN
brj-24403	406	31	2(3	2(3	NUM
brj-24403	406	32	)	)	PUNCT
brj-24403	406	33	,	,	PUNCT
brj-24403	406	34	article	article	NOUN
brj-24403	406	35	8488	8488	NUM
brj-24403	406	36	.	.	PUNCT
brj-24403	407	1	doi	doi	NOUN
brj-24403	407	2	:	:	PUNCT
brj-24403	407	3	10.4161	10.4161	NUM
brj-24403	407	4	/	/	SYM
brj-24403	407	5	oxim.2.3.8488	oxim.2.3.8488	NOUN
brj-24403	407	6	rodrigues	rodrigue	NOUN
brj-24403	407	7	,	,	PUNCT
brj-24403	407	8	a.	a.	PROPN
brj-24403	407	9	d.	d.	PROPN
brj-24403	407	10	,	,	PUNCT
brj-24403	407	11	scheffel	scheffel	ADJ
brj-24403	407	12	,	,	PUNCT
brj-24403	407	13	t.	t.	PROPN
brj-24403	407	14	b.	b.	PROPN
brj-24403	407	15	,	,	PUNCT
brj-24403	407	16	scola	scola	PROPN
brj-24403	407	17	,	,	PUNCT
brj-24403	407	18	g.	g.	PROPN
brj-24403	407	19	,	,	PUNCT
brj-24403	407	20	dos	do	NOUN
brj-24403	407	21	santos	santo	NOUN
brj-24403	407	22	,	,	PUNCT
brj-24403	407	23	m.	m.	NOUN
brj-24403	407	24	t.	t.	PROPN
brj-24403	407	25	,	,	PUNCT
brj-24403	407	26	fank	fank	PROPN
brj-24403	407	27	,	,	PUNCT
brj-24403	407	28	b.	b.	PROPN
brj-24403	407	29	,	,	PUNCT
brj-24403	407	30	dani	dani	PROPN
brj-24403	407	31	,	,	PUNCT
brj-24403	407	32	c.	c.	PROPN
brj-24403	407	33	,	,	PUNCT
brj-24403	407	34	vanderlinde	vanderlinde	PROPN
brj-24403	407	35	,	,	PUNCT
brj-24403	407	36	r.	r.	PROPN
brj-24403	407	37	,	,	PUNCT
brj-24403	407	38	henriques	henrique	NOUN
brj-24403	407	39	,	,	PUNCT
brj-24403	407	40	j.	j.	PROPN
brj-24403	407	41	a.	a.	PROPN
brj-24403	407	42	p.	p.	PROPN
brj-24403	407	43	,	,	PUNCT
brj-24403	407	44	coitinho	coitinho	NOUN
brj-24403	407	45	,	,	PUNCT
brj-24403	407	46	a.	a.	PROPN
brj-24403	407	47	s.	s.	PROPN
brj-24403	407	48	,	,	PUNCT
brj-24403	407	49	and	and	CCONJ
brj-24403	407	50	salvador	salvador	NOUN
brj-24403	407	51	,	,	PUNCT
brj-24403	407	52	m.	m.	NOUN
brj-24403	407	53	(	(	PUNCT
brj-24403	407	54	2013	2013	NUM
brj-24403	407	55	)	)	PUNCT
brj-24403	407	56	.	.	PUNCT
brj-24403	408	1	“	"	PUNCT
brj-24403	408	2	purple	purple	ADJ
brj-24403	408	3	grape	grape	NOUN
brj-24403	408	4	juices	juice	NOUN
brj-24403	408	5	prevent	prevent	VERB
brj-24403	408	6	pentylenetetrazol	pentylenetetrazol	NOUN
brj-24403	408	7	-	-	PUNCT
brj-24403	408	8	induced	induce	VERB
brj-24403	408	9	oxidative	oxidative	ADJ
brj-24403	408	10	damage	damage	NOUN
brj-24403	408	11	in	in	ADP
brj-24403	408	12	the	the	DET
brj-24403	408	13	liver	liver	NOUN
brj-24403	408	14	and	and	CCONJ
brj-24403	408	15	serum	serum	NOUN
brj-24403	408	16	of	of	ADP
brj-24403	408	17	wistar	wistar	PROPN
brj-24403	408	18	rats	rat	NOUN
brj-24403	408	19	,	,	PUNCT
brj-24403	408	20	”	"	PUNCT
brj-24403	408	21	nutrition	nutrition	NOUN
brj-24403	408	22	research	research	NOUN
brj-24403	408	23	33(2	33(2	NUM
brj-24403	408	24	)	)	PUNCT
brj-24403	408	25	.	.	PUNCT
brj-24403	409	1	doi	doi	NOUN
brj-24403	409	2	:	:	PUNCT
brj-24403	409	3	10.1016	10.1016	NUM
brj-24403	409	4	/	/	SYM
brj-24403	409	5	j.nutres.2012.12.002	j.nutres.2012.12.002	PROPN
brj-24403	409	6	rodrigues	rodrigues	PROPN
brj-24403	409	7	,	,	PUNCT
brj-24403	409	8	a.	a.	PROPN
brj-24403	409	9	d.	d.	PROPN
brj-24403	409	10	,	,	PUNCT
brj-24403	409	11	scheffel	scheffel	ADJ
brj-24403	409	12	,	,	PUNCT
brj-24403	409	13	t.	t.	PROPN
brj-24403	409	14	b.	b.	PROPN
brj-24403	409	15	,	,	PUNCT
brj-24403	409	16	scola	scola	PROPN
brj-24403	409	17	,	,	PUNCT
brj-24403	409	18	g.	g.	PROPN
brj-24403	409	19	,	,	PUNCT
brj-24403	409	20	santos	santos	PROPN
brj-24403	409	21	,	,	PUNCT
brj-24403	409	22	m.	m.	NOUN
brj-24403	409	23	t.	t.	PROPN
brj-24403	409	24	dos	dos	PROPN
brj-24403	409	25	,	,	PUNCT
brj-24403	409	26	fank	fank	PROPN
brj-24403	409	27	,	,	PUNCT
brj-24403	409	28	b.	b.	PROPN
brj-24403	409	29	,	,	PUNCT
brj-24403	409	30	de	de	PROPN
brj-24403	409	31	freitas	freitas	PROPN
brj-24403	409	32	,	,	PUNCT
brj-24403	409	33	s.	s.	PROPN
brj-24403	409	34	c.	c.	PROPN
brj-24403	409	35	v.	v.	PROPN
brj-24403	409	36	,	,	PUNCT
brj-24403	409	37	dani	dani	PROPN
brj-24403	409	38	,	,	PUNCT
brj-24403	409	39	c.	c.	PROPN
brj-24403	409	40	,	,	PUNCT
brj-24403	409	41	vanderlinde	vanderlinde	PROPN
brj-24403	409	42	,	,	PUNCT
brj-24403	409	43	r.	r.	PROPN
brj-24403	409	44	,	,	PUNCT
brj-24403	409	45	henriques	henrique	NOUN
brj-24403	409	46	,	,	PUNCT
brj-24403	409	47	j.	j.	PROPN
brj-24403	409	48	a.	a.	PROPN
brj-24403	409	49	p.	p.	PROPN
brj-24403	409	50	,	,	PUNCT
brj-24403	409	51	coitinho	coitinho	NOUN
brj-24403	409	52	,	,	PUNCT
brj-24403	409	53	a.	a.	PROPN
brj-24403	409	54	s.	s.	PROPN
brj-24403	409	55	,	,	PUNCT
brj-24403	409	56	and	and	CCONJ
brj-24403	409	57	salvador	salvador	NOUN
brj-24403	409	58	,	,	PUNCT
brj-24403	409	59	m.	m.	NOUN
brj-24403	409	60	(	(	PUNCT
brj-24403	409	61	2012	2012	NUM
brj-24403	409	62	)	)	PUNCT
brj-24403	409	63	.	.	PUNCT
brj-24403	410	1	“	"	PUNCT
brj-24403	410	2	neuroprotective	neuroprotective	ADJ
brj-24403	410	3	and	and	CCONJ
brj-24403	410	4	anticonvulsant	anticonvulsant	ADJ
brj-24403	410	5	effects	effect	NOUN
brj-24403	410	6	of	of	ADP
brj-24403	410	7	organic	organic	ADJ
brj-24403	410	8	and	and	CCONJ
brj-24403	410	9	conventional	conventional	ADJ
brj-24403	410	10	purple	purple	ADJ
brj-24403	410	11	grape	grape	NOUN
brj-24403	410	12	juices	juice	NOUN
brj-24403	410	13	on	on	ADP
brj-24403	410	14	seizures	seizure	NOUN
brj-24403	410	15	in	in	ADP
brj-24403	410	16	wistar	wistar	PROPN
brj-24403	410	17	rats	rat	NOUN
brj-24403	410	18	induced	induce	VERB
brj-24403	410	19	by	by	ADP
brj-24403	410	20	pentylenetetrazole	pentylenetetrazole	NOUN
brj-24403	410	21	,	,	PUNCT
brj-24403	410	22	”	"	PUNCT
brj-24403	410	23	neurochemistry	neurochemistry	PROPN
brj-24403	410	24	international	international	PROPN
brj-24403	410	25	60(8	60(8	NUM
brj-24403	410	26	)	)	PUNCT
brj-24403	410	27	.	.	PUNCT
brj-24403	411	1	doi	doi	NOUN
brj-24403	411	2	:	:	PUNCT
brj-24403	411	3	10.1016	10.1016	NUM
brj-24403	411	4	/	/	SYM
brj-24403	411	5	j.neuint.2012.01.009	j.neuint.2012.01.009	PROPN
brj-24403	411	6	saklani	saklani	PROPN
brj-24403	411	7	,	,	PUNCT
brj-24403	411	8	a.	a.	NOUN
brj-24403	411	9	,	,	PUNCT
brj-24403	411	10	and	and	CCONJ
brj-24403	411	11	kutty	kutty	PROPN
brj-24403	411	12	,	,	PUNCT
brj-24403	411	13	s.	s.	PROPN
brj-24403	411	14	k.	k.	PROPN
brj-24403	411	15	(	(	PUNCT
brj-24403	411	16	2008	2008	NUM
brj-24403	411	17	)	)	PUNCT
brj-24403	411	18	.	.	PUNCT
brj-24403	412	1	“	"	PUNCT
brj-24403	412	2	plant	plant	NOUN
brj-24403	412	3	-	-	PUNCT
brj-24403	412	4	derived	derive	VERB
brj-24403	412	5	compounds	compound	NOUN
brj-24403	412	6	in	in	ADP
brj-24403	412	7	clinical	clinical	ADJ
brj-24403	412	8	trials	trial	NOUN
brj-24403	412	9	,	,	PUNCT
brj-24403	412	10	”	"	PUNCT
brj-24403	412	11	drug	drug	NOUN
brj-24403	412	12	discovery	discovery	NOUN
brj-24403	412	13	today	today	NOUN
brj-24403	412	14	13(3	13(3	NUM
brj-24403	412	15	-	-	PUNCT
brj-24403	412	16	4	4	NUM
brj-24403	412	17	)	)	PUNCT
brj-24403	412	18	,	,	PUNCT
brj-24403	412	19	161	161	NUM
brj-24403	412	20	-	-	SYM
brj-24403	412	21	171	171	NUM
brj-24403	412	22	.	.	PUNCT
brj-24403	413	1	doi	doi	NOUN
brj-24403	413	2	:	:	PUNCT
brj-24403	413	3	10.1016	10.1016	NUM
brj-24403	413	4	/	/	SYM
brj-24403	413	5	j.drudis.2007.10.010	j.drudis.2007.10.010	NOUN
brj-24403	413	6	sanz	sanz	PROPN
brj-24403	413	7	-	-	PUNCT
brj-24403	413	8	novo	novo	PROPN
brj-24403	413	9	,	,	PUNCT
brj-24403	413	10	m.	m.	NOUN
brj-24403	413	11	,	,	PUNCT
brj-24403	413	12	kolesniková	kolesniková	PROPN
brj-24403	413	13	,	,	PUNCT
brj-24403	413	14	l.	l.	PROPN
brj-24403	413	15	,	,	PUNCT
brj-24403	413	16	insausti	insausti	PROPN
brj-24403	413	17	,	,	PUNCT
brj-24403	413	18	a.	a.	NOUN
brj-24403	413	19	,	,	PUNCT
brj-24403	413	20	alonso	alonso	PROPN
brj-24403	413	21	,	,	PUNCT
brj-24403	413	22	j.	j.	PROPN
brj-24403	413	23	l.	l.	PROPN
brj-24403	413	24	,	,	PUNCT
brj-24403	413	25	león	león	PROPN
brj-24403	413	26	,	,	PUNCT
brj-24403	413	27	i.	i.	NOUN
brj-24403	413	28	,	,	PUNCT
brj-24403	413	29	and	and	CCONJ
brj-24403	413	30	alonso	alonso	PROPN
brj-24403	413	31	,	,	PUNCT
brj-24403	413	32	e.	e.	PROPN
brj-24403	413	33	r.	r.	PROPN
brj-24403	413	34	(	(	PUNCT
brj-24403	413	35	2023	2023	NUM
brj-24403	413	36	)	)	PUNCT
brj-24403	413	37	.	.	PUNCT
brj-24403	414	1	“	"	PUNCT
brj-24403	414	2	a	a	DET
brj-24403	414	3	journey	journey	NOUN
brj-24403	414	4	across	across	ADP
brj-24403	414	5	dopamine	dopamine	NOUN
brj-24403	414	6	metabolism	metabolism	NOUN
brj-24403	414	7	:	:	PUNCT
brj-24403	414	8	a	a	DET
brj-24403	414	9	rotational	rotational	ADJ
brj-24403	414	10	study	study	NOUN
brj-24403	414	11	of	of	ADP
brj-24403	414	12	dopac	dopac	PROPN
brj-24403	414	13	,	,	PUNCT
brj-24403	414	14	”	"	PUNCT
brj-24403	414	15	spectrochimica	spectrochimica	NOUN
brj-24403	414	16	acta	acta	PROPN
brj-24403	414	17	part	part	NOUN
brj-24403	414	18	a	a	DET
brj-24403	414	19	:	:	PUNCT
brj-24403	414	20	molecular	molecular	ADJ
brj-24403	414	21	and	and	CCONJ
brj-24403	414	22	biomolecular	biomolecular	ADJ
brj-24403	414	23	spectroscopy	spectroscopy	NOUN
brj-24403	414	24	290	290	NUM
brj-24403	414	25	,	,	PUNCT
brj-24403	414	26	article	article	NOUN
brj-24403	414	27	122303	122303	NUM
brj-24403	414	28	.	.	PUNCT
brj-24403	415	1	doi	doi	NOUN
brj-24403	415	2	:	:	PUNCT
brj-24403	415	3	10.1016	10.1016	NUM
brj-24403	415	4	/	/	SYM
brj-24403	415	5	j.saa.2022.122303	j.saa.2022.122303	PROPN
brj-24403	415	6	sanz	sanz	PROPN
brj-24403	415	7	-	-	PUNCT
brj-24403	415	8	novo	novo	PROPN
brj-24403	415	9	,	,	PUNCT
brj-24403	415	10	p.	p.	PROPN
brj-24403	415	11	,	,	PUNCT
brj-24403	415	12	perea	perea	PROPN
brj-24403	415	13	,	,	PUNCT
brj-24403	415	14	g.	g.	PROPN
brj-24403	415	15	,	,	PUNCT
brj-24403	415	16	and	and	CCONJ
brj-24403	415	17	martín	martín	PROPN
brj-24403	415	18	,	,	PUNCT
brj-24403	415	19	e.	e.	PROPN
brj-24403	415	20	d.	d.	PROPN
brj-24403	415	21	(	(	PUNCT
brj-24403	415	22	2023	2023	NUM
brj-24403	415	23	)	)	PUNCT
brj-24403	415	24	.	.	PUNCT
brj-24403	416	1	“	"	PUNCT
brj-24403	416	2	dopamine	dopamine	NOUN
brj-24403	416	3	signaling	signal	VERB
brj-24403	416	4	in	in	ADP
brj-24403	416	5	epilepsy	epilepsy	NOUN
brj-24403	416	6	:	:	PUNCT
brj-24403	416	7	emerging	emerge	VERB
brj-24403	416	8	roles	role	NOUN
brj-24403	416	9	and	and	CCONJ
brj-24403	416	10	therapeutic	therapeutic	ADJ
brj-24403	416	11	implications	implication	NOUN
brj-24403	416	12	,	,	PUNCT
brj-24403	416	13	”	"	PUNCT
brj-24403	416	14	neuropharmacology	neuropharmacology	NOUN
brj-24403	416	15	234	234	NUM
brj-24403	416	16	,	,	PUNCT
brj-24403	416	17	article	article	NOUN
brj-24403	416	18	peer	peer	NOUN
brj-24403	416	19	-	-	PUNCT
brj-24403	416	20	reviewed	review	VERB
brj-24403	416	21	article	article	NOUN
brj-24403	416	22	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	416	23	li	li	PROPN
brj-24403	416	24	et	et	PROPN
brj-24403	416	25	al	al	PROPN
brj-24403	416	26	.	.	PROPN
brj-24403	417	1	(	(	PUNCT
brj-24403	417	2	2025	2025	NUM
brj-24403	417	3	)	)	PUNCT
brj-24403	417	4	.	.	PUNCT
brj-24403	418	1	“	"	PUNCT
brj-24403	418	2	herbal	herbal	ADJ
brj-24403	418	3	anti	anti	ADJ
brj-24403	418	4	-	-	ADJ
brj-24403	418	5	epileptic	epileptic	ADJ
brj-24403	418	6	extract	extract	NOUN
brj-24403	418	7	,	,	PUNCT
brj-24403	418	8	”	"	PUNCT
brj-24403	418	9	bioresources	bioresource	NOUN
brj-24403	418	10	20(2	20(2	NUM
brj-24403	418	11	)	)	PUNCT
brj-24403	418	12	,	,	PUNCT
brj-24403	418	13	4701	4701	NUM
brj-24403	418	14	-	-	SYM
brj-24403	418	15	4719	4719	NUM
brj-24403	418	16	.	.	PUNCT
brj-24403	418	17	4718	4718	NUM
brj-24403	418	18	109419	109419	NUM
brj-24403	418	19	.	.	PUNCT
brj-24403	419	1	doi	doi	NOUN
brj-24403	419	2	:	:	PUNCT
brj-24403	419	3	10.1016	10.1016	NUM
brj-24403	419	4	/	/	SYM
brj-24403	419	5	j.neuropharm.2023.109419	j.neuropharm.2023.109419	PROPN
brj-24403	419	6	scharfman	scharfman	PROPN
brj-24403	419	7	,	,	PUNCT
brj-24403	419	8	h.	h.	PROPN
brj-24403	419	9	e.	e.	PROPN
brj-24403	419	10	(	(	PUNCT
brj-24403	419	11	2007	2007	NUM
brj-24403	419	12	)	)	PUNCT
brj-24403	419	13	.	.	PUNCT
brj-24403	420	1	“	"	PUNCT
brj-24403	420	2	the	the	DET
brj-24403	420	3	neurobiology	neurobiology	NOUN
brj-24403	420	4	of	of	ADP
brj-24403	420	5	epilepsy	epilepsy	NOUN
brj-24403	420	6	,	,	PUNCT
brj-24403	420	7	”	"	PUNCT
brj-24403	420	8	current	current	ADJ
brj-24403	420	9	neurology	neurology	NOUN
brj-24403	420	10	and	and	CCONJ
brj-24403	420	11	neuroscience	neuroscience	NOUN
brj-24403	420	12	reports	report	NOUN
brj-24403	420	13	7(4	7(4	NUM
brj-24403	420	14	)	)	PUNCT
brj-24403	420	15	,	,	PUNCT
brj-24403	420	16	348	348	NUM
brj-24403	420	17	-	-	SYM
brj-24403	420	18	354	354	NUM
brj-24403	420	19	.	.	PUNCT
brj-24403	421	1	doi	doi	NOUN
brj-24403	421	2	:	:	PUNCT
brj-24403	421	3	10.1007	10.1007	NUM
brj-24403	421	4	/	/	SYM
brj-24403	421	5	s11910	s11910	NOUN
brj-24403	421	6	-	-	PUNCT
brj-24403	421	7	007	007	NUM
brj-24403	421	8	-	-	PUNCT
brj-24403	421	9	0053	0053	NUM
brj-24403	421	10	-	-	PUNCT
brj-24403	421	11	z	z	NOUN
brj-24403	421	12	sharifi	sharifi	NOUN
brj-24403	421	13	-	-	PUNCT
brj-24403	421	14	rad	rad	PROPN
brj-24403	421	15	,	,	PUNCT
brj-24403	421	16	j.	j.	PROPN
brj-24403	421	17	,	,	PUNCT
brj-24403	421	18	quispe	quispe	PROPN
brj-24403	421	19	,	,	PUNCT
brj-24403	421	20	c.	c.	NOUN
brj-24403	421	21	,	,	PUNCT
brj-24403	421	22	herrera	herrera	NOUN
brj-24403	421	23	-	-	PUNCT
brj-24403	421	24	bravo	bravo	PROPN
brj-24403	421	25	,	,	PUNCT
brj-24403	421	26	j.	j.	PROPN
brj-24403	421	27	,	,	PUNCT
brj-24403	421	28	martorell	martorell	PROPN
brj-24403	421	29	,	,	PUNCT
brj-24403	421	30	m.	m.	NOUN
brj-24403	421	31	,	,	PUNCT
brj-24403	421	32	sharopov	sharopov	PROPN
brj-24403	421	33	,	,	PUNCT
brj-24403	421	34	f.	f.	PROPN
brj-24403	421	35	,	,	PUNCT
brj-24403	421	36	tumer	tumer	NOUN
brj-24403	421	37	,	,	PUNCT
brj-24403	421	38	t.	t.	PROPN
brj-24403	421	39	b.	b.	PROPN
brj-24403	421	40	,	,	PUNCT
brj-24403	421	41	kurt	kurt	PROPN
brj-24403	421	42	,	,	PUNCT
brj-24403	421	43	b.	b.	PROPN
brj-24403	421	44	,	,	PUNCT
brj-24403	421	45	lankatillake	lankatillake	PROPN
brj-24403	421	46	,	,	PUNCT
brj-24403	421	47	c.	c.	PROPN
brj-24403	421	48	,	,	PUNCT
brj-24403	421	49	docea	docea	PROPN
brj-24403	421	50	,	,	PUNCT
brj-24403	421	51	a.	a.	NOUN
brj-24403	421	52	o.	o.	PROPN
brj-24403	421	53	,	,	PUNCT
brj-24403	421	54	moreira	moreira	PROPN
brj-24403	421	55	,	,	PUNCT
brj-24403	421	56	a.	a.	PROPN
brj-24403	421	57	c.	c.	PROPN
brj-24403	421	58	,	,	PUNCT
brj-24403	421	59	dias	dias	PROPN
brj-24403	421	60	,	,	PUNCT
brj-24403	421	61	d.	d.	PROPN
brj-24403	421	62	a.	a.	PROPN
brj-24403	421	63	,	,	PUNCT
brj-24403	421	64	mahomoodally	mahomoodally	ADV
brj-24403	421	65	,	,	PUNCT
brj-24403	421	66	m.	m.	PROPN
brj-24403	421	67	f.	f.	PROPN
brj-24403	421	68	,	,	PUNCT
brj-24403	421	69	lobine	lobine	PROPN
brj-24403	421	70	,	,	PUNCT
brj-24403	421	71	d.	d.	PROPN
brj-24403	421	72	,	,	PUNCT
brj-24403	421	73	cruz	cruz	NOUN
brj-24403	421	74	-	-	PUNCT
brj-24403	421	75	martins	martin	NOUN
brj-24403	421	76	,	,	PUNCT
brj-24403	421	77	n.	n.	NOUN
brj-24403	421	78	,	,	PUNCT
brj-24403	421	79	kumar	kumar	PROPN
brj-24403	421	80	,	,	PUNCT
brj-24403	421	81	m.	m.	NOUN
brj-24403	421	82	,	,	PUNCT
brj-24403	421	83	and	and	CCONJ
brj-24403	421	84	calina	calina	PROPN
brj-24403	421	85	,	,	PUNCT
brj-24403	421	86	d.	d.	PROPN
brj-24403	421	87	(	(	PUNCT
brj-24403	421	88	2021	2021	NUM
brj-24403	421	89	)	)	PUNCT
brj-24403	421	90	.	.	PUNCT
brj-24403	422	1	“	"	PUNCT
brj-24403	422	2	a	a	DET
brj-24403	422	3	pharmacological	pharmacological	ADJ
brj-24403	422	4	perspective	perspective	NOUN
brj-24403	422	5	on	on	ADP
brj-24403	422	6	plant	plant	NOUN
brj-24403	422	7	-	-	PUNCT
brj-24403	422	8	derived	derive	VERB
brj-24403	422	9	bioactive	bioactive	ADJ
brj-24403	422	10	molecules	molecule	NOUN
brj-24403	422	11	for	for	ADP
brj-24403	422	12	epilepsy	epilepsy	NOUN
brj-24403	422	13	,	,	PUNCT
brj-24403	422	14	”	"	PUNCT
brj-24403	422	15	neurochemical	neurochemical	ADJ
brj-24403	422	16	research	research	NOUN
brj-24403	422	17	46(9	46(9	NUM
brj-24403	422	18	)	)	PUNCT
brj-24403	422	19	.	.	PUNCT
brj-24403	423	1	doi	doi	NOUN
brj-24403	423	2	:	:	PUNCT
brj-24403	423	3	10.1007	10.1007	NUM
brj-24403	423	4	/	/	SYM
brj-24403	423	5	s11064	s11064	PROPN
brj-24403	423	6	-	-	PUNCT
brj-24403	423	7	021	021	NUM
brj-24403	423	8	-	-	PUNCT
brj-24403	423	9	03376	03376	NUM
brj-24403	423	10	-	-	SYM
brj-24403	423	11	0	0	NUM
brj-24403	423	12	shehta	shehta	NOUN
brj-24403	423	13	,	,	PUNCT
brj-24403	423	14	n.	n.	PROPN
brj-24403	423	15	,	,	PUNCT
brj-24403	423	16	kamel	kamel	PROPN
brj-24403	423	17	,	,	PUNCT
brj-24403	423	18	a.	a.	PROPN
brj-24403	423	19	e.	e.	PROPN
brj-24403	423	20	,	,	PUNCT
brj-24403	423	21	sobhy	sobhy	PROPN
brj-24403	423	22	,	,	PUNCT
brj-24403	423	23	e.	e.	PROPN
brj-24403	423	24	,	,	PUNCT
brj-24403	423	25	and	and	CCONJ
brj-24403	423	26	ismail	ismail	PROPN
brj-24403	423	27	,	,	PUNCT
brj-24403	423	28	m.	m.	NOUN
brj-24403	423	29	h.	h.	PROPN
brj-24403	423	30	(	(	PUNCT
brj-24403	423	31	2022	2022	NUM
brj-24403	423	32	)	)	PUNCT
brj-24403	423	33	.	.	PUNCT
brj-24403	424	1	“	"	PUNCT
brj-24403	424	2	malondialdehyde	malondialdehyde	NOUN
brj-24403	424	3	and	and	CCONJ
brj-24403	424	4	superoxide	superoxide	NOUN
brj-24403	424	5	dismutase	dismutase	NOUN
brj-24403	424	6	levels	level	NOUN
brj-24403	424	7	in	in	ADP
brj-24403	424	8	patients	patient	NOUN
brj-24403	424	9	with	with	ADP
brj-24403	424	10	epilepsy	epilepsy	NOUN
brj-24403	424	11	:	:	PUNCT
brj-24403	424	12	a	a	DET
brj-24403	424	13	case	case	NOUN
brj-24403	424	14	–	–	PUNCT
brj-24403	424	15	control	control	NOUN
brj-24403	424	16	study	study	NOUN
brj-24403	424	17	,	,	PUNCT
brj-24403	424	18	”	"	PUNCT
brj-24403	424	19	egyptian	egyptian	ADJ
brj-24403	424	20	journal	journal	PROPN
brj-24403	424	21	of	of	ADP
brj-24403	424	22	neurology	neurology	NOUN
brj-24403	424	23	,	,	PUNCT
brj-24403	424	24	psychiatry	psychiatry	NOUN
brj-24403	424	25	and	and	CCONJ
brj-24403	424	26	neurosurgery	neurosurgery	NOUN
brj-24403	424	27	58(1	58(1	NUM
brj-24403	424	28	)	)	PUNCT
brj-24403	424	29	.	.	PUNCT
brj-24403	425	1	doi	doi	NOUN
brj-24403	425	2	:	:	PUNCT
brj-24403	425	3	10.1186	10.1186	NUM
brj-24403	425	4	/	/	SYM
brj-24403	425	5	s41983	s41983	NOUN
brj-24403	425	6	-	-	PUNCT
brj-24403	425	7	022	022	NUM
brj-24403	425	8	-	-	PUNCT
brj-24403	425	9	00479	00479	NUM
brj-24403	425	10	-	-	SYM
brj-24403	425	11	5	5	NUM
brj-24403	425	12	soni	soni	NOUN
brj-24403	425	13	,	,	PUNCT
brj-24403	425	14	r.	r.	PROPN
brj-24403	425	15	k.	k.	PROPN
brj-24403	425	16	,	,	PUNCT
brj-24403	425	17	dixit	dixit	PROPN
brj-24403	425	18	,	,	PUNCT
brj-24403	425	19	v.	v.	PROPN
brj-24403	425	20	,	,	PUNCT
brj-24403	425	21	and	and	CCONJ
brj-24403	425	22	alok	alok	PROPN
brj-24403	425	23	,	,	PUNCT
brj-24403	425	24	s.	s.	PROPN
brj-24403	425	25	(	(	PUNCT
brj-24403	425	26	2014	2014	NUM
brj-24403	425	27	)	)	PUNCT
brj-24403	425	28	.	.	PUNCT
brj-24403	426	1	“	"	PUNCT
brj-24403	426	2	callicarpa	callicarpa	ADJ
brj-24403	426	3	macrophylla	macrophylla	NOUN
brj-24403	426	4	:	:	PUNCT
brj-24403	426	5	a	a	DET
brj-24403	426	6	review	review	NOUN
brj-24403	426	7	update	update	NOUN
brj-24403	426	8	on	on	ADP
brj-24403	426	9	its	its	PRON
brj-24403	426	10	botany	botany	NOUN
brj-24403	426	11	,	,	PUNCT
brj-24403	426	12	ethnobotany	ethnobotany	NOUN
brj-24403	426	13	,	,	PUNCT
brj-24403	426	14	phytochemistry	phytochemistry	NOUN
brj-24403	426	15	and	and	CCONJ
brj-24403	426	16	pharmacology	pharmacology	NOUN
brj-24403	426	17	,	,	PUNCT
brj-24403	426	18	”	"	PUNCT
brj-24403	426	19	international	international	ADJ
brj-24403	426	20	journal	journal	NOUN
brj-24403	426	21	of	of	ADP
brj-24403	426	22	pharmacognosy	pharmacognosy	PROPN
brj-24403	426	23	1(2	1(2	NUM
brj-24403	426	24	)	)	PUNCT
brj-24403	426	25	.	.	PUNCT
brj-24403	427	1	sudha	sudha	PROPN
brj-24403	427	2	,	,	PUNCT
brj-24403	427	3	k.	k.	PROPN
brj-24403	427	4	,	,	PUNCT
brj-24403	427	5	rao	rao	PROPN
brj-24403	427	6	,	,	PUNCT
brj-24403	427	7	a.	a.	NOUN
brj-24403	427	8	v.	v.	PROPN
brj-24403	427	9	,	,	PUNCT
brj-24403	427	10	and	and	CCONJ
brj-24403	427	11	rao	rao	PROPN
brj-24403	427	12	,	,	PUNCT
brj-24403	427	13	a.	a.	NOUN
brj-24403	427	14	(	(	PUNCT
brj-24403	427	15	2001	2001	NUM
brj-24403	427	16	)	)	PUNCT
brj-24403	427	17	.	.	PUNCT
brj-24403	428	1	“	"	PUNCT
brj-24403	428	2	oxidative	oxidative	ADJ
brj-24403	428	3	stress	stress	NOUN
brj-24403	428	4	and	and	CCONJ
brj-24403	428	5	antioxidants	antioxidant	NOUN
brj-24403	428	6	in	in	ADP
brj-24403	428	7	epilepsy	epilepsy	NOUN
brj-24403	428	8	,	,	PUNCT
brj-24403	428	9	”	"	PUNCT
brj-24403	428	10	clinica	clinica	PROPN
brj-24403	428	11	chimica	chimica	PROPN
brj-24403	428	12	acta	acta	PROPN
brj-24403	428	13	303(1	303(1	PROPN
brj-24403	428	14	-	-	SYM
brj-24403	428	15	2	2	NUM
brj-24403	428	16	)	)	PUNCT
brj-24403	428	17	.	.	PUNCT
brj-24403	429	1	doi	doi	NOUN
brj-24403	429	2	:	:	PUNCT
brj-24403	429	3	10.1016	10.1016	NUM
brj-24403	429	4	/	/	SYM
brj-24403	429	5	s0009	s0009	PROPN
brj-24403	429	6	-	-	PUNCT
brj-24403	429	7	8981(00)00337	8981(00)00337	NUM
brj-24403	429	8	-	-	SYM
brj-24403	429	9	5	5	NUM
brj-24403	429	10	turski	turski	NOUN
brj-24403	429	11	,	,	PUNCT
brj-24403	429	12	w.	w.	PROPN
brj-24403	429	13	a.	a.	PROPN
brj-24403	429	14	,	,	PUNCT
brj-24403	429	15	cavalheiro	cavalheiro	NOUN
brj-24403	429	16	,	,	PUNCT
brj-24403	429	17	e.	e.	PROPN
brj-24403	429	18	a.	a.	PROPN
brj-24403	429	19	,	,	PUNCT
brj-24403	429	20	mello	mello	PROPN
brj-24403	429	21	,	,	PUNCT
brj-24403	429	22	l.	l.	PROPN
brj-24403	429	23	g.	g.	PROPN
brj-24403	429	24	,	,	PUNCT
brj-24403	429	25	schwartzkroin	schwartzkroin	VERB
brj-24403	429	26	,	,	PUNCT
brj-24403	429	27	p.	p.	NOUN
brj-24403	429	28	a.	a.	NOUN
brj-24403	429	29	,	,	PUNCT
brj-24403	429	30	and	and	CCONJ
brj-24403	429	31	almeida	almeida	PROPN
brj-24403	429	32	,	,	PUNCT
brj-24403	429	33	h.	h.	PROPN
brj-24403	429	34	w.	w.	PROPN
brj-24403	429	35	(	(	PUNCT
brj-24403	429	36	1983	1983	NUM
brj-24403	429	37	)	)	PUNCT
brj-24403	429	38	.	.	PUNCT
brj-24403	430	1	“	"	PUNCT
brj-24403	430	2	pilocarpine	pilocarpine	NOUN
brj-24403	430	3	-	-	PUNCT
brj-24403	430	4	induced	induce	VERB
brj-24403	430	5	seizures	seizure	NOUN
brj-24403	430	6	in	in	ADP
brj-24403	430	7	rats	rat	NOUN
brj-24403	430	8	:	:	PUNCT
brj-24403	430	9	a	a	DET
brj-24403	430	10	model	model	NOUN
brj-24403	430	11	of	of	ADP
brj-24403	430	12	temporal	temporal	ADJ
brj-24403	430	13	lobe	lobe	NOUN
brj-24403	430	14	epilepsy	epilepsy	NOUN
brj-24403	430	15	,	,	PUNCT
brj-24403	430	16	”	"	PUNCT
brj-24403	430	17	brain	brain	NOUN
brj-24403	430	18	research	research	NOUN
brj-24403	430	19	263	263	NUM
brj-24403	430	20	,	,	PUNCT
brj-24403	430	21	199	199	NUM
brj-24403	430	22	-	-	SYM
brj-24403	430	23	207	207	NUM
brj-24403	430	24	.	.	PUNCT
brj-24403	431	1	doi	doi	NOUN
brj-24403	431	2	:	:	PUNCT
brj-24403	431	3	10.1016/0006	10.1016/0006	NUM
brj-24403	431	4	-	-	SYM
brj-24403	431	5	8993(83)90175	8993(83)90175	NUM
brj-24403	431	6	-	-	PUNCT
brj-24403	431	7	2	2	NUM
brj-24403	431	8	.	.	PUNCT
brj-24403	432	1	turski	turski	PROPN
brj-24403	432	2	,	,	PUNCT
brj-24403	432	3	l.	l.	PROPN
brj-24403	432	4	,	,	PUNCT
brj-24403	432	5	ikonomidou	ikonomidou	NOUN
brj-24403	432	6	,	,	PUNCT
brj-24403	432	7	c.	c.	PROPN
brj-24403	432	8	,	,	PUNCT
brj-24403	432	9	turski	turski	PROPN
brj-24403	432	10	,	,	PUNCT
brj-24403	432	11	w.	w.	PROPN
brj-24403	432	12	a.	a.	PROPN
brj-24403	432	13	,	,	PUNCT
brj-24403	432	14	bortolotto	bortolotto	PROPN
brj-24403	432	15	,	,	PUNCT
brj-24403	432	16	z.	z.	PROPN
brj-24403	432	17	a.	a.	PROPN
brj-24403	432	18	,	,	PUNCT
brj-24403	432	19	and	and	CCONJ
brj-24403	432	20	cavalheiro	cavalheiro	NOUN
brj-24403	432	21	,	,	PUNCT
brj-24403	432	22	e.	e.	PROPN
brj-24403	432	23	a.	a.	PROPN
brj-24403	432	24	(	(	PUNCT
brj-24403	432	25	1989	1989	NUM
brj-24403	432	26	)	)	PUNCT
brj-24403	432	27	.	.	PUNCT
brj-24403	433	1	“	"	PUNCT
brj-24403	433	2	review	review	NOUN
brj-24403	433	3	:	:	PUNCT
brj-24403	433	4	cholinergic	cholinergic	ADJ
brj-24403	433	5	mechanisms	mechanism	NOUN
brj-24403	433	6	and	and	CCONJ
brj-24403	433	7	epileptogenesis	epileptogenesis	NOUN
brj-24403	433	8	.	.	PUNCT
brj-24403	434	1	the	the	DET
brj-24403	434	2	seizures	seizure	NOUN
brj-24403	434	3	induced	induce	VERB
brj-24403	434	4	by	by	ADP
brj-24403	434	5	pilocarpine	pilocarpine	NOUN
brj-24403	434	6	:	:	PUNCT
brj-24403	434	7	a	a	DET
brj-24403	434	8	novel	novel	ADJ
brj-24403	434	9	experimental	experimental	ADJ
brj-24403	434	10	model	model	NOUN
brj-24403	434	11	of	of	ADP
brj-24403	434	12	intractable	intractable	ADJ
brj-24403	434	13	epilepsy	epilepsy	NOUN
brj-24403	434	14	,	,	PUNCT
brj-24403	434	15	”	"	PUNCT
brj-24403	434	16	synapse	synapse	VERB
brj-24403	434	17	3(2	3(2	NUM
brj-24403	434	18	)	)	PUNCT
brj-24403	434	19	,	,	PUNCT
brj-24403	434	20	154	154	NUM
brj-24403	434	21	-	-	SYM
brj-24403	434	22	171	171	NUM
brj-24403	434	23	.	.	PUNCT
brj-24403	435	1	doi	doi	NOUN
brj-24403	435	2	:	:	PUNCT
brj-24403	435	3	10.1002	10.1002	NUM
brj-24403	435	4	/	/	SYM
brj-24403	435	5	syn.890030207	syn.890030207	NOUN
brj-24403	435	6	waldbaum	waldbaum	ADV
brj-24403	435	7	,	,	PUNCT
brj-24403	435	8	s.	s.	PROPN
brj-24403	435	9	,	,	PUNCT
brj-24403	435	10	and	and	CCONJ
brj-24403	435	11	patel	patel	NOUN
brj-24403	435	12	,	,	PUNCT
brj-24403	435	13	m.	m.	NOUN
brj-24403	435	14	(	(	PUNCT
brj-24403	435	15	2010	2010	NUM
brj-24403	435	16	)	)	PUNCT
brj-24403	435	17	.	.	PUNCT
brj-24403	436	1	“	"	PUNCT
brj-24403	436	2	mitochondria	mitochondria	NOUN
brj-24403	436	3	,	,	PUNCT
brj-24403	436	4	oxidative	oxidative	ADJ
brj-24403	436	5	stress	stress	NOUN
brj-24403	436	6	,	,	PUNCT
brj-24403	436	7	and	and	CCONJ
brj-24403	436	8	temporal	temporal	ADJ
brj-24403	436	9	lobe	lobe	ADJ
brj-24403	436	10	epilepsy	epilepsy	NOUN
brj-24403	436	11	,	,	PUNCT
brj-24403	436	12	”	"	PUNCT
brj-24403	436	13	epilepsy	epilepsy	PROPN
brj-24403	436	14	research	research	NOUN
brj-24403	436	15	88(1	88(1	NOUN
brj-24403	436	16	)	)	PUNCT
brj-24403	436	17	,	,	PUNCT
brj-24403	436	18	23	23	NUM
brj-24403	436	19	-	-	SYM
brj-24403	436	20	45	45	NUM
brj-24403	436	21	.	.	PUNCT
brj-24403	437	1	doi	doi	NOUN
brj-24403	437	2	:	:	PUNCT
brj-24403	437	3	10.1016	10.1016	NUM
brj-24403	437	4	/	/	SYM
brj-24403	437	5	j.eplepsyres.2009.09.020	j.eplepsyres.2009.09.020	PROPN
brj-24403	437	6	wang	wang	PROPN
brj-24403	437	7	,	,	PUNCT
brj-24403	437	8	h.	h.	PROPN
brj-24403	437	9	,	,	PUNCT
brj-24403	437	10	li	li	PROPN
brj-24403	437	11	,	,	PUNCT
brj-24403	437	12	y.	y.	PROPN
brj-24403	437	13	,	,	PUNCT
brj-24403	437	14	wang	wang	PROPN
brj-24403	437	15	,	,	PUNCT
brj-24403	437	16	y.	y.	PROPN
brj-24403	437	17	,	,	PUNCT
brj-24403	437	18	shi	shi	PROPN
brj-24403	437	19	,	,	PUNCT
brj-24403	437	20	t.	t.	PROPN
brj-24403	437	21	,	,	PUNCT
brj-24403	437	22	and	and	CCONJ
brj-24403	437	23	wang	wang	PROPN
brj-24403	437	24	,	,	PUNCT
brj-24403	437	25	b.	b.	PROPN
brj-24403	437	26	(	(	PUNCT
brj-24403	437	27	2024	2024	NUM
brj-24403	437	28	)	)	PUNCT
brj-24403	437	29	.	.	PUNCT
brj-24403	438	1	“	"	PUNCT
brj-24403	438	2	penicillium	penicillium	NOUN
brj-24403	438	3	janthinellum	janthinellum	NOUN
brj-24403	438	4	:	:	PUNCT
brj-24403	438	5	a	a	DET
brj-24403	438	6	potential	potential	ADJ
brj-24403	438	7	producer	producer	NOUN
brj-24403	438	8	of	of	ADP
brj-24403	438	9	natural	natural	ADJ
brj-24403	438	10	products	product	NOUN
brj-24403	438	11	,	,	PUNCT
brj-24403	438	12	”	"	PUNCT
brj-24403	438	13	fermentation	fermentation	NOUN
brj-24403	438	14	10(3	10(3	NUM
brj-24403	438	15	)	)	PUNCT
brj-24403	438	16	,	,	PUNCT
brj-24403	438	17	article	article	NOUN
brj-24403	438	18	157	157	NUM
brj-24403	438	19	.	.	PUNCT
brj-24403	439	1	doi	doi	NOUN
brj-24403	439	2	:	:	PUNCT
brj-24403	439	3	10.3390	10.3390	NUM
brj-24403	439	4	/	/	SYM
brj-24403	439	5	fermentation10030157	fermentation10030157	PROPN
brj-24403	439	6	wang	wang	PROPN
brj-24403	439	7	,	,	PUNCT
brj-24403	439	8	l.	l.	PROPN
brj-24403	439	9	,	,	PUNCT
brj-24403	439	10	ding	ding	PROPN
brj-24403	439	11	,	,	PUNCT
brj-24403	439	12	l.	l.	PROPN
brj-24403	439	13	,	,	PUNCT
brj-24403	439	14	wang	wang	PROPN
brj-24403	439	15	,	,	PUNCT
brj-24403	439	16	y.	y.	PROPN
brj-24403	439	17	,	,	PUNCT
brj-24403	439	18	zhang	zhang	PROPN
brj-24403	439	19	,	,	PUNCT
brj-24403	439	20	l.	l.	PROPN
brj-24403	439	21	,	,	PUNCT
brj-24403	439	22	and	and	CCONJ
brj-24403	439	23	zhang	zhang	PROPN
brj-24403	439	24	,	,	PUNCT
brj-24403	439	25	y.	y.	PROPN
brj-24403	439	26	(	(	PUNCT
brj-24403	439	27	2018	2018	NUM
brj-24403	439	28	)	)	PUNCT
brj-24403	439	29	.	.	PUNCT
brj-24403	440	1	“	"	PUNCT
brj-24403	440	2	chemical	chemical	ADJ
brj-24403	440	3	constituents	constituent	NOUN
brj-24403	440	4	from	from	ADP
brj-24403	440	5	callicarpa	callicarpa	ADJ
brj-24403	440	6	species	specie	NOUN
brj-24403	440	7	and	and	CCONJ
brj-24403	440	8	their	their	PRON
brj-24403	440	9	biological	biological	ADJ
brj-24403	440	10	activities	activity	NOUN
brj-24403	440	11	,	,	PUNCT
brj-24403	440	12	”	"	PUNCT
brj-24403	440	13	phytochemistry	phytochemistry	NOUN
brj-24403	440	14	reviews	review	NOUN
brj-24403	440	15	17	17	NUM
brj-24403	440	16	,	,	PUNCT
brj-24403	440	17	59	59	NUM
brj-24403	440	18	-	-	SYM
brj-24403	440	19	84	84	NUM
brj-24403	440	20	.	.	PUNCT
brj-24403	441	1	doi	doi	NOUN
brj-24403	441	2	:	:	PUNCT
brj-24403	441	3	10.1007	10.1007	NUM
brj-24403	441	4	/	/	SYM
brj-24403	441	5	s11101	s11101	NOUN
brj-24403	441	6	-	-	PUNCT
brj-24403	441	7	017	017	NUM
brj-24403	441	8	-	-	PUNCT
brj-24403	441	9	9508	9508	NUM
brj-24403	441	10	-	-	SYM
brj-24403	441	11	0	0	NUM
brj-24403	441	12	yang	yang	PROPN
brj-24403	441	13	,	,	PUNCT
brj-24403	441	14	y.	y.	PROPN
brj-24403	441	15	,	,	PUNCT
brj-24403	441	16	li	li	PROPN
brj-24403	441	17	,	,	PUNCT
brj-24403	441	18	z.	z.	PROPN
brj-24403	441	19	y.	y.	PROPN
brj-24403	441	20	,	,	PUNCT
brj-24403	441	21	shao	shao	PROPN
brj-24403	441	22	,	,	PUNCT
brj-24403	441	23	j.	j.	PROPN
brj-24403	441	24	j.	j.	PROPN
brj-24403	441	25	,	,	PUNCT
brj-24403	441	26	wang	wang	PROPN
brj-24403	441	27	,	,	PUNCT
brj-24403	441	28	g.	g.	PROPN
brj-24403	441	29	,	,	PUNCT
brj-24403	441	30	wen	wen	PROPN
brj-24403	441	31	,	,	PUNCT
brj-24403	441	32	r.	r.	PROPN
brj-24403	441	33	,	,	PUNCT
brj-24403	441	34	tian	tian	PROPN
brj-24403	441	35	,	,	PUNCT
brj-24403	441	36	j.	j.	PROPN
brj-24403	441	37	z.	z.	PROPN
brj-24403	441	38	,	,	PUNCT
brj-24403	441	39	and	and	CCONJ
brj-24403	441	40	hou	hou	NOUN
brj-24403	441	41	,	,	PUNCT
brj-24403	441	42	l.	l.	PROPN
brj-24403	441	43	(	(	PUNCT
brj-24403	441	44	2021	2021	NUM
brj-24403	441	45	)	)	PUNCT
brj-24403	441	46	.	.	PUNCT
brj-24403	442	1	“	"	PUNCT
brj-24403	442	2	callicarpa	callicarpa	VERB
brj-24403	442	3	nudiflora	nudiflora	PROPN
brj-24403	442	4	hook	hook	NOUN
brj-24403	442	5	.	.	PUNCT
brj-24403	443	1	and	and	CCONJ
brj-24403	443	2	arn	arn	VERB
brj-24403	443	3	.	.	PUNCT
brj-24403	443	4	:	:	PUNCT
brj-24403	444	1	a	a	DET
brj-24403	444	2	comprehensive	comprehensive	ADJ
brj-24403	444	3	review	review	NOUN
brj-24403	444	4	of	of	ADP
brj-24403	444	5	its	its	PRON
brj-24403	444	6	phytochemistry	phytochemistry	NOUN
brj-24403	444	7	and	and	CCONJ
brj-24403	444	8	pharmacology	pharmacology	NOUN
brj-24403	444	9	,	,	PUNCT
brj-24403	444	10	”	"	PUNCT
brj-24403	444	11	journal	journal	NOUN
brj-24403	444	12	of	of	ADP
brj-24403	444	13	ethnopharmacology	ethnopharmacology	NOUN
brj-24403	444	14	264	264	NUM
brj-24403	444	15	,	,	PUNCT
brj-24403	444	16	article	article	NOUN
brj-24403	444	17	113123	113123	NUM
brj-24403	444	18	.	.	PUNCT
brj-24403	445	1	doi	doi	NOUN
brj-24403	445	2	:	:	PUNCT
brj-24403	445	3	10.1016	10.1016	NUM
brj-24403	445	4	/	/	SYM
brj-24403	445	5	j.jep.2020.113123	j.jep.2020.113123	PROPN
brj-24403	445	6	zavvari	zavvari	X
brj-24403	445	7	,	,	PUNCT
brj-24403	445	8	f.	f.	PROPN
brj-24403	445	9	,	,	PUNCT
brj-24403	445	10	azhdari	azhdari	PROPN
brj-24403	445	11	-	-	PUNCT
brj-24403	445	12	zarmehri	zarmehri	PROPN
brj-24403	445	13	,	,	PUNCT
brj-24403	445	14	h.	h.	PROPN
brj-24403	445	15	,	,	PUNCT
brj-24403	445	16	anvari	anvari	ADJ
brj-24403	445	17	,	,	PUNCT
brj-24403	445	18	m.	m.	NOUN
brj-24403	445	19	,	,	PUNCT
brj-24403	445	20	rashidy	rashidy	ADJ
brj-24403	445	21	-	-	PUNCT
brj-24403	445	22	pour	pour	NOUN
brj-24403	445	23	,	,	PUNCT
brj-24403	445	24	a.	a.	NOUN
brj-24403	445	25	,	,	PUNCT
brj-24403	445	26	and	and	CCONJ
brj-24403	445	27	vafaei	vafaei	NOUN
brj-24403	445	28	,	,	PUNCT
brj-24403	445	29	a.	a.	NOUN
brj-24403	445	30	a.	a.	NOUN
brj-24403	445	31	(	(	PUNCT
brj-24403	445	32	2018	2018	NUM
brj-24403	445	33	)	)	PUNCT
brj-24403	445	34	.	.	PUNCT
brj-24403	446	1	“	"	PUNCT
brj-24403	446	2	neuroprotective	neuroprotective	ADJ
brj-24403	446	3	effects	effect	NOUN
brj-24403	446	4	of	of	ADP
brj-24403	446	5	phytosterols	phytosterol	NOUN
brj-24403	446	6	in	in	ADP
brj-24403	446	7	neurological	neurological	ADJ
brj-24403	446	8	diseases	disease	NOUN
brj-24403	446	9	:	:	PUNCT
brj-24403	446	10	a	a	DET
brj-24403	446	11	review	review	NOUN
brj-24403	446	12	of	of	ADP
brj-24403	446	13	molecular	molecular	ADJ
brj-24403	446	14	mechanisms	mechanism	NOUN
brj-24403	446	15	,	,	PUNCT
brj-24403	446	16	”	"	PUNCT
brj-24403	446	17	neurochemistry	neurochemistry	NOUN
brj-24403	446	18	international	international	ADJ
brj-24403	446	19	120	120	NUM
brj-24403	446	20	,	,	PUNCT
brj-24403	446	21	104	104	NUM
brj-24403	446	22	-	-	SYM
brj-24403	446	23	117	117	NUM
brj-24403	446	24	.	.	PUNCT
brj-24403	447	1	doi	doi	NOUN
brj-24403	447	2	:	:	PUNCT
brj-24403	447	3	10.1016	10.1016	NUM
brj-24403	447	4	/	/	SYM
brj-24403	447	5	j.neuint.2018.08.009	j.neuint.2018.08.009	PROPN
brj-24403	447	6	zhang	zhang	PROPN
brj-24403	447	7	,	,	PUNCT
brj-24403	447	8	t.	t.	PROPN
brj-24403	447	9	l.	l.	PROPN
brj-24403	447	10	,	,	PUNCT
brj-24403	447	11	yi	yi	PROPN
brj-24403	447	12	,	,	PUNCT
brj-24403	447	13	q.	q.	PROPN
brj-24403	447	14	q.	q.	PROPN
brj-24403	447	15	,	,	PUNCT
brj-24403	447	16	han	han	PROPN
brj-24403	447	17	,	,	PUNCT
brj-24403	447	18	y.	y.	PROPN
brj-24403	447	19	x.	x.	PROPN
brj-24403	447	20	,	,	PUNCT
brj-24403	447	21	zhao	zhao	PROPN
brj-24403	447	22	,	,	PUNCT
brj-24403	447	23	l.	l.	PROPN
brj-24403	447	24	,	,	PUNCT
brj-24403	447	25	gui	gui	PROPN
brj-24403	447	26	,	,	PUNCT
brj-24403	447	27	s.	s.	PROPN
brj-24403	447	28	q.	q.	PROPN
brj-24403	447	29	,	,	PUNCT
brj-24403	447	30	liu	liu	PROPN
brj-24403	447	31	,	,	PUNCT
brj-24403	447	32	w.	w.	PROPN
brj-24403	447	33	x.	x.	PROPN
brj-24403	447	34	,	,	PUNCT
brj-24403	447	35	and	and	CCONJ
brj-24403	447	36	wang	wang	PROPN
brj-24403	447	37	,	,	PUNCT
brj-24403	447	38	h.	h.	PROPN
brj-24403	447	39	g.	g.	PROPN
brj-24403	447	40	(	(	PUNCT
brj-24403	447	41	2023	2023	NUM
brj-24403	447	42	)	)	PUNCT
brj-24403	447	43	.	.	PUNCT
brj-24403	448	1	“	"	PUNCT
brj-24403	448	2	chemical	chemical	ADJ
brj-24403	448	3	constituents	constituent	NOUN
brj-24403	448	4	from	from	ADP
brj-24403	448	5	the	the	DET
brj-24403	448	6	leaves	leave	NOUN
brj-24403	448	7	of	of	ADP
brj-24403	448	8	callicarpa	callicarpa	PROPN
brj-24403	448	9	arborea	arborea	PROPN
brj-24403	448	10	roxb	roxb	PROPN
brj-24403	448	11	.	.	PUNCT
brj-24403	449	1	and	and	CCONJ
brj-24403	449	2	their	their	PRON
brj-24403	449	3	chemotaxonomic	chemotaxonomic	ADJ
brj-24403	449	4	significance	significance	NOUN
brj-24403	449	5	,	,	PUNCT
brj-24403	449	6	”	"	PUNCT
brj-24403	449	7	biochemical	biochemical	ADJ
brj-24403	449	8	systematics	systematic	NOUN
brj-24403	449	9	and	and	CCONJ
brj-24403	449	10	ecology	ecology	NOUN
brj-24403	449	11	110	110	NUM
brj-24403	449	12	,	,	PUNCT
brj-24403	449	13	article	article	NOUN
brj-24403	449	14	104683	104683	NUM
brj-24403	449	15	.	.	PUNCT
brj-24403	450	1	doi	doi	NOUN
brj-24403	450	2	:	:	PUNCT
brj-24403	450	3	10.1016	10.1016	NUM
brj-24403	450	4	/	/	SYM
brj-24403	450	5	j.bse.2023.104683	j.bse.2023.104683	PROPN
brj-24403	450	6	zhao	zhao	PROPN
brj-24403	450	7	,	,	PUNCT
brj-24403	450	8	l.	l.	PROPN
brj-24403	450	9	,	,	PUNCT
brj-24403	450	10	xu	xu	PROPN
brj-24403	450	11	,	,	PUNCT
brj-24403	450	12	f.	f.	PROPN
brj-24403	450	13	,	,	PUNCT
brj-24403	450	14	yi	yi	PROPN
brj-24403	450	15	,	,	PUNCT
brj-24403	450	16	q.	q.	PROPN
brj-24403	450	17	q.	q.	PROPN
brj-24403	450	18	,	,	PUNCT
brj-24403	450	19	zhang	zhang	PROPN
brj-24403	450	20	,	,	PUNCT
brj-24403	450	21	t.	t.	PROPN
brj-24403	450	22	l.	l.	PROPN
brj-24403	450	23	,	,	PUNCT
brj-24403	450	24	and	and	CCONJ
brj-24403	450	25	wang	wang	PROPN
brj-24403	450	26	,	,	PUNCT
brj-24403	450	27	h.	h.	PROPN
brj-24403	450	28	g.	g.	PROPN
brj-24403	450	29	(	(	PUNCT
brj-24403	450	30	2021	2021	NUM
brj-24403	450	31	)	)	PUNCT
brj-24403	450	32	.	.	PUNCT
brj-24403	451	1	“	"	PUNCT
brj-24403	451	2	chemical	chemical	ADJ
brj-24403	451	3	constituents	constituent	NOUN
brj-24403	451	4	from	from	ADP
brj-24403	451	5	callicarpa	callicarpa	NOUN
brj-24403	451	6	longifolia	longifolia	NOUN
brj-24403	451	7	and	and	CCONJ
brj-24403	451	8	their	their	PRON
brj-24403	451	9	anti	anti	ADJ
brj-24403	451	10	-	-	ADJ
brj-24403	451	11	inflammatory	inflammatory	ADJ
brj-24403	451	12	activity	activity	NOUN
brj-24403	451	13	,	,	PUNCT
brj-24403	451	14	”	"	PUNCT
brj-24403	451	15	tianran	tianran	VERB
brj-24403	451	16	chanwu	chanwu	PROPN
brj-24403	451	17	yanjiu	yanjiu	PROPN
brj-24403	451	18	yu	yu	PROPN
brj-24403	451	19	kaifa	kaifa	PROPN
brj-24403	451	20	33(12	33(12	PROPN
brj-24403	451	21	)	)	PUNCT
brj-24403	451	22	.	.	PUNCT
brj-24403	452	1	doi	doi	NOUN
brj-24403	452	2	:	:	PUNCT
brj-24403	452	3	10.16333	10.16333	NUM
brj-24403	452	4	/	/	SYM
brj-24403	452	5	j.1001	j.1001	NOUN
brj-24403	452	6	-	-	PUNCT
brj-24403	452	7	6880.2021.12.006	6880.2021.12.006	PROPN
brj-24403	452	8	peer	peer	NOUN
brj-24403	452	9	-	-	PUNCT
brj-24403	452	10	reviewed	review	VERB
brj-24403	452	11	article	article	NOUN
brj-24403	452	12	bioresources.cnr.ncsu.edu	bioresources.cnr.ncsu.edu	ADP
brj-24403	452	13	li	li	PROPN
brj-24403	452	14	et	et	PROPN
brj-24403	452	15	al	al	PROPN
brj-24403	452	16	.	.	PROPN
brj-24403	453	1	(	(	PUNCT
brj-24403	453	2	2025	2025	NUM
brj-24403	453	3	)	)	PUNCT
brj-24403	453	4	.	.	PUNCT
brj-24403	454	1	“	"	PUNCT
brj-24403	454	2	herbal	herbal	ADJ
brj-24403	454	3	anti	anti	ADJ
brj-24403	454	4	-	-	ADJ
brj-24403	454	5	epileptic	epileptic	ADJ
brj-24403	454	6	extract	extract	NOUN
brj-24403	454	7	,	,	PUNCT
brj-24403	454	8	”	"	PUNCT
brj-24403	454	9	bioresources	bioresource	NOUN
brj-24403	454	10	20(2	20(2	NUM
brj-24403	454	11	)	)	PUNCT
brj-24403	454	12	,	,	PUNCT
brj-24403	454	13	4701	4701	NUM
brj-24403	454	14	-	-	SYM
brj-24403	454	15	4719	4719	NUM
brj-24403	454	16	.	.	PUNCT
brj-24403	455	1	4719	4719	NUM
brj-24403	455	2	zheng	zheng	PROPN
brj-24403	455	3	,	,	PUNCT
brj-24403	455	4	j.	j.	PROPN
brj-24403	455	5	n.	n.	PROPN
brj-24403	455	6	,	,	PUNCT
brj-24403	455	7	zhuo	zhuo	PROPN
brj-24403	455	8	,	,	PUNCT
brj-24403	455	9	j.	j.	PROPN
brj-24403	455	10	y.	y.	PROPN
brj-24403	455	11	,	,	PUNCT
brj-24403	455	12	nie	nie	PROPN
brj-24403	455	13	,	,	PUNCT
brj-24403	455	14	j.	j.	PROPN
brj-24403	455	15	,	,	PUNCT
brj-24403	455	16	liu	liu	PROPN
brj-24403	455	17	,	,	PUNCT
brj-24403	455	18	y.	y.	PROPN
brj-24403	455	19	l.	l.	PROPN
brj-24403	455	20	,	,	PUNCT
brj-24403	455	21	chen	chen	PROPN
brj-24403	455	22	,	,	PUNCT
brj-24403	455	23	b.	b.	PROPN
brj-24403	455	24	y.	y.	PROPN
brj-24403	455	25	,	,	PUNCT
brj-24403	455	26	wu	wu	PROPN
brj-24403	455	27	,	,	PUNCT
brj-24403	455	28	a.	a.	PROPN
brj-24403	455	29	z.	z.	PROPN
brj-24403	455	30	,	,	PUNCT
brj-24403	455	31	and	and	CCONJ
brj-24403	455	32	li	li	PROPN
brj-24403	455	33	,	,	PUNCT
brj-24403	455	34	y.	y.	PROPN
brj-24403	455	35	c.	c.	PROPN
brj-24403	455	36	(	(	PUNCT
brj-24403	455	37	2021	2021	NUM
brj-24403	455	38	)	)	PUNCT
brj-24403	455	39	.	.	PUNCT
brj-24403	456	1	“	"	PUNCT
brj-24403	456	2	phenylethanoid	phenylethanoid	ADJ
brj-24403	456	3	glycosides	glycoside	NOUN
brj-24403	456	4	from	from	ADP
brj-24403	456	5	callicarpa	callicarpa	PROPN
brj-24403	456	6	kwangtungensis	kwangtungensis	PROPN
brj-24403	456	7	chun	chun	PROPN
brj-24403	456	8	attenuate	attenuate	VERB
brj-24403	456	9	tnf	tnf	PROPN
brj-24403	456	10	-	-	PUNCT
brj-24403	456	11	α	α	ADV
brj-24403	456	12	-	-	PUNCT
brj-24403	456	13	induced	induce	VERB
brj-24403	456	14	cell	cell	NOUN
brj-24403	456	15	damage	damage	NOUN
brj-24403	456	16	by	by	ADP
brj-24403	456	17	inhibiting	inhibit	VERB
brj-24403	456	18	nf	nf	NOUN
brj-24403	456	19	-	-	PUNCT
brj-24403	456	20	κb	κb	NOUN
brj-24403	456	21	pathway	pathway	NOUN
brj-24403	456	22	and	and	CCONJ
brj-24403	456	23	enhancing	enhance	VERB
brj-24403	456	24	nrf2	nrf2	NOUN
brj-24403	456	25	pathway	pathway	NOUN
brj-24403	456	26	in	in	ADP
brj-24403	456	27	a549	a549	PROPN
brj-24403	456	28	cells	cell	NOUN
brj-24403	456	29	,	,	PUNCT
brj-24403	456	30	”	"	PUNCT
brj-24403	456	31	frontiers	frontier	NOUN
brj-24403	456	32	in	in	ADP
brj-24403	456	33	pharmacology	pharmacology	NOUN
brj-24403	456	34	12	12	NUM
brj-24403	456	35	,	,	PUNCT
brj-24403	456	36	article	article	NOUN
brj-24403	456	37	693983	693983	NUM
brj-24403	456	38	.	.	PUNCT
brj-24403	457	1	doi	doi	NOUN
brj-24403	457	2	:	:	PUNCT
brj-24403	457	3	10.3389	10.3389	NUM
brj-24403	457	4	/	/	SYM
brj-24403	457	5	fphar.2021.693983	fphar.2021.693983	ADJ
brj-24403	457	6	article	article	NOUN
brj-24403	457	7	submitted	submit	VERB
brj-24403	457	8	:	:	PUNCT
brj-24403	457	9	january	january	PROPN
brj-24403	457	10	18	18	NUM
brj-24403	457	11	,	,	PUNCT
brj-24403	457	12	2025	2025	NUM
brj-24403	457	13	;	;	PUNCT
brj-24403	457	14	peer	peer	NOUN
brj-24403	457	15	review	review	NOUN
brj-24403	457	16	completed	complete	VERB
brj-24403	457	17	:	:	PUNCT
brj-24403	457	18	feb	feb	PROPN
brj-24403	457	19	.	.	PROPN
brj-24403	457	20	22	22	NUM
brj-24403	457	21	,	,	PUNCT
brj-24403	457	22	2025	2025	NUM
brj-24403	457	23	;	;	PUNCT
brj-24403	457	24	revised	revise	VERB
brj-24403	457	25	version	version	NOUN
brj-24403	457	26	received	receive	VERB
brj-24403	457	27	:	:	PUNCT
brj-24403	457	28	march	march	PROPN
brj-24403	457	29	29	29	NUM
brj-24403	457	30	,	,	PUNCT
brj-24403	457	31	2025	2025	NUM
brj-24403	457	32	;	;	PUNCT
brj-24403	457	33	accepted	accept	VERB
brj-24403	457	34	:	:	PUNCT
brj-24403	457	35	april	april	PROPN
brj-24403	457	36	10	10	NUM
brj-24403	457	37	,	,	PUNCT
brj-24403	457	38	2025	2025	NUM
brj-24403	457	39	;	;	PUNCT
brj-24403	457	40	published	publish	VERB
brj-24403	457	41	:	:	PUNCT
brj-24403	457	42	may	may	AUX
brj-24403	457	43	1	1	NUM
brj-24403	457	44	,	,	PUNCT
brj-24403	457	45	2025	2025	NUM
brj-24403	457	46	,	,	PUNCT
brj-24403	457	47	doi	doi	NOUN
brj-24403	457	48	:	:	PUNCT
brj-24403	457	49	10.15376	10.15376	NUM
brj-24403	457	50	/	/	SYM
brj-24403	457	51	biores.20.2.4701	biores.20.2.4701	NOUN
brj-24403	457	52	-	-	PUNCT
brj-24403	457	53	4719	4719	NUM